Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABCB6 "EST45597, MTABC3, umat" ENSG00000115657 "ATP binding cassette subfamily B member 6 (Langereis blood group)" Q9NP58 2 219209772-219218994 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport Translocase "Disease variant, Dyskeratosis congenita, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Astrocytes: 14.7;Excitatory neurons: 12.9;Gastric mucus-secreting cells: 5.1;Inhibitory neurons: 10.9;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 5.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 65.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046723, HPA058011" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol" "Intracellular and membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "Nucleoplasm, Plasma membrane, Mitochondria, Cytosol" "HPA046723: AB_10960288, HPA058011: AB_2683578" "unprognostic (8.04e-2)" "unprognostic (3.22e-2)" "unprognostic (4.53e-3)" "unprognostic (3.19e-2)" "unprognostic (2.55e-1)" "unprognostic (9.11e-2)" "prognostic unfavorable (9.45e-7)" "unprognostic (2.26e-1)" "unprognostic (3.62e-2)" "unprognostic (1.53e-1)" "unprognostic (1.18e-4)" "unprognostic (3.02e-3)" "prognostic unfavorable (1.52e-7)" "unprognostic (1.51e-1)" "unprognostic (9.55e-2)" "unprognostic (7.75e-2)" "unprognostic (2.30e-1)" 10.2 8.7 4.3 3.4 3.9 10.4 7.6 3.2 4.6 7.7 4.4 6.5 6.9 8.4 8.2 11.4 9.6 7.1 8.5 4.0 5.1 5.2 15.9 5.9 1.9 4.4 4.2 12.9 5.7 4.8 6.0 3.1 6.2 8.0 3.3 3.0 6.2 8.6 30.4 6.8 6.3 7.9 4.1 3.9 7.9 18.0 5.7 2.6 10.7 9.8 2.9 14.9 7.9 5.0 0.3 22.9 4.7 28.8 30.8 11.1 27.6 8.5 7.9 9.2 9.2 35.5 5.0 0.3 42.8 8.6 5.0 49.1 0.6 3.6 3.0 15.0 4.7 36.3 24.9 65.8 37.0 0.0 12.0 16.3 4.2 6.2 0.1 13.9 16.3 4.8 31.4 4.4 6.3 12.0 2.3 0.1 7.2 53.6 9.2 12.3 14.3 1.6 5.1 0.4 16.6 17.8 17.6 41.4 18.7 17.4 12.4 0.8 7.5 12.5 0.5 16.9 10.3 11.2 9.6 0.1 14.0 0.4 17.0 0.7 0.4 0.0 0.7 0.4 0.2 1.0 0.5 0.2 0.3 0.8 1.2 0.8 0.0 0.4 0.3 2.3 0.5 1.0 4.3 3.9 3.2 4.6 4.0 5.1 4.4 4.2 6.2 4.1 5.7 5.0 0.2 0.0 0.0 14.7 0.3 0.3 0.0 0.5 1.2 1.0 0.2 0.0 0.2 0.0 1.3 0.0 0.0 0.2 0.2 0.1 0.0 0.8 1.2 0.3 0.6 0.4 0.0 1.3 12.9 0.0 0.1 0.7 5.1 0.2 0.0 0.5 0.0 0.4 0.1 0.0 10.9 0.3 0.0 0.3 0.4 1.0 0.3 0.3 0.0 3.7 0.0 0.3 0.0 13.6 5.6 0.3 0.0 0.4 0.5 0.0 0.5 0.2 2.2 0.8 0.0 0.4 0.3 1.0 0.3 2.8 0.3 0.3 0.1 0.4 0.2 0.1 AFP "FETA, HPAFP" ENSG00000081051 "Alpha fetoprotein" P02771 4 73431138-73456174 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "liver: 3.7" "Group enriched" "Detected in some" 10 "Hepatocytes: 107.5;Proximal tubular cells: 101.6" "Cancer enriched" "Detected in some" 4 "liver cancer: 208.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 192 "Hep G2: 2165.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA010607, HPA023600, CAB024283, CAB025339" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 3010000 150000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" Cytosol "CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769" "unprognostic (4.69e-1)" "unprognostic (1.87e-1)" "unprognostic (3.34e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-3)" "unprognostic (2.95e-2)" "unprognostic (3.35e-1)" "unprognostic (1.54e-1)" "unprognostic (3.81e-2)" "unprognostic (1.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.63e-6)" "unprognostic (1.98e-2)" "unprognostic (5.80e-2)" "unprognostic (1.14e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2165.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 9.7 5.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 7.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 2.7 2.8 0.3 0.0 0.1 0.0 0.1 2.5 107.5 2.3 0.0 0.1 0.1 0.0 3.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 101.6 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 1.5 0.2 0.1 0.2 0.0 AIG1 "AIG-1, dJ95L4.1, FLJ10485" ENSG00000146416 "Androgen induced 1" Q9NVV5 6 143060496-143341058 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 235.8" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 245.4;Proximal tubular cells: 261.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060766 Approved Approved "Golgi apparatus" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 15: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA060766: AB_2684356" "unprognostic (2.70e-2)" "prognostic unfavorable (3.26e-6)" "unprognostic (4.27e-2)" "prognostic unfavorable (3.06e-4)" "unprognostic (5.34e-2)" "prognostic unfavorable (3.25e-7)" "unprognostic (1.91e-2)" "unprognostic (8.75e-3)" "unprognostic (2.17e-1)" "unprognostic (5.53e-2)" "unprognostic (2.75e-1)" "unprognostic (1.93e-1)" "unprognostic (2.74e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (9.11e-2)" "unprognostic (2.75e-1)" 42.0 29.8 43.7 10.4 44.6 31.6 30.0 43.3 46.1 17.6 48.2 23.0 46.6 14.4 33.0 34.1 34.4 24.5 54.1 44.1 49.1 102.0 235.8 19.9 10.7 45.0 43.4 34.7 31.0 31.0 36.6 11.9 46.4 22.7 18.8 33.9 19.8 24.1 23.7 16.8 45.9 15.2 47.1 20.1 20.8 15.7 51.0 6.8 42.9 32.5 14.8 29.4 26.1 52.5 32.6 25.2 20.6 56.9 29.7 22.3 7.6 28.3 57.1 26.8 61.9 37.5 81.5 20.0 40.5 66.1 41.7 42.0 26.5 79.2 64.2 67.2 63.0 5.6 35.6 157.3 40.8 46.0 2.7 32.9 76.7 35.7 129.6 88.2 10.9 30.8 4.0 67.6 59.3 45.6 14.2 9.8 40.8 37.4 27.6 20.2 61.6 36.6 100.6 77.6 75.5 42.4 35.5 33.2 17.2 36.0 31.7 96.0 3.0 25.2 27.8 22.7 33.4 99.6 95.1 2.1 59.7 9.5 26.9 12.0 6.2 9.6 6.6 29.3 15.1 9.6 12.4 10.6 33.0 5.6 13.1 10.0 11.3 11.8 35.4 2.9 9.7 9.2 43.7 44.6 43.3 46.1 44.1 49.1 45.0 43.4 46.4 47.1 51.0 52.5 40.8 16.0 27.7 114.9 22.0 25.0 51.8 82.5 27.9 68.3 69.9 65.4 73.7 72.9 66.9 51.5 25.0 79.6 8.6 12.6 52.8 60.3 22.4 99.8 25.9 32.8 39.5 29.3 204.3 31.5 10.5 42.2 26.0 83.1 36.8 90.9 36.8 229.6 32.7 53.8 245.4 33.3 59.0 40.1 42.3 7.0 32.0 37.2 55.2 100.2 18.2 74.3 8.2 105.1 172.9 25.8 65.2 38.4 47.7 35.3 232.9 261.5 69.1 36.9 32.9 41.7 50.8 5.6 17.3 53.1 45.7 108.1 18.5 61.5 42.4 53.2 AL132671.2 ENSG00000282218 "Novel protein, GOPC-ROS1 readthrough" 6 117318211-117573571 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "Alveolar cells type 2: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 36 "U-138 MG: 8.9" "Low region specificity" "Detected in all" HPA019477 Uncertain Approved "Golgi apparatus" NA NA "Cluster 10: BJ & FHDF - ECM organization" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA019477: AB_1849890" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AMBP "EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI" ENSG00000106927 "Alpha-1-microglobulin/bikunin precursor" P02760 9 114060127-114078328 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "liver: 10947.9" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 10517.4" "Cancer enriched" "Detected in many" 115 "liver cancer: 2620.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 173 "Hep G2: 1398.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA001497, CAB069436, HPA075585" Approved Approved "Golgi apparatus,Vesicles,Cytosol" "Secreted to blood" NA NA 47000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" Vesicles "Golgi apparatus, Cytosol" "CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: " "unprognostic (6.92e-2)" "unprognostic (3.61e-1)" "unprognostic (4.95e-3)" "prognostic favorable (1.20e-4)" "unprognostic (9.79e-2)" "unprognostic (2.90e-1)" "unprognostic (1.04e-3)" "unprognostic (7.59e-2)" "unprognostic (2.83e-2)" "unprognostic (2.04e-1)" "unprognostic (2.14e-1)" "unprognostic (7.84e-2)" "unprognostic (4.36e-2)" "unprognostic (2.89e-3)" "unprognostic (4.66e-2)" "unprognostic (2.97e-3)" "unprognostic (9.45e-3)" 0.7 0.2 0.1 0.0 0.1 0.0 6.4 0.3 0.4 0.2 0.3 0.3 2.3 0.1 0.4 0.3 0.4 160.4 0.5 0.1 0.1 11.0 10947.9 0.3 0.0 0.1 0.1 0.2 125.3 0.0 0.2 0.4 0.1 0.2 0.5 0.2 0.1 0.0 0.2 0.3 0.7 0.0 0.1 3.1 2.6 1.0 0.1 0.1 0.4 0.0 0.2 0.1 0.2 0.0 0.0 6.7 0.1 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 1.8 0.0 1.8 2.1 0.2 0.9 0.5 0.0 0.0 0.0 3.2 0.0 3.0 1.0 1398.1 0.0 5.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.1 0.3 0.0 0.9 3.1 0.0 0.2 8.1 0.4 5.9 0.6 1.7 0.0 2.8 1.1 0.0 0.1 0.0 0.2 1.0 0.0 0.8 0.0 0.4 1.0 0.3 1.5 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.0 19.1 1.5 0.6 0.0 2.2 0.0 1.9 0.4 0.2 2585.0 0.6 1.8 0.0 0.1 0.0 0.6 3.9 216.5 30.4 0.2 0.1 10.0 2.4 219.2 0.1 28.2 0.8 0.1 0.0 1.0 0.0 0.0 181.3 10517.4 0.7 0.0 0.1 1.6 0.0 243.7 0.5 59.4 0.6 0.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 14.9 1.7 0.0 0.0 0.6 0.6 13.7 0.0 0.0 0.0 0.0 0.5 0.6 0.2 1.1 0.4 1.4 14.3 0.0 1.2 0.3 ANO9 "PIG5, TMEM16J, TP53I5" ENSG00000185101 "Anoctamin 9" A1A5B4 11 417933-442011 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.2;skin 1: 27.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 81.0;Intestinal goblet cells: 50.5;Paneth cells: 50.5;Proximal enterocytes: 87.7;Undifferentiated cells: 45.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 26.1" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 48 "B-cells: 2.1;NK-cells: 4.1;T-cells: 8.2" "Cell line enhanced" "Detected in some" "BEWO: 9.2;CAPAN-2: 29.5;HaCaT: 16.8;RPMI-8226: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039948, HPA040112" Approved Uncertain "Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA039948: AB_2676765, HPA040112: " "unprognostic (3.62e-3)" "unprognostic (2.83e-2)" "unprognostic (4.68e-2)" "unprognostic (1.62e-1)" "unprognostic (1.41e-2)" "unprognostic (8.93e-2)" "unprognostic (6.98e-2)" "unprognostic (8.94e-3)" "unprognostic (1.39e-1)" "unprognostic (2.28e-3)" "unprognostic (1.54e-1)" "unprognostic (7.94e-2)" "unprognostic (1.91e-2)" "unprognostic (1.18e-2)" "unprognostic (2.08e-1)" "unprognostic (3.92e-1)" "prognostic favorable (8.81e-4)" 0.7 0.1 0.0 7.0 0.0 2.2 1.7 0.0 0.0 1.1 0.2 16.0 34.2 0.5 7.0 6.3 1.2 2.0 0.1 0.0 0.0 3.7 0.3 2.9 12.0 0.0 0.0 0.1 6.5 0.7 1.3 0.1 0.0 2.9 9.1 0.0 3.0 0.7 0.0 27.8 30.0 0.8 0.0 4.7 7.0 0.2 0.0 9.0 2.4 0.1 8.7 2.4 3.4 0.0 2.7 0.6 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 3.1 29.5 1.9 1.4 0.0 0.1 16.8 0.0 7.0 0.0 2.1 0.0 0.0 0.6 5.1 0.0 0.4 0.0 0.0 5.6 0.0 1.2 0.1 0.0 4.5 0.1 1.9 0.0 3.8 0.5 0.1 0.0 6.0 0.0 0.1 0.0 20.6 5.1 4.4 1.6 0.0 0.3 7.3 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 5.5 2.1 6.5 3.3 0.0 0.8 3.7 2.8 0.0 4.1 0.0 0.0 8.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.7 0.3 9.1 5.2 4.6 15.3 6.2 0.0 5.5 3.9 2.4 8.6 9.1 3.7 0.0 0.3 3.0 81.0 0.0 10.5 0.8 4.9 1.0 0.8 15.5 0.0 0.3 6.5 3.7 0.6 29.0 11.0 0.0 0.0 0.7 0.3 0.4 0.0 0.2 50.5 14.2 0.3 1.9 0.1 0.0 1.2 3.6 0.0 1.3 0.0 0.0 0.0 0.0 9.0 50.5 0.0 5.0 2.7 87.7 3.7 9.2 0.0 0.0 0.1 1.0 0.2 0.2 7.0 6.3 0.1 12.8 0.0 45.2 5.7 APOH "B2G1, BG" ENSG00000091583 "Apolipoprotein H" P02749 17 66212033-66256525 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 563 "liver: 17965.3" "Cell type enriched" "Detected in some" 41 "Hepatocytes: 7680.6" "Cancer enriched" "Detected in many" 232 "liver cancer: 2878.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "Hep G2: 1253.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA001654, HPA003732, CAB022214" Enhanced Supported "Golgi apparatus" "Secreted to blood" NA NA 247000000000 41000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183" "unprognostic (2.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "prognostic favorable (2.39e-7)" "unprognostic (1.26e-1)" "unprognostic (5.99e-2)" "unprognostic (2.88e-3)" "prognostic unfavorable (1.10e-6)" "unprognostic (1.26e-2)" "unprognostic (5.76e-2)" 0.9 0.3 0.0 0.1 0.1 0.4 0.2 0.1 0.2 0.2 0.3 0.8 2.5 0.1 1.0 0.2 0.8 2.8 0.6 0.2 0.0 31.9 17965.3 5.6 0.3 0.2 0.1 0.2 10.9 0.0 0.2 0.4 0.1 0.2 0.7 0.2 0.1 0.3 0.1 0.2 1.0 0.0 0.1 4.3 3.8 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.0 33.5 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 60.8 0.0 1.4 0.1 0.0 1.7 1.1 0.0 0.0 0.0 0.4 0.0 2.6 1.4 1253.3 0.0 6.4 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.4 0.5 0.2 0.0 0.2 0.1 0.6 31.5 0.0 0.8 6.4 0.1 0.0 0.9 0.4 0.0 3.4 0.1 0.2 0.0 0.0 0.0 1.7 0.2 0.1 0.1 0.0 0.8 0.1 2.9 15.3 2.4 0.2 0.2 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.0 12.3 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 183.0 0.6 0.0 0.0 0.0 0.0 0.2 3.9 0.8 0.2 0.2 0.0 5.2 0.0 109.7 0.2 2.3 0.6 0.0 0.0 0.1 0.0 0.0 120.0 7680.6 0.5 0.0 0.2 0.4 0.0 182.4 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.8 0.0 0.0 0.0 0.4 25.6 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 8.8 0.0 0.8 0.0 ARFRP1 "ARL18, ARP, Arp1" ENSG00000101246 "ADP ribosylation factor related protein 1" Q13795 20 63698642-63708025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047028, HPA050634" Approved Supported "Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA047028: AB_2679908, HPA050634: AB_2681196" "unprognostic (6.33e-2)" "unprognostic (2.12e-2)" "unprognostic (1.95e-2)" "unprognostic (6.03e-2)" "unprognostic (1.19e-2)" "unprognostic (2.18e-1)" "unprognostic (1.36e-3)" "unprognostic (2.13e-2)" "unprognostic (9.70e-2)" "unprognostic (2.25e-2)" "unprognostic (3.22e-2)" "unprognostic (6.53e-2)" "unprognostic (5.58e-2)" "unprognostic (3.93e-2)" "unprognostic (1.72e-2)" "unprognostic (5.48e-2)" "unprognostic (3.39e-1)" 26.8 27.8 23.4 14.0 23.4 10.0 25.0 22.8 29.1 31.8 22.4 29.3 18.9 29.3 5.3 36.2 27.9 8.8 41.0 22.7 22.7 34.1 36.5 26.0 17.8 23.1 23.2 29.3 24.4 12.6 25.1 11.6 23.1 32.4 8.4 5.5 22.4 16.0 31.8 22.9 27.2 10.1 22.7 42.0 24.6 20.1 24.5 17.7 25.6 15.5 11.2 29.5 28.3 23.9 26.5 31.9 10.1 10.6 10.0 10.8 14.6 31.8 21.1 67.7 24.6 60.0 22.4 32.4 21.6 18.8 27.3 35.8 11.0 35.5 11.9 11.3 16.5 23.8 36.1 52.2 34.7 27.3 21.5 15.1 45.2 17.8 21.6 17.9 25.1 30.5 36.0 24.1 16.9 14.9 54.0 37.7 15.8 19.5 46.7 42.3 14.0 33.4 14.5 21.7 16.9 17.3 32.3 46.5 11.4 6.1 20.5 34.8 20.0 39.6 15.9 14.9 32.6 24.9 11.1 25.1 26.5 17.9 22.8 44.3 30.9 23.5 41.5 31.6 34.7 32.6 37.5 39.8 28.3 33.7 46.8 41.5 15.7 37.6 34.7 49.2 32.3 36.5 23.4 23.4 22.8 29.1 22.7 22.7 23.1 23.2 23.1 22.7 24.5 23.9 40.7 12.8 11.9 12.4 25.9 13.9 25.5 26.1 19.4 44.6 20.8 28.7 34.0 8.6 15.8 25.8 20.9 42.2 28.0 48.9 39.2 31.2 12.8 13.5 27.0 34.3 26.4 25.7 10.6 20.4 25.5 31.6 18.3 10.7 24.7 28.4 24.3 18.4 36.9 37.0 10.6 31.6 18.3 20.7 15.3 10.5 23.9 24.1 24.9 5.6 41.0 40.8 29.9 4.0 11.9 51.6 34.6 29.7 23.4 22.9 52.4 33.4 12.3 42.3 19.7 21.8 35.1 44.5 32.7 22.4 14.2 30.2 30.7 35.7 33.1 17.0 ARSI "FLJ16069, SPG66" ENSG00000183876 "Arylsulfatase family member I" Q5FYB1 5 150296343-150339307 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 12.1;Fibroblasts: 10.8;Melanocytes: 21.4;Smooth muscle cells: 6.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 15.7;HaCaT: 31.4;Hep G2: 19.9;hTEC/SVTERT24-B: 30.9;U-87 MG: 39.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA038386, HPA038398" Uncertain Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA038386: AB_10669781, HPA038398: AB_2675995" "unprognostic (6.08e-2)" "unprognostic (1.70e-2)" "unprognostic (9.41e-3)" "unprognostic (4.77e-3)" "unprognostic (1.54e-3)" "unprognostic (2.83e-3)" "unprognostic (2.76e-1)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.06e-1)" "unprognostic (5.81e-3)" "unprognostic (4.85e-2)" "unprognostic (1.26e-1)" "unprognostic (3.39e-7)" "unprognostic (7.18e-2)" "unprognostic (1.29e-1)" "unprognostic (3.64e-3)" "prognostic unfavorable (1.19e-4)" 1.2 0.3 1.6 2.3 2.6 0.6 0.4 2.5 2.1 2.7 0.7 1.6 0.6 3.1 0.6 1.8 2.1 1.1 1.3 1.4 1.8 0.7 0.4 4.5 0.3 3.6 2.4 0.4 0.4 0.6 1.0 2.8 3.9 1.7 0.4 0.4 0.5 0.8 0.8 4.8 0.7 2.8 2.6 0.8 0.8 0.4 2.8 0.3 0.2 0.5 0.4 3.8 2.7 5.5 1.0 3.8 1.1 0.0 0.0 0.8 0.0 8.1 12.1 15.7 11.5 1.1 1.8 0.0 3.1 11.5 1.3 31.4 0.2 5.3 5.6 0.0 0.1 0.0 0.4 19.9 1.5 0.0 0.0 0.8 3.4 30.9 0.9 10.7 0.2 0.0 0.0 0.2 2.5 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 0.1 0.4 0.0 0.2 0.0 6.7 0.9 1.3 11.2 0.0 0.0 0.0 0.3 10.2 0.3 0.0 0.0 0.0 0.0 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.6 2.5 2.1 1.4 1.8 3.6 2.4 3.9 2.6 2.8 5.5 0.1 0.0 0.0 0.3 0.0 12.1 0.0 2.4 0.0 0.1 0.1 0.4 1.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.0 0.0 0.1 0.0 1.1 10.8 0.0 0.0 4.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.1 0.0 0.8 0.2 0.6 0.0 21.4 0.0 0.0 3.9 0.0 0.0 2.5 0.4 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.3 0.0 1.8 6.6 0.1 0.9 0.9 4.7 1.4 1.1 0.0 0.0 0.0 ARSL "ARSE, CDPX, CDPX1" ENSG00000157399 "Arylsulfatase L" P51690 X 2934521-2968475 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 36.6;liver: 86.3;pancreas: 105.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "liver cancer: 34.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 68.9;CACO-2: 42.7;GAMG: 30.8;Hep G2: 64.1;NTERA-2: 33.6" "Low region specificity" "Detected in all" "HPA060518, HPA070651" Approved Supported "Golgi apparatus" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA060518: AB_2684301, HPA070651: AB_2732160" "unprognostic (2.07e-1)" "unprognostic (6.60e-3)" "prognostic favorable (8.95e-4)" "unprognostic (8.74e-3)" "unprognostic (1.14e-3)" "unprognostic (3.48e-2)" "unprognostic (2.38e-1)" "unprognostic (8.27e-2)" "unprognostic (5.45e-2)" "unprognostic (2.25e-1)" "unprognostic (2.27e-1)" "unprognostic (2.37e-1)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (1.28e-1)" "unprognostic (5.94e-2)" "unprognostic (4.76e-2)" 0.4 0.7 2.6 2.2 2.7 0.3 1.1 2.1 2.8 1.7 4.5 20.8 17.9 3.2 2.2 0.4 4.1 8.2 1.0 2.8 2.6 36.6 86.3 2.7 0.1 2.8 2.8 7.1 105.2 0.0 0.7 0.7 2.9 0.5 16.7 0.3 1.3 2.9 0.2 0.2 13.6 1.9 2.4 0.0 2.9 0.4 2.6 0.0 0.2 0.3 0.1 0.5 1.6 2.3 4.5 68.9 8.2 0.0 3.3 4.0 1.3 3.9 6.4 4.0 4.0 42.7 0.0 0.0 13.7 0.1 30.8 0.0 0.0 0.9 2.3 0.0 4.5 0.0 0.0 64.1 1.8 0.0 0.1 9.6 0.0 3.8 0.0 7.3 3.8 0.0 0.0 0.1 10.5 0.1 0.0 0.0 33.6 2.4 0.2 2.8 1.1 0.3 7.1 0.0 0.1 0.2 0.0 0.0 2.6 13.7 0.0 0.2 5.0 0.1 0.2 0.0 7.4 0.0 0.0 0.1 9.1 0.1 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.7 2.1 2.8 2.8 2.6 2.8 2.8 2.9 2.4 2.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ATAT1 "C6orf134, Em:AB023049.7, FLJ13158, MEC17" ENSG00000137343 "Alpha tubulin acetyltransferase 1" Q5SQI0 6 30626842-30646823 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 87.6;Late spermatids: 42.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 8.0;AN3-CA: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046816, HPA050999" Approved Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" No No "Cluster 46: Basophils - DNA binding" "Cluster 71: Testis - DNA repair" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Golgi apparatus, Cytosol" "HPA046816: AB_2679822, HPA050999: AB_2681303" "unprognostic (3.98e-1)" "unprognostic (3.18e-1)" "unprognostic (4.30e-2)" "unprognostic (2.67e-2)" "unprognostic (8.86e-2)" "unprognostic (8.18e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.49e-2)" "unprognostic (5.39e-2)" "unprognostic (2.37e-2)" "unprognostic (1.29e-3)" "unprognostic (1.25e-2)" "prognostic unfavorable (7.78e-5)" "unprognostic (2.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.02e-1)" "prognostic favorable (1.35e-4)" 5.3 6.0 2.3 0.6 2.9 0.6 7.6 1.8 3.3 12.4 0.9 8.6 0.5 9.7 3.6 7.6 9.8 0.7 5.5 2.6 3.3 11.3 7.6 5.8 0.6 2.3 2.7 13.4 6.0 0.2 21.3 0.4 2.5 13.5 0.6 2.5 7.7 0.3 4.9 6.6 7.8 0.7 1.9 5.6 7.4 13.5 2.5 0.7 9.3 0.0 0.7 9.2 8.4 3.1 1.4 0.7 8.0 5.3 0.9 0.7 0.6 0.3 0.0 0.2 0.4 2.3 1.4 0.1 1.1 1.1 2.2 1.5 2.5 0.9 0.0 1.0 4.2 0.1 0.1 2.6 0.4 0.5 1.1 1.4 0.5 0.3 0.0 1.0 0.5 3.8 1.5 0.0 1.3 1.5 1.0 0.3 0.4 2.2 0.0 1.0 0.1 0.4 1.3 2.4 0.3 3.2 0.6 0.6 0.4 0.0 2.9 0.4 1.0 3.0 1.3 0.0 0.5 0.9 2.5 0.8 1.6 3.4 2.1 0.5 0.4 0.3 0.1 0.3 0.1 0.5 0.2 0.1 0.4 0.2 0.4 0.4 0.3 0.1 0.2 0.5 0.1 0.1 2.3 2.9 1.8 3.3 2.6 3.3 2.3 2.7 2.5 1.9 2.5 3.1 6.2 0.0 1.5 14.7 6.4 5.6 14.0 16.9 14.2 9.0 9.4 11.4 1.9 5.7 8.6 14.7 10.4 11.9 4.1 7.6 7.9 11.9 87.6 9.0 7.7 7.9 18.0 3.0 7.8 4.5 6.3 6.9 8.2 8.0 1.3 16.0 3.3 2.9 6.1 1.7 11.4 8.9 14.2 1.6 3.1 42.4 4.1 3.1 0.0 5.6 9.1 12.5 6.2 16.6 13.1 9.3 10.8 8.6 4.1 11.6 9.7 5.4 10.8 10.7 6.6 8.0 7.8 12.4 11.8 8.0 5.4 8.9 4.7 6.1 11.1 15.3 ATP6V0A1 "a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1" ENSG00000033627 "ATPase H+ transporting V0 subunit a1" Q93050 17 42458844-42522582 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 130.7" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 294.0;Rod photoreceptor cells: 403.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022144 Enhanced Approved "Nuclear speckles,Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 58: Brain - Synaptic function" "Cluster 2: Karpas-707 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus, Vesicles" "Nuclear speckles, Cytosol" "HPA022144: AB_1845189" "unprognostic (3.93e-2)" "unprognostic (2.02e-1)" "unprognostic (4.35e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-2)" "unprognostic (8.69e-2)" "unprognostic (1.84e-2)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.05e-4)" "unprognostic (3.25e-1)" "prognostic favorable (1.28e-4)" "unprognostic (3.07e-1)" "unprognostic (3.68e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (6.90e-4)" 17.7 28.2 30.6 18.0 35.2 21.5 16.3 16.8 42.7 13.4 0.0 22.1 34.6 20.9 19.6 17.4 17.1 22.7 18.9 43.6 44.1 37.4 21.0 24.1 13.1 25.6 26.2 20.0 17.4 86.0 39.0 21.2 34.6 17.4 20.5 130.7 13.5 18.6 59.3 28.1 24.3 21.5 12.1 21.8 16.3 18.7 30.9 15.2 30.3 25.3 14.9 11.9 12.8 27.2 18.4 37.0 22.1 40.1 36.5 31.7 12.9 12.7 23.3 26.4 34.2 23.9 39.9 3.4 22.6 26.2 36.2 38.7 34.5 21.5 30.4 28.3 36.2 29.2 27.3 19.0 22.7 12.8 50.9 23.5 30.3 42.4 18.0 32.6 18.9 13.2 108.0 111.3 39.7 15.8 5.1 11.3 14.3 23.9 0.4 0.2 23.0 51.2 30.2 14.4 60.9 32.0 19.7 17.7 37.1 28.8 43.0 19.0 11.4 22.3 0.9 33.0 15.3 45.0 66.1 6.8 29.7 0.2 26.5 21.6 14.5 11.2 1.0 4.4 1.6 4.7 0.7 0.2 12.2 7.3 1.2 0.9 18.7 0.1 3.3 6.2 3.7 6.6 30.6 35.2 16.8 42.7 43.6 44.1 25.6 26.2 34.6 12.1 30.9 27.2 20.0 19.2 48.0 47.0 23.0 19.8 56.7 15.7 32.5 164.8 15.7 16.5 21.1 28.6 18.3 14.7 294.0 34.3 16.7 46.2 11.7 16.3 4.0 32.8 27.4 22.2 84.9 45.8 125.0 18.5 15.7 31.0 23.4 74.0 24.1 74.5 16.4 37.8 53.8 95.9 112.3 27.3 12.2 37.8 29.2 3.9 17.4 42.8 40.9 38.4 17.7 59.3 3.1 61.3 80.5 24.2 37.6 23.7 13.8 32.7 56.9 32.5 11.4 403.4 6.6 39.4 32.3 38.8 18.2 21.7 20.2 99.9 6.9 35.0 24.5 14.9 ATP7B WND ENSG00000123191 "ATPase copper transporting beta" P35670 13 51930436-52012125 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" Translocase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 22.9;Early spermatids: 30.2;Excitatory neurons: 24.5;Hepatocytes: 23.6;Inhibitory neurons: 25.4;Late spermatids: 74.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 32.8;CACO-2: 21.1;HEL: 53.0;RPTEC TERT1: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA009137, HPA013187" Supported Supported "Golgi apparatus" NA NA "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 36: HEL - Hemostasis" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA009137: AB_2668214, HPA013187: AB_1845206" "unprognostic (1.13e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (3.49e-1)" "unprognostic (5.51e-2)" "unprognostic (1.55e-2)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (5.77e-2)" "unprognostic (8.29e-2)" "unprognostic (1.17e-1)" "unprognostic (3.26e-3)" "unprognostic (4.66e-2)" "unprognostic (3.54e-1)" "unprognostic (6.21e-3)" "unprognostic (1.40e-1)" 3.6 0.9 1.3 0.6 1.2 2.2 1.7 2.0 2.1 1.8 0.8 2.9 10.6 1.5 0.1 0.7 2.0 7.0 2.1 2.5 1.4 2.2 8.6 1.4 0.3 0.8 1.2 1.9 2.0 6.4 1.2 7.1 1.1 2.0 2.7 3.7 3.0 0.9 1.1 1.0 6.0 1.7 0.5 0.4 4.4 8.4 1.7 0.7 1.2 1.8 0.2 1.6 1.2 0.7 0.8 2.8 5.2 4.5 1.0 0.8 32.8 1.5 0.5 1.6 1.2 21.1 0.1 0.1 0.6 2.7 3.6 0.3 4.0 4.4 1.0 0.4 7.5 53.0 0.5 14.7 1.4 0.6 11.8 1.9 4.7 0.2 2.0 2.1 3.7 3.7 14.4 0.2 1.5 1.0 0.2 0.9 1.7 6.6 1.8 2.0 1.4 0.0 22.5 3.4 3.3 2.2 1.9 2.8 1.8 5.5 8.0 0.5 2.0 0.3 1.7 2.8 0.6 0.6 0.7 0.2 0.1 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 2.0 2.1 2.5 1.4 0.8 1.2 1.1 0.5 1.7 0.7 5.4 6.4 0.0 10.7 0.9 0.4 0.7 1.7 0.0 3.1 2.3 1.8 2.1 4.3 5.2 1.8 22.9 14.3 1.8 6.6 0.0 1.6 30.2 2.4 1.3 2.7 2.4 4.2 24.5 1.0 5.5 2.1 9.2 4.2 0.0 13.3 3.9 23.6 2.3 0.0 25.4 3.4 4.1 0.8 0.3 74.2 2.1 0.2 1.8 15.0 0.2 0.2 0.0 12.1 4.3 2.0 3.0 0.7 0.2 1.3 11.4 2.2 4.3 6.1 6.6 1.0 1.4 2.2 1.7 0.7 0.4 4.5 0.2 0.4 5.0 1.2 ATR "FRP1, MEC1, SCKL, SCKL1" ENSG00000175054 "ATR serine/threonine kinase" Q13535 3 142449007-142578733 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "DNA damage, DNA repair" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 93.0;Inhibitory neurons: 94.4;Microglial cells: 73.1;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 71.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054320 Supported "Nucleoplasm,Golgi apparatus" No No "Cluster 15: NK-cells - Transcription" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Golgi apparatus" "HPA054320: AB_2682448" "unprognostic (1.47e-1)" "unprognostic (8.90e-2)" "unprognostic (2.90e-1)" "unprognostic (4.23e-2)" "unprognostic (2.25e-2)" "unprognostic (6.42e-2)" "prognostic unfavorable (8.39e-5)" "unprognostic (3.44e-1)" "unprognostic (1.67e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.94e-1)" "unprognostic (5.61e-2)" "unprognostic (1.06e-1)" "unprognostic (3.55e-1)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" 3.0 8.6 0.7 4.1 1.1 1.2 3.2 0.9 1.4 3.8 3.7 2.7 1.7 3.3 2.3 3.1 3.3 3.4 2.3 1.2 1.9 3.7 3.6 2.9 4.8 1.5 1.2 2.7 3.8 5.2 3.7 3.1 1.4 3.0 2.9 2.9 3.5 2.5 2.9 2.7 3.1 3.2 1.0 4.2 2.8 5.2 1.2 4.9 5.0 1.4 4.6 4.1 2.7 1.2 28.6 13.2 7.1 7.0 9.6 13.6 8.8 14.8 8.4 10.1 9.7 6.4 6.8 19.9 14.6 10.1 14.6 16.1 10.9 12.8 15.0 7.5 7.9 11.9 8.2 4.1 4.2 20.5 5.3 9.8 4.8 9.5 10.3 5.8 11.6 8.7 8.2 7.5 9.6 7.5 13.9 2.6 7.3 15.6 9.6 11.8 12.5 13.5 6.3 11.1 5.2 5.1 28.6 8.3 8.0 7.8 12.0 5.4 14.6 10.5 4.9 12.3 15.2 10.8 7.4 18.5 13.8 6.5 8.5 0.0 0.3 0.0 0.5 0.4 1.0 0.1 0.3 0.5 0.7 0.3 0.4 0.4 0.0 1.3 0.2 0.2 0.4 0.2 0.7 1.1 0.9 1.4 1.2 1.9 1.5 1.2 1.4 1.0 1.2 1.2 11.5 6.4 10.6 39.2 22.4 4.0 7.2 8.8 14.2 14.1 9.2 6.5 7.6 5.7 10.1 3.7 37.5 7.7 14.9 3.5 0.0 5.9 16.4 18.8 18.6 10.2 7.7 14.5 93.0 4.9 3.6 8.3 14.8 10.3 1.3 16.3 7.9 7.3 6.4 8.4 94.4 4.8 14.2 9.4 4.0 8.7 6.5 12.8 10.6 73.1 12.0 6.0 9.2 65.4 71.9 6.4 1.8 7.2 23.1 8.1 1.9 6.5 25.4 23.6 0.0 14.6 9.8 50.1 18.5 14.7 4.5 5.1 15.1 13.8 7.6 6.1 B4GALNT3 "B4GalNac-T3, FLJ16224, FLJ40362" ENSG00000139044 "Beta-1,4-N-acetyl-galactosaminyltransferase 3" Q6L9W6 12 459939-563509 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 61.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 81.1;Gastric mucus-secreting cells: 128.0;Glandular and luminal cells: 47.4;Late spermatids: 89.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 33.5;HDLM-2: 13.2;HEK 293: 12.5;NTERA-2: 14.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011404 Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 28: BEWO - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" Vesicles "HPA011404: AB_1845242" "unprognostic (2.38e-2)" "unprognostic (9.59e-3)" "unprognostic (1.38e-1)" "prognostic favorable (1.69e-10)" "unprognostic (4.22e-2)" "unprognostic (4.63e-2)" "unprognostic (1.46e-2)" "unprognostic (9.53e-3)" "unprognostic (3.29e-1)" "unprognostic (1.61e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (9.99e-3)" "unprognostic (2.82e-1)" "unprognostic (2.48e-2)" "unprognostic (2.98e-1)" 0.2 7.0 0.5 3.2 0.7 2.1 1.3 0.0 1.0 7.4 1.0 18.4 1.0 6.2 2.7 7.5 3.7 2.2 23.9 0.5 0.0 4.6 0.1 5.2 0.1 0.0 0.0 0.4 2.6 16.9 9.3 0.1 0.0 2.0 12.5 0.1 4.8 0.7 1.5 14.8 2.0 2.2 0.0 0.3 61.0 8.0 0.0 2.3 2.3 0.1 0.7 1.4 5.6 0.7 0.0 0.0 0.3 1.2 0.0 0.0 33.5 0.0 0.0 0.0 0.0 8.0 6.6 0.0 0.9 0.0 0.7 3.6 8.0 1.1 0.1 13.2 12.5 0.0 0.0 1.8 0.0 0.1 5.3 0.0 5.3 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.4 0.0 0.1 14.8 10.5 0.6 0.5 5.0 0.0 7.1 6.8 3.8 2.7 0.8 0.3 1.0 4.9 0.8 2.9 0.0 0.0 2.7 0.2 0.9 0.0 0.0 0.0 0.0 9.2 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 7.0 1.3 0.3 7.5 6.0 3.4 0.0 0.6 2.9 0.6 15.1 1.5 6.2 9.2 0.0 0.0 0.6 81.1 0.0 12.0 26.3 20.4 4.8 0.6 10.3 0.0 32.6 4.8 0.1 1.6 128.0 47.4 0.0 0.1 0.0 0.1 0.7 0.0 5.2 18.6 2.0 0.0 1.1 89.2 0.0 0.5 0.0 2.8 0.6 0.0 0.0 1.0 3.6 16.6 33.4 0.0 0.2 12.7 1.9 0.2 9.1 0.2 0.0 0.2 0.8 2.8 1.3 0.9 17.3 0.0 1.5 1.9 26.1 14.4 B4GALT1 "beta4Gal-T1, GGTB2" ENSG00000086062 "Beta-1,4-galactosyltransferase 1" P15291 9 33104082-33167356 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 333.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 215.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 346.6;SiHa: 635.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010806, HPA010807" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA 97000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 20: HeLa - Mitochondria" "Cluster 30: Mammary glandular cells - Lactation" "Golgi apparatus" "HPA010806: AB_1078255, HPA010807: AB_1078254" "unprognostic (7.57e-2)" "unprognostic (1.24e-2)" "unprognostic (2.09e-1)" "prognostic favorable (6.85e-7)" "unprognostic (1.83e-2)" "unprognostic (9.94e-2)" "unprognostic (3.08e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.07e-1)" "unprognostic (5.45e-2)" "unprognostic (1.68e-3)" "unprognostic (2.78e-1)" "unprognostic (7.93e-3)" "unprognostic (4.98e-2)" "unprognostic (3.91e-2)" "unprognostic (7.07e-2)" "unprognostic (3.46e-2)" 52.4 39.2 5.6 43.9 5.1 80.2 91.1 7.3 6.4 64.9 17.9 38.0 21.9 35.7 35.7 49.7 49.3 47.8 55.4 5.4 6.8 42.1 89.4 50.1 33.3 8.6 6.4 77.4 43.9 77.1 21.2 52.9 7.7 38.8 34.3 26.2 70.3 34.0 30.9 35.8 28.1 55.2 8.1 39.7 52.1 38.3 8.3 26.8 60.8 16.7 41.2 79.4 44.9 9.4 99.1 71.8 13.1 18.1 64.9 113.7 235.9 100.6 125.7 59.5 58.8 44.0 112.1 37.8 62.4 147.3 77.2 51.9 13.7 124.5 59.4 346.6 13.6 21.6 277.6 34.1 127.4 17.9 35.0 128.0 218.1 68.0 82.2 127.6 64.0 11.5 24.9 45.5 57.0 86.1 16.3 35.4 8.1 54.1 21.8 21.0 12.2 25.1 177.0 84.6 9.8 12.7 635.5 122.2 25.8 40.4 154.8 32.3 59.9 42.2 49.4 137.2 39.8 7.6 17.9 23.3 131.0 24.2 15.8 30.6 33.2 20.3 45.2 30.5 59.2 87.1 30.4 40.7 23.3 69.9 17.9 23.3 96.5 72.4 24.8 215.3 22.0 24.0 5.6 5.1 7.3 6.4 5.4 6.8 8.6 6.4 7.7 8.1 8.3 9.4 104.4 86.6 71.9 3.3 112.0 141.9 53.0 59.2 75.7 3.8 215.8 66.7 37.2 88.6 59.5 167.3 20.9 94.9 206.2 146.1 15.6 78.2 21.9 108.6 39.7 60.6 8.4 12.8 4.1 125.9 155.8 99.9 80.0 163.7 36.8 19.6 91.1 195.4 53.9 0.0 4.5 64.0 24.4 82.3 333.3 11.1 50.7 129.0 96.0 33.7 31.3 7.7 39.1 3.0 1.0 157.8 57.4 44.4 116.4 89.0 23.9 57.7 33.8 40.1 52.6 80.0 50.8 6.4 13.8 86.1 108.4 173.9 92.7 33.9 41.6 93.2 C12orf40 FLJ40126 ENSG00000180116 "Chromosome 12 open reading frame 40" Q86WS4 12 39626167-39908300 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 8.7" "Cell type enhanced" "Detected in some" "Early spermatids: 11.5;Late spermatids: 5.2;Spermatocytes: 33.2;Spermatogonia: 7.6" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "K-562: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA039032 Approved "Golgi apparatus,Cytosol" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" Cytosol "HPA039032: AB_2676316" "unprognostic (1.75e-1)" "unprognostic (2.76e-6)" "unprognostic (3.45e-1)" "unprognostic (1.96e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.2 7.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 C4BPB C4BP ENSG00000123843 "Complement component 4 binding protein beta" P20851 1 207088860-207099993 "Human disease related genes, Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "liver: 471.3" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 597.6" "Cancer enriched" "Detected in many" 19 "liver cancer: 83.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 16 "CACO-2: 116.4;HeLa: 46.2;Hep G2: 151.6;OE19: 57.1" "Not detected" "Not detected" "HPA000925, HPA051620" Approved Uncertain "Golgi apparatus" "Secreted to blood" NA NA 265000000000 1100000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 39: CACO-2 - Unknown function" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "HPA000925: , HPA051620: AB_2681554" "unprognostic (1.73e-1)" "unprognostic (2.62e-1)" "unprognostic (3.26e-1)" "unprognostic (2.07e-3)" "unprognostic (1.72e-1)" "unprognostic (2.54e-2)" "unprognostic (4.58e-3)" "unprognostic (9.49e-2)" "unprognostic (1.37e-1)" "unprognostic (4.25e-1)" "unprognostic (6.39e-2)" "unprognostic (2.64e-2)" "unprognostic (1.21e-2)" "unprognostic (1.55e-1)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (8.25e-2)" 3.0 0.1 0.0 3.4 0.0 0.0 1.8 0.0 0.1 2.8 0.0 3.6 3.8 0.1 0.0 0.2 0.5 3.1 0.1 0.0 0.0 0.4 471.3 1.5 0.4 0.0 0.0 44.2 9.1 0.0 0.0 6.2 0.1 0.0 1.8 0.0 0.5 0.0 0.1 0.2 4.4 0.6 0.0 0.4 8.4 0.7 0.0 0.1 0.0 0.1 0.2 0.4 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 116.4 5.8 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 46.2 151.6 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 12.8 2.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 7.3 2.2 0.5 54.3 3.2 0.0 0.0 1.0 0.2 10.2 1.9 11.4 4.1 0.7 0.1 0.8 1.8 8.0 0.1 88.8 0.3 3.4 5.6 0.8 0.0 0.3 9.7 597.6 2.1 0.0 0.2 5.6 0.0 13.1 0.3 2.8 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 69.2 15.9 0.0 0.1 0.2 4.3 0.0 2.2 0.0 0.0 1.1 0.4 0.1 0.4 0.0 0.0 0.1 1.1 143.8 4.8 0.1 C8orf34 "vest-1, VEST1" ENSG00000165084 "Chromosome 8 open reading frame 34" Q49A92 8 68330955-68819023 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.2;fallopian tube: 9.1;parathyroid gland: 7.4" "Cell type enriched" "Detected in some" 5 "Inhibitory neurons: 396.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.3;HEK 293: 2.3;LHCN-M2: 2.7;RH-30: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044420, HPA053065" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus" No NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA044420: AB_10963791, HPA053065: AB_2682030" "unprognostic (1.75e-1)" "unprognostic (2.20e-1)" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (3.07e-1)" "unprognostic (2.85e-2)" "unprognostic (3.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.80e-1)" "unprognostic (1.74e-1)" "unprognostic (8.55e-2)" "unprognostic (5.86e-2)" "unprognostic (1.80e-4)" "unprognostic (5.21e-2)" "unprognostic (8.87e-2)" "unprognostic (2.84e-4)" "unprognostic (1.33e-1)" 2.7 0.3 4.0 0.2 5.4 0.5 0.7 3.6 3.9 2.1 2.0 0.2 0.2 0.6 0.6 1.0 9.1 0.6 0.7 6.2 3.8 0.4 0.2 2.5 0.2 6.4 10.2 0.4 1.1 7.4 1.7 0.3 4.6 2.1 0.3 1.0 0.6 1.0 0.3 0.9 0.2 0.1 4.0 0.2 0.8 0.7 6.7 0.8 0.4 0.9 0.2 0.4 0.2 6.1 0.1 0.0 0.3 0.1 0.6 1.0 0.1 0.9 2.3 0.3 0.3 0.1 0.2 0.1 0.3 0.5 0.1 0.1 0.1 0.3 0.1 0.0 2.3 0.3 0.5 0.2 0.1 0.0 0.2 0.1 0.3 0.4 0.8 0.1 0.0 0.3 0.1 0.4 2.7 0.3 0.0 0.2 1.0 0.0 0.0 0.1 2.7 0.0 0.2 0.2 0.5 0.0 0.1 0.1 0.0 0.2 1.4 0.1 0.0 0.4 0.2 1.6 0.0 0.4 0.0 0.0 0.1 0.1 0.4 0.5 0.1 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.3 0.2 0.3 0.5 0.2 0.1 0.4 0.1 0.1 4.0 5.4 3.6 3.9 6.2 3.8 6.4 10.2 4.6 4.0 6.7 6.1 0.2 16.0 18.7 9.4 0.0 1.7 0.8 0.2 0.0 1.5 0.2 0.0 1.2 0.0 3.9 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.5 26.4 0.7 0.5 0.0 0.0 79.2 0.0 0.3 1.9 0.0 4.3 1.3 0.1 0.0 0.0 0.3 0.0 396.6 0.1 0.0 0.0 1.2 1.3 0.3 0.4 1.8 3.7 0.1 0.0 0.0 9.5 10.1 0.5 0.0 0.4 0.0 0.8 0.0 0.0 20.8 0.7 0.0 0.6 1.7 0.6 0.4 0.1 0.9 0.4 0.4 0.2 0.0 0.4 C9orf85 MGC61599 ENSG00000155621 "Chromosome 9 open reading frame 85" Q96MD7 9 71911510-71986054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 112.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050767, HPA076627" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" No No "Cluster 15: NK-cells - Transcription" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA050767: AB_2681229, HPA076627: " "unprognostic (7.81e-2)" "unprognostic (2.80e-1)" "unprognostic (6.21e-2)" "unprognostic (3.04e-1)" "unprognostic (2.89e-2)" "unprognostic (2.87e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (3.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.48e-1)" "unprognostic (1.10e-2)" "unprognostic (8.10e-2)" "unprognostic (6.60e-2)" "unprognostic (4.02e-1)" "unprognostic (6.18e-2)" 7.5 6.6 7.5 6.4 9.0 6.0 8.9 8.2 7.8 9.2 5.0 7.8 11.9 7.3 5.7 9.9 6.5 6.8 6.2 7.0 7.2 7.1 7.9 5.0 8.7 8.5 7.6 9.5 7.8 4.9 5.9 8.4 8.2 7.2 7.5 6.3 8.9 5.0 8.7 11.2 8.2 6.3 6.5 6.7 6.8 5.4 8.2 8.5 8.5 8.4 8.0 9.8 8.4 12.9 11.6 7.5 12.6 10.4 12.7 23.4 12.8 13.8 22.0 11.1 11.0 1.5 6.4 18.5 6.9 12.1 11.7 20.1 13.4 13.6 15.4 12.9 6.5 11.3 10.3 9.5 13.9 16.7 8.5 19.2 18.2 11.4 25.2 17.5 13.8 17.1 13.8 11.8 14.5 5.7 20.4 11.8 11.6 17.8 17.6 11.6 22.4 0.5 16.3 16.7 10.1 13.9 7.0 17.8 25.0 13.8 6.0 9.6 12.1 10.2 13.3 23.7 10.6 12.0 21.7 8.5 14.0 12.6 6.5 15.1 6.6 10.6 9.9 7.5 10.5 8.7 8.4 8.5 7.3 8.6 10.2 10.8 7.6 13.0 6.8 10.5 8.4 7.4 7.5 9.0 8.2 7.8 7.0 7.2 8.5 7.6 8.2 6.5 8.2 12.9 19.2 6.4 17.0 35.6 15.7 7.6 13.6 12.8 25.6 10.9 13.9 22.9 14.0 8.6 12.6 5.5 8.4 20.3 18.4 25.2 21.5 14.2 10.8 9.4 19.7 15.0 6.6 8.2 27.4 19.9 19.0 14.1 19.9 10.8 18.4 13.7 18.5 9.7 14.8 5.0 19.2 23.4 10.2 16.1 8.9 7.5 20.8 15.2 3.6 24.4 17.7 12.5 33.0 44.2 112.1 17.8 30.6 13.2 9.5 12.7 29.3 22.8 8.4 13.0 13.1 19.3 17.3 20.6 14.6 23.2 9.8 10.8 16.2 21.9 16.8 27.0 CALML4 "MGC4809, NY-BR-20" ENSG00000129007 "Calmodulin like 4" Q96GE6 15 68190705-68206079 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 91.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 49.2;Gastric mucus-secreting cells: 31.6;Paneth cells: 39.3;Proximal enterocytes: 36.2;Respiratory ciliated cells: 107.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 184.3;non-classical monocyte: 216.9" "Lineage enriched" "Detected in many" 7 "monocytes: 216.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051109 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes No "Cluster 51: Monocytes - Innate immune response" "Cluster 9: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA051109: AB_2681346" "unprognostic (1.69e-2)" "unprognostic (1.78e-1)" "unprognostic (4.97e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (3.71e-2)" "unprognostic (4.05e-2)" "unprognostic (6.53e-2)" "unprognostic (6.77e-2)" "unprognostic (2.10e-1)" "unprognostic (4.19e-3)" "unprognostic (6.24e-2)" "unprognostic (3.85e-2)" "unprognostic (7.92e-3)" "unprognostic (2.46e-1)" "unprognostic (7.49e-2)" "unprognostic (1.32e-1)" 5.2 5.1 2.9 14.5 2.9 4.5 3.1 3.9 3.8 9.2 12.6 70.1 91.9 3.3 1.4 2.1 19.3 18.7 1.2 3.1 2.7 29.1 15.0 5.1 3.9 2.8 2.7 1.7 7.0 0.9 3.5 5.4 2.9 6.2 64.7 4.3 2.2 4.4 3.4 4.8 76.0 7.3 2.4 5.9 15.6 3.3 3.0 4.5 1.6 0.7 4.0 3.5 2.3 3.3 3.4 11.6 7.9 4.8 1.6 1.7 5.7 2.2 2.3 4.8 3.0 22.1 29.8 3.7 3.0 1.9 3.7 15.1 18.2 2.8 2.0 3.3 16.9 6.7 21.6 7.9 3.5 5.8 14.7 1.6 4.4 1.8 3.4 3.0 5.9 10.8 6.2 3.9 0.7 10.2 14.5 12.6 8.5 24.1 3.4 30.1 8.1 8.2 1.3 6.0 4.4 4.3 3.5 3.2 9.9 3.1 2.8 12.6 3.5 5.0 4.5 9.2 8.7 14.4 9.4 10.0 3.3 14.9 2.2 0.1 43.7 0.2 0.1 184.3 0.6 0.6 0.6 0.2 29.1 0.1 0.5 0.3 21.3 0.0 216.9 1.4 0.4 18.3 2.9 2.9 3.9 3.8 3.1 2.7 2.8 2.7 2.9 2.4 3.0 3.3 1.3 0.0 1.5 3.3 0.7 1.5 0.8 2.8 1.8 11.1 0.4 0.1 0.3 12.8 15.8 3.7 0.0 0.5 0.3 49.2 0.0 2.5 6.5 9.4 0.6 6.4 7.7 1.3 3.8 4.3 0.5 3.2 31.6 0.4 0.0 0.4 5.0 8.1 3.9 8.4 4.0 17.1 0.0 11.7 1.5 0.5 3.7 8.1 0.0 4.7 3.9 2.0 2.1 3.0 3.4 3.0 39.3 6.8 2.4 1.1 36.2 25.4 107.8 3.1 0.0 1.1 0.7 0.0 0.4 1.3 2.0 0.1 1.2 0.1 21.1 1.1 CAND1 "DKFZp434M1414, KIAA0829, TIP120, TIP120A" ENSG00000111530 "Cullin associated and neddylation dissociated 1" Q86VP6 12 67269358-67319953 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055748, HPA062833, HPA069053" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No 5900000 "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074" "unprognostic (1.50e-2)" "unprognostic (1.60e-1)" "unprognostic (1.39e-3)" "unprognostic (2.31e-1)" "unprognostic (2.19e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (2.02e-2)" "unprognostic (2.17e-2)" "unprognostic (3.02e-1)" "unprognostic (3.38e-3)" "unprognostic (1.66e-1)" "unprognostic (2.54e-2)" "unprognostic (2.88e-1)" "unprognostic (1.58e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" 18.4 23.1 19.6 19.9 21.4 22.6 25.9 25.3 21.8 21.4 15.9 19.8 19.5 21.2 27.8 22.5 19.2 18.3 12.6 20.9 21.7 24.3 27.4 16.8 27.5 18.8 19.0 25.0 18.7 28.3 19.3 23.2 21.2 22.4 20.6 37.5 16.5 20.0 9.9 29.3 18.5 21.6 19.5 19.1 18.2 27.8 19.5 38.8 26.0 11.4 30.8 23.3 19.3 19.5 62.1 62.6 93.1 66.6 69.7 54.3 62.4 60.2 51.6 62.0 54.2 58.4 34.5 132.9 51.0 60.6 38.9 57.8 101.1 68.3 70.6 50.8 60.5 75.1 46.5 55.7 45.7 89.5 40.9 51.5 51.0 56.8 51.9 75.8 58.7 63.9 60.4 72.3 67.7 61.0 81.6 60.3 98.8 47.4 43.1 78.4 79.8 56.3 57.3 103.9 95.2 47.3 74.9 68.0 49.9 77.8 73.2 40.7 50.3 49.0 31.5 34.1 46.1 23.5 31.1 111.5 58.3 52.2 51.4 9.3 6.4 7.4 14.0 7.4 17.0 10.9 16.8 15.3 10.0 14.7 17.7 14.9 2.7 19.0 14.0 8.6 19.3 5.7 19.6 21.4 25.3 21.8 20.9 21.7 18.8 19.0 21.2 19.5 19.5 19.5 37.6 60.9 36.3 38.5 61.2 58.1 50.2 51.6 57.5 92.4 51.4 40.6 17.0 42.9 42.0 44.1 116.7 37.4 61.5 47.3 13.7 30.7 3.9 45.2 53.9 44.6 45.4 34.9 48.8 28.6 42.7 47.7 41.3 51.1 7.6 71.0 40.4 49.8 31.3 87.5 61.7 50.4 34.6 42.4 52.4 11.0 69.0 35.9 33.8 32.8 54.6 53.8 48.4 49.8 63.5 35.2 28.6 60.9 55.1 56.6 59.8 32.3 55.3 115.3 26.3 52.1 50.7 82.5 47.7 47.1 63.9 44.6 59.3 66.4 46.5 64.2 CCDC126 FLJ23031 ENSG00000169193 "Coiled-coil domain containing 126" Q96EE4 7 23597382-23644708 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.6" "Group enriched" "Detected in all" 18 "Early spermatids: 642.3;Late spermatids: 490.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "basophil: 479.0" "Lineage enriched" "Detected in all" 23 "granulocytes: 479.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010969, HPA026883" Uncertain Approved "Golgi apparatus" "Secreted to blood" NA NA 39000000 "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "HPA010969: , HPA026883: AB_1846131" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (9.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.18e-1)" "unprognostic (5.96e-3)" "unprognostic (1.16e-2)" "unprognostic (3.90e-1)" "unprognostic (9.30e-2)" "unprognostic (1.42e-2)" "unprognostic (3.44e-2)" "unprognostic (3.29e-2)" "unprognostic (7.35e-3)" "unprognostic (5.90e-2)" "unprognostic (1.20e-1)" "unprognostic (1.62e-1)" "unprognostic (3.28e-1)" 6.5 7.5 3.7 4.5 4.1 7.6 8.4 6.5 4.9 6.6 2.5 5.2 8.6 7.2 4.8 5.9 6.4 5.9 5.0 3.6 4.6 7.2 11.6 6.1 8.9 5.0 5.2 6.8 8.4 11.7 4.3 4.5 4.5 5.5 6.1 8.4 5.4 5.5 7.1 4.8 7.0 6.2 4.6 6.3 6.5 34.6 4.7 5.4 9.4 10.0 8.8 6.3 4.4 4.1 6.0 4.1 8.9 11.3 14.6 8.1 20.4 7.4 7.3 6.2 9.0 4.3 1.9 12.8 11.3 6.2 11.8 3.4 3.9 3.5 8.1 2.7 5.1 2.2 1.6 5.6 5.8 5.9 10.9 8.7 10.0 2.0 1.9 5.2 8.4 5.3 5.2 3.5 7.6 2.8 4.1 7.1 4.2 7.9 5.1 2.7 14.0 3.9 6.5 2.7 5.4 10.2 7.6 7.2 5.6 13.8 6.1 5.4 10.2 3.7 6.5 8.4 5.9 9.9 10.5 9.2 4.1 8.5 20.2 479.0 18.0 86.7 14.7 17.0 17.6 20.7 15.8 17.0 15.6 19.3 19.2 15.0 35.2 16.8 17.1 3.2 19.3 15.6 3.7 4.1 6.5 4.9 3.6 4.6 5.0 5.2 4.5 4.6 4.7 4.1 17.3 6.4 8.1 12.7 12.8 19.1 7.9 8.0 13.6 14.1 15.4 10.7 9.0 12.8 8.2 12.9 8.4 10.2 9.3 7.3 7.9 10.1 642.3 11.1 9.0 10.8 15.0 4.8 14.0 9.1 6.8 11.5 13.3 9.5 7.0 3.7 10.8 15.2 6.9 8.4 17.4 8.7 16.2 7.9 9.6 490.0 11.5 9.5 14.2 12.2 11.4 7.7 14.4 18.6 20.1 10.4 7.3 14.3 12.8 8.3 8.4 8.9 14.6 14.1 13.1 12.0 12.9 31.1 26.3 12.1 23.7 20.2 11.3 29.2 5.9 6.9 CCDC68 SE57-1 ENSG00000166510 "Coiled-coil domain containing 68" Q9H2F9 18 54901509-54959461 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 24.8;placenta: 32.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 95.2;Early spermatids: 95.4;Pancreatic endocrine cells: 87.9;Paneth cells: 68.7;Proximal enterocytes: 61.1" "Cancer enhanced" "Detected in many" "stomach cancer: 4.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 10.8;HHSteC: 13.6;HSkMC: 14.9;RT4: 10.5;TIME: 28.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA040865, HPA048197" Supported Approved "Golgi apparatus,Cytosol" No NA "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Cytosol "HPA040865: AB_2677176, HPA048197: AB_2680310" "unprognostic (1.36e-2)" "prognostic unfavorable (4.50e-4)" "unprognostic (1.47e-3)" "unprognostic (7.38e-2)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (2.65e-2)" "unprognostic (6.29e-2)" "unprognostic (2.71e-1)" "unprognostic (1.16e-1)" "unprognostic (1.15e-3)" "unprognostic (1.13e-1)" "prognostic favorable (5.28e-4)" "unprognostic (1.77e-2)" "unprognostic (9.71e-2)" "unprognostic (6.12e-2)" "unprognostic (2.38e-1)" 5.5 3.8 1.6 4.1 1.5 0.4 3.4 1.4 2.7 4.2 2.3 18.9 20.2 3.3 0.8 1.8 2.4 5.1 5.7 1.5 3.6 2.8 9.5 13.0 0.8 2.0 2.3 15.7 2.8 0.8 3.6 32.4 2.0 4.2 18.2 0.6 1.8 1.3 1.5 0.9 24.8 2.7 1.2 7.2 14.3 8.8 3.3 0.6 2.6 4.4 1.3 2.3 1.8 1.3 10.8 3.3 0.0 0.0 3.0 8.3 0.0 0.3 4.2 0.6 0.7 5.9 6.2 0.0 7.6 0.0 0.1 0.1 0.7 6.8 0.5 0.0 1.6 0.8 3.6 1.2 13.6 0.0 0.0 14.9 0.0 3.2 0.1 0.0 4.9 0.0 0.0 0.1 0.4 0.8 0.0 0.2 0.0 7.6 3.6 0.3 0.0 0.3 1.2 10.5 0.1 2.5 3.3 1.0 0.1 1.2 0.0 0.0 28.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.6 1.5 1.4 2.7 1.5 3.6 2.0 2.3 2.0 1.2 3.3 1.3 38.5 19.2 10.3 0.3 1.0 0.3 7.4 4.8 1.2 0.1 2.0 1.9 5.5 10.0 13.3 1.8 0.0 2.3 0.3 95.2 1.9 7.2 95.4 15.0 2.5 40.8 6.0 3.6 5.7 35.6 2.7 9.6 38.2 27.1 8.8 2.6 37.5 7.0 0.4 0.0 0.5 21.8 8.2 3.2 1.3 36.7 3.4 0.6 0.0 12.2 1.0 3.3 1.0 0.0 0.1 87.9 68.7 0.7 0.0 32.4 61.1 5.3 4.2 0.2 6.6 0.9 3.0 1.2 2.2 1.1 0.0 6.0 0.4 3.8 20.2 6.4 CCL15 "HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3" ENSG00000275718 "C-C motif chemokine ligand 15" Q16663 17 35996440-36001553 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Cytokine, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 83.0;liver: 31.6" "Cell type enhanced" "Detected in some" "Distal enterocytes: 262.6;Intestinal goblet cells: 208.3;Paneth cells: 380.6;Proximal enterocytes: 461.4;Undifferentiated cells: 138.2" "Cancer enhanced" "Detected in many" "liver cancer: 11.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "Hep G2: 35.4;OE19: 28.7" HPA058608 Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 3270000 11000000 "Cluster 2: Granulocytes - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" Vesicles "HPA058608: AB_2683776" "unprognostic (1.26e-1)" "unprognostic (1.23e-1)" "unprognostic (1.31e-2)" "unprognostic (1.40e-1)" "unprognostic (8.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-1)" "unprognostic (2.41e-2)" "unprognostic (1.96e-2)" "unprognostic (9.94e-2)" "unprognostic (1.15e-1)" "unprognostic (1.07e-2)" "prognostic favorable (3.02e-4)" 0.2 0.4 0.1 7.8 0.1 0.1 0.4 0.1 0.3 0.3 0.0 59.7 37.6 0.1 0.0 0.2 9.6 9.2 0.0 0.1 0.1 10.0 31.6 2.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 83.0 0.0 0.1 0.1 0.0 0.1 62.0 1.4 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.3 4.9 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 35.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 28.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.5 0.0 0.5 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.1 7.2 5.0 0.0 0.0 0.0 0.0 262.6 0.0 0.0 0.0 12.2 0.1 0.7 71.8 0.0 0.0 0.7 0.0 0.0 0.0 0.1 8.9 0.0 2.5 40.2 0.1 0.0 0.0 208.3 2.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 380.6 0.0 0.0 0.0 461.4 61.3 76.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 138.2 0.2 CCN2 "CTGF, IGFBP8" ENSG00000118523 "Cellular communication network factor 2" P29279 6 131948176-131951372 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Cell adhesion, DNA synthesis" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 101.2;Cardiomyocytes: 38.7;Extravillous trophoblasts: 47.1;Fibroblasts: 261.8;Smooth muscle cells: 104.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 7 "naive B-cell: 8.1" "Lineage enriched" "Detected in single" 81 "B-cells: 8.1" "Cell line enhanced" "Detected in many" "EFO-21: 1605.0;HUVEC TERT2: 1377.0;TIME: 2874.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005123, HPA031074, HPA031075" Approved Approved "Golgi apparatus,Vesicles" "Secreted in other tissues" No No 1010000 5900000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Vesicles" "CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248" "unprognostic (2.87e-1)" "unprognostic (1.43e-1)" "unprognostic (4.41e-2)" "unprognostic (5.68e-2)" "unprognostic (9.79e-2)" "unprognostic (1.82e-2)" "unprognostic (3.38e-1)" "unprognostic (4.96e-2)" "unprognostic (1.68e-1)" "unprognostic (3.89e-2)" "unprognostic (2.39e-1)" "unprognostic (2.06e-1)" "unprognostic (1.27e-3)" "prognostic unfavorable (5.04e-4)" "unprognostic (1.62e-1)" "unprognostic (1.77e-2)" "unprognostic (3.84e-3)" 265.9 107.5 18.9 168.0 18.8 2.0 206.4 16.3 34.0 531.0 31.5 148.8 43.7 418.5 34.4 271.9 243.8 441.4 371.8 25.8 14.2 235.7 82.9 226.3 73.6 18.8 32.1 77.0 194.0 43.0 44.8 198.2 20.2 364.6 136.1 2.4 138.2 154.3 51.8 155.1 151.2 576.3 14.2 569.1 182.6 24.7 20.8 49.5 464.7 61.9 14.9 324.0 102.5 18.2 4.6 7.5 126.8 3.7 279.9 158.5 1.8 373.1 178.2 226.8 119.4 0.2 12.2 0.6 1605.0 482.7 185.0 6.2 4.2 26.4 211.3 2.5 3.5 0.2 55.7 137.3 109.6 0.3 0.5 232.2 5.9 163.9 40.2 340.7 1377.0 0.0 0.4 0.3 650.8 2.5 0.5 1.2 61.8 41.3 21.7 32.6 6.0 0.7 81.9 0.4 0.5 0.8 38.3 62.2 18.3 308.5 6.1 3.1 2874.4 311.6 242.4 397.8 694.0 11.5 1.7 4.1 42.5 0.7 399.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 18.9 18.8 16.3 34.0 25.8 14.2 18.8 32.1 20.2 14.2 20.8 18.2 101.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.7 0.0 0.0 0.0 0.0 17.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.0 0.0 47.1 261.8 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.4 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 CCNI2 FLJ16793 ENSG00000205089 "Cyclin I family member 2" Q6ZMN8 5 132747426-132754403 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.3;intestine: 3.6" "Cell type enhanced" "Detected in some" "Distal tubular cells: 3.9;Gastric mucus-secreting cells: 7.1;Intestinal goblet cells: 3.5;Muller glia cells: 4.9;Plasma cells: 4.8;Undifferentiated cells: 4.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "MOLT-4: 25.7" "Low region specificity" "Detected in all" HPA056288 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA "Cluster 13: T-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA056288: AB_2683086" "unprognostic (3.84e-2)" "unprognostic (2.44e-3)" "prognostic favorable (8.21e-4)" "unprognostic (5.97e-2)" "unprognostic (3.39e-1)" "unprognostic (6.71e-3)" "unprognostic (1.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (1.77e-1)" "unprognostic (4.95e-1)" "unprognostic (1.71e-7)" "unprognostic (1.58e-1)" 0.2 0.3 1.2 0.9 1.9 0.1 0.2 1.3 1.5 0.5 0.0 2.6 3.6 0.1 0.3 0.1 0.3 0.4 0.3 0.9 0.8 3.1 0.0 0.5 0.8 2.2 1.3 0.2 1.2 0.0 0.6 0.1 1.6 0.9 2.7 1.1 2.6 1.3 0.3 0.3 2.1 0.1 0.9 0.4 2.4 0.7 1.5 1.5 0.4 0.0 0.9 0.9 0.2 4.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.4 0.0 0.6 25.7 0.1 0.4 1.6 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 1.3 1.0 0.3 0.3 0.0 0.0 0.0 0.0 1.7 4.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.5 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.8 0.1 1.2 1.9 1.3 1.5 0.9 0.8 2.2 1.3 1.6 0.9 1.5 4.3 0.2 0.0 0.5 0.0 0.9 0.1 0.4 0.8 0.0 0.1 0.4 0.1 0.6 0.0 0.4 0.0 0.0 0.4 0.1 3.4 3.9 0.4 2.2 0.4 0.0 0.1 1.2 0.0 0.6 1.5 0.2 0.3 7.1 0.5 1.3 0.0 0.0 0.0 0.1 1.7 0.5 3.5 0.0 0.0 0.0 2.1 0.3 0.4 0.0 0.0 0.0 4.9 0.0 1.0 2.4 1.5 2.3 0.0 4.8 0.6 1.8 0.3 1.0 0.2 0.0 0.1 0.2 0.2 0.7 0.0 0.1 0.0 1.9 0.1 4.2 0.6 CCPG1 "CPR8, KIAA1254" ENSG00000260916 "Cell cycle progression 1" Q9ULG6 15 55340032-55408510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 279.2;neutrophil: 296.6" "Group enriched" "Detected in all" 7 "granulocytes: 296.6;monocytes: 84.2" "Cell line enhanced" "Detected in many" "HHSteC: 223.9;Karpas-707: 337.4;U-266/84: 259.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009432, HPA026861" Approved Approved "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "Endoplasmic reticulum" "HPA009432: AB_2668242, HPA026861: AB_1846192" "unprognostic (3.14e-2)" "unprognostic (2.94e-2)" "unprognostic (3.03e-1)" "unprognostic (2.51e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (1.40e-2)" "unprognostic (8.34e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (3.17e-2)" "unprognostic (2.61e-2)" "prognostic unfavorable (5.07e-4)" "prognostic unfavorable (5.02e-5)" "unprognostic (1.15e-1)" "unprognostic (1.71e-2)" "unprognostic (1.72e-2)" 38.9 37.8 24.0 23.7 27.7 63.8 34.1 23.1 28.4 61.1 36.8 33.3 24.3 26.7 36.1 20.1 22.0 53.8 56.2 24.7 26.9 51.5 66.9 39.3 22.2 18.4 17.3 22.9 84.8 73.3 32.3 27.4 17.7 41.0 33.2 48.2 77.1 42.3 53.0 13.5 25.6 33.5 17.2 28.7 47.5 29.6 27.3 12.2 84.4 35.3 24.2 29.9 9.7 22.9 13.9 47.7 10.9 24.4 173.6 59.3 15.5 30.0 56.4 17.2 26.1 14.4 23.5 20.8 99.5 97.5 33.6 18.7 9.5 25.1 14.4 55.5 14.2 28.1 58.4 12.8 223.9 39.6 84.2 49.5 59.8 35.6 34.4 143.3 65.2 0.8 47.7 337.4 55.1 17.9 0.2 19.3 6.5 54.4 11.8 6.2 17.4 84.8 36.1 10.1 14.0 21.5 35.3 19.5 151.4 35.0 31.0 85.1 65.7 50.8 11.1 38.9 20.4 65.2 259.6 13.0 95.6 77.2 41.0 220.8 59.4 279.2 26.8 50.7 22.5 18.1 16.6 20.7 27.6 13.4 13.9 20.0 296.6 25.7 84.2 4.7 23.0 32.9 24.0 27.7 23.1 28.4 24.7 26.9 18.4 17.3 17.7 17.2 27.3 22.9 92.3 115.4 118.1 0.0 44.6 15.4 30.3 99.2 13.6 68.7 40.2 40.1 14.4 50.1 136.5 88.3 93.8 29.3 42.9 43.7 5.9 60.9 136.2 49.6 41.0 60.1 16.7 25.2 0.0 145.3 23.2 78.6 33.1 62.3 39.1 30.0 76.1 96.1 51.0 85.8 0.0 28.8 114.0 55.9 25.2 216.1 56.5 71.7 48.0 0.0 89.8 72.6 38.1 0.0 0.0 67.6 45.1 116.6 180.8 42.6 29.5 36.7 123.8 128.0 52.6 80.2 48.1 43.3 41.1 11.8 16.6 24.6 41.8 70.0 16.2 21.8 CD36 "FAT, GP3B, GP4, GPIV, SCARB3" ENSG00000135218 "CD36 molecule" P16671 7 80369575-80679277 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Transport" Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 1533.6" "Cell type enhanced" "Detected in many" "Adipocytes: 3219.2;Cardiomyocytes: 623.1;Hofbauer cells: 1369.8;Sertoli cells: 696.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 962.6;intermediate monocyte: 270.6;myeloid DC: 507.1" "Group enriched" "Detected in all" 46 "dendritic cells: 507.1;monocytes: 962.6" "Group enriched" "Detected in some" 4 "ASC diff: 322.6;HEL: 158.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "spinal cord: 16.9" "HPA002018, CAB025866, HPA071026" Enhanced Enhanced "Golgi apparatus" NA NA 5300000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170" "unprognostic (7.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.06e-3)" "unprognostic (6.52e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (2.63e-1)" "unprognostic (9.35e-2)" "unprognostic (2.64e-2)" "unprognostic (1.97e-1)" "unprognostic (1.23e-3)" "unprognostic (1.18e-1)" "unprognostic (1.84e-3)" "prognostic unfavorable (4.47e-4)" "unprognostic (7.05e-3)" "unprognostic (4.87e-2)" "unprognostic (2.73e-3)" 1533.6 24.6 3.4 51.7 2.5 148.2 540.4 1.6 2.0 11.6 2.7 40.5 113.6 8.7 38.2 19.6 40.5 84.0 540.9 2.6 6.9 7.0 80.8 131.2 18.8 22.0 21.2 4.0 31.2 25.0 2.0 413.3 15.7 5.0 40.9 0.3 31.9 8.6 248.5 28.6 119.7 39.4 14.0 309.9 31.2 7.7 24.0 22.1 69.1 381.6 7.2 22.2 13.4 3.9 0.0 0.0 1.0 0.2 322.6 3.3 0.7 0.9 10.7 0.1 0.1 0.0 0.0 0.1 0.6 1.4 0.3 0.1 4.3 0.5 0.1 0.6 0.4 158.1 0.5 25.7 0.2 0.1 0.1 31.0 12.6 0.1 0.2 7.7 0.9 0.0 5.8 0.0 1.8 0.2 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.5 0.5 0.1 0.9 1.3 0.8 0.6 0.3 2.7 11.1 19.3 0.4 0.5 0.5 0.6 0.3 0.2 0.8 0.4 0.1 54.3 41.8 12.3 962.6 3.7 1.9 270.6 2.1 3.6 0.6 0.6 507.1 0.5 0.8 0.4 15.8 5.9 72.0 128.3 1.5 692.4 3.4 2.5 1.6 2.0 2.6 6.9 22.0 21.2 15.7 14.0 24.0 3.9 3219.2 6.4 63.1 0.0 7.9 7.4 0.2 3.0 0.6 0.2 189.9 24.8 623.1 4.3 9.8 7.3 0.0 10.1 55.0 0.0 0.0 0.2 11.7 5.0 5.9 303.3 0.0 419.5 6.3 0.0 11.1 69.6 1.1 38.4 15.2 0.6 406.2 9.0 1369.8 0.0 2.2 0.6 8.2 153.7 67.3 3.9 0.6 159.6 16.0 17.8 255.2 0.0 7.2 0.5 1.3 0.1 0.0 0.0 4.2 0.8 9.9 0.4 1.2 0.3 696.8 33.1 452.1 4.6 0.7 0.8 4.7 18.3 5.9 1.9 0.2 0.3 CD37 TSPAN26 ENSG00000104894 "CD37 molecule" P11049 19 49335171-49343335 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 155.2;intestine: 116.3;lymphoid tissue: 235.7" "Cell type enhanced" "Detected in many" "B-cells: 1643.9;dendritic cells: 489.6;Hofbauer cells: 345.3;Langerhans cells: 358.4;Macrophages: 319.7;monocytes: 365.0;NK-cells: 394.4;T-cells: 390.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 306.4;HMC-1: 290.0;RPMI-8226: 110.7;THP-1: 109.0;U-698: 69.4;U-937: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002492, HPA032120, HPA032121" Enhanced Approved "Golgi apparatus,Plasma membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" "Golgi apparatus" "Plasma membrane" "CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163" "unprognostic (4.30e-3)" "unprognostic (2.39e-3)" "unprognostic (8.85e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.46e-2)" "unprognostic (4.59e-3)" "unprognostic (1.76e-1)" "unprognostic (6.23e-2)" "unprognostic (5.34e-2)" "unprognostic (2.23e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-1)" "unprognostic (2.45e-3)" "unprognostic (7.12e-2)" "unprognostic (3.35e-2)" "unprognostic (7.22e-2)" "unprognostic (7.71e-2)" 16.6 7.0 7.5 100.2 7.4 155.2 6.5 9.4 13.7 4.2 5.9 13.9 8.2 3.7 0.7 7.3 5.8 13.9 5.2 6.3 11.4 7.6 6.4 46.9 215.0 17.0 12.0 1.7 3.2 1.8 3.4 15.1 16.5 6.9 3.8 0.3 11.5 2.8 1.9 4.1 116.3 3.9 16.7 235.7 14.8 7.4 15.6 57.5 8.3 2.4 88.0 19.1 5.2 28.7 0.2 0.6 1.5 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 306.4 0.1 0.0 0.0 0.6 0.0 0.0 0.0 49.5 0.2 53.1 0.0 0.5 0.0 9.4 290.0 0.0 0.0 0.0 0.0 0.2 0.0 18.5 2.6 16.3 0.0 0.0 0.4 5.8 0.2 0.0 0.0 2.9 0.3 110.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 109.0 0.8 0.3 1.0 0.2 0.0 0.3 0.1 69.4 0.2 81.4 0.1 550.2 658.2 829.6 353.2 601.6 357.4 1511.6 426.3 376.2 449.7 1722.2 435.3 368.6 903.8 321.8 747.8 586.3 467.1 816.2 7.5 7.4 9.4 13.7 6.3 11.4 17.0 12.0 16.5 16.7 15.6 28.7 7.1 9.6 14.3 0.3 1643.9 11.7 1.3 0.1 4.6 12.1 4.6 12.1 1.6 2.8 2.5 1.8 6.2 1.9 489.6 2.2 0.0 0.5 94.2 1.2 1.9 9.7 1.2 67.7 0.1 0.0 2.3 6.9 11.7 1.5 264.6 0.3 11.4 4.1 345.3 0.0 0.2 1.7 0.0 272.0 358.4 221.3 2.8 319.7 28.4 21.5 365.0 1.1 394.4 0.0 0.1 0.0 8.0 0.7 119.8 1.1 0.6 2.9 0.9 6.3 0.0 3.2 5.7 1.1 1.3 2.6 11.8 2.9 390.3 0.9 1.9 1.1 CD44 "CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1" ENSG00000026508 "CD44 molecule (Indian blood group)" P16070 11 35138882-35232402 "Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Blood group antigen, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 504.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 999.7;Ductal cells: 992.1;Exocrine glandular cells: 869.6;Langerhans cells: 1934.2;Suprabasal keratinocytes: 1024.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 1650.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000112, CAB000316, HPA005785" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA 1200000000 "Cluster 39: Non-specific - mRNA processing" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane" "Golgi apparatus" "CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467" "unprognostic (5.33e-2)" "unprognostic (1.85e-1)" "unprognostic (4.97e-2)" "unprognostic (9.90e-3)" "unprognostic (3.50e-3)" "unprognostic (1.46e-2)" "unprognostic (1.56e-2)" "unprognostic (8.12e-2)" "unprognostic (1.57e-1)" "unprognostic (4.18e-2)" "unprognostic (1.51e-3)" "unprognostic (4.63e-2)" "prognostic unfavorable (1.78e-8)" "unprognostic (6.41e-2)" "unprognostic (4.14e-2)" "unprognostic (3.93e-2)" "unprognostic (7.98e-2)" 143.7 42.4 29.2 218.0 33.9 308.1 164.7 63.0 25.1 146.0 16.8 91.1 53.0 200.4 20.1 227.8 69.0 129.7 30.4 33.0 116.5 31.3 31.0 214.1 108.8 114.9 102.3 11.7 263.2 6.0 8.1 74.1 118.3 87.3 111.5 38.0 504.2 57.0 17.1 433.3 60.8 175.8 114.3 83.8 61.5 6.6 62.8 64.2 76.2 27.7 188.7 235.2 193.4 114.9 493.0 448.6 4.3 1.2 252.6 691.5 1.6 962.2 740.3 521.3 288.2 30.4 150.4 0.7 126.5 1350.2 1065.4 820.1 9.9 1013.9 716.4 110.3 6.2 18.9 198.3 0.3 262.3 254.6 1124.3 315.4 778.3 693.2 552.7 1650.0 184.3 0.1 4.0 157.9 518.9 3.0 25.6 166.9 9.8 8.7 136.4 1.4 89.3 7.5 777.4 138.1 2.0 1.4 185.2 5.5 462.8 38.6 25.7 15.1 547.3 646.6 120.0 815.8 1006.0 281.6 327.7 3.7 980.4 145.1 969.8 127.4 403.0 35.4 140.6 257.8 196.5 122.5 210.1 186.5 229.0 90.0 179.7 153.6 92.6 322.3 356.1 79.9 309.7 437.3 29.2 33.9 63.0 25.1 33.0 116.5 114.9 102.3 118.3 114.3 62.8 114.9 41.0 96.1 361.8 54.5 250.1 999.7 297.7 335.3 228.2 0.6 139.6 71.2 8.6 27.1 125.6 20.2 2.1 4.5 257.0 14.0 1.9 992.1 41.3 43.6 395.4 50.9 100.1 94.4 0.4 869.6 3.6 282.2 39.8 196.9 763.2 25.2 13.2 3.6 226.6 0.0 0.4 93.3 30.5 474.3 1934.2 24.3 22.4 523.9 604.7 8.4 594.2 29.6 62.8 0.5 11.2 813.1 10.9 0.4 216.3 386.7 6.0 1.6 18.8 2.0 157.8 197.2 227.9 0.4 0.4 279.3 1024.9 17.9 430.8 1.0 79.1 330.7 CD74 DHLAG ENSG00000019582 "CD74 molecule" P04233 5 150400041-150412969 "Cancer-related genes, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Immunity" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 5258.9" "Cell type enhanced" "Detected in many" "B-cells: 10167.0;Kupffer cells: 5201.6;Langerhans cells: 23363.4;Macrophages: 7290.2;monocytes: 10305.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 11041.2;intermediate monocyte: 15961.1;memory B-cell: 26889.3;myeloid DC: 23750.6;naive B-cell: 27930.3;non-classical monocyte: 8003.3;plasmacytoid DC: 16940.0" "Group enriched" "Detected in all" 6 "B-cells: 27930.3;dendritic cells: 23750.6;monocytes: 15961.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 2171.7;Daudi: 3523.2;HDLM-2: 4787.6;REH: 3026.0;RPMI-8226: 2014.2;U-266/70: 1443.4;U-698: 1978.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002506, HPA010592, CAB079994" Enhanced Supported "Golgi apparatus" NA NA 210000 "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "CAB002506: AB_563630, CAB079994: , HPA010592: AB_1078482" "prognostic favorable (1.06e-4)" "unprognostic (1.48e-2)" "unprognostic (4.80e-3)" "prognostic favorable (6.53e-6)" "unprognostic (1.41e-1)" "unprognostic (4.53e-2)" "unprognostic (2.05e-1)" "unprognostic (3.69e-3)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (2.20e-2)" "unprognostic (2.64e-1)" "unprognostic (5.44e-3)" "unprognostic (1.73e-1)" "unprognostic (4.95e-2)" "unprognostic (2.05e-1)" "unprognostic (4.24e-2)" 1512.1 976.5 338.1 2741.2 301.9 984.3 1157.2 365.5 474.4 1562.8 429.1 992.3 1826.2 593.6 490.6 618.8 1139.0 1477.9 604.0 306.7 506.8 1271.1 1142.0 3786.3 4995.6 598.7 431.8 464.3 392.4 390.6 469.3 305.7 533.4 556.7 1155.8 58.1 1999.3 911.8 307.2 682.4 2438.8 1014.2 514.2 4897.4 1511.5 207.5 514.4 2160.2 853.5 374.2 5258.9 1557.5 483.5 771.8 35.7 0.3 1.5 2.4 2.3 2.5 11.0 0.0 0.0 0.7 0.6 443.0 2171.7 3523.2 124.2 0.0 9.2 9.4 0.0 0.0 0.1 4787.6 0.0 109.1 1.2 250.2 6.6 9.2 6.5 24.5 0.0 0.8 0.0 0.6 0.0 0.0 8.0 1270.7 0.4 0.0 4.2 14.0 5.3 0.0 0.1 3026.0 5.2 2014.2 9.0 133.5 5.1 8.2 5.5 4.7 94.9 19.2 81.2 414.4 5.6 10.3 9.9 9.0 4.5 1443.4 170.7 1978.6 745.9 154.2 678.6 410.8 11041.2 3996.9 808.7 15961.1 899.9 26889.3 688.4 1188.4 23750.6 27930.3 378.9 646.6 839.6 2378.1 8003.3 16940.0 2157.2 17779.7 338.1 301.9 365.5 474.4 306.7 506.8 598.7 431.8 533.4 514.2 514.4 771.8 2080.4 419.9 2160.4 0.7 10167.0 715.9 154.0 762.2 398.4 1.7 220.3 437.5 69.6 401.7 1063.3 502.1 0.0 28.3 3199.0 139.7 117.4 1264.4 10.4 111.3 11.5 1787.6 242.9 562.5 0.7 527.5 32.6 278.6 538.2 85.5 417.2 113.4 514.7 52.5 4361.8 1.7 0.6 475.7 390.6 5201.6 23363.4 31.3 117.1 7290.2 1197.1 137.7 10305.9 16.8 403.7 0.5 1.4 384.2 487.3 17.7 2068.3 174.9 5034.4 815.8 1153.1 10.0 164.3 45.1 146.7 2.8 12.6 170.9 575.8 41.6 790.7 12.9 450.7 743.4 CERT1 "CERT, COL4A3BP, GPBP, STARD11" ENSG00000113163 "Ceramide transporter 1" Q9Y5P4 5 75356345-75512138 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 23.3;Cardiomyocytes: 37.1;Cytotrophoblasts: 17.7;dendritic cells: 20.2;Extravillous trophoblasts: 16.8;Hofbauer cells: 36.8;Plasma cells: 12.4;Syncytiotrophoblasts: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 132.3;WM-115: 118.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035645, HPA042608" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" Nucleoplasm "HPA035645: AB_10600700, HPA042608: AB_2678075" "unprognostic (2.45e-1)" "unprognostic (7.16e-2)" "unprognostic (6.56e-3)" "unprognostic (1.53e-2)" "unprognostic (2.44e-1)" "unprognostic (9.29e-2)" "unprognostic (4.06e-2)" "unprognostic (3.22e-1)" "unprognostic (2.51e-1)" "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "unprognostic (4.29e-2)" "prognostic favorable (1.24e-5)" "unprognostic (9.12e-2)" "unprognostic (2.29e-1)" "unprognostic (2.83e-1)" "unprognostic (2.91e-1)" 38.1 26.1 12.4 16.5 16.1 27.2 17.6 18.0 15.4 33.9 14.0 20.8 18.7 20.6 15.1 24.9 22.4 23.3 20.8 14.0 15.1 27.9 31.2 24.3 20.3 14.7 17.5 23.1 16.4 26.1 8.0 22.9 16.7 24.3 19.6 18.2 14.0 19.9 28.9 18.7 21.1 18.3 14.7 25.3 23.5 28.8 15.5 21.2 49.9 28.3 22.7 23.7 16.0 17.6 44.9 22.7 21.6 19.0 132.3 36.6 29.0 24.8 30.8 18.8 24.8 34.4 25.3 21.5 52.3 26.9 25.8 26.7 33.4 34.4 28.6 27.1 15.2 18.2 24.4 18.4 33.6 18.2 20.1 27.9 23.8 22.3 24.9 30.5 22.1 28.3 33.0 32.0 25.0 23.0 21.6 13.2 27.9 10.2 16.8 18.0 28.5 20.2 30.5 54.0 16.4 16.5 31.6 21.6 31.8 45.4 21.3 30.5 30.1 12.6 15.1 22.8 20.3 29.1 41.6 24.8 21.4 30.7 118.2 9.6 19.8 16.0 8.2 22.4 7.8 9.1 8.3 7.7 14.5 9.1 7.7 7.8 29.6 7.8 25.4 8.3 13.0 9.0 12.4 16.1 18.0 15.4 14.0 15.1 14.7 17.5 16.7 14.7 15.5 17.6 23.3 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 17.7 20.2 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 16.8 10.5 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 27.8 3.8 0.0 0.0 0.0 CMTM5 "CKLFSF5, FLJ37521" ENSG00000166091 "CKLF like MARVEL transmembrane domain containing 5" Q96DZ9 14 23376773-23379772 "Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 182.4;choroid plexus: 49.5" "Cell type enhanced" "Detected in some" "Macrophages: 93.7;Muller glia cells: 32.0;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 106.2" "Group enriched" "Detected in some" 37 "glioma: 8.4;melanoma: 3.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 20.8" "Lineage enriched" "Detected in many" 19 "granulocytes: 20.8" "Cell line enriched" "Detected in some" 7 "HEL: 91.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052338 Enhanced Approved "Golgi apparatus,Vesicles" NA NA 540000 "Cluster 34: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" "Golgi apparatus, Vesicles" "HPA052338: AB_2681793" "unprognostic (2.73e-3)" "unprognostic (1.51e-1)" "unprognostic (5.24e-1)" "unprognostic (2.43e-3)" "unprognostic (2.63e-1)" "unprognostic (6.40e-2)" "unprognostic (8.34e-3)" "unprognostic (1.78e-1)" "unprognostic (2.27e-2)" "unprognostic (8.40e-2)" "unprognostic (6.24e-4)" "unprognostic (3.03e-3)" "unprognostic (1.97e-3)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" 1.1 1.0 75.6 0.5 119.1 8.2 0.9 123.8 101.7 2.8 49.5 5.8 0.5 0.8 1.1 1.2 1.2 2.1 22.7 73.9 85.2 0.5 0.3 1.5 0.2 150.9 106.2 0.8 0.2 0.1 0.6 0.7 135.2 2.1 0.8 2.3 2.2 3.2 3.1 0.7 1.7 0.8 113.4 2.8 1.4 0.1 110.2 0.1 0.5 0.9 0.0 1.2 2.6 182.4 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 91.8 0.0 0.0 0.2 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.2 20.8 0.7 0.9 0.1 0.4 0.0 0.1 0.2 0.0 0.3 0.1 0.0 0.0 4.2 0.0 0.0 1.0 0.4 30.0 75.6 119.1 123.8 101.7 73.9 85.2 150.9 106.2 135.2 113.4 110.2 182.4 0.5 0.0 0.0 6.5 0.4 1.0 0.1 0.0 1.2 0.2 1.3 5.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.2 0.0 0.0 1.3 0.4 0.0 0.0 93.7 5.4 0.0 1.5 32.0 0.0 20.6 106.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 3.4 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.1 COG8 "DOR1, FLJ22315" ENSG00000213380 "Component of oligomeric golgi complex 8" Q96MW5 16 69320140-69339583 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041406, HPA049429" Approved Supported "Golgi apparatus" No No "Cluster 41: Basophils - Cellular respiration" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "HPA041406: AB_2677459, HPA049429: AB_2680763" "unprognostic (4.02e-2)" "unprognostic (6.46e-2)" "unprognostic (2.90e-1)" "unprognostic (1.19e-2)" "unprognostic (2.77e-1)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (4.35e-2)" "unprognostic (1.11e-1)" "unprognostic (2.02e-1)" "prognostic favorable (3.12e-5)" "unprognostic (3.10e-1)" "prognostic favorable (2.47e-7)" "unprognostic (4.73e-2)" "unprognostic (2.58e-1)" "unprognostic (7.83e-2)" "unprognostic (1.35e-2)" 9.9 14.5 19.7 8.5 23.2 6.5 11.1 23.2 24.4 9.8 24.0 10.5 10.5 10.8 14.1 9.9 13.9 7.7 11.2 19.4 19.7 13.4 15.0 10.2 11.3 21.1 20.6 13.7 14.2 19.9 12.0 7.9 21.2 10.3 9.9 7.7 13.8 10.6 18.1 16.3 10.0 10.5 20.3 10.9 11.2 20.3 20.9 12.2 13.0 15.8 11.3 9.4 7.7 28.1 13.2 28.5 18.2 26.7 30.1 21.0 19.4 16.9 18.6 23.0 18.7 26.2 19.8 23.7 18.1 23.0 12.4 24.9 29.5 24.3 19.8 11.9 26.4 17.0 19.9 35.0 21.3 21.1 14.8 25.2 23.5 25.2 14.7 22.2 22.6 20.4 35.4 5.7 16.7 38.3 19.4 31.3 32.2 17.8 20.5 35.6 12.6 33.3 23.6 11.1 26.0 31.1 37.5 15.0 17.5 18.4 35.4 17.8 20.5 16.8 14.4 15.8 14.1 31.3 27.1 36.8 17.3 18.8 19.2 41.4 19.6 20.6 17.8 19.0 19.6 13.3 19.2 18.2 18.6 19.0 17.4 16.7 15.6 22.2 17.6 10.7 19.6 16.8 19.7 23.2 23.2 24.4 19.4 19.7 21.1 20.6 21.2 20.3 20.9 28.1 3.2 9.6 9.7 1.3 9.4 4.2 10.4 5.8 5.2 18.9 7.3 6.7 0.0 24.3 10.6 11.0 18.8 15.0 5.0 12.6 1.9 7.6 17.4 6.1 6.4 7.2 12.7 5.5 1.9 8.0 9.1 7.4 7.1 4.6 7.0 9.0 15.7 28.5 9.5 11.8 2.0 11.7 20.3 7.9 3.3 4.8 12.8 3.1 5.4 1.0 8.4 12.1 10.3 2.0 2.6 5.4 9.5 15.8 9.0 9.6 19.3 15.3 10.2 19.9 13.1 15.5 6.2 9.9 13.6 7.2 4.1 9.2 8.3 5.4 16.7 7.2 COMP "EDM1, EPD1, MED, PSACH, THBS5" ENSG00000105664 "Cartilage oligomeric matrix protein" P49747 19 18782773-18791305 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Cell adhesion" Heparin-binding "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 77.6;heart muscle: 65.3;skin 1: 80.6" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 19.3;Early spermatids: 37.0;Fibroblasts: 32.0;Glandular and luminal cells: 32.0;Late spermatids: 75.3;Spermatocytes: 16.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 859.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA077555 Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA 1500000000 "Cluster 31: Skin - Epidermis development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "HPA077555: " "unprognostic (1.26e-1)" "unprognostic (7.22e-2)" "prognostic unfavorable (9.08e-5)" "prognostic unfavorable (2.04e-4)" "unprognostic (8.05e-2)" "unprognostic (8.45e-2)" "unprognostic (3.62e-2)" "unprognostic (5.12e-2)" "unprognostic (1.65e-1)" "unprognostic (1.55e-2)" "unprognostic (2.18e-2)" "unprognostic (3.85e-1)" "prognostic unfavorable (1.52e-6)" "unprognostic (5.96e-3)" "unprognostic (1.44e-1)" "unprognostic (2.87e-2)" "prognostic unfavorable (6.95e-4)" 77.6 0.2 0.0 1.1 0.2 0.0 11.0 1.3 0.2 7.5 0.0 2.3 0.0 4.6 7.6 9.5 1.2 16.1 65.3 0.0 0.0 5.2 0.3 8.0 3.6 0.3 0.1 0.4 2.8 2.2 0.4 8.2 0.1 10.2 0.0 0.0 14.1 6.7 18.0 80.6 0.9 12.1 0.3 0.3 2.5 14.9 0.0 0.1 10.3 0.6 0.3 6.5 22.7 0.1 0.0 0.0 0.0 0.0 178.4 0.4 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 859.6 0.0 0.2 1.2 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.3 0.0 0.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.2 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.1 0.1 3.2 0.5 0.0 0.0 11.5 0.6 19.3 0.0 1.4 0.3 0.3 0.8 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 37.0 2.8 3.7 1.0 0.0 0.0 0.1 0.2 0.2 32.0 0.0 32.0 0.0 0.1 0.4 0.0 0.5 0.0 0.0 1.3 0.0 0.0 10.7 75.3 0.9 0.7 10.6 0.0 0.1 1.6 0.0 0.0 0.1 0.2 0.0 0.7 0.0 0.3 0.0 0.0 0.7 0.4 6.6 2.4 4.2 16.8 1.6 0.0 7.1 0.5 1.0 0.0 0.2 0.3 COPE epsilon-COP ENSG00000105669 "COPI coat complex subunit epsilon" O14579 19 18899514-18919387 "Metabolic proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034345, HPA041605, HPA043576" Supported Enhanced "Golgi apparatus" NA NA 66000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "CAB034345: AB_2081323, HPA041605: AB_2677578, HPA043576: AB_2678563" "unprognostic (1.48e-1)" "prognostic favorable (2.41e-4)" "unprognostic (1.15e-1)" "unprognostic (5.17e-3)" "unprognostic (1.04e-1)" "unprognostic (7.40e-2)" "unprognostic (3.39e-2)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (1.97e-2)" "unprognostic (8.75e-2)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (2.26e-1)" "unprognostic (3.16e-2)" "unprognostic (6.75e-2)" 102.3 163.7 127.2 85.5 133.4 159.6 100.3 139.4 176.0 101.3 131.3 113.8 90.5 104.1 45.0 160.3 89.8 44.1 135.2 122.4 131.0 141.9 194.3 108.3 91.7 140.6 132.0 80.8 152.0 80.8 160.1 59.3 130.0 127.4 37.7 23.5 144.2 65.4 128.0 120.9 107.8 42.9 137.1 150.0 126.8 171.9 135.9 82.4 123.7 50.0 56.9 99.2 107.1 151.2 186.7 177.4 99.3 177.3 89.0 104.7 287.2 159.2 150.8 174.8 198.7 215.1 148.2 150.8 210.5 134.9 112.9 123.2 82.5 161.0 33.9 94.2 369.9 89.6 150.9 331.1 236.1 180.0 221.1 128.3 149.2 106.2 115.6 92.5 138.9 170.5 140.2 373.6 90.0 443.0 196.9 341.0 188.4 243.0 420.2 222.4 89.6 448.2 115.8 185.4 138.8 222.4 100.0 159.1 181.1 44.9 134.8 291.3 140.9 110.5 81.5 283.3 170.9 357.7 337.5 187.7 189.1 309.9 187.3 656.0 598.5 639.1 337.1 533.1 298.1 391.2 321.9 298.6 528.4 381.9 236.4 270.9 594.9 344.4 468.5 659.3 449.3 930.0 127.2 133.4 139.4 176.0 122.4 131.0 140.6 132.0 130.0 137.1 135.9 151.2 110.5 3.2 16.2 22.2 204.7 159.8 197.9 390.9 54.1 53.2 140.5 111.6 10.4 111.5 205.8 115.8 29.2 386.5 242.8 408.9 463.7 323.7 179.7 134.4 131.8 127.1 168.5 130.5 8.6 368.7 439.1 140.7 166.2 187.8 102.9 176.7 113.6 153.4 447.2 57.2 11.3 445.5 303.2 189.4 286.8 381.0 144.8 217.8 245.5 4.7 373.5 251.9 187.4 8.5 20.8 336.7 421.4 133.2 417.5 255.7 425.6 493.1 152.6 72.1 124.9 92.8 200.5 178.4 202.1 108.6 196.6 542.2 174.9 235.3 297.4 267.2 COPG1 COPG ENSG00000181789 "COPI coat complex subunit gamma 1" Q9Y678 3 129249606-129277773 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037866, HPA037867, HPA045712" Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No 57000 "Cluster 18: Basophils - Vesicular transport" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428" "unprognostic (8.86e-2)" "unprognostic (2.22e-2)" "unprognostic (4.22e-3)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (1.22e-6)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-3)" "unprognostic (3.29e-1)" "unprognostic (1.23e-3)" "unprognostic (2.10e-1)" "unprognostic (3.20e-1)" "unprognostic (2.99e-1)" "unprognostic (1.60e-1)" 84.7 111.0 66.6 59.0 68.2 59.4 79.8 69.5 80.7 100.4 93.0 107.6 86.7 75.5 157.4 86.8 70.0 53.8 95.5 70.3 73.7 82.7 149.5 84.4 54.8 74.3 71.5 77.9 162.4 96.3 139.0 81.9 77.4 107.7 109.8 33.4 130.7 72.7 75.7 74.4 86.7 72.2 66.4 81.9 114.0 46.5 73.2 53.5 83.3 43.2 67.1 67.2 72.2 73.2 167.8 83.2 119.1 104.0 272.8 219.0 126.9 266.3 251.8 179.5 225.2 153.9 101.2 91.1 150.8 380.7 145.6 98.4 99.5 157.2 193.6 112.0 41.4 151.9 103.2 252.6 247.9 116.4 156.4 230.9 135.6 143.8 235.0 196.1 164.3 68.9 54.2 213.6 219.2 253.4 68.7 117.7 71.3 243.6 100.9 73.3 111.8 178.3 227.3 136.7 74.1 86.1 204.2 150.3 255.9 129.8 167.1 167.6 223.9 96.9 91.7 207.2 104.2 165.7 86.1 158.9 236.4 86.9 190.0 79.1 49.9 37.2 44.1 59.2 53.6 24.9 39.8 43.9 57.0 26.9 30.0 36.2 37.2 57.0 57.3 52.2 43.8 56.2 66.6 68.2 69.5 80.7 70.3 73.7 74.3 71.5 77.4 66.4 73.2 73.2 16.6 16.0 31.5 7.8 19.2 8.8 16.9 35.4 12.0 9.2 18.9 8.6 23.3 17.2 34.6 27.6 4.2 55.6 19.7 77.0 43.0 44.5 10.4 26.2 27.7 22.8 38.6 22.9 14.1 46.5 63.1 32.5 53.0 36.9 15.2 28.6 28.9 56.5 39.0 5.0 14.8 75.1 22.4 31.2 14.8 4.7 41.0 21.6 23.2 7.5 36.5 12.7 18.6 4.5 11.8 40.8 44.6 31.2 68.4 24.4 64.5 39.5 32.6 7.1 19.7 20.2 33.3 24.3 17.0 16.4 10.2 72.2 19.4 27.7 44.6 20.6 CXCL8 "3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1" ENSG00000169429 "C-X-C motif chemokine ligand 8" P10145 4 73740541-73743716 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 3301.3" "Group enriched" "Detected in many" 5 "Basal prostatic cells: 13262.1;Macrophages: 3685.4;Prostatic glandular cells: 8869.1;Urothelial cells: 13149.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 9 "cerebral cortex: 136.1" "Immune cell enriched" "Detected in some" 451 "neutrophil: 483.0" "Lineage enriched" "Detected in single" 788 "granulocytes: 483.0" "Group enriched" "Detected in many" 5 "BJ hTERT+: 4072.6;GAMG: 1080.2" "Not detected" "Not detected" HPA057179 Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 7260 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA057179: AB_2683362" "unprognostic (3.42e-1)" "prognostic unfavorable (1.18e-5)" "unprognostic (3.91e-3)" "unprognostic (8.49e-2)" "unprognostic (3.29e-2)" "unprognostic (3.03e-3)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.37e-3)" "unprognostic (3.19e-1)" "unprognostic (4.46e-1)" "unprognostic (7.19e-3)" "unprognostic (7.16e-2)" "prognostic unfavorable (3.13e-6)" "unprognostic (4.73e-2)" "unprognostic (8.57e-2)" "unprognostic (1.64e-2)" "unprognostic (6.15e-2)" 67.9 13.5 1.8 209.9 2.8 3301.3 3.6 1.7 136.1 54.5 7.6 10.6 3.6 41.0 0.2 3.7 8.9 177.2 33.8 1.7 1.6 10.8 77.7 91.2 1.2 2.1 1.6 6.0 16.1 1.8 3.2 41.1 15.1 9.6 7.3 0.9 25.4 1.5 1.3 3.2 4.9 12.7 1.9 10.3 8.8 0.7 4.9 15.2 3.4 8.1 8.7 456.7 4.0 1.9 2.7 1.4 0.0 0.1 3.9 19.4 0.2 25.7 4072.6 35.9 117.0 0.2 13.0 0.2 547.6 1.3 1080.2 48.2 0.0 1.0 562.3 1.8 0.2 0.9 0.4 6.5 6.8 41.0 2.5 12.4 1.7 119.0 2.9 12.9 124.9 0.0 1.4 0.8 0.7 0.0 0.0 55.7 0.0 14.7 20.3 0.3 0.5 0.9 317.3 17.2 0.1 0.0 1.9 0.1 61.1 0.8 0.1 5.6 308.3 56.8 5.1 15.1 55.0 0.4 0.7 1.7 252.5 30.9 88.2 1.0 0.6 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 483.0 0.0 0.0 0.0 0.0 0.1 1.8 2.8 1.7 136.1 1.7 1.6 2.1 1.6 15.1 1.9 4.9 1.9 28.6 51.3 254.1 0.0 26.4 0.0 13262.1 0.0 164.4 0.5 40.2 15.4 23.8 127.2 426.5 0.0 0.0 4.3 17.7 14.4 0.0 1695.0 3.2 717.6 257.1 712.2 19.1 8.0 0.0 260.7 5.2 1475.1 54.0 1708.7 51.2 0.5 15.7 3.6 367.1 0.0 0.0 26.4 0.0 543.0 0.0 1.9 0.6 3685.4 0.0 0.0 1178.5 0.5 0.0 0.0 0.0 584.9 0.3 0.4 27.3 8869.1 0.9 1.0 178.6 1.1 39.5 44.3 263.0 0.3 2.5 124.9 0.0 21.3 138.8 0.0 18.5 13149.4 CYP2D6 "CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D" ENSG00000100197 "Cytochrome P450 family 2 subfamily D member 6" P10635 22 42126499-42130865 "Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "liver: 320.0" "Group enriched" "Detected in many" 35 "Hepatocytes: 512.8;Proximal enterocytes: 465.2" "Cancer enriched" "Detected in many" 35 "liver cancer: 90.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 1.8" "Low region specificity" "Detected in many" HPA045223 Enhanced Approved "Golgi apparatus" No No "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "HPA045223: AB_10962927" "unprognostic (4.40e-3)" "unprognostic (7.68e-3)" "unprognostic (5.45e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (1.29e-4)" "unprognostic (3.83e-2)" "unprognostic (7.27e-3)" "unprognostic (1.13e-1)" "unprognostic (1.71e-1)" "unprognostic (4.03e-4)" "unprognostic (2.11e-2)" "unprognostic (5.61e-5)" "unprognostic (3.01e-1)" "unprognostic (2.23e-1)" "unprognostic (4.08e-1)" "unprognostic (4.82e-5)" 0.1 0.2 0.2 0.0 0.3 0.3 0.1 0.8 0.2 0.1 0.3 0.3 3.7 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.3 320.0 0.1 0.1 0.2 0.0 0.2 0.8 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.2 11.7 0.0 0.1 0.3 0.1 0.4 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.2 0.2 0.0 0.2 0.0 0.1 0.1 0.1 0.3 0.6 0.0 1.1 5.5 0.7 0.5 0.7 1.3 2.8 7.3 1.1 1.4 0.4 2.8 0.7 1.8 2.1 0.1 0.6 2.9 1.9 0.7 3.1 0.8 0.6 0.6 1.2 0.0 6.5 0.6 0.1 0.3 4.1 1.4 0.0 0.7 5.7 512.8 0.1 11.8 9.4 7.6 0.0 5.6 0.0 13.6 0.0 0.4 0.0 0.0 0.1 0.7 0.0 5.0 4.9 0.7 11.3 1.5 0.4 0.6 465.2 0.5 1.3 2.3 0.0 0.4 2.1 0.8 0.4 0.6 1.1 0.4 1.0 0.1 3.4 0.3 DSCAM "CHD2-42, CHD2-52" ENSG00000171587 "DS cell adhesion molecule" O60469 21 40010999-40847158 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.6;pituitary gland: 4.2;retina: 1.9" "Cell type enriched" "Detected in some" 4 "Oligodendrocyte precursor cells: 4376.6" "Cancer enriched" "Detected in single" 14 "glioma: 3.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 3.6;MCF7: 8.3;NTERA-2: 2.2;SCLC-21H: 3.3;T-47d: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019324, HPA057493" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA019324: AB_2670118, HPA057493: " "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (7.59e-2)" "unprognostic (1.99e-2)" "unprognostic (9.98e-2)" "unprognostic (5.49e-4)" "unprognostic (1.78e-1)" "unprognostic (9.58e-2)" "unprognostic (7.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.85e-3)" "unprognostic (2.12e-2)" "unprognostic (2.00e-3)" "unprognostic (2.17e-2)" "unprognostic (2.29e-1)" "unprognostic (8.75e-2)" "unprognostic (5.46e-3)" 0.0 0.0 5.4 0.0 5.8 0.0 0.1 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 5.6 4.2 0.0 0.1 0.0 0.0 2.3 2.8 0.0 0.1 0.0 4.2 0.7 3.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.8 0.0 0.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 5.8 0.1 6.6 5.6 4.2 2.3 2.8 3.5 2.9 4.1 4.1 0.0 0.0 0.0 19.9 0.0 0.0 0.1 0.0 0.0 19.6 0.0 0.4 1.1 1.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.4 0.0 0.0 1083.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 16.8 649.1 0.0 0.0 2.4 0.0 4.2 0.0 0.0 0.0 200.5 0.0 0.7 0.0 4376.6 21.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.0 0.1 1.7 1.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 DTX3 "FLJ34766, RNF154" ENSG00000178498 "Deltex E3 ubiquitin ligase 3" Q8N9I9 12 57604622-57609804 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 70.7" "Cancer enriched" "Detected in all" 4 "glioma: 54.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 5 "NK-cells: 1.0;T-cells: 2.5" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 84.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059654 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" No No "Cluster 20: T-cells - T-cell receptor" "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA059654: AB_2684097" "unprognostic (2.31e-2)" "unprognostic (8.80e-2)" "unprognostic (2.06e-2)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.58e-2)" "unprognostic (6.91e-2)" "prognostic favorable (9.87e-4)" "unprognostic (1.84e-1)" "unprognostic (4.26e-2)" "prognostic favorable (1.44e-4)" "unprognostic (8.62e-2)" "unprognostic (5.44e-3)" "unprognostic (7.99e-2)" "unprognostic (8.81e-2)" "unprognostic (9.51e-2)" "unprognostic (3.48e-2)" 36.6 58.2 117.1 15.8 120.2 7.2 36.4 117.5 138.2 97.6 115.0 117.4 11.5 95.5 50.7 24.2 92.0 24.5 67.6 124.5 111.4 63.8 12.3 37.2 21.2 107.8 112.1 124.3 41.9 39.4 145.1 28.1 108.6 82.1 16.8 80.8 31.4 48.2 21.0 21.1 46.2 48.5 105.3 46.0 51.0 29.0 112.6 23.6 75.9 16.6 15.5 65.0 60.7 119.0 8.8 22.7 65.9 0.1 0.0 0.1 0.4 13.8 35.4 29.7 30.0 11.8 36.5 12.3 20.5 30.0 0.3 14.2 0.0 1.7 20.9 31.1 4.1 7.1 39.4 12.5 49.4 0.0 0.1 24.5 16.7 22.8 0.3 84.4 33.6 0.1 0.0 40.9 23.1 19.2 38.4 0.3 52.1 7.2 2.0 0.0 55.1 0.7 2.8 22.7 47.7 75.5 10.9 3.1 7.0 15.8 38.4 18.9 0.1 38.6 15.3 17.9 20.2 66.2 53.6 0.2 24.8 0.1 20.6 0.0 0.0 0.0 2.5 0.0 0.6 0.1 0.9 1.2 0.1 0.1 0.8 1.6 0.0 1.0 0.0 0.3 2.2 1.2 117.1 120.2 117.5 138.2 124.5 111.4 107.8 112.1 108.6 105.3 112.6 119.0 4.9 16.0 15.6 25.8 2.9 6.2 10.0 8.7 21.1 47.8 12.2 19.9 11.0 11.5 10.5 12.9 50.1 0.5 10.6 0.5 13.7 8.2 0.9 17.8 17.4 8.5 15.6 4.4 29.9 1.9 0.3 15.1 6.1 5.5 5.7 17.2 15.0 0.6 0.6 70.7 29.3 0.9 10.2 2.0 2.1 2.8 34.2 1.6 3.6 8.4 0.8 27.4 36.0 25.1 19.0 2.6 0.0 31.6 5.8 7.1 0.0 4.6 30.9 42.0 46.0 11.5 37.5 4.6 5.7 2.8 2.8 1.2 10.4 16.8 0.7 3.5 DUSP10 "MKP-5, MKP5" ENSG00000143507 "Dual specificity phosphatase 10" Q9Y6W6 1 221701424-221742089 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 32.9" "Cell type enhanced" "Detected in many" "granulocytes: 133.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 19.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 102.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016758 Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No "Cluster 15: NK-cells - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Golgi apparatus, Cytosol" "HPA016758: AB_1847880" "unprognostic (1.55e-1)" "unprognostic (2.73e-1)" "unprognostic (1.44e-1)" "unprognostic (6.65e-2)" "unprognostic (3.83e-2)" "unprognostic (2.85e-3)" "prognostic favorable (5.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.89e-2)" "unprognostic (9.68e-2)" "unprognostic (2.38e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (4.18e-2)" "unprognostic (2.57e-1)" "unprognostic (8.88e-3)" "unprognostic (1.97e-2)" 3.8 2.4 4.3 5.2 7.4 25.0 6.0 7.7 5.3 4.5 4.7 8.0 1.4 3.6 1.2 6.0 6.4 6.6 2.6 4.5 4.5 1.4 32.9 6.2 9.1 7.1 6.0 1.6 17.0 1.2 1.2 3.8 5.8 2.7 4.1 14.9 6.3 0.9 22.9 6.1 3.9 8.9 3.8 6.1 2.5 3.1 9.0 5.6 4.4 3.6 7.6 6.1 2.7 13.5 15.2 6.4 0.5 0.4 45.4 22.6 0.5 10.1 25.9 16.2 12.5 0.3 4.2 11.6 3.3 26.1 11.9 102.3 2.2 9.8 14.0 30.5 1.2 20.4 3.0 1.8 10.6 9.1 13.3 31.9 7.0 17.6 17.8 7.5 0.6 3.0 2.1 4.0 16.0 0.3 1.8 7.2 1.5 3.2 0.7 1.1 28.5 0.9 5.7 9.1 37.4 3.0 1.3 1.2 43.6 5.6 2.1 5.5 3.6 8.1 2.2 12.6 12.4 6.8 5.1 6.2 12.8 4.1 8.9 8.2 5.5 0.3 4.5 4.6 3.9 0.8 2.9 3.1 7.0 0.9 1.0 1.7 0.5 19.7 1.9 0.2 16.9 2.2 4.3 7.4 7.7 5.3 4.5 4.5 7.1 6.0 5.8 3.8 9.0 13.5 4.9 0.0 1.7 2.6 21.7 50.9 13.5 13.6 25.6 6.0 42.4 18.7 4.7 14.3 19.2 3.7 20.9 2.8 39.0 3.1 0.0 35.9 61.1 57.9 6.6 6.7 43.9 2.5 0.3 9.1 3.7 7.9 4.6 53.7 133.5 0.2 1.8 53.6 22.3 1.7 30.9 17.7 69.2 9.7 46.9 7.1 24.8 26.0 23.2 2.8 14.1 14.3 17.5 17.1 50.5 26.2 0.8 12.8 9.9 11.0 0.4 1.1 18.5 34.2 0.0 33.7 5.3 9.7 3.2 16.7 41.3 3.4 47.0 28.7 3.6 16.5 EFHD1 FLJ13612 ENSG00000115468 "EF-hand domain family member D1" Q9BUP0 2 232606057-232682780 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 414.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 241.8;Breast myoepithelial cells: 129.0;Distal tubular cells: 393.2;Oligodendrocytes: 173.4;Sertoli cells: 197.2;Smooth muscle cells: 130.9;Syncytiotrophoblasts: 263.9" "Cancer enriched" "Detected in all" 5 "breast cancer: 100.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 125.8;RPTEC TERT1: 68.6;SK-BR-3: 301.8;T-47d: 236.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049331, HPA056959" Enhanced Supported "Nucleoli fibrillar center,Golgi apparatus" No NA 14000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 57: Non-specific - Angiogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "Golgi apparatus" "Nucleoli fibrillar center" "HPA049331: AB_2680716, HPA056959: AB_2683288" "unprognostic (9.51e-3)" "unprognostic (2.21e-2)" "unprognostic (4.78e-3)" "unprognostic (3.25e-1)" "unprognostic (3.40e-1)" "unprognostic (9.70e-2)" "unprognostic (9.02e-2)" "unprognostic (1.13e-1)" "unprognostic (3.29e-3)" "unprognostic (1.21e-1)" "unprognostic (5.57e-2)" "unprognostic (9.99e-2)" "prognostic favorable (2.93e-7)" "unprognostic (2.00e-2)" "unprognostic (1.84e-1)" "unprognostic (2.51e-2)" "unprognostic (2.29e-3)" 86.3 7.0 199.7 3.7 303.2 0.8 180.7 244.9 261.3 86.9 129.9 16.9 4.4 72.4 33.7 9.6 73.7 12.0 46.0 196.6 217.4 186.2 54.6 15.3 3.9 253.6 258.7 76.5 86.5 10.5 16.5 77.9 261.8 25.6 5.7 9.5 22.2 27.7 35.5 30.9 16.2 20.6 201.4 52.5 17.6 20.1 237.8 3.0 32.7 42.7 2.4 22.0 44.5 414.6 0.0 3.4 5.7 1.4 2.2 0.1 125.8 26.8 2.1 2.3 1.9 0.9 0.6 0.1 2.0 11.6 2.9 0.2 19.0 0.0 0.3 0.5 9.2 0.0 2.4 1.9 0.0 0.1 0.3 1.0 0.4 0.2 0.0 0.4 0.0 5.5 3.9 0.5 0.5 2.3 0.6 0.2 8.4 0.0 0.2 0.6 7.2 0.4 68.6 0.7 0.3 3.2 9.1 301.8 18.3 42.3 236.9 2.6 0.0 0.0 1.8 0.4 0.8 0.2 0.1 0.1 0.3 0.1 13.4 1.0 0.2 0.1 0.2 0.1 0.4 0.3 0.3 0.4 0.1 0.1 0.6 0.6 2.2 0.1 0.1 0.2 0.1 0.1 199.7 303.2 244.9 261.3 196.6 217.4 253.6 258.7 261.8 201.4 237.8 414.6 15.6 0.0 0.0 37.5 1.5 3.6 2.8 1.3 1.2 0.5 241.8 129.0 7.4 1.5 4.6 35.0 0.0 112.0 3.0 0.3 393.2 0.0 9.0 1.1 37.8 16.8 0.0 2.7 2.6 0.0 19.7 41.1 0.0 1.7 0.0 3.2 6.4 89.4 8.7 0.0 5.3 0.1 59.0 1.3 3.0 7.0 44.4 2.1 8.8 18.7 0.0 48.0 0.0 1.5 173.4 0.0 0.0 57.2 0.1 4.6 0.0 116.5 1.9 1.4 197.2 8.7 130.9 17.3 13.6 0.4 3.1 263.9 2.5 1.5 0.3 2.0 EHF "ESE3, ESEJ" ENSG00000135373 "ETS homologous factor" Q9NZC4 11 34621093-34663288 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 287.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 400.8;Basal respiratory cells: 271.6;Club cells: 323.3;Endometrial ciliated cells: 229.6;Glandular and luminal cells: 281.8;Squamous epithelial cells: 251.1;Urothelial cells: 397.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 11 "myeloid DC: 1.7" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 138.4;HaCaT: 95.7;HBEC3-KT: 107.6;OE19: 132.9;RT4: 214.8;T-47d: 213.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA050923, HPA060734" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" No NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "Golgi apparatus" "HPA050923: AB_2681275, HPA060734: AB_2684351" "unprognostic (1.06e-2)" "unprognostic (1.06e-1)" "prognostic favorable (5.81e-4)" "unprognostic (2.82e-1)" "unprognostic (5.62e-2)" "unprognostic (1.22e-3)" "unprognostic (2.44e-1)" "unprognostic (2.04e-1)" "unprognostic (1.38e-1)" "unprognostic (6.79e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (1.29e-1)" "unprognostic (6.26e-2)" "unprognostic (3.47e-3)" "unprognostic (2.24e-1)" "unprognostic (2.89e-1)" "unprognostic (7.08e-2)" 0.9 1.1 0.9 14.7 1.7 0.2 199.5 0.9 0.6 120.8 1.3 99.3 42.2 13.9 95.0 200.7 129.6 32.2 0.3 1.1 0.8 25.7 1.3 23.4 1.5 2.6 4.0 0.2 41.1 18.5 0.7 0.1 2.8 82.7 126.3 0.8 287.7 153.4 0.2 53.6 34.1 3.5 2.5 1.2 59.5 0.7 1.3 1.3 2.5 0.0 67.3 50.7 79.2 4.7 46.5 26.8 0.0 0.3 0.0 0.0 0.8 0.0 3.9 0.0 0.2 0.4 138.4 0.1 17.1 0.0 0.2 95.7 0.0 107.6 0.5 0.1 0.2 0.0 1.5 0.2 0.0 0.2 0.0 0.0 41.7 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.1 2.6 0.1 0.8 0.2 132.9 1.0 0.0 0.1 1.0 20.2 214.8 0.0 0.2 0.5 14.8 0.2 0.0 213.5 0.5 0.0 0.2 1.2 5.1 0.4 0.5 0.2 0.3 0.3 0.2 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 0.9 0.6 1.1 0.8 2.6 4.0 2.8 2.5 1.3 4.7 0.8 48.1 97.2 1.3 0.6 109.6 400.8 271.6 133.1 0.0 123.0 51.9 0.9 60.1 323.3 55.2 0.0 0.1 1.1 62.7 15.6 77.8 14.2 229.6 17.7 4.0 23.3 0.0 0.7 86.5 0.0 3.2 53.5 281.8 1.3 0.0 0.0 0.4 0.1 0.0 0.0 82.8 116.0 0.0 17.7 1.0 0.0 5.1 12.4 0.0 5.6 3.8 0.0 0.0 2.4 104.8 30.2 0.0 1.2 173.1 14.1 0.3 204.6 0.0 0.0 0.0 9.6 0.4 0.1 251.1 170.1 1.4 4.9 0.0 74.5 397.3 ENPP6 MGC33971 ENSG00000164303 "Ectonucleotide pyrophosphatase/phosphodiesterase 6" Q6UWR7 4 184088706-184221230 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4;kidney: 30.6;ovary: 12.5" "Cell type enhanced" "Detected in some" "Oligodendrocytes: 119.9;Peritubular cells: 35.3;Proximal tubular cells: 31.3;Theca cells: 23.9" "Cancer enriched" "Detected in some" 5 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 3.2;SH-SY5Y: 3.6;U-266/70: 2.9;U-266/84: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042740, HPA069197" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA 290000 "Cluster 21: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA042740: AB_10793984, HPA069197: " "unprognostic (4.81e-4)" "unprognostic (1.47e-1)" "unprognostic (3.54e-2)" "unprognostic (1.24e-1)" "unprognostic (2.56e-1)" "unprognostic (6.69e-3)" "unprognostic (3.07e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-1)" "unprognostic (7.60e-3)" "unprognostic (3.04e-2)" "unprognostic (1.72e-1)" "unprognostic (2.98e-2)" "unprognostic (2.82e-1)" "unprognostic (3.93e-3)" "unprognostic (2.01e-1)" 0.2 0.3 2.7 0.8 11.8 0.9 0.8 14.2 5.5 0.2 2.3 1.0 1.7 0.2 6.1 1.0 0.3 0.5 0.2 2.7 6.1 30.6 0.1 0.3 0.9 20.4 9.6 12.5 0.0 0.0 4.2 0.1 18.1 2.2 1.0 0.1 0.7 6.1 0.2 0.1 2.2 0.1 12.5 1.0 1.2 2.4 11.1 1.9 0.1 1.3 2.8 0.6 0.3 29.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 3.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.9 1.7 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 2.7 11.8 14.2 5.5 2.7 6.1 20.4 9.6 18.1 12.5 11.1 29.4 0.5 0.0 0.0 5.9 0.1 0.0 0.2 0.9 0.6 0.0 0.1 0.5 0.9 0.0 0.4 1.8 0.0 0.0 0.0 0.0 3.9 1.1 1.0 0.0 0.0 0.5 0.0 0.0 4.3 0.2 0.0 8.7 0.0 0.0 5.7 0.0 0.0 0.4 0.2 0.0 1.5 0.0 0.0 0.6 0.0 0.4 4.1 0.6 1.8 4.7 1.1 0.0 0.0 6.6 119.9 0.0 0.0 35.3 0.5 0.1 0.0 31.3 0.2 0.0 0.0 5.1 0.6 0.1 1.6 0.0 0.0 0.0 0.3 23.9 0.0 0.3 ESD ENSG00000139684 "Esterase D" P10768 13 46771256-46797420 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 569.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039700 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 12000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039700: AB_10697553" "unprognostic (3.05e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (7.66e-2)" "unprognostic (1.75e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.73e-2)" "unprognostic (3.31e-1)" "unprognostic (1.01e-1)" "unprognostic (2.12e-2)" "unprognostic (1.49e-2)" "unprognostic (1.08e-1)" "unprognostic (2.91e-2)" "unprognostic (2.71e-2)" "unprognostic (2.18e-1)" "unprognostic (6.44e-2)" "unprognostic (1.37e-3)" 123.8 87.5 83.0 73.0 85.5 95.1 146.7 86.3 110.8 141.0 87.7 125.7 106.7 129.7 160.1 93.6 121.8 96.4 151.5 84.3 98.6 194.4 277.2 92.3 93.5 87.3 85.6 179.0 67.3 109.9 81.5 81.9 89.7 112.5 135.0 122.0 92.8 140.3 149.8 83.3 93.4 166.2 94.3 63.9 83.0 54.2 82.4 155.7 155.0 179.0 110.3 104.9 96.2 100.0 138.4 77.9 229.8 160.4 264.5 441.9 62.5 190.8 280.9 264.7 204.6 131.6 162.8 156.5 56.9 233.3 194.0 137.1 256.8 227.2 333.0 180.4 270.4 200.3 70.7 208.6 220.5 400.1 82.2 304.6 207.0 167.9 229.4 316.2 253.2 260.3 200.3 40.7 433.5 135.1 352.7 260.0 59.8 175.2 148.8 277.1 133.6 106.2 378.4 55.4 115.0 130.1 85.0 72.6 160.3 157.6 137.1 223.0 169.2 94.4 113.0 187.5 181.8 27.6 63.5 135.7 205.3 223.2 131.2 35.0 129.4 55.7 48.5 113.6 80.9 104.1 97.6 76.3 142.8 83.4 114.1 90.5 15.0 109.3 106.1 170.7 90.6 100.3 83.0 85.5 86.3 110.8 84.3 98.6 87.3 85.6 89.7 94.3 82.4 100.0 139.0 54.5 56.8 37.5 77.2 134.1 227.4 300.5 148.0 51.5 114.1 123.2 99.2 167.3 111.7 154.5 41.7 160.4 51.2 59.1 360.0 168.0 135.5 102.2 120.6 112.5 108.8 99.5 22.7 103.2 141.0 162.9 51.0 80.7 96.4 71.1 132.1 154.7 227.5 21.9 19.3 114.6 175.0 140.2 148.0 34.8 267.8 108.2 165.4 25.3 144.3 199.5 36.0 23.6 36.2 85.4 92.3 211.4 35.9 99.1 137.1 569.1 94.2 77.3 151.2 196.0 484.2 61.6 46.3 120.6 129.3 74.4 78.2 151.2 199.8 143.6 FAM114A1 Noxp20 ENSG00000197712 "Family with sequence similarity 114 member A1" Q8IWE2 4 38867677-38945739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 3.6" "Group enriched" "Detected in many" 6 "dendritic cells: 2.6;granulocytes: 2.4;monocytes: 3.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 204.7;BJ hTERT+: 244.1;fHDF/TERT166: 273.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067948, HPA069104, HPA069701" Uncertain Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No 96000 "Cluster 7: Monocytes - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus, Cytosol" Nucleoplasm "HPA067948: AB_2685931, HPA069104: AB_2686087, HPA069701: AB_2686175" "unprognostic (2.13e-3)" "unprognostic (4.68e-2)" "unprognostic (1.94e-1)" "unprognostic (4.66e-2)" "unprognostic (9.40e-3)" "unprognostic (6.77e-2)" "unprognostic (2.54e-1)" "unprognostic (2.31e-2)" "unprognostic (4.88e-2)" "unprognostic (1.55e-1)" "unprognostic (3.06e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.63e-6)" "unprognostic (1.31e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (3.44e-3)" 28.4 48.1 7.9 23.6 11.8 2.0 20.2 7.8 9.2 48.4 23.7 34.6 22.9 29.2 17.8 35.1 19.5 36.4 23.7 9.9 11.4 11.8 54.2 21.2 8.9 13.7 12.5 41.5 25.6 22.4 18.5 35.6 11.2 35.5 33.7 3.1 61.2 27.8 16.6 15.6 24.4 61.7 9.0 8.8 34.4 12.5 12.1 4.3 17.6 22.7 19.5 35.6 26.4 13.4 43.5 30.7 18.5 21.9 197.4 204.7 6.1 167.9 244.1 69.7 105.8 8.1 33.0 0.0 23.0 273.8 118.8 11.9 0.1 53.7 80.1 0.2 4.6 3.1 30.3 40.6 70.6 0.1 5.8 122.1 17.0 101.2 23.3 157.2 101.4 0.1 3.4 0.2 102.9 11.0 0.1 2.3 3.8 18.3 15.6 0.8 90.9 3.2 23.4 8.7 0.7 9.4 33.8 0.7 33.8 42.8 20.8 3.8 156.3 75.4 34.8 95.3 39.5 0.7 0.2 0.3 123.3 3.3 63.0 0.6 3.2 0.0 0.1 3.6 0.0 0.4 0.1 0.1 2.6 0.1 0.1 0.1 2.4 0.0 1.4 0.3 0.0 0.9 7.9 11.8 7.8 9.2 9.9 11.4 13.7 12.5 11.2 9.0 12.1 13.4 28.1 16.0 13.2 5.9 2.2 12.2 47.4 43.7 15.4 0.3 29.9 21.2 17.2 14.3 56.0 7.3 0.0 2.2 0.2 46.8 9.8 45.6 1.0 17.5 88.6 35.2 15.7 3.6 1.0 61.0 47.0 94.9 35.7 39.1 1.3 30.4 31.1 68.3 16.1 0.0 1.8 78.7 83.4 7.2 15.0 6.3 110.9 8.7 21.4 17.8 6.4 12.2 0.0 14.6 31.0 47.6 41.6 116.2 8.5 92.6 39.0 11.7 47.8 1.2 19.7 49.4 44.3 1.2 5.5 23.6 10.2 3.4 3.1 94.1 32.0 82.7 FAM222A "C12orf34, FLJ14721" ENSG00000139438 "Family with sequence similarity 222 member A" Q5U5X8 12 109713825-109770495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 65.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 33.3;Early spermatids: 29.1;Horizontal cells: 77.4;Oligodendrocytes: 78.5;Rod photoreceptor cells: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 116.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040181, HPA075616" Uncertain Approved "Golgi apparatus,Cell Junctions,Midbody ring" Yes NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus" "Cell Junctions, Midbody ring" "HPA040181: AB_10796448, HPA075616: " "unprognostic (8.59e-3)" "prognostic favorable (1.82e-5)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-2)" "unprognostic (1.03e-1)" "unprognostic (6.66e-2)" "unprognostic (8.17e-2)" "prognostic favorable (4.81e-4)" "unprognostic (1.15e-1)" "unprognostic (4.16e-2)" "prognostic favorable (8.59e-4)" "unprognostic (3.93e-2)" "unprognostic (2.77e-1)" "unprognostic (1.24e-1)" 0.7 19.0 23.7 0.7 45.2 0.6 1.2 36.7 34.2 0.6 5.6 1.9 4.8 0.3 0.8 2.3 0.4 0.8 8.9 20.0 27.6 10.6 4.0 2.1 0.4 41.2 43.1 13.4 3.9 0.7 22.4 0.1 37.7 1.8 1.0 22.1 3.4 0.5 4.3 3.2 2.2 0.4 29.0 6.2 7.2 23.4 48.4 0.4 0.7 0.6 0.6 0.9 1.8 65.6 2.0 3.1 1.6 3.7 1.0 0.0 1.1 0.6 0.3 1.6 0.2 28.1 0.5 0.3 2.2 0.8 1.7 1.2 1.9 0.1 0.6 16.8 4.0 3.5 0.9 6.5 0.2 2.8 3.6 0.2 0.2 0.3 0.0 0.4 0.1 2.0 1.2 0.6 0.3 11.5 0.7 3.6 3.0 3.3 5.3 2.3 8.0 1.2 3.5 1.5 19.2 116.4 2.5 3.7 8.2 0.5 4.5 3.0 0.2 0.5 3.2 1.3 2.4 2.9 4.0 2.4 0.3 2.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 45.2 36.7 34.2 20.0 27.6 41.2 43.1 37.7 29.0 48.4 65.6 2.1 0.0 0.0 2.3 3.6 2.2 0.9 0.1 3.4 23.4 7.4 6.1 8.1 1.5 0.8 1.8 33.3 0.3 10.4 1.2 7.9 1.7 29.1 1.2 0.5 1.3 7.7 0.0 1.3 0.8 0.2 1.5 1.5 1.8 0.0 0.7 0.7 1.3 0.3 77.4 6.7 5.8 0.0 0.0 2.1 13.4 1.2 1.9 7.2 0.0 0.1 11.2 0.0 9.5 78.5 1.1 0.2 0.4 1.3 1.7 0.9 0.7 0.6 50.3 0.0 2.6 1.5 1.1 5.7 3.3 1.8 0.8 3.7 6.0 1.6 0.4 FKBP9 "FKBP60, FKBP63" ENSG00000122642 "FKBP prolyl isomerase 9" O95302 7 32957404-33006930 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 108.6;Fibroblasts: 89.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 379.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012595, HPA055256" Approved Approved "Golgi apparatus,Vesicles,Mitochondria" "Intracellular and membrane" No No 63000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus, Mitochondria" Vesicles "HPA012595: AB_1848629, HPA055256: AB_2682761" "unprognostic (1.23e-2)" "prognostic unfavorable (4.22e-4)" "unprognostic (6.94e-2)" "unprognostic (6.25e-3)" "prognostic unfavorable (5.80e-4)" "prognostic unfavorable (2.02e-4)" "prognostic unfavorable (8.69e-4)" "unprognostic (3.40e-2)" "unprognostic (9.59e-2)" "unprognostic (2.58e-1)" "unprognostic (3.63e-2)" "unprognostic (3.30e-2)" "unprognostic (1.36e-2)" "unprognostic (6.31e-2)" "unprognostic (1.97e-1)" "unprognostic (8.90e-3)" "prognostic unfavorable (7.02e-6)" 80.7 44.8 23.9 16.8 24.0 2.3 59.1 26.5 25.3 65.9 28.1 44.8 19.7 55.7 22.4 35.6 50.6 44.4 77.1 21.4 32.1 38.2 21.1 49.6 13.6 28.9 30.2 46.3 40.8 25.1 34.8 77.4 29.3 42.3 45.3 11.7 36.0 52.1 35.0 64.4 31.0 74.4 28.0 23.7 41.0 11.4 34.2 8.2 40.8 49.7 15.8 43.3 52.2 27.9 38.9 71.4 27.6 113.4 254.1 290.2 36.4 202.6 209.9 65.5 103.9 31.6 89.2 0.2 80.7 379.5 105.1 73.3 40.8 100.0 75.2 0.1 11.9 6.6 72.3 31.6 105.6 0.4 10.8 191.8 59.6 59.0 56.9 156.3 83.9 0.1 15.0 7.7 137.3 37.1 0.2 19.4 5.8 76.6 37.3 0.3 73.7 0.3 73.0 13.0 25.7 62.4 115.6 58.4 73.4 69.6 41.1 18.7 112.8 107.0 99.8 67.4 46.8 23.9 48.9 0.2 104.4 0.3 218.5 0.9 2.2 0.5 0.0 1.6 0.0 0.2 0.0 0.0 0.8 0.1 0.1 0.0 4.0 0.1 0.4 0.1 0.0 0.6 23.9 24.0 26.5 25.3 21.4 32.1 28.9 30.2 29.3 28.0 34.2 27.9 108.6 12.8 21.7 22.9 0.6 34.3 12.7 31.4 10.2 8.2 15.7 16.5 46.1 17.2 10.3 18.4 10.4 18.8 0.6 23.2 5.9 19.5 0.5 22.6 25.8 80.1 12.2 1.7 9.8 41.5 27.7 89.1 17.9 23.0 5.7 81.0 60.0 18.0 7.6 11.8 10.2 25.4 10.2 8.6 23.5 3.2 36.7 5.4 60.5 15.0 2.9 30.5 0.0 8.5 8.8 36.5 22.1 55.3 4.4 8.1 18.8 8.1 11.0 5.2 46.0 21.2 45.8 1.0 1.3 12.1 28.6 13.1 3.1 12.3 27.7 10.5 FUT6 "FCT3A, FLJ40754, FT1A, FucT-VI" ENSG00000156413 "Fucosyltransferase 6" P51993 19 5830408-5839722 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 79.4;kidney: 36.1;salivary gland: 45.7" "Cell type enhanced" "Detected in some" "Distal enterocytes: 35.6;Intestinal goblet cells: 39.4;Paneth cells: 21.5;Proximal enterocytes: 101.4;Proximal tubular cells: 45.3;Undifferentiated cells: 29.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 9.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "Hep G2: 10.5;RPMI-8226: 4.0" "HPA043707, HPA046966" Approved Supported "Golgi apparatus" "Secreted to blood" NA NA 51000 "Cluster 10: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA043707: AB_2678628, HPA046966: AB_2679879" "unprognostic (3.65e-2)" "unprognostic (3.00e-3)" "unprognostic (2.13e-3)" "unprognostic (2.78e-3)" "unprognostic (6.35e-2)" "prognostic favorable (2.12e-4)" "unprognostic (8.02e-2)" "unprognostic (6.68e-3)" "unprognostic (4.01e-2)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (4.94e-2)" "prognostic favorable (3.17e-8)" "unprognostic (1.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" 0.1 0.0 0.1 2.6 0.1 0.4 1.7 0.2 0.1 17.3 0.4 17.3 28.6 0.3 0.0 79.4 0.6 9.3 0.0 0.1 0.1 36.1 12.4 0.2 0.1 0.1 0.1 0.0 3.7 0.0 0.0 0.0 0.1 0.2 11.6 2.0 45.7 2.5 0.0 0.1 27.0 0.4 0.1 0.1 4.8 0.2 0.1 0.0 0.0 0.0 6.7 0.0 26.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.2 10.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.7 4.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.5 0.0 0.7 0.0 0.4 3.5 0.0 0.4 3.7 1.9 0.3 18.6 15.7 1.8 0.0 0.2 0.3 35.6 3.9 6.8 0.3 0.6 0.7 0.3 4.9 0.0 0.1 0.4 0.1 0.3 0.0 0.7 0.0 0.2 0.7 5.1 0.1 0.0 0.1 39.4 8.2 0.0 0.8 0.0 0.3 0.4 0.0 0.0 0.0 0.9 0.0 0.5 0.1 2.7 21.5 0.0 0.0 0.2 101.4 45.3 6.4 11.5 0.0 0.3 0.7 1.0 0.6 3.6 0.1 0.0 0.5 0.1 29.0 1.7 GALNT14 "FLJ12691, GalNac-T10, GalNac-T14" ENSG00000158089 "Polypeptide N-acetylgalactosaminyltransferase 14" Q96FL9 2 30910467-31155202 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 41.3" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 21.6;Excitatory neurons: 29.1;Inhibitory neurons: 79.2;Proximal enterocytes: 21.9;Proximal tubular cells: 45.5" "Cancer enriched" "Detected in many" 7 "renal cancer: 45.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 8 "neutrophil: 8.5" "Lineage enriched" "Detected in many" 8 "granulocytes: 8.5" "Cell line enhanced" "Detected in many" "A549: 28.6;RPMI-8226: 32.3;RPTEC TERT1: 41.3;RT4: 35.3;SCLC-21H: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030138 Approved "Nucleoplasm,Golgi apparatus" NA NA 27000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Nucleoplasm "HPA030138: AB_2673332" "unprognostic (5.69e-2)" "unprognostic (1.35e-1)" "unprognostic (2.05e-2)" "unprognostic (2.82e-3)" "unprognostic (3.85e-2)" "unprognostic (2.10e-2)" "unprognostic (3.32e-1)" "unprognostic (7.58e-2)" "unprognostic (1.96e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-3)" "unprognostic (5.18e-3)" "unprognostic (2.67e-2)" "unprognostic (2.56e-1)" "unprognostic (9.51e-3)" 1.2 1.5 3.9 1.0 10.6 5.9 0.8 2.0 4.5 1.3 3.6 0.3 0.5 0.3 0.3 11.8 1.2 2.2 0.3 2.9 3.2 41.3 1.3 0.6 2.2 1.7 6.7 0.1 3.1 4.0 5.9 0.0 0.8 1.6 0.1 0.6 1.2 0.0 0.1 2.1 3.3 0.7 1.8 2.4 0.5 2.5 10.9 0.4 0.9 0.4 4.8 2.3 1.3 3.3 23.6 28.6 0.0 0.0 0.0 0.0 0.0 7.9 4.1 4.9 0.6 0.0 0.0 22.1 7.8 0.4 0.0 0.0 1.0 1.0 0.8 0.6 2.8 12.1 0.0 0.0 0.0 18.2 0.0 0.1 4.5 0.0 17.0 0.2 0.0 0.6 0.0 19.0 0.0 10.7 0.1 0.0 12.6 0.0 0.0 15.5 0.0 32.3 41.3 35.3 24.4 18.3 0.0 0.0 0.1 4.4 0.1 0.0 0.0 0.0 19.6 0.0 0.5 1.9 6.2 0.1 0.0 11.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 3.9 10.6 2.0 4.5 2.9 3.2 1.7 6.7 0.8 1.8 10.9 3.3 2.2 0.0 0.0 1.0 1.4 2.8 4.1 5.3 21.6 0.3 0.6 2.4 1.1 0.0 6.2 9.2 0.0 0.0 0.0 0.3 13.7 2.9 5.7 0.0 0.1 1.2 0.0 0.0 29.1 0.4 0.0 1.1 0.5 0.4 0.0 0.0 8.2 0.2 0.1 0.0 79.2 0.9 2.0 0.6 0.3 12.0 0.0 0.4 0.0 2.8 0.0 0.2 0.0 4.0 8.7 2.6 0.0 0.0 3.1 14.2 21.9 45.5 1.1 0.4 6.6 0.4 2.2 3.4 6.9 9.2 0.9 0.0 0.4 0.2 1.8 5.1 GALNT5 GalNAc-T5 ENSG00000136542 "Polypeptide N-acetylgalactosaminyltransferase 5" Q7Z7M9 2 157257705-157318491 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.5;lung: 10.2;stomach 1: 12.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 157.0;Distal enterocytes: 48.3;Intestinal goblet cells: 75.5;Pancreatic endocrine cells: 53.5;Prostatic glandular cells: 40.1;Urothelial cells: 115.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 9 "cerebellum: 4.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 45.3;BJ: 29.8;BJ hTERT+: 53.5;fHDF/TERT166: 64.5;HaCaT: 51.8;K-562: 30.7;LHCN-M2: 52.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA008963, HPA009035" Approved Approved "Nucleoli,Golgi apparatus,Vesicles,Cytosol" NA NA 1300000 "Cluster 37: Intestine - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus, Cytosol" "Nucleoli, Vesicles" "HPA008963: AB_1078942, HPA009035: AB_1078943" "unprognostic (6.34e-3)" "unprognostic (9.31e-2)" "unprognostic (2.11e-2)" "unprognostic (9.89e-2)" "unprognostic (3.19e-2)" "unprognostic (2.46e-2)" "unprognostic (4.63e-3)" "unprognostic (1.88e-1)" "unprognostic (1.09e-1)" "unprognostic (6.93e-2)" "unprognostic (4.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-2)" "unprognostic (6.27e-2)" "unprognostic (1.29e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-3)" 0.1 0.0 0.0 0.7 0.0 0.6 1.1 4.0 0.3 1.1 5.2 10.6 2.2 0.1 0.1 4.5 0.0 2.7 0.4 0.4 0.0 0.0 0.0 10.2 0.0 0.1 0.1 0.1 0.0 0.1 0.6 0.0 0.2 0.7 13.5 0.1 8.2 0.1 0.0 0.3 4.1 0.4 0.0 0.1 12.8 0.1 0.1 0.1 0.1 0.1 1.7 4.5 4.6 0.2 45.3 4.8 0.0 0.0 2.0 17.0 0.0 29.8 53.5 0.5 1.1 1.9 24.4 0.0 0.1 64.5 0.0 51.8 0.9 10.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.0 0.2 0.0 0.9 0.0 0.0 0.0 30.7 0.0 52.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 25.4 0.3 0.6 0.1 0.0 0.1 0.0 4.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.3 0.4 0.0 0.1 0.1 0.2 0.0 0.1 0.2 0.1 157.0 36.1 0.0 0.1 0.8 13.3 20.2 6.2 0.0 0.5 2.8 0.5 2.8 32.9 0.0 0.0 0.0 0.2 48.3 0.0 1.2 6.9 1.2 0.0 0.6 2.4 5.2 0.8 3.2 0.0 2.1 35.7 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.1 75.5 6.1 0.0 0.7 0.5 0.0 0.3 3.6 0.0 1.6 0.0 0.0 0.0 0.1 53.5 26.4 0.0 1.4 40.1 3.1 0.2 10.0 0.0 0.0 0.5 1.2 2.6 0.5 4.5 0.1 0.0 0.3 0.0 22.7 115.1 GCNT2 "bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3" ENSG00000111846 "Glucosaminyl (N-acetyl) transferase 2 (I blood group)" Q8N0V5 6 10492223-10629368 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 13.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Endometrial ciliated cells: 79.1;Glandular and luminal cells: 105.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 44.2;Hep G2: 19.7;SK-MEL-30: 17.1;SuSa: 21.4" "Region enriched" "Detected in all" 4 "basal ganglia: 61.1" "Low region specificity" "Detected in all" HPA026776 Approved Approved "Golgi apparatus" No No 750000 "Cluster 41: Basophils - Cellular respiration" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "HPA026776: AB_1849573" "unprognostic (2.47e-1)" "unprognostic (6.87e-3)" "unprognostic (3.12e-1)" "unprognostic (1.42e-2)" "unprognostic (9.31e-2)" "unprognostic (2.51e-1)" "unprognostic (4.11e-2)" "unprognostic (2.39e-1)" "unprognostic (1.27e-1)" "unprognostic (2.11e-2)" "unprognostic (6.28e-4)" "unprognostic (3.96e-2)" "unprognostic (1.58e-3)" "unprognostic (6.54e-2)" "unprognostic (6.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" 0.6 0.3 0.7 1.0 0.6 0.3 10.1 2.5 1.1 4.2 4.5 3.6 5.2 1.4 0.2 1.4 0.8 1.5 6.6 0.8 1.1 5.7 5.1 3.9 1.8 1.2 1.0 0.3 1.3 0.4 1.4 2.6 1.4 13.5 2.0 0.3 4.2 0.3 0.7 1.4 5.8 1.6 0.9 1.5 5.9 2.5 0.9 0.5 1.2 1.8 2.4 1.0 0.7 1.0 6.3 4.9 1.5 4.8 0.0 0.0 9.6 0.0 4.1 1.1 0.5 11.0 5.2 3.5 44.2 0.0 3.2 0.3 0.4 5.1 2.9 3.1 1.8 0.5 2.6 19.7 0.0 1.7 4.7 0.0 0.0 0.5 0.0 2.4 9.1 0.0 0.4 0.0 0.4 0.0 0.0 4.0 4.4 0.0 3.6 0.2 3.8 6.0 16.0 2.9 4.0 1.2 0.0 14.4 17.1 21.4 0.3 0.8 6.4 0.8 0.5 0.0 5.0 0.1 0.0 2.4 0.8 0.3 2.3 1.9 1.1 0.5 0.1 0.8 0.0 0.7 0.1 0.1 0.8 0.4 0.1 0.2 0.1 0.2 0.2 0.2 0.0 0.3 0.7 0.6 2.5 1.1 0.8 1.1 1.2 1.0 1.4 0.9 0.9 1.0 1.4 76.9 32.4 1.0 9.5 4.6 6.6 15.5 9.6 5.1 30.5 16.1 18.4 2.8 28.6 7.3 0.0 27.9 6.4 15.5 11.7 2.9 4.3 79.1 5.5 11.0 2.4 25.9 0.7 24.7 2.1 2.0 16.8 105.5 2.5 0.0 12.8 32.0 15.8 3.3 11.8 5.6 6.1 7.7 9.4 8.2 0.3 7.8 49.8 52.5 11.1 2.4 0.0 18.6 1.1 12.0 11.9 0.0 1.0 16.6 44.3 13.4 27.9 0.6 0.0 0.7 2.2 6.2 27.6 11.2 1.7 10.9 3.1 0.0 16.3 8.1 GCNT3 "C2/4GnT, C2GnT-M, C2GnT2" ENSG00000140297 "Glucosaminyl (N-acetyl) transferase 3, mucin type" O95395 15 59594875-59640239 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 75.5;intestine: 142.9;salivary gland: 55.8" "Cell type enhanced" "Detected in many" "Collecting duct cells: 104.8;Distal enterocytes: 360.1;Ductal cells: 92.6;Glandular and luminal cells: 75.6;Paneth cells: 163.2;Proximal enterocytes: 85.5" "Group enriched" "Detected in many" 4 "colorectal cancer: 16.4;pancreatic cancer: 29.8;stomach cancer: 20.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 147.4;EFO-21: 24.6;Hep G2: 30.3;OE19: 75.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011154 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Vesicles "HPA011154: AB_1078961" "unprognostic (5.09e-2)" "unprognostic (2.39e-1)" "unprognostic (5.92e-2)" "prognostic favorable (1.78e-4)" "unprognostic (3.99e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (6.49e-5)" "unprognostic (1.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.34e-1)" "unprognostic (1.64e-2)" "unprognostic (1.63e-1)" "unprognostic (4.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-2)" "unprognostic (4.65e-2)" "unprognostic (2.43e-1)" 0.2 0.7 0.2 11.9 0.2 0.5 0.4 0.6 0.4 19.2 0.2 142.9 97.5 2.0 0.0 15.8 4.2 75.5 0.1 0.2 0.1 17.9 0.4 0.7 0.9 0.1 0.4 0.1 2.1 0.9 0.1 0.1 0.2 1.2 123.2 0.1 55.8 0.3 0.2 0.3 123.3 4.6 0.0 0.1 25.8 4.3 0.2 1.3 2.1 0.0 10.6 9.1 29.9 0.4 0.1 147.4 0.0 0.2 0.0 1.0 0.2 0.1 7.7 0.0 0.0 6.3 6.0 0.6 24.6 0.0 9.5 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.5 30.3 0.0 0.2 0.2 0.3 3.5 0.7 0.0 0.1 0.0 0.2 0.0 0.4 1.4 0.6 0.1 0.2 0.2 75.9 0.3 0.4 0.0 0.6 10.2 1.2 0.2 0.2 0.0 0.2 0.4 0.1 0.1 0.0 0.1 0.2 0.4 7.3 0.1 0.2 0.5 0.8 8.9 0.3 0.1 0.9 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.7 0.2 0.1 0.3 0.1 0.0 0.2 0.2 0.6 0.4 0.2 0.1 0.1 0.4 0.2 0.0 0.2 0.4 0.0 0.0 2.2 0.0 1.0 0.0 18.3 8.9 0.0 0.0 0.5 0.0 0.7 11.5 40.5 104.8 0.0 0.0 0.1 360.1 0.0 92.6 9.8 23.3 8.6 0.3 7.8 0.0 0.0 14.9 0.0 0.2 27.5 75.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 26.9 8.2 0.6 0.0 19.2 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 58.4 163.2 0.0 0.1 8.0 85.5 4.4 9.8 0.0 6.6 0.6 1.5 3.0 0.3 1.4 0.0 0.0 0.8 0.0 48.5 52.4 GCNT4 "C2GNT3, LINC01336" ENSG00000176928 "Glucosaminyl (N-acetyl) transferase 4" Q9P109 5 75025346-75052558 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 24.0;lymphoid tissue: 15.4;stomach 1: 18.5" "Cell type enhanced" "Detected in many" "Cholangiocytes: 32.9;Cytotrophoblasts: 39.6;Glandular and luminal cells: 16.7;Proximal enterocytes: 28.0;Syncytiotrophoblasts: 24.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 20 "amygdala: 1.1;basal ganglia: 1.8;cerebral cortex: 3.3;hippocampal formation: 2.1;white matter: 1.4" "Immune cell enhanced" "Detected in many" "basophil: 22.4" "Group enriched" "Detected in many" 53 "granulocytes: 22.4;T-cells: 18.2" "Cell line enriched" "Detected in some" 5 "RT4: 37.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037431 Approved Supported "Nucleoplasm,Golgi apparatus" No NA "Cluster 20: T-cells - T-cell receptor" "Cluster 56: Intestine - Transmembrane transport" "Cluster 15: RT4 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" Nucleoplasm "HPA037431: AB_10670382" "unprognostic (1.88e-2)" "unprognostic (5.63e-2)" "unprognostic (6.05e-2)" "unprognostic (1.28e-1)" "unprognostic (1.12e-1)" "unprognostic (4.98e-2)" "unprognostic (4.11e-3)" "unprognostic (1.63e-2)" "unprognostic (3.47e-1)" "unprognostic (2.20e-2)" "unprognostic (4.49e-3)" "unprognostic (6.04e-2)" "prognostic favorable (1.93e-7)" "unprognostic (8.39e-2)" "unprognostic (1.93e-1)" "unprognostic (6.06e-2)" "unprognostic (5.82e-2)" 0.9 0.8 1.1 2.9 1.8 0.7 1.3 0.0 3.3 1.4 0.0 1.4 24.0 1.2 1.9 2.2 2.1 5.3 0.4 2.1 0.0 4.1 1.1 1.7 4.4 0.0 0.0 1.0 4.6 9.6 0.2 6.3 0.0 1.7 1.3 0.1 0.5 4.8 1.0 2.1 20.2 2.3 0.0 1.7 18.5 1.6 0.0 15.4 0.5 1.4 3.0 4.1 1.8 1.4 0.3 0.2 1.4 2.3 2.5 0.8 0.1 2.8 7.2 1.5 1.2 3.7 0.2 0.0 0.4 2.2 0.8 1.0 1.4 2.5 0.3 0.0 0.1 1.2 0.3 0.3 1.1 0.0 0.0 0.4 3.9 0.1 0.5 0.0 0.0 2.2 0.0 0.5 0.2 0.0 2.1 0.1 0.6 8.0 0.0 0.0 0.0 3.6 0.3 37.1 0.0 0.1 0.3 0.0 0.1 7.0 0.0 0.0 0.0 0.8 0.2 1.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 22.4 0.0 0.0 1.2 0.0 5.0 0.0 11.4 3.7 0.0 0.0 11.1 8.1 0.2 0.3 0.2 0.1 18.2 2.3 1.1 1.8 0.0 3.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 3.2 5.0 0.7 0.3 0.6 8.7 0.5 0.0 0.0 0.9 2.3 0.5 32.9 2.7 12.9 0.0 39.6 0.8 4.9 9.8 7.1 0.1 11.9 2.4 1.8 0.0 0.0 1.3 4.4 0.9 2.5 14.8 16.7 7.6 2.0 3.3 0.7 2.3 0.0 0.0 2.7 0.0 0.3 0.0 0.3 4.1 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.2 6.9 2.6 0.5 3.0 28.0 0.7 0.6 0.0 6.6 1.6 2.5 0.2 1.7 0.6 0.1 24.4 3.7 0.0 4.4 4.2 GDPD5 "GDE2, PP1665" ENSG00000158555 "Glycerophosphodiester phosphodiesterase domain containing 5" Q8WTR4 11 75434640-75525941 "Enzymes, Predicted membrane proteins" Neurogenesis Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 116.6;retina: 83.5" "Group enriched" "Detected in many" 4 "Bipolar cells: 60.9;Cone photoreceptor cells: 148.0;Early spermatids: 52.1;Late spermatids: 178.0;Rod photoreceptor cells: 88.4;Syncytiotrophoblasts: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 7.7" "Group enriched" "Detected in many" 6 "granulocytes: 7.7;T-cells: 2.0" "Cell line enhanced" "Detected in many" "EFO-21: 32.8;fHDF/TERT166: 32.4;HDLM-2: 66.9;U-2 OS: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065257, HPA066762, HPA069281" Uncertain Approved "Golgi apparatus" No No "Cluster 38: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "HPA065257: AB_2685447, HPA066762: AB_2685715, HPA069281: AB_2686107" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.48e-1)" "unprognostic (6.12e-2)" "unprognostic (9.97e-3)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-1)" "unprognostic (3.07e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.59e-9)" "unprognostic (8.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.65e-1)" 31.0 8.7 19.5 4.8 22.1 12.8 24.6 17.4 12.9 12.4 6.0 7.3 2.7 17.9 1.8 3.3 10.3 4.3 9.5 10.5 14.5 7.8 8.1 15.2 6.7 14.2 27.0 7.3 38.1 0.8 19.1 14.0 10.2 11.5 1.6 83.5 21.3 5.3 13.1 7.4 10.0 6.5 7.4 116.6 4.8 38.9 42.1 3.1 7.7 8.7 4.7 12.6 9.9 12.4 2.1 7.5 3.2 3.7 2.2 1.1 11.1 2.3 3.1 1.1 0.7 10.0 4.4 14.2 32.8 32.4 8.1 4.7 4.0 3.8 0.6 66.9 3.1 2.6 11.7 21.2 3.2 1.6 10.7 2.4 2.0 0.8 1.6 3.2 26.7 12.7 4.7 6.3 1.5 4.5 3.9 7.1 5.7 3.7 10.6 4.5 0.9 3.9 0.9 3.6 1.7 1.2 4.8 18.3 9.3 4.1 2.7 6.3 7.9 7.5 30.4 5.8 2.6 1.6 0.3 2.8 1.7 8.5 0.8 7.7 0.8 0.5 1.2 0.3 1.7 0.6 1.3 0.9 0.2 0.2 0.7 0.9 0.1 0.0 0.0 0.7 2.0 0.5 19.5 22.1 17.4 12.9 10.5 14.5 14.2 27.0 10.2 7.4 42.1 12.4 4.2 6.4 0.0 1.6 5.4 1.0 0.3 0.7 0.6 60.9 3.6 3.4 3.0 1.5 1.3 0.0 148.0 3.2 9.1 0.5 0.0 4.2 52.1 1.0 10.4 7.0 0.0 8.2 5.0 9.3 1.5 6.6 1.1 1.5 4.5 1.6 20.7 2.4 1.9 5.0 15.8 0.7 0.0 2.8 3.7 178.0 5.9 3.1 5.4 8.4 4.9 8.9 1.0 1.0 0.8 4.7 0.3 2.6 5.0 0.8 0.3 0.1 0.8 88.4 0.0 4.6 1.9 12.9 8.2 0.1 1.1 46.0 7.0 0.9 2.0 0.6 GNPTAB "GNPTA, KIAA1208, MGC4170" ENSG00000111670 "N-acetylglucosamine-1-phosphate transferase subunits alpha and beta" Q3T906 12 101745499-101830959 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Cancer-related genes, Disease variant, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 192.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014558, HPA042343" Approved Supported "Golgi apparatus" NA NA 160000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "HPA014558: AB_2732409, HPA042343: " "unprognostic (6.72e-2)" "unprognostic (1.66e-1)" "unprognostic (8.71e-3)" "prognostic favorable (8.48e-4)" "unprognostic (1.39e-1)" "unprognostic (8.37e-2)" "unprognostic (2.73e-1)" "unprognostic (8.57e-2)" "unprognostic (3.73e-2)" "unprognostic (1.09e-2)" "unprognostic (2.28e-2)" "unprognostic (2.00e-1)" "unprognostic (6.86e-2)" "unprognostic (3.44e-1)" "unprognostic (1.02e-1)" "unprognostic (5.44e-2)" "unprognostic (4.98e-2)" 11.9 7.9 18.8 16.2 22.2 23.9 16.4 14.4 20.0 17.4 2.7 29.6 14.2 11.8 6.2 15.6 8.8 14.8 21.5 22.7 10.8 14.5 9.4 27.0 20.6 8.5 11.1 7.2 11.3 23.0 8.4 14.8 9.7 20.1 30.3 13.0 54.3 13.0 16.4 25.1 16.2 15.9 8.9 19.0 21.3 10.4 12.4 34.1 13.9 25.9 17.8 19.3 12.0 13.3 18.2 17.5 6.4 10.9 52.3 24.8 19.6 25.4 52.3 24.7 32.2 13.5 12.4 38.1 17.9 35.1 20.1 23.2 29.8 32.8 38.4 18.1 15.6 16.3 15.4 19.3 9.7 15.0 31.7 19.3 17.7 23.5 13.8 61.4 44.0 30.0 25.9 11.0 23.4 27.8 45.6 21.0 22.0 22.6 12.5 10.6 32.6 51.2 39.5 46.8 13.6 11.2 42.3 29.7 60.7 23.5 30.6 9.8 43.6 23.1 12.5 19.6 14.4 30.0 32.9 21.5 26.4 21.8 14.6 8.6 3.8 4.4 18.8 3.6 6.2 3.0 4.0 10.3 7.1 4.9 5.1 7.9 1.4 17.0 4.6 6.9 3.3 3.7 18.8 22.2 14.4 20.0 22.7 10.8 8.5 11.1 9.7 8.9 12.4 13.3 25.3 60.9 65.0 35.9 42.1 16.8 32.9 16.2 17.1 23.6 25.2 18.9 43.5 18.6 27.8 22.0 25.0 25.7 107.3 68.3 7.9 10.3 0.6 25.3 23.7 21.1 18.0 19.5 84.5 15.1 15.0 18.9 33.1 61.6 122.8 24.6 10.4 9.7 46.7 8.4 83.8 29.6 24.4 46.7 17.6 3.8 17.1 41.2 42.7 30.0 43.5 26.9 192.6 135.2 19.8 15.7 129.3 12.8 63.9 28.1 17.7 13.8 10.0 37.0 0.0 18.6 14.9 12.4 33.0 26.7 14.3 8.8 63.4 30.6 49.7 46.5 GOLGA1 "golgin-97, MGC33154" ENSG00000136935 "Golgin A1" Q92805 9 124878275-124948492 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013065, HPA044329, HPA050555" Supported Enhanced "Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 77: Retina - Visual perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" "CAB013065: AB_221447, HPA044329: AB_2678897, HPA050555: AB_2681174" "unprognostic (5.44e-2)" "unprognostic (9.35e-2)" "unprognostic (6.92e-2)" "prognostic favorable (2.21e-4)" "unprognostic (9.34e-2)" "unprognostic (4.43e-1)" "unprognostic (4.40e-2)" "unprognostic (6.03e-2)" "unprognostic (5.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.03e-3)" "unprognostic (3.06e-1)" "unprognostic (6.28e-3)" "unprognostic (4.05e-3)" "unprognostic (2.38e-1)" "unprognostic (2.24e-3)" "unprognostic (2.52e-2)" 8.7 9.4 5.4 8.7 7.0 5.9 7.8 5.8 6.3 8.0 7.1 10.8 10.1 8.8 5.9 9.9 7.7 7.6 10.2 5.1 5.9 6.8 9.5 7.5 7.6 6.1 6.4 8.0 10.8 9.1 8.0 5.6 6.9 8.3 9.3 37.7 8.4 8.3 13.2 10.8 9.6 8.6 6.1 8.5 8.7 15.2 6.8 5.3 8.2 9.6 7.4 10.4 8.1 9.0 8.4 14.7 8.6 9.1 14.7 13.0 11.0 13.5 14.3 14.0 10.2 9.7 9.6 5.6 6.5 15.0 10.8 21.2 7.1 11.4 10.2 8.0 7.0 5.9 20.5 12.9 16.9 7.1 13.7 8.8 8.1 13.5 16.3 9.9 12.7 7.0 9.8 9.4 10.0 17.5 5.1 8.0 3.2 19.7 13.5 3.2 12.7 12.3 7.0 11.3 5.0 9.5 16.2 13.0 8.5 7.6 25.1 5.0 14.8 13.0 7.2 16.8 12.6 11.4 19.6 6.5 16.3 7.4 13.8 8.1 3.4 4.3 4.2 3.5 3.4 3.0 2.6 4.5 3.3 3.5 2.7 2.5 7.6 3.2 2.8 4.6 2.7 1.3 5.4 7.0 5.8 6.3 5.1 5.9 6.1 6.4 6.9 6.1 6.8 9.0 11.8 6.4 14.4 32.3 8.1 2.0 4.2 5.8 6.2 16.3 10.2 10.2 21.0 7.2 10.8 5.5 64.6 6.8 11.5 11.7 3.9 9.5 16.2 10.4 13.6 10.0 5.4 5.0 31.7 8.9 4.9 7.8 10.7 8.8 15.8 14.6 10.8 14.8 6.6 18.5 31.4 9.7 12.2 7.3 4.2 9.8 5.9 9.3 8.8 20.6 10.1 15.2 9.2 27.2 34.3 9.0 2.7 9.1 11.1 4.5 7.8 6.1 17.8 38.0 6.6 15.4 12.3 50.1 21.4 11.0 4.3 8.6 9.1 10.9 8.8 4.0 GOLGA8A "CFAP286, FAP286, GM88, GOLGIN-67" ENSG00000175265 "Golgin A8 family member A" A7E2F4 15 34379068-34437466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 211.5;Oligodendrocyte precursor cells: 146.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 48.0;HeLa: 80.1" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Cluster 15: NK-cells - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (4.80e-2)" "unprognostic (1.26e-2)" "unprognostic (4.54e-1)" "unprognostic (1.32e-1)" "unprognostic (2.42e-2)" "unprognostic (2.10e-2)" "unprognostic (8.11e-3)" "prognostic favorable (7.58e-4)" "unprognostic (2.74e-2)" "unprognostic (4.37e-1)" "unprognostic (2.63e-3)" "unprognostic (2.25e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (2.23e-1)" "unprognostic (1.39e-1)" "unprognostic (2.26e-1)" "prognostic favorable (5.68e-6)" 24.5 18.6 16.1 10.4 11.7 7.9 32.4 18.5 21.4 56.3 11.0 32.7 10.5 31.6 31.8 31.2 37.6 7.3 23.6 13.1 10.0 33.2 6.8 22.4 14.0 17.8 8.8 62.5 22.9 6.3 22.8 2.2 11.9 37.8 2.2 26.4 26.8 10.2 7.6 36.8 38.2 3.2 7.0 48.1 30.3 40.0 12.8 1.2 56.8 1.0 2.1 33.0 40.2 12.2 2.4 13.4 3.7 12.5 0.1 0.0 2.8 20.3 0.1 3.4 1.5 23.3 0.0 0.1 3.6 2.4 6.9 21.7 9.5 6.8 5.3 20.1 7.6 48.0 80.1 15.0 1.3 18.4 12.6 0.0 19.5 2.3 0.5 2.3 0.3 7.0 46.0 40.0 9.2 4.3 4.7 34.6 6.9 6.4 7.2 19.6 11.2 16.2 7.7 13.8 17.1 8.2 13.6 9.2 2.2 0.1 3.6 11.4 10.5 15.7 3.5 0.0 3.6 37.5 13.4 5.5 4.7 38.9 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.1 11.7 18.5 21.4 13.1 10.0 17.8 8.8 11.9 7.0 12.8 12.2 37.3 211.5 71.6 82.9 16.1 26.1 10.9 13.4 7.4 95.3 36.1 41.9 35.0 5.7 127.6 1.8 100.1 2.9 21.1 6.5 0.0 4.2 37.5 17.6 83.9 18.4 16.1 2.5 114.4 2.6 5.0 17.4 13.7 52.3 13.9 39.3 14.6 1.5 2.4 84.1 91.8 11.9 14.2 6.8 20.1 8.4 31.4 8.5 23.2 38.4 1.7 14.8 6.2 146.8 62.5 4.7 6.9 21.1 19.3 8.5 6.6 0.9 52.0 117.6 0.0 26.7 22.4 33.0 23.5 7.8 21.6 3.3 32.9 39.9 11.7 9.4 GOLGA8B ENSG00000215252 "Golgin A8 family member B" A8MQT2 15 34525207-34588503 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 228.4" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 192.3;Excitatory neurons: 133.4;Inhibitory neurons: 126.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 14.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 20.4;Hep G2: 16.2;NB-4: 24.5" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Cluster 41: Basophils - Cellular respiration" "Cluster 25: Pancreas - Digestion" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (2.12e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.89e-1)" "unprognostic (2.43e-1)" "unprognostic (4.06e-2)" "unprognostic (7.90e-3)" "unprognostic (9.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.06e-1)" "unprognostic (1.60e-3)" "unprognostic (1.49e-2)" "prognostic unfavorable (9.38e-6)" "unprognostic (2.14e-1)" "unprognostic (5.31e-3)" "unprognostic (2.31e-1)" "prognostic favorable (5.79e-4)" 16.5 28.8 10.9 7.2 11.0 18.4 20.8 13.8 15.0 28.7 10.8 18.6 0.9 16.8 11.9 10.0 27.9 6.9 15.5 11.0 11.1 41.1 41.8 23.8 19.6 11.2 10.9 55.6 228.4 0.7 60.6 3.0 10.9 37.8 1.4 8.0 18.1 10.6 10.1 13.4 25.2 2.0 10.9 38.5 28.7 43.2 11.1 2.8 113.8 1.3 7.4 19.7 13.4 11.2 2.6 2.8 0.3 5.3 2.8 5.4 7.3 2.3 0.7 2.5 4.0 2.8 3.5 0.0 4.7 2.5 0.3 2.1 0.9 2.4 1.9 3.6 8.4 0.4 20.4 16.2 3.9 2.3 2.5 7.8 3.3 1.5 4.5 2.7 2.6 4.0 0.9 0.2 2.3 1.2 1.2 24.5 3.2 5.0 4.6 0.1 0.0 0.4 2.2 4.9 3.8 5.8 1.3 0.4 3.2 3.9 2.2 4.8 0.0 3.7 8.8 1.1 4.0 1.8 1.7 3.9 1.2 1.2 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 11.0 13.8 15.0 11.0 11.1 11.2 10.9 10.9 10.9 11.1 11.2 19.0 192.3 66.5 95.0 34.8 21.9 8.8 10.9 33.0 53.6 30.9 34.3 37.4 20.0 74.7 31.3 73.0 7.6 30.6 2.8 1.9 9.2 53.8 17.3 27.1 11.0 7.2 13.0 133.4 13.0 5.4 12.7 20.4 24.5 9.5 36.4 11.0 28.7 1.5 45.4 126.1 10.1 12.2 6.6 9.9 10.8 39.4 5.0 21.4 12.2 6.4 9.3 32.0 112.1 24.2 16.8 4.9 37.6 45.1 7.6 7.1 5.8 39.9 67.8 13.1 13.5 13.8 48.9 28.4 10.0 14.8 2.9 49.8 22.0 9.4 6.6 GOPC "CAL, dJ94G16.2, FIG, GOPC1, PIST" ENSG00000047932 "Golgi associated PDZ and coiled-coil motif containing" Q9HD26 6 117560269-117602542 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019477, HPA024018" Approved Enhanced "Golgi apparatus" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA019477: AB_1849890, HPA024018: AB_1849891" "unprognostic (2.48e-2)" "unprognostic (1.63e-3)" "unprognostic (1.71e-1)" "unprognostic (5.56e-2)" "unprognostic (1.84e-2)" "unprognostic (3.17e-2)" "unprognostic (3.12e-2)" "unprognostic (9.21e-2)" "unprognostic (6.22e-2)" "unprognostic (6.77e-2)" "unprognostic (8.23e-2)" "unprognostic (9.46e-2)" "unprognostic (1.40e-2)" "unprognostic (2.67e-2)" "unprognostic (1.38e-1)" "unprognostic (9.55e-2)" "unprognostic (3.01e-2)" 15.5 14.2 14.6 15.8 14.9 7.1 20.2 15.6 18.0 23.4 11.0 18.7 12.2 23.5 18.0 12.1 17.4 16.3 22.1 15.9 13.3 14.5 16.4 13.6 19.9 12.5 12.5 25.6 12.7 22.1 16.1 19.9 13.1 16.2 20.3 13.5 14.3 17.3 15.8 18.7 15.0 18.4 13.6 16.9 14.9 17.7 12.6 21.0 23.9 17.4 17.2 15.1 14.7 16.8 14.1 15.0 19.1 25.6 40.1 47.9 30.3 57.1 41.7 30.6 31.5 23.1 15.5 42.2 24.3 32.4 60.4 31.2 37.2 27.6 42.8 21.2 20.8 38.7 39.9 37.5 42.4 52.2 24.8 57.4 74.9 22.8 65.7 60.6 26.5 29.0 36.7 16.8 62.2 12.9 21.8 40.3 16.5 24.0 16.0 33.0 37.0 30.8 23.3 12.9 26.7 21.0 57.6 19.7 15.8 36.3 14.3 49.7 31.8 2.2 27.9 28.5 62.6 29.9 28.8 35.4 37.9 43.4 23.9 10.5 4.2 3.2 6.7 3.9 9.3 7.9 7.1 7.1 5.5 7.7 8.2 8.5 2.9 9.2 4.7 9.2 7.7 4.1 14.6 14.9 15.6 18.0 15.9 13.3 12.5 12.5 13.1 13.6 12.6 16.8 43.2 22.4 22.7 46.4 33.4 46.7 25.1 63.9 46.7 59.2 47.0 67.3 46.2 34.3 32.2 20.2 22.9 77.0 28.6 40.4 27.4 27.9 35.1 30.4 77.4 38.1 33.6 26.5 52.9 25.6 62.4 48.3 30.1 30.6 31.1 50.4 35.0 38.7 38.5 74.0 46.2 65.2 24.4 24.2 22.9 13.7 42.3 27.0 28.4 32.8 24.1 39.3 35.0 73.9 64.5 21.1 40.9 42.2 38.7 40.3 20.9 27.1 35.3 35.9 32.9 50.0 44.3 115.6 51.4 36.7 59.8 52.3 38.7 43.3 37.7 27.3 GPR108 LUSTR2 ENSG00000125734 "G protein-coupled receptor 108" Q9NPR9 19 6729914-6737603 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041924, HPA041951, HPA063863" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" Vesicles "HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: AB_2685135" "unprognostic (2.00e-1)" "unprognostic (1.69e-1)" "unprognostic (1.07e-1)" "prognostic favorable (1.04e-7)" "unprognostic (1.58e-1)" "unprognostic (5.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (4.23e-2)" "unprognostic (3.01e-2)" "unprognostic (7.89e-2)" "unprognostic (3.57e-2)" "prognostic favorable (1.29e-9)" "unprognostic (8.68e-3)" "unprognostic (2.95e-2)" "unprognostic (4.96e-3)" "unprognostic (4.13e-3)" 29.9 45.2 26.9 18.8 29.3 26.2 32.7 29.7 27.2 36.8 29.9 39.9 32.9 31.6 31.6 39.6 40.1 32.2 22.5 24.2 29.4 42.1 34.4 32.4 23.2 28.9 28.1 34.5 46.7 49.0 23.2 22.2 27.5 34.4 28.1 27.8 57.5 40.2 18.4 31.2 36.6 26.3 27.7 33.3 35.8 25.5 29.1 23.5 41.3 20.5 27.8 31.0 32.9 27.8 33.5 35.9 21.7 42.6 83.0 44.8 24.4 25.6 77.0 34.7 36.7 22.2 37.5 15.8 46.4 52.4 41.6 28.1 24.7 53.3 17.8 64.1 28.4 25.7 37.7 29.6 81.3 16.7 33.7 48.7 100.2 33.5 67.2 45.9 41.3 37.9 26.4 102.7 35.6 23.3 29.5 24.0 15.6 60.2 31.5 23.7 24.7 61.0 72.7 32.6 0.2 23.4 25.9 41.8 38.7 18.4 39.9 40.0 34.4 19.7 12.5 63.2 27.6 66.2 39.3 11.4 68.0 52.9 21.7 79.3 116.1 123.0 82.6 109.7 75.2 48.2 65.2 70.4 84.6 49.9 45.9 52.8 178.4 80.9 130.5 30.0 81.2 132.7 26.9 29.3 29.7 27.2 24.2 29.4 28.9 28.1 27.5 27.7 29.1 27.8 40.8 9.6 14.5 12.7 26.3 26.5 43.7 107.4 21.1 28.3 42.7 33.0 8.0 45.8 59.7 36.8 22.9 58.7 31.1 76.4 37.2 87.7 38.0 30.8 23.6 32.7 21.7 6.9 5.4 110.1 37.2 27.4 39.3 44.1 26.0 15.0 40.7 26.7 57.1 21.9 6.0 57.6 81.4 30.3 46.7 94.9 23.6 42.4 30.2 5.6 50.3 46.0 42.2 7.5 9.6 83.3 83.7 18.4 27.8 29.1 121.2 55.0 39.8 43.0 39.5 22.2 26.4 34.3 19.9 27.2 31.8 58.6 38.9 28.3 47.1 36.1 GSX1 "Gsh-1, GSH1" ENSG00000169840 "GS homeobox 1" Q9H4S2 13 27792483-27794768 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 41 "brain: 7.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 29 "glioma: 3.9" "Region enriched" "Detected in some" 4 "hypothalamus: 7.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA047096 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 43: Cardiomyocytes - Nuclear processes" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA047096: AB_2679929" "unprognostic (1.62e-1)" 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.5 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.3 0.3 7.5 0.4 0.2 0.2 0.2 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HELLS "LSH, Nbla10143, PASG, SMARCA6" ENSG00000119969 "Helicase, lymphoid specific" Q9NRZ9 10 94501434-94613905 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Developmental protein, Helicase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.3;lymphoid tissue: 15.9" "Cell type enhanced" "Detected in many" "Spermatocytes: 182.0;Spermatogonia: 173.9" "Cancer enhanced" "Detected in all" "testis cancer: 16.1" "Region enhanced" "Detected in many" "cerebellum: 5.5" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 36.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004491, HPA063242" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" No Yes "Cluster 35: T-regs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Golgi apparatus, Vesicles" "CAB004491: AB_627895, HPA063242: AB_2684968" "unprognostic (1.94e-1)" "prognostic favorable (1.36e-4)" "unprognostic (9.85e-2)" "unprognostic (3.38e-2)" "unprognostic (8.65e-2)" "unprognostic (4.85e-3)" "unprognostic (1.76e-5)" "unprognostic (7.59e-3)" "unprognostic (7.03e-3)" "unprognostic (6.49e-2)" "unprognostic (2.05e-2)" "unprognostic (9.45e-5)" "unprognostic (9.93e-13)" "unprognostic (2.25e-2)" "unprognostic (1.72e-1)" "unprognostic (6.24e-2)" "unprognostic (3.03e-2)" 1.1 1.2 0.8 6.4 0.3 16.3 3.0 5.5 1.2 3.2 1.3 4.3 2.9 2.9 1.4 5.9 1.7 2.0 0.7 0.4 1.3 2.5 1.8 1.7 12.4 0.8 0.8 2.6 1.2 1.4 3.0 4.1 1.0 2.1 5.1 1.1 1.9 1.0 0.3 5.3 3.9 2.2 0.9 4.3 3.7 12.8 0.9 15.9 1.1 0.2 12.6 3.6 3.2 1.5 57.7 55.4 70.6 90.1 2.9 6.4 37.4 42.9 27.8 34.4 54.6 70.3 45.5 70.0 16.7 15.5 29.1 56.3 40.9 34.9 50.7 68.5 45.5 37.3 56.3 58.0 1.7 71.2 31.6 3.6 2.0 42.1 20.0 9.4 24.0 46.0 20.7 43.5 43.1 54.9 75.2 35.6 73.4 42.3 24.1 70.3 62.1 16.3 24.2 72.2 28.4 22.8 50.3 14.5 7.8 59.0 60.9 23.1 17.2 38.4 19.4 35.4 52.4 22.3 47.6 74.5 19.0 42.8 17.9 0.3 0.7 0.0 7.0 1.5 2.4 18.8 11.4 9.4 2.3 23.2 5.2 7.7 1.0 10.2 1.0 36.8 19.7 2.3 0.8 0.3 5.5 1.2 0.4 1.3 0.8 0.8 1.0 0.9 0.9 1.5 4.7 9.6 3.9 0.0 19.7 21.5 11.5 12.6 13.1 16.4 10.0 15.0 1.0 12.8 12.6 22.0 0.0 46.3 13.2 26.2 3.9 9.0 2.0 9.3 16.4 8.1 10.8 50.5 3.3 6.2 43.4 13.0 17.9 16.3 5.7 60.6 5.7 3.6 15.1 6.7 5.4 17.8 8.2 2.2 10.3 5.3 9.0 7.3 1.8 9.4 5.7 4.3 1.0 4.5 6.6 4.7 1.8 5.7 37.5 3.7 1.7 1.6 6.3 11.4 19.7 10.5 16.4 182.0 173.9 22.9 9.9 11.1 15.7 16.5 30.9 11.7 HEPN1 ENSG00000221932 "Hepatocellular carcinoma, down-regulated 1" Q6WQI6 11 124919244-124920677 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 11.4;brain: 37.3;liver: 20.9" "Group enriched" "Detected in some" 23 "Astrocytes: 94.3;Muller glia cells: 29.1;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 114.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 287 "Hep G2: 55.5" "HPA043768, HPA063054" Uncertain Approved "Golgi apparatus" Yes NA "Cluster 15: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 64: Astrocytes - Nervous system maintenance" "Golgi apparatus" "HPA043768: AB_2678662, HPA063054: AB_2684932" 11.4 0.2 6.1 0.1 23.1 0.0 8.3 0.3 9.4 0.4 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.6 5.0 6.1 0.2 20.9 0.1 0.1 37.3 10.3 0.1 0.2 0.0 2.4 0.0 13.5 0.8 0.0 2.2 0.4 0.0 0.2 0.3 0.7 0.0 5.1 0.1 0.5 0.5 19.0 0.0 0.2 0.0 0.0 0.2 0.5 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 23.1 0.3 9.4 5.0 6.1 37.3 10.3 13.5 5.1 19.0 17.9 0.2 0.0 0.0 94.3 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 3.1 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.5 0.6 0.0 0.0 1.9 0.0 29.1 0.0 49.3 114.6 0.0 0.0 1.2 0.0 0.1 0.0 2.2 0.0 1.9 0.0 0.1 0.1 1.8 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 HGD "AKU, HGO" ENSG00000113924 "Homogentisate 1,2-dioxygenase" Q93099 3 120628172-120682269 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "kidney: 200.3;liver: 752.6" "Cell type enhanced" "Detected in many" "Distal tubular cells: 103.7;Endometrial ciliated cells: 113.9;Glandular and luminal cells: 127.8;Hepatocytes: 534.7;Proximal tubular cells: 477.5" "Cancer enriched" "Detected in many" 4 "liver cancer: 119.8" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 6 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "CACO-2: 55.8;EFO-21: 82.7;Hep G2: 186.6;OE19: 328.0;RPTEC TERT1: 212.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.2" "HPA047374, HPA052359" Enhanced Approved "Golgi apparatus" NA NA 700000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA047374: AB_2680019, HPA052359: AB_2681798" "unprognostic (1.36e-1)" "unprognostic (9.89e-2)" "unprognostic (3.93e-2)" "prognostic favorable (1.78e-4)" "unprognostic (1.56e-1)" "unprognostic (2.05e-1)" "unprognostic (5.65e-3)" "unprognostic (7.20e-2)" "unprognostic (6.05e-2)" "unprognostic (2.41e-3)" "unprognostic (2.68e-2)" "unprognostic (1.16e-1)" "unprognostic (4.29e-3)" "unprognostic (8.57e-2)" "unprognostic (1.78e-1)" "unprognostic (3.71e-3)" "unprognostic (1.43e-1)" 0.4 0.3 0.4 2.5 1.9 0.5 12.5 0.6 0.8 27.4 1.5 16.7 31.6 3.1 13.0 0.4 4.2 61.7 0.3 0.5 0.4 200.3 752.6 0.8 0.4 0.4 0.4 0.2 31.2 7.0 0.2 0.2 0.4 44.5 20.3 0.7 4.2 4.2 0.1 0.9 25.6 0.5 0.4 0.6 25.5 0.1 0.5 0.7 55.1 0.2 0.1 0.2 0.1 0.6 0.0 12.3 4.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 55.8 10.7 0.1 82.7 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.2 186.6 0.0 0.4 1.0 0.0 0.2 0.1 0.0 0.1 0.1 0.4 0.0 0.3 0.5 0.0 0.0 0.2 0.3 328.0 0.0 0.1 0.3 0.1 212.2 0.0 0.2 0.2 0.2 0.9 0.0 0.0 0.2 1.0 0.6 0.1 0.9 0.2 0.1 0.0 0.3 0.5 0.2 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.3 0.4 1.9 0.6 0.8 0.5 0.4 0.4 0.4 0.4 0.4 0.5 0.6 0.1 0.0 2.0 0.3 5.9 0.0 0.4 0.6 0.0 0.3 7.5 1.7 0.3 81.5 4.9 27.6 2.1 0.0 0.3 18.5 103.7 7.2 0.2 113.9 17.1 1.2 43.8 24.0 3.2 17.8 0.0 0.4 19.4 127.8 1.3 0.0 16.4 534.7 0.2 0.0 0.6 16.0 2.0 16.1 0.0 0.0 0.0 21.3 0.0 1.9 2.0 4.2 0.0 0.0 0.5 12.1 35.6 0.0 0.0 12.9 54.6 477.5 4.1 0.2 0.0 0.2 1.1 0.1 0.0 0.0 0.0 0.0 3.8 0.4 9.1 0.4 IGFBP1 "AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12" ENSG00000146678 "Insulin like growth factor binding protein 1" P08833 7 45888360-45893660 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 1198.4" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 994.8" "Cancer enriched" "Detected in many" 29 "liver cancer: 385.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "Hep G2: 54.7;U-2197: 84.9;U-87 MG: 145.3" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004445, HPA046972, HPA050640" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 28100000 25000000 "Cluster 85: Liver - Metabolism" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus" "CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197" "unprognostic (8.66e-3)" "unprognostic (1.45e-1)" "unprognostic (9.41e-2)" "unprognostic (7.80e-2)" "unprognostic (7.04e-2)" "unprognostic (2.93e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.89e-2)" "unprognostic (2.09e-3)" "unprognostic (8.95e-2)" "prognostic unfavorable (6.90e-11)" "prognostic unfavorable (6.64e-4)" "unprognostic (7.20e-2)" "unprognostic (7.98e-2)" "unprognostic (3.43e-1)" 2.6 0.1 0.2 0.0 0.2 0.0 2.4 0.2 0.3 0.3 0.1 0.0 0.3 79.6 0.1 0.0 4.1 0.3 0.5 0.2 0.3 1.6 1198.4 0.1 0.1 0.8 0.3 46.3 0.5 0.0 0.5 204.5 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.5 0.1 0.1 0.3 1.1 0.3 0.0 0.0 0.0 0.2 0.2 0.2 6.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.6 0.3 1.4 0.1 1.6 0.3 0.0 0.0 0.7 0.0 0.0 0.3 0.5 54.7 0.3 1.1 0.1 0.1 0.7 11.3 0.1 0.6 0.3 0.0 0.2 0.1 1.3 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.3 0.0 2.2 0.0 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 84.9 0.0 0.0 0.0 0.2 145.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.3 0.8 0.3 0.9 0.2 0.3 0.2 0.4 0.0 0.5 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 5.7 1.0 35.8 0.7 0.0 0.0 0.9 0.0 0.0 0.0 11.0 0.1 4.7 94.3 0.9 3.5 10.7 0.1 0.0 1.6 1.8 0.0 15.9 0.0 2.1 6.8 994.8 1.7 0.0 0.1 0.0 0.0 14.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.7 0.1 0.5 0.0 0.0 3.4 0.8 0.0 0.0 0.0 INPPL1 SHIP2 ENSG00000165458 "Inositol polyphosphate phosphatase like 1" O15357 11 72223701-72239147 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell adhesion, Immunity" "Actin-binding, Hydrolase" "Cancer-related genes, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 344.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037601 Approved Supported "Golgi apparatus,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 20: HeLa - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "Golgi apparatus" "HPA037601: AB_10672281" "unprognostic (2.68e-1)" "unprognostic (2.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.68e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (7.37e-4)" "unprognostic (2.49e-2)" "unprognostic (3.54e-2)" "unprognostic (1.51e-2)" "unprognostic (1.64e-1)" "unprognostic (4.34e-2)" "unprognostic (3.66e-2)" "unprognostic (2.33e-1)" "unprognostic (2.88e-1)" "unprognostic (1.99e-3)" "unprognostic (2.07e-1)" 45.2 56.4 39.0 34.4 43.4 51.3 44.7 41.3 40.5 63.8 47.3 87.5 35.9 56.1 18.2 34.6 61.3 33.7 73.6 33.2 42.5 60.0 36.6 61.8 36.8 53.9 43.2 68.6 55.7 36.4 60.5 39.7 45.8 68.7 23.3 14.9 53.8 39.5 116.6 31.4 57.1 33.4 45.0 66.1 60.8 24.2 48.8 19.3 67.7 43.0 23.2 59.9 43.4 41.2 28.7 62.1 71.5 49.8 35.4 41.1 122.5 118.9 61.2 80.6 49.6 84.3 72.2 79.5 125.6 101.7 57.8 106.7 60.4 37.6 28.0 101.9 59.1 84.8 344.5 31.9 68.1 56.1 176.7 58.2 39.1 78.0 31.4 100.5 44.2 29.3 59.7 34.7 45.1 78.8 42.1 224.9 67.7 20.7 93.7 185.0 161.0 18.2 94.8 48.6 33.8 48.6 133.9 85.1 182.8 36.6 88.8 106.0 74.5 86.4 96.7 129.9 43.1 94.5 17.5 80.1 24.7 51.7 47.2 2.5 3.5 3.3 1.9 2.0 1.7 0.9 1.6 1.3 2.4 1.0 1.1 1.6 2.3 2.2 3.6 1.8 1.5 1.8 39.0 43.4 41.3 40.5 33.2 42.5 53.9 43.2 45.8 45.0 48.8 41.2 13.9 3.2 12.8 47.0 8.1 7.1 4.9 10.8 14.2 1.7 20.3 17.3 13.6 11.5 11.7 12.9 27.1 27.9 9.1 28.3 1.9 11.6 1.5 14.6 16.3 11.2 22.7 5.7 2.6 12.5 15.4 10.8 24.5 25.5 7.6 21.0 8.9 12.5 21.7 10.1 2.2 16.4 18.3 27.6 16.2 2.1 9.9 29.8 10.6 18.7 17.6 16.8 14.4 15.1 6.1 14.9 17.5 13.9 7.8 7.8 15.2 16.2 10.2 17.2 6.6 12.9 14.5 1.4 4.9 6.7 4.8 32.4 11.6 10.1 21.8 5.4 ITIH2 H2P ENSG00000151655 "Inter-alpha-trypsin inhibitor heavy chain 2" P19823 10 7703316-7749520 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 668 "liver: 2156.1" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 489.6" "Cancer enriched" "Detected in many" 279 "liver cancer: 626.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 453 "Hep G2: 1103.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA059150 Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 32000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "HPA059150: AB_2683930" "unprognostic (4.82e-2)" "unprognostic (6.10e-2)" "unprognostic (2.48e-2)" "unprognostic (1.21e-2)" "unprognostic (2.01e-2)" "unprognostic (2.55e-3)" "prognostic favorable (1.48e-4)" "unprognostic (1.37e-1)" "unprognostic (1.79e-1)" "unprognostic (1.47e-2)" "unprognostic (2.28e-1)" "unprognostic (2.02e-1)" "unprognostic (2.10e-8)" "unprognostic (9.91e-3)" "unprognostic (1.70e-1)" "unprognostic (2.35e-1)" "unprognostic (4.46e-4)" 0.1 0.2 0.3 0.1 1.1 0.1 3.0 1.6 3.2 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.1 0.6 1.0 0.8 2156.1 0.6 0.1 0.6 0.5 0.0 0.2 0.0 1.7 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.8 0.4 0.0 0.0 0.9 0.3 0.5 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.6 1103.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 2.4 0.0 0.1 0.7 0.0 0.4 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.1 1.6 3.2 0.6 1.0 0.6 0.5 0.6 0.9 0.9 0.7 0.1 0.0 2.2 0.7 1.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.4 117.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.1 0.0 0.0 0.6 0.0 2.7 3.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 8.2 489.6 0.1 0.0 1.4 0.0 0.0 9.4 0.0 2.1 0.0 0.0 0.0 18.7 0.0 0.0 0.0 1.5 1.8 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 LAMC2 "BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa" ENSG00000058085 "Laminin subunit gamma 2" Q13753 1 183186238-183245127 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 39.3" "Cell type enriched" "Detected in many" 5 "Pancreatic endocrine cells: 1531.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 231.3" "Region enhanced" "Detected in some" "cerebellum: 2.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 574.7;CAPAN-2: 501.6;HBEC3-KT: 2492.2;hTERT-HME1: 1487.5;RPTEC TERT1: 579.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004257, HPA024638, HPA046539, CAB078165" Enhanced Uncertain "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" No No 130000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Endoplasmic reticulum, Golgi apparatus" "CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689, HPA046539: " "unprognostic (7.27e-3)" "unprognostic (7.21e-3)" "unprognostic (3.24e-1)" "unprognostic (6.20e-3)" "unprognostic (9.43e-2)" "unprognostic (4.94e-3)" "unprognostic (4.12e-2)" "prognostic unfavorable (4.20e-6)" "unprognostic (1.25e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (7.11e-5)" "unprognostic (2.77e-1)" "unprognostic (7.24e-2)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" 3.5 0.1 0.2 16.2 1.9 0.1 20.9 2.6 0.6 15.1 0.2 12.1 2.6 12.3 2.1 7.7 34.9 13.0 3.0 0.2 0.2 13.8 0.7 24.9 8.0 0.0 0.1 1.0 3.3 0.0 4.2 10.9 0.1 5.4 12.9 0.1 12.9 6.1 1.7 17.5 15.0 3.3 0.0 0.9 14.9 2.8 0.1 11.3 18.5 2.3 12.3 39.3 6.3 0.2 574.7 25.4 0.0 0.7 4.9 11.9 40.2 4.3 4.7 2.1 0.7 41.4 501.6 0.0 207.9 1.4 16.4 252.4 0.1 2492.2 2.7 0.7 0.2 0.0 0.5 0.1 1.2 0.0 0.2 6.1 189.7 6.0 1487.5 2.3 32.6 0.0 0.0 0.2 2.5 1.1 0.0 0.1 4.5 206.7 35.2 0.1 1.2 0.0 579.4 147.1 30.5 0.1 14.7 0.4 0.9 14.9 2.0 2.7 3.8 2.2 30.2 15.0 7.8 0.9 0.7 0.7 4.1 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.9 2.6 0.6 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.5 218.0 17.8 0.0 0.2 86.3 227.1 232.7 105.3 0.0 8.2 26.2 2.3 10.0 56.8 23.9 0.0 30.7 0.4 74.4 0.0 183.4 19.6 68.9 3.6 7.8 9.0 0.0 0.4 94.0 11.7 17.2 59.7 97.4 0.0 0.0 0.0 0.0 2.5 0.0 0.3 34.1 14.2 0.0 4.9 11.8 3.4 3.1 8.8 1.0 2.6 0.0 0.0 0.0 0.3 1531.1 91.2 0.4 0.3 302.0 16.7 0.2 69.3 0.0 0.0 3.4 9.6 3.6 1.0 60.3 29.7 83.3 5.3 0.1 15.3 169.9 LHX1 "LIM-1, LIM1" ENSG00000273706 "LIM homeobox 1" P48742 17 36936785-36944612 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "kidney: 10.7" "Cell type enriched" "Detected in some" 8 "Horizontal cells: 361.7" "Group enriched" "Detected in some" 4 "ovarian cancer: 8.1;testis cancer: 2.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.8;HMC-1: 1.6;WM-115: 7.0" "Region enhanced" "Detected in many" "cerebellum: 19.1" "Region enriched" "Detected in many" 4 "cerebellum: 15.7" "HPA044307, HPA073521, HPA074382" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 17: WM-115 - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA044307: , HPA073521: AB_2732226, HPA074382: " "unprognostic (3.86e-5)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.63e-5)" "unprognostic (3.85e-2)" "unprognostic (1.06e-4)" "unprognostic (2.67e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (4.20e-3)" "unprognostic (1.74e-5)" "unprognostic (1.33e-1)" "unprognostic (8.62e-2)" "unprognostic (3.05e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 10.7 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.5 0.2 0.5 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.4 2.1 0.0 0.0 42.3 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 361.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 13.0 0.0 1.6 0.0 0.0 0.2 1.1 2.3 0.0 0.0 0.4 0.3 0.0 0.2 0.0 LRRC8C AD158 ENSG00000171488 "Leucine rich repeat containing 8 VRAC subunit C" Q8TDW0 1 89633072-89769903 "Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 73.5;Excitatory neurons: 73.6;Inhibitory neurons: 99.2;Microglial cells: 185.5;Oligodendrocytes: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 8.9;monocytes: 6.6;T-cells: 11.3" "Cell line enhanced" "Detected in many" "THP-1: 41.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029347 Uncertain Approved "Golgi apparatus" No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 28: Placenta - Pregnancy" "Cluster 43: THP-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA029347: AB_10601544" "unprognostic (2.61e-2)" "unprognostic (3.09e-2)" "unprognostic (3.83e-2)" "unprognostic (1.76e-2)" "unprognostic (3.32e-2)" "unprognostic (1.65e-2)" "unprognostic (5.02e-2)" "unprognostic (3.76e-3)" "unprognostic (4.28e-2)" "unprognostic (4.90e-3)" "unprognostic (5.32e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (3.75e-4)" "unprognostic (2.78e-2)" "unprognostic (4.42e-2)" "unprognostic (1.94e-2)" "unprognostic (3.38e-2)" 14.3 7.6 3.8 9.0 4.5 8.0 7.7 4.5 5.8 3.2 11.4 3.2 3.2 7.3 1.9 2.9 2.8 6.6 6.2 4.1 4.1 2.5 3.3 7.7 12.2 4.6 5.0 5.3 1.8 2.8 2.3 6.6 5.1 2.3 3.7 1.6 2.0 2.0 2.7 6.0 3.8 15.8 4.8 9.2 2.9 4.0 4.7 5.6 3.5 8.0 7.7 6.2 2.0 6.0 0.3 3.8 3.0 2.7 9.1 10.2 1.4 19.3 21.6 8.7 8.0 0.0 1.3 6.0 5.3 8.5 14.9 13.1 10.1 29.0 20.9 14.8 6.1 5.7 2.9 0.3 7.4 26.6 1.9 4.4 5.8 18.8 10.0 5.8 35.6 9.2 3.9 7.9 7.5 0.7 3.9 26.2 3.3 0.1 7.8 26.5 1.4 2.0 1.8 3.2 2.3 10.7 7.1 0.7 16.2 4.7 0.2 41.3 29.9 15.3 7.3 5.3 14.9 2.9 2.6 3.1 4.7 19.6 2.6 0.4 6.0 0.0 3.8 5.2 3.3 0.7 6.1 5.1 8.9 0.5 4.8 4.5 0.8 2.0 6.6 0.7 11.3 3.2 3.8 4.5 4.5 5.8 4.1 4.1 4.6 5.0 5.1 4.8 4.7 6.0 73.5 3.2 3.6 31.3 7.6 45.4 3.8 5.6 3.4 2.3 1.7 2.9 6.3 2.8 2.7 0.0 0.0 0.1 24.6 0.3 0.0 1.7 36.3 0.2 1.9 47.3 1.2 4.8 73.6 2.4 1.1 8.7 2.6 0.6 0.0 58.5 28.9 0.1 13.6 1.7 99.2 0.3 2.0 29.5 36.9 21.3 0.0 27.8 26.6 185.5 21.3 0.5 13.4 22.1 85.2 12.8 1.9 0.7 20.8 2.1 0.3 0.6 2.9 1.2 0.0 2.2 24.2 3.9 2.0 1.3 44.9 0.3 27.1 3.4 0.3 2.5 MAGEA9 "CT1.9, MAGE9, MGC8421" ENSG00000123584 "MAGE family member A9" P43362 X 149781930-149787737 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 38 "testis: 3.7" "Group enriched" "Detected in some" 16 "Spermatocytes: 2.3;Spermatogonia: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "U-266/70: 45.2;U-266/84: 32.9" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA045401: AB_2679315, HPA051687: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.2 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA9B ENSG00000267978 "MAGE family member A9B" P43362 X 149581653-149587453 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 29 "testis: 10.0" "Group enriched" "Detected in some" 4 "Spermatocytes: 39.6;Spermatogonia: 16.0" "Cancer enhanced" "Detected in some" "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "OE19: 82.4;RT4: 131.1;U-266/70: 55.1;U-266/84: 73.7" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 21: OE19 - Mitochondria" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA045401: AB_2679315, HPA051687: " "unprognostic (6.12e-3)" "unprognostic (3.26e-1)" 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 2.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.4 0.0 0.1 0.0 0.0 0.1 82.4 0.0 0.2 0.0 6.3 0.0 131.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 55.1 73.7 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 39.6 16.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 MAN1A1 ENSG00000111885 "Mannosidase alpha class 1A member 1" P33908 6 119177205-119349761 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 154.6" "Cell type enhanced" "Detected in many" "Early spermatids: 232.5;Excitatory neurons: 165.0;Hepatocytes: 270.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 273.1;Hep G2: 204.0;Karpas-707: 219.6;U-266/70: 294.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037058, HPA053198, HPA063561" Uncertain Supported "Golgi apparatus" NA NA 460000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus" "CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: AB_2685042" "unprognostic (1.50e-1)" "unprognostic (7.36e-3)" "unprognostic (4.83e-2)" "unprognostic (2.21e-2)" "unprognostic (2.95e-2)" "unprognostic (2.19e-1)" "unprognostic (3.33e-3)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" "unprognostic (5.11e-2)" "unprognostic (1.68e-3)" "unprognostic (4.62e-1)" "unprognostic (2.37e-2)" "unprognostic (3.49e-2)" "unprognostic (2.25e-1)" "unprognostic (6.89e-2)" "unprognostic (3.40e-1)" 102.2 48.5 4.2 32.8 12.3 28.9 34.3 1.2 8.9 25.9 5.1 36.1 52.7 23.8 8.8 22.7 16.0 47.1 15.3 8.0 4.6 66.6 154.6 35.8 34.8 2.9 5.0 20.1 32.7 25.8 4.6 79.4 2.5 18.1 29.3 6.2 42.7 15.0 7.6 14.3 69.8 27.2 3.3 36.5 25.9 7.0 8.4 18.9 22.6 31.0 25.9 56.0 17.1 5.9 0.2 0.0 3.4 0.0 273.1 119.9 6.6 6.9 41.4 5.1 12.5 19.8 2.6 43.2 0.3 26.5 65.7 0.4 7.6 0.1 6.4 64.5 19.4 36.3 3.9 204.0 27.2 0.1 17.7 82.4 5.3 41.6 25.3 22.1 3.4 12.6 128.1 219.6 39.7 6.1 1.7 0.3 2.3 20.0 10.0 12.1 4.2 66.6 13.4 35.4 14.1 21.0 0.1 0.6 0.0 8.3 10.4 4.8 24.8 16.9 15.4 32.0 15.8 294.5 44.6 84.8 50.2 0.7 10.4 4.3 0.3 1.1 1.1 0.5 2.3 0.7 0.6 0.6 0.3 0.4 0.3 0.9 1.9 0.9 0.5 2.8 0.7 0.3 4.2 12.3 1.2 8.9 8.0 4.6 2.9 5.0 2.5 3.3 8.4 5.9 37.1 9.6 46.1 19.9 31.0 31.7 5.7 1.2 5.2 28.1 18.8 5.8 4.4 44.3 6.9 106.7 0.0 6.8 40.6 23.3 5.9 9.4 232.5 5.9 63.9 42.1 48.0 40.4 165.0 37.8 12.4 98.4 18.8 10.7 3.8 24.0 97.5 270.5 101.1 0.0 79.4 61.1 0.0 84.6 91.2 39.3 26.4 98.0 28.4 128.4 13.5 1.7 42.2 4.5 3.7 14.8 18.9 4.1 147.5 5.3 92.2 33.5 4.6 5.0 6.6 12.9 27.8 2.8 3.9 3.4 27.8 6.2 24.3 14.6 18.9 9.7 MANEA "FLJ12838, mandaselin" ENSG00000172469 "Mannosidase endo-alpha" Q5SRI9 6 95577535-95609452 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 59.8;Plasma cells: 113.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011046, HPA011069" Enhanced Supported "Golgi apparatus" NA NA 140000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 1: Thyroid gland - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA011046: AB_1079303, HPA011069: AB_1079304" "unprognostic (6.00e-2)" "unprognostic (7.81e-2)" "prognostic favorable (3.04e-4)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (5.03e-2)" "unprognostic (2.98e-3)" "unprognostic (2.74e-1)" "unprognostic (5.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.44e-1)" "unprognostic (9.07e-2)" "unprognostic (2.86e-3)" "unprognostic (5.18e-2)" "unprognostic (3.08e-1)" "unprognostic (9.68e-2)" "unprognostic (7.47e-2)" 11.9 6.9 3.1 7.9 3.6 3.3 8.9 3.7 3.7 8.4 4.2 8.1 8.8 6.8 6.3 8.0 6.4 7.9 5.6 2.5 3.7 12.0 24.0 7.3 9.2 4.3 3.3 9.7 8.4 11.1 2.1 6.3 4.4 7.0 8.7 6.1 5.6 7.9 1.4 6.8 8.8 6.7 3.6 9.6 12.1 6.1 3.7 9.1 11.6 3.4 11.2 9.0 3.5 5.6 6.5 5.3 20.4 16.6 33.1 38.5 7.7 17.7 16.2 10.1 14.8 6.1 16.0 12.3 21.7 11.7 14.9 10.4 14.1 12.0 23.2 20.9 12.6 16.6 4.7 10.2 11.5 22.3 14.4 38.4 13.7 12.0 8.5 14.6 24.3 12.1 26.2 28.1 22.0 4.5 13.1 9.5 3.0 17.1 5.5 15.4 19.9 18.8 15.5 11.2 16.3 8.8 10.0 7.2 6.5 14.3 11.4 20.7 22.0 10.1 7.1 18.4 17.8 20.9 12.9 15.2 18.2 19.1 23.6 8.5 2.3 1.3 3.2 4.1 4.6 4.5 3.9 3.8 2.5 2.3 4.5 3.1 0.5 2.9 3.7 1.0 7.7 2.4 3.1 3.6 3.7 3.7 2.5 3.7 4.3 3.3 4.4 3.6 3.7 5.6 11.6 12.8 8.4 7.8 15.5 7.4 4.4 6.4 8.6 8.1 8.4 7.4 4.5 10.0 7.4 12.9 4.2 5.4 5.4 1.8 5.9 4.1 16.7 7.3 14.4 10.7 1.8 8.2 6.0 7.3 5.6 12.0 8.2 8.1 2.5 17.8 28.2 59.8 11.0 11.8 7.3 4.6 0.0 12.0 5.8 11.7 5.9 7.9 8.8 8.4 6.8 10.5 3.1 16.1 18.7 3.4 2.8 15.8 113.4 3.4 4.8 8.5 8.5 5.3 13.1 9.8 17.1 7.1 12.1 11.8 7.0 1.4 9.2 13.5 5.0 3.5 MANSC1 "FLJ10298, LOH12CR3" ENSG00000111261 "MANSC domain containing 1" Q9H8J5 12 12326056-12350242 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 70.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 15 "neutrophil: 98.3" "Lineage enriched" "Detected in many" 39 "granulocytes: 98.3" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 50.7;OE19: 54.3;RPTEC TERT1: 25.9" "Low region specificity" "Detected in all" "HPA007955, HPA007956" Approved Approved "Golgi apparatus,Vesicles" NA NA 44000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus, Vesicles" "HPA007955: AB_1079306, HPA007956: AB_1079305" "unprognostic (5.41e-3)" "unprognostic (3.10e-2)" "unprognostic (1.24e-1)" "unprognostic (5.46e-3)" "unprognostic (9.64e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-2)" "unprognostic (8.47e-2)" "unprognostic (9.18e-2)" "unprognostic (5.20e-2)" "unprognostic (2.06e-2)" "unprognostic (3.03e-1)" "prognostic favorable (3.30e-5)" "unprognostic (1.15e-2)" "unprognostic (4.46e-2)" "unprognostic (3.65e-1)" "unprognostic (1.03e-2)" 18.9 12.1 3.4 4.3 4.1 3.5 19.5 3.9 6.5 16.9 5.0 22.9 11.7 22.1 11.5 42.3 16.6 10.2 11.2 4.1 3.0 13.2 9.7 12.3 2.3 3.2 3.3 11.3 25.2 11.3 17.9 9.5 3.2 15.1 15.8 5.4 70.0 10.8 4.0 21.7 15.2 12.1 2.6 11.3 21.5 8.4 3.8 1.4 13.8 4.4 6.4 16.3 20.6 4.0 0.3 5.7 1.8 0.1 5.6 5.5 6.2 3.9 4.6 2.0 2.5 4.8 18.2 0.0 4.2 3.9 2.1 0.8 7.1 3.3 1.5 0.0 6.9 8.3 6.4 4.2 0.9 1.4 2.3 3.5 5.3 1.3 0.9 13.8 50.7 0.1 5.6 0.1 0.6 11.0 0.0 0.6 6.5 54.3 3.0 0.2 0.0 0.1 25.9 18.8 2.6 10.3 2.1 16.9 6.0 2.8 15.4 5.0 20.5 2.8 2.3 0.7 5.5 0.4 0.2 2.8 2.0 0.0 2.1 6.6 1.2 1.0 0.1 0.9 0.0 0.2 0.3 0.0 0.6 0.4 2.5 0.4 98.3 0.6 0.4 0.1 0.0 0.6 3.4 4.1 3.9 6.5 4.1 3.0 3.2 3.3 3.2 2.6 3.8 4.0 29.0 9.6 21.2 8.8 3.3 4.0 7.1 7.2 6.2 6.1 21.2 13.5 2.6 28.6 11.9 23.9 8.4 35.4 4.5 33.6 1.9 19.0 0.9 15.1 5.2 28.8 21.7 3.6 16.6 37.9 7.4 10.4 23.0 20.5 2.5 8.6 37.1 9.8 8.0 10.1 13.5 33.4 8.2 5.5 0.7 2.2 13.7 2.0 0.0 15.0 2.7 11.4 9.2 7.5 11.4 16.3 25.2 16.6 1.0 7.4 16.7 3.0 18.1 13.1 0.0 4.8 6.5 2.1 1.5 22.1 4.7 17.0 3.0 9.7 26.5 8.8 MARCHF1 "FLJ20668, MARCH-I, MARCH1, RNF171" ENSG00000145416 "Membrane associated ring-CH-type finger 1" Q8TCQ1 4 163524298-164384050 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.6;retina: 27.5" "Group enriched" "Detected in some" 4 "B-cells: 21.4;Hofbauer cells: 46.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 94 "classical monocyte: 41.8;eosinophil: 25.5;intermediate monocyte: 41.0;memory B-cell: 42.3;myeloid DC: 44.2;naive B-cell: 35.8;non-classical monocyte: 45.4;plasmacytoid DC: 16.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 7.1;U-266/70: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014600, HPA048024" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Vesicles "Endoplasmic reticulum, Golgi apparatus" "HPA014600: AB_1853573, HPA048024: " "unprognostic (7.29e-2)" "unprognostic (5.82e-2)" "unprognostic (1.48e-1)" "unprognostic (9.09e-2)" "unprognostic (8.25e-2)" "unprognostic (2.98e-2)" "unprognostic (4.79e-3)" "unprognostic (9.00e-2)" "unprognostic (3.00e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-1)" "unprognostic (2.20e-1)" "unprognostic (1.24e-1)" "unprognostic (7.00e-2)" "unprognostic (2.48e-2)" "unprognostic (2.70e-1)" "unprognostic (2.91e-2)" 6.4 3.5 7.8 21.5 8.1 3.9 2.7 3.6 7.7 3.1 1.8 3.5 3.9 2.5 0.7 3.0 2.8 5.3 1.7 6.6 10.1 1.8 4.1 8.0 31.6 8.0 8.2 2.7 2.8 0.8 2.5 9.9 6.9 2.3 4.5 27.5 3.2 1.2 1.0 4.5 7.0 6.2 7.0 25.8 3.9 1.7 12.1 5.6 2.1 1.0 25.5 7.7 2.9 14.4 0.6 0.5 2.1 1.2 0.0 0.0 1.3 0.9 0.0 0.0 0.0 1.2 2.4 7.1 2.5 0.0 0.2 1.0 0.0 0.0 0.0 0.8 0.7 5.0 3.0 0.5 0.0 3.1 1.6 0.0 0.0 0.0 0.1 2.8 0.0 1.3 1.9 3.6 2.4 0.7 1.8 1.9 2.6 0.2 0.9 2.0 0.3 0.5 0.1 1.1 1.0 0.9 0.6 1.0 0.4 1.4 2.9 0.5 2.3 0.8 1.4 0.5 1.7 7.0 2.5 1.9 0.9 1.5 1.1 0.0 41.8 25.5 0.1 41.0 0.0 42.3 0.1 0.0 44.2 35.8 0.0 0.0 0.3 0.3 45.4 16.5 0.0 18.4 7.8 8.1 3.6 7.7 6.6 10.1 8.0 8.2 6.9 7.0 12.1 14.4 0.1 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 46.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 MGAT4A "GnT-4a, GnT-Iva" ENSG00000071073 "Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A" Q9UM21 2 98619106-98731132 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 96.0" "Cell type enhanced" "Detected in many" "Microglial cells: 175.2;Proximal enterocytes: 132.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 127.2;HUVEC TERT2: 48.3;JURKAT: 86.5;TIME: 78.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007608 Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 28: BEWO - Transcription regulation" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA007608: AB_10602008" "prognostic unfavorable (4.30e-4)" "unprognostic (1.15e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.48e-8)" "unprognostic (1.35e-1)" "unprognostic (2.28e-2)" "unprognostic (3.82e-3)" "unprognostic (1.89e-1)" "unprognostic (3.76e-1)" "unprognostic (3.58e-1)" "unprognostic (2.80e-2)" "unprognostic (2.32e-2)" "unprognostic (4.17e-2)" "unprognostic (1.50e-1)" "unprognostic (4.62e-2)" "unprognostic (4.04e-2)" "unprognostic (2.04e-1)" 11.2 7.8 13.2 20.8 17.8 96.0 12.5 26.1 15.6 8.9 15.1 24.4 29.5 5.8 3.7 6.3 7.0 12.7 7.6 13.1 15.2 27.5 9.7 16.9 21.1 16.4 15.8 3.2 38.8 28.0 9.8 19.6 15.5 7.5 25.5 5.4 25.9 6.4 3.8 4.1 43.8 11.5 18.1 8.1 11.3 6.3 15.5 20.5 8.7 4.7 18.2 13.1 4.7 22.9 8.8 1.7 3.4 7.3 0.0 0.0 127.2 0.0 0.1 0.9 0.0 21.0 10.6 0.0 18.9 0.0 2.4 0.4 7.2 1.0 0.2 10.6 7.9 0.5 0.0 36.7 0.2 17.8 6.4 0.0 4.7 0.0 0.7 0.3 48.3 86.5 1.6 9.2 0.0 17.3 39.3 30.9 1.1 7.6 1.4 9.8 0.0 10.5 24.8 17.6 10.4 3.3 2.5 32.2 4.8 9.2 7.6 23.8 78.8 0.0 4.0 0.1 2.6 3.2 7.6 2.2 0.0 26.7 0.6 7.0 5.1 12.7 20.8 1.0 27.5 3.6 25.2 23.7 3.8 2.5 32.6 27.2 14.0 15.3 2.5 17.1 16.0 12.5 13.2 17.8 26.1 15.6 13.1 15.2 16.4 15.8 15.5 18.1 15.5 22.9 80.8 54.5 25.7 19.2 22.7 9.9 21.1 6.1 11.4 19.8 28.2 15.6 13.4 11.5 17.6 22.0 4.2 6.2 116.9 92.4 21.5 20.8 12.7 14.2 3.8 39.8 53.0 6.3 58.0 29.8 77.9 7.2 19.4 35.1 13.3 5.1 18.9 10.4 57.2 48.8 48.6 41.3 34.6 33.9 18.3 17.5 2.5 54.5 10.6 175.2 21.0 13.4 89.6 36.7 42.0 21.6 58.2 2.2 31.4 17.8 132.4 27.3 7.1 4.8 6.6 6.8 4.9 2.5 7.7 8.6 10.5 14.9 112.2 0.7 40.9 30.2 MYOM3 FLJ35961 ENSG00000142661 "Myomesin 3" Q5VTT5 1 24056035-24112135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "heart muscle: 222.5;skeletal muscle: 321.5;tongue: 255.9" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 198.3" "Cancer enhanced" "Detected in some" "renal cancer: 6.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A549: 4.6;Hep G2: 18.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028132, HPA028340" Approved "Golgi apparatus,Vesicles,Cytokinetic bridge" Yes No 830000 "Cluster 38: Heart - Muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 54: Cardiomyocytes - Muscle contraction" Vesicles "Golgi apparatus, Cytokinetic bridge" "HPA028132: AB_10599293, HPA028340: " "unprognostic (8.59e-2)" "unprognostic (2.85e-2)" "unprognostic (2.39e-1)" "unprognostic (8.60e-3)" "unprognostic (1.52e-2)" "unprognostic (7.31e-2)" "unprognostic (3.00e-2)" "unprognostic (1.40e-2)" "unprognostic (4.66e-1)" "unprognostic (2.21e-1)" "unprognostic (2.73e-4)" "unprognostic (2.09e-1)" "prognostic favorable (4.28e-6)" "unprognostic (2.77e-2)" "unprognostic (1.60e-3)" "unprognostic (7.75e-2)" "unprognostic (1.68e-1)" 0.4 0.2 0.0 0.2 0.0 0.0 0.7 0.3 0.1 0.2 0.0 0.6 1.1 0.3 0.0 6.0 0.9 0.4 222.5 0.1 0.1 31.4 0.2 0.3 0.1 0.1 0.1 0.1 1.2 0.0 0.0 0.0 0.1 4.5 0.7 1.2 7.1 0.0 321.5 2.2 5.2 0.2 0.0 0.0 0.2 9.0 0.0 1.7 0.3 255.9 0.1 0.1 0.4 0.2 0.1 4.6 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.3 0.0 1.9 0.6 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.8 18.1 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.2 0.1 1.0 0.2 0.5 0.6 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.0 0.6 0.2 0.1 0.6 0.0 0.1 0.6 198.3 0.0 0.0 3.7 0.0 0.0 0.1 3.6 1.9 0.1 16.2 0.4 0.0 1.6 1.2 0.0 0.4 0.4 0.0 6.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.7 10.3 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 2.5 2.4 0.0 0.0 0.2 13.0 33.2 0.0 2.5 6.6 10.0 1.3 0.0 0.2 0.0 0.6 0.0 0.3 2.3 2.2 0.3 MZB1 "HSPC190, MEDA-7, MGC29506, PACAP, pERp1" ENSG00000170476 "Marginal zone B and B1 cell specific protein" Q8WU39 5 139387467-139390081 "Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 89.8;lymphoid tissue: 272.2" "Cell type enriched" "Detected in many" 6 "Plasma cells: 4000.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 160.4;plasmacytoid DC: 569.3" "Group enriched" "Detected in many" 116 "B-cells: 160.4;dendritic cells: 569.3" "Group enriched" "Detected in some" 5 "Karpas-707: 581.5;RPMI-8226: 2193.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043745, HPA052694" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 350000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA043745: AB_10960359, HPA052694: AB_2681919" "unprognostic (4.97e-3)" "unprognostic (1.75e-2)" "unprognostic (4.23e-2)" "prognostic favorable (7.27e-4)" "unprognostic (2.21e-2)" "prognostic favorable (4.60e-5)" "unprognostic (6.57e-2)" "unprognostic (1.35e-1)" "unprognostic (6.45e-3)" "unprognostic (7.10e-3)" "unprognostic (2.57e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.15e-8)" "unprognostic (7.22e-2)" "unprognostic (3.14e-1)" "unprognostic (9.46e-2)" "unprognostic (7.36e-2)" 4.4 9.1 0.0 87.4 0.1 33.0 21.0 0.0 0.7 18.3 0.2 70.1 89.8 1.8 0.4 10.1 5.7 14.3 2.3 0.0 0.0 5.9 5.8 15.9 123.2 0.1 0.0 4.9 1.3 0.0 0.7 0.0 0.1 5.1 39.9 0.0 56.7 4.9 0.1 0.4 47.8 2.1 0.4 272.2 66.6 2.4 0.1 147.3 9.1 0.0 117.8 58.7 3.6 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 256.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 144.6 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 128.5 0.5 581.5 0.0 0.0 227.8 2.2 0.0 0.0 0.0 90.1 0.3 2193.9 0.0 0.0 0.3 0.8 0.0 11.4 0.0 0.0 3.1 0.1 0.6 0.0 1.8 0.1 0.0 262.0 16.7 223.0 0.1 0.4 0.0 0.0 0.1 0.1 1.5 0.1 3.0 160.4 0.6 1.1 0.5 75.6 0.1 0.2 3.1 2.7 0.0 569.3 0.2 26.1 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.3 0.4 6.4 10.1 0.0 665.7 2.5 1.3 0.1 0.0 0.0 3.7 3.2 1.1 4.3 2.0 0.0 0.0 0.1 235.0 0.9 0.0 0.1 0.1 1.8 0.4 2.0 1.2 49.3 0.0 0.0 0.1 2.0 6.1 0.4 2.5 0.1 11.4 14.0 0.1 0.0 0.0 1.1 0.0 7.1 3.4 1.1 0.0 4.7 540.7 0.0 1.0 0.0 4.1 0.0 0.0 0.1 0.4 0.0 4000.1 3.0 1.2 1.9 1.2 0.0 0.0 1.7 2.1 0.1 0.1 0.4 2.4 2.2 100.7 0.5 9.7 0.4 NAA25 "C12orf30, FLJ13089" ENSG00000111300 "N-alpha-acetyltransferase 25, NatB auxiliary subunit" Q14CX7 12 112026689-112108796 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 146.0;Oligodendrocytes: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039322 Approved Supported "Golgi apparatus,Cytosol" No No "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus, Cytosol" "HPA039322: AB_10697548" "unprognostic (1.26e-1)" "unprognostic (1.31e-1)" "unprognostic (3.91e-2)" "prognostic unfavorable (2.26e-4)" "unprognostic (1.91e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (5.53e-5)" "unprognostic (9.09e-3)" "unprognostic (3.24e-2)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (8.34e-2)" "prognostic unfavorable (1.32e-8)" "unprognostic (2.44e-2)" "unprognostic (2.01e-1)" "unprognostic (9.34e-2)" "unprognostic (9.18e-2)" 5.5 6.1 4.6 6.0 5.0 9.8 6.8 6.4 8.1 6.8 8.5 6.8 3.9 5.5 4.3 7.6 5.8 3.7 5.6 5.3 5.1 4.6 5.6 4.9 6.6 5.6 4.7 7.0 6.9 5.9 4.3 5.3 7.7 5.4 4.2 14.8 4.9 4.4 14.9 7.5 4.8 5.4 3.6 5.3 4.9 5.1 4.9 6.0 5.7 9.9 6.9 6.4 6.7 8.0 16.7 16.1 14.8 11.9 8.1 14.0 17.9 15.3 12.4 18.3 12.4 16.2 8.6 28.9 14.4 12.3 10.5 19.2 32.8 13.0 25.1 16.6 22.9 23.6 15.9 15.0 13.2 34.0 13.7 12.1 15.9 21.3 21.8 15.5 16.1 12.6 35.3 3.7 16.7 13.5 19.6 24.9 22.1 34.2 18.6 21.5 15.2 19.7 14.0 27.0 19.1 10.5 16.9 19.8 15.0 14.0 19.3 13.4 13.7 15.2 13.6 17.0 21.3 15.0 30.4 33.0 19.4 14.7 15.5 0.0 1.7 0.5 2.4 1.9 3.7 2.5 3.0 2.3 3.5 2.8 4.2 4.1 0.0 1.6 2.5 3.7 2.5 1.6 4.6 5.0 6.4 8.1 5.3 5.1 5.6 4.7 7.7 3.6 4.9 8.0 16.1 9.6 16.2 44.1 23.3 66.7 34.5 17.1 22.8 38.9 18.9 12.4 23.5 12.8 26.5 7.3 146.0 25.6 20.4 10.1 3.9 15.3 26.5 15.1 23.9 17.4 16.2 17.0 71.6 19.4 21.6 17.8 15.8 14.8 20.3 20.7 15.4 19.4 14.0 23.5 68.0 11.9 28.5 15.4 25.2 8.6 17.4 16.5 16.0 30.0 83.8 13.0 12.3 48.2 109.6 17.4 7.5 12.8 15.7 61.5 7.4 4.7 25.0 67.7 6.6 28.7 22.7 31.5 29.5 28.5 70.2 22.6 15.3 20.0 14.7 48.1 NOD2 "BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1" ENSG00000167207 "Nucleotide binding oligomerization domain containing 2" Q9HC29 16 50693588-50734041 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "Immunity, Innate immunity" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.6;esophagus: 11.7;skin 1: 14.4;vagina: 12.3" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 8.3;Kupffer cells: 9.0;Langerhans cells: 22.5;Macrophages: 15.2;monocytes: 15.6;Suprabasal keratinocytes: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "classical monocyte: 23.0;eosinophil: 6.0;intermediate monocyte: 13.1;myeloid DC: 21.3;neutrophil: 10.5;non-classical monocyte: 9.0" "Group enriched" "Detected in many" 5 "dendritic cells: 21.3;granulocytes: 10.5;monocytes: 23.0" "Cell line enhanced" "Detected in some" "HMC-1: 11.6;T-47d: 5.8;THP-1: 7.3;U-266/70: 15.9;U-266/84: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA041985, HPA054494" Enhanced Approved "Golgi apparatus,Cytosol" No NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus, Cytosol" "HPA041985: AB_2677780, HPA054494: AB_2682505" "unprognostic (1.01e-1)" "unprognostic (4.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.02e-3)" "unprognostic (9.91e-3)" "unprognostic (5.84e-2)" "unprognostic (5.90e-3)" "unprognostic (1.23e-1)" "unprognostic (4.17e-1)" "unprognostic (3.88e-2)" "unprognostic (6.94e-3)" "unprognostic (1.48e-2)" "unprognostic (2.31e-9)" "unprognostic (4.38e-2)" "unprognostic (1.08e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-1)" 1.5 0.5 0.5 5.9 0.2 13.6 1.5 0.2 1.0 5.6 0.7 0.9 1.5 0.6 0.3 11.7 0.9 1.3 0.7 0.2 0.4 0.6 1.7 4.3 2.7 1.0 0.9 0.4 0.3 0.2 0.4 1.2 0.7 0.9 0.9 0.0 4.3 0.4 0.6 14.4 1.3 1.8 0.7 4.4 1.4 0.5 1.4 0.8 0.4 0.3 2.3 1.6 12.3 0.8 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 11.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.8 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.1 0.0 1.5 0.0 0.0 5.8 7.3 0.0 0.0 0.0 0.0 0.0 15.9 7.2 0.0 0.3 0.1 0.0 3.0 23.0 6.0 0.4 13.1 0.7 0.1 1.3 1.4 21.3 0.0 0.1 0.5 10.5 3.4 9.0 1.0 0.9 11.1 0.5 0.2 0.2 1.0 0.2 0.4 1.0 0.9 0.7 0.7 1.4 0.8 0.2 0.0 3.7 0.0 1.9 5.9 0.3 1.2 0.0 0.0 1.4 1.1 0.4 1.5 2.3 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 5.6 0.8 0.6 1.2 0.8 0.1 0.0 0.0 0.4 0.0 8.3 1.3 0.5 0.0 0.5 2.5 0.0 0.1 0.0 2.0 9.0 22.5 0.0 0.0 15.2 1.8 1.9 15.6 0.0 1.0 0.0 0.2 0.0 0.0 0.4 4.3 0.4 0.0 0.1 1.0 0.0 0.0 0.1 0.4 0.1 0.4 6.1 15.5 0.3 2.3 0.1 0.1 0.3 NSF "SEC18, SKD2" ENSG00000073969 "N-ethylmaleimide sensitive factor, vesicle fusing ATPase" P46459 17 46590669-46757464 "Enzymes, Predicted intracellular proteins, Transporters" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 276.3;Inhibitory neurons: 284.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003154, CAB009324, HPA071089" Enhanced Supported "Golgi apparatus,Cytosol" NA NA 59000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 58: Brain - Synaptic function" "Cluster 21: OE19 - Mitochondria" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "Golgi apparatus" "CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: AB_2686343" "unprognostic (5.70e-2)" "unprognostic (1.50e-1)" "unprognostic (1.07e-3)" "unprognostic (1.98e-1)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (1.09e-1)" "unprognostic (3.95e-2)" "unprognostic (5.48e-2)" "unprognostic (2.37e-2)" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" "unprognostic (2.07e-2)" "unprognostic (3.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.74e-1)" 13.5 20.2 29.9 8.0 28.8 5.7 12.5 7.7 58.7 14.1 0.0 18.3 4.9 11.8 7.3 21.6 9.7 8.0 11.3 39.2 28.6 12.9 13.7 11.6 9.6 36.8 14.3 7.0 22.9 15.3 43.1 7.7 36.6 12.4 13.9 63.0 18.4 5.8 38.9 16.5 16.1 6.4 4.1 14.9 15.6 16.7 15.6 7.9 11.9 13.5 10.0 13.2 14.3 21.1 11.7 25.4 16.6 1.2 9.6 13.4 13.5 15.6 18.2 14.7 14.3 17.5 0.1 28.5 27.3 34.8 15.3 2.0 18.9 5.8 23.9 10.1 24.6 1.0 17.4 24.2 14.3 0.8 6.1 12.3 7.8 29.8 12.3 7.8 23.4 7.0 19.4 15.0 32.9 22.8 19.4 7.5 9.4 36.0 29.9 13.7 16.1 26.7 16.7 24.0 15.2 17.2 23.1 0.1 11.1 17.5 28.5 35.1 19.3 41.2 14.4 22.0 23.7 32.0 19.9 16.4 11.5 15.2 29.7 9.3 11.5 6.6 6.1 9.8 6.7 5.4 6.2 8.1 12.6 6.1 5.1 6.1 4.8 5.9 10.8 5.0 9.4 7.5 29.9 28.8 7.7 58.7 39.2 28.6 36.8 14.3 36.6 4.1 15.6 21.1 16.3 9.6 11.3 54.9 28.2 4.0 3.6 6.7 6.2 106.6 14.0 10.0 8.1 7.2 10.9 22.0 87.6 13.0 18.8 32.3 11.7 12.4 45.2 8.3 19.7 11.5 30.5 8.6 276.3 16.2 14.4 10.9 13.7 11.2 9.5 8.2 11.0 19.3 18.8 43.7 284.7 26.3 24.4 29.9 10.9 45.8 5.9 20.5 10.6 69.3 35.4 24.5 8.2 98.5 71.8 13.7 17.4 8.6 21.7 9.0 18.5 14.7 8.7 89.9 0.0 10.6 12.9 40.6 31.4 9.5 5.7 18.5 14.8 18.3 20.6 8.6 NSG2 "CALY3, HMP19" ENSG00000170091 "Neuronal vesicle trafficking associated 2" Q9Y328 5 174045706-174243501 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 198.5" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 8 "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 59 "SCLC-21H: 39.5;SH-SY5Y: 64.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046531, HPA056191" Enhanced Enhanced "Golgi apparatus" NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA046531: AB_2732528, HPA056191: AB_2683062" "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (3.27e-1)" "unprognostic (3.36e-5)" "unprognostic (1.93e-1)" "unprognostic (2.77e-1)" "unprognostic (3.81e-2)" "unprognostic (3.07e-1)" "unprognostic (3.29e-1)" "unprognostic (1.76e-1)" "unprognostic (3.86e-3)" "unprognostic (8.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.02e-2)" "unprognostic (5.20e-2)" "unprognostic (9.31e-4)" "unprognostic (1.55e-1)" 0.5 33.3 115.8 2.6 198.5 0.0 0.1 43.8 152.8 0.0 1.7 6.9 2.3 0.0 0.4 0.1 0.0 0.3 1.0 125.2 171.9 0.7 0.4 0.3 0.0 54.5 82.1 0.1 0.9 0.0 7.0 0.0 101.1 0.2 3.9 39.2 0.1 0.1 0.3 0.1 3.8 1.8 52.4 0.2 3.0 14.7 100.3 0.0 0.6 0.0 0.0 0.1 1.2 47.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 64.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 115.8 198.5 43.8 152.8 125.2 171.9 54.5 82.1 101.1 52.4 100.3 47.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 NTAN1 ENSG00000157045 "N-terminal asparagine amidase" Q96AB6 16 15037854-15056079 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 17.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 18.5;REH: 9.2;U-266/84: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051418 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "Golgi apparatus" "HPA051418: " "unprognostic (2.21e-2)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (6.69e-4)" "unprognostic (1.87e-2)" "unprognostic (9.16e-2)" "unprognostic (8.11e-3)" "unprognostic (2.79e-1)" "unprognostic (1.75e-1)" "unprognostic (5.05e-2)" "unprognostic (1.65e-1)" "unprognostic (9.30e-3)" "prognostic unfavorable (9.07e-4)" "unprognostic (4.35e-1)" "unprognostic (2.12e-2)" "unprognostic (1.10e-1)" 38.6 10.2 3.6 0.5 3.9 2.2 28.1 3.8 8.9 25.3 2.1 30.3 0.1 20.7 1.4 19.4 18.8 1.2 19.3 3.4 3.7 15.9 15.2 21.6 0.7 3.8 4.1 19.7 11.0 0.5 6.5 0.4 4.1 20.2 0.3 1.3 15.8 0.4 24.5 21.6 15.6 0.8 2.9 20.5 17.9 20.3 3.7 0.8 13.5 0.6 0.4 27.8 21.8 3.5 3.6 0.0 1.8 0.7 1.2 0.6 0.6 6.2 2.6 1.0 2.8 0.0 0.0 3.2 2.5 4.7 1.7 0.1 0.9 0.7 0.9 5.0 5.9 0.3 0.0 0.0 1.1 1.7 4.3 0.8 0.4 3.4 1.5 1.5 1.3 2.6 0.5 3.2 0.9 0.3 5.3 18.5 1.1 0.0 0.2 9.2 0.1 1.3 1.2 0.0 0.7 2.1 0.0 0.1 1.5 0.4 0.0 0.6 4.1 1.1 3.8 1.1 1.1 4.2 10.1 2.5 1.5 1.3 2.2 4.9 1.3 17.5 2.8 1.7 3.0 4.2 3.4 2.6 1.9 3.8 3.9 1.3 1.6 3.8 2.0 5.7 5.9 3.1 3.6 3.9 3.8 8.9 3.4 3.7 3.8 4.1 4.1 2.9 3.7 3.5 79.7 3.2 3.9 7.8 24.7 33.6 16.4 24.1 7.4 6.1 20.2 33.4 3.2 12.8 13.8 18.4 10.4 77.4 30.4 25.1 45.0 49.3 48.9 8.8 29.3 55.0 6.7 25.3 12.6 23.6 23.8 51.3 8.2 12.7 8.8 22.0 62.8 23.0 116.6 25.2 15.6 7.2 30.5 75.0 48.3 32.4 83.0 53.9 58.7 12.2 46.0 15.2 37.0 3.0 6.6 56.9 14.6 75.2 37.6 21.2 9.6 38.6 6.0 9.4 39.5 20.8 52.3 33.3 30.7 16.0 21.7 56.9 25.6 23.5 13.5 23.9 ODF3L2 "C19orf19, FLJ40059" ENSG00000181781 "Outer dense fiber of sperm tails 3 like 2" Q3SX64 19 463346-474983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 8.2;testis: 23.4" "Cell type enriched" "Detected in some" 5 "Late spermatids: 1184.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA067065, HPA067973" Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 25: Spermatids - Spermatogenesis" Nucleoli "Nucleoplasm, Golgi apparatus" "HPA067065: , HPA067973: AB_2685937" "unprognostic (3.75e-4)" "unprognostic (1.79e-2)" "unprognostic (1.83e-3)" "unprognostic (9.69e-3)" "unprognostic (5.88e-2)" "unprognostic (5.65e-2)" "unprognostic (9.32e-2)" "unprognostic (1.35e-1)" "unprognostic (2.34e-2)" "unprognostic (1.77e-2)" "unprognostic (2.13e-2)" "unprognostic (4.06e-2)" "unprognostic (2.02e-5)" "unprognostic (3.13e-3)" "unprognostic (8.99e-2)" "unprognostic (3.05e-1)" "unprognostic (1.99e-1)" 0.3 0.3 0.7 0.0 0.7 0.0 0.3 0.4 0.9 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.5 0.5 0.2 0.3 0.2 0.0 0.7 0.6 0.1 0.1 0.0 0.1 0.2 0.7 0.2 0.0 0.1 0.0 0.0 8.2 0.1 0.2 0.0 0.5 0.7 0.1 23.4 0.8 0.0 0.3 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.4 0.9 0.5 0.5 0.7 0.6 0.7 0.5 0.8 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 212.8 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 5.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1184.9 8.4 0.6 0.0 1.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 7.6 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 P3H2 "FLJ10718, LEPREL1, MLAT4" ENSG00000090530 "Prolyl 3-hydroxylase 2" Q8IVL5 3 189956728-190122437 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 80.3;Granulosa cells: 124.1;Microglial cells: 91.8;Theca cells: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 22 "plasmacytoid DC: 28.9" "Lineage enriched" "Detected in single" 90 "dendritic cells: 28.9" "Cell line enhanced" "Detected in many" "GAMG: 120.2;HaCaT: 109.9;RPTEC TERT1: 109.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007890, HPA013355, HPA013611" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Intracellular and membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" "Nucleoplasm, Vesicles, Cytosol" "HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: " "unprognostic (4.90e-2)" "unprognostic (1.57e-1)" "unprognostic (3.76e-1)" "unprognostic (4.32e-3)" "unprognostic (1.97e-2)" "unprognostic (7.75e-2)" "unprognostic (9.68e-2)" "unprognostic (2.17e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-1)" "unprognostic (1.03e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-2)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" 4.9 41.6 2.8 4.9 3.1 1.0 6.5 3.0 3.1 17.0 1.8 24.0 2.7 17.6 18.5 11.0 8.0 4.8 8.8 3.3 4.8 51.3 7.0 28.7 2.4 7.6 4.7 16.1 3.6 2.3 8.2 9.2 6.7 37.6 10.4 19.3 4.9 26.5 1.2 17.8 6.7 32.4 5.2 54.8 23.9 4.2 4.9 5.2 3.0 1.7 2.0 11.9 19.9 8.3 46.9 18.2 35.1 0.2 0.6 1.4 42.1 48.7 19.3 7.8 12.6 15.0 18.0 0.1 27.1 8.6 120.2 109.9 0.1 65.3 16.3 0.4 6.2 0.1 12.1 0.3 35.4 0.2 0.3 16.9 21.4 15.2 5.4 73.5 1.4 0.1 0.1 0.4 12.3 1.1 0.1 0.4 11.0 31.3 3.7 0.1 7.1 2.8 109.8 77.5 2.5 0.3 66.1 3.7 29.3 51.1 0.1 0.7 24.4 45.9 16.8 0.4 8.9 3.4 0.2 0.5 10.6 0.2 60.2 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.1 0.0 28.9 0.0 0.2 2.8 3.1 3.0 3.1 3.3 4.8 7.6 4.7 6.7 5.2 4.9 8.3 5.7 48.1 80.3 19.2 1.0 0.0 7.7 0.0 13.6 2.3 1.6 9.9 1.0 2.8 3.1 44.1 4.2 42.0 9.5 19.8 5.9 4.7 19.6 2.0 27.3 10.5 0.0 2.7 55.6 0.8 14.7 10.3 8.6 1.5 1.3 124.1 32.5 0.8 11.4 10.1 60.4 0.5 0.0 3.2 0.0 14.9 4.7 5.6 0.0 91.8 0.8 44.5 0.0 43.7 4.4 30.6 1.9 0.0 0.2 15.1 0.0 26.2 0.0 1.2 0.0 10.9 45.2 0.5 0.9 13.5 0.0 38.6 0.7 74.3 2.1 3.9 PCDH10 "KIAA1400, OL-PCDH" ENSG00000138650 "Protocadherin 10" Q9P2E7 4 133149294-133208606 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 35.4;placenta: 25.9;prostate: 10.6;seminal vesicle: 17.3" "Cell type enhanced" "Detected in many" "Astrocytes: 58.1;Endometrial ciliated cells: 26.5;Excitatory neurons: 64.9;Glandular and luminal cells: 29.1;Inhibitory neurons: 57.7;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 59.6" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 11.5;HUVEC TERT2: 27.4;MOLT-4: 24.1;TIME: 55.4;U-138 MG: 14.5;U-251 MG: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011220, HPA073462" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA 88000 "Cluster 65: Brain - Ion transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA011220: AB_1855041, HPA073462: AB_2686605" "unprognostic (7.20e-2)" "unprognostic (8.74e-3)" "unprognostic (4.30e-2)" "unprognostic (8.12e-5)" "unprognostic (8.33e-2)" "unprognostic (3.20e-1)" "unprognostic (5.27e-3)" "unprognostic (4.51e-1)" "unprognostic (3.83e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-3)" "unprognostic (8.72e-2)" "unprognostic (1.45e-1)" "unprognostic (8.68e-4)" "unprognostic (8.88e-2)" "unprognostic (6.31e-2)" "unprognostic (2.16e-4)" 0.5 5.1 20.5 0.2 35.4 0.0 0.1 0.9 23.9 1.5 0.0 0.5 0.1 1.6 0.5 0.3 1.2 0.5 1.2 19.6 15.2 2.1 0.1 0.7 0.0 7.7 24.9 2.3 0.2 0.0 1.4 25.9 11.3 10.6 0.2 3.0 0.5 17.3 0.0 0.0 0.4 0.7 3.7 0.0 0.4 1.4 16.8 0.1 0.5 0.0 0.0 1.8 2.8 19.1 0.0 0.7 8.7 0.0 0.3 0.0 0.0 8.6 4.6 0.7 0.4 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.9 0.0 4.9 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 11.5 27.4 0.0 0.3 0.0 4.2 0.0 24.1 0.0 0.0 0.0 0.3 0.5 0.3 0.5 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.3 55.4 14.5 0.0 0.1 12.9 0.0 0.0 0.0 1.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 35.4 0.9 23.9 19.6 15.2 7.7 24.9 11.3 3.7 16.8 19.1 1.4 0.0 0.6 58.1 0.0 0.1 0.5 0.1 1.2 15.0 1.2 2.7 2.3 0.0 0.7 0.0 0.0 0.8 0.0 0.9 1.9 0.0 5.6 26.5 4.6 4.0 0.0 0.0 64.9 0.0 0.9 15.5 0.0 29.1 0.0 5.0 0.0 0.0 1.8 0.0 57.7 0.2 0.0 0.0 0.0 1.7 0.0 0.5 0.0 6.5 0.0 8.6 0.0 46.8 59.6 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.1 2.7 0.0 4.3 11.5 17.4 0.9 0.0 0.3 2.9 0.2 3.9 0.1 0.4 PCDH18 "KIAA1562, PCDH68L" ENSG00000189184 "Protocadherin 18" Q9HCL0 4 137518918-137532494 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 44.2" "Group enriched" "Detected in many" 4 "Endometrial stromal cells: 72.3;Fibroblasts: 56.3;Leydig cells: 37.9;Peritubular cells: 58.6;Sertoli cells: 19.7;Smooth muscle cells: 25.5;Theca cells: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 148.2;ASC diff: 175.0;ASC TERT1: 190.8;BJ hTERT+: 86.8;fHDF/TERT166: 143.3;HHSteC: 129.4;HSkMC: 195.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017976 Approved Approved "Golgi apparatus,Cytosol" No NA 5900000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" Cytosol "Golgi apparatus" "HPA017976: AB_1855045" "unprognostic (2.77e-1)" "unprognostic (1.86e-2)" "unprognostic (3.73e-3)" "unprognostic (9.19e-2)" "unprognostic (1.59e-1)" "unprognostic (3.39e-2)" "unprognostic (2.36e-1)" "unprognostic (4.30e-2)" "unprognostic (1.97e-3)" "unprognostic (2.20e-2)" "unprognostic (8.76e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (1.79e-2)" "unprognostic (6.27e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (4.71e-4)" 22.2 5.2 2.6 7.9 3.0 0.1 13.5 2.8 3.2 25.3 2.6 12.2 9.3 30.4 11.2 6.4 11.7 22.5 6.5 2.5 4.8 7.1 2.1 7.2 1.7 4.1 5.8 21.0 1.5 2.0 2.4 44.2 3.8 17.5 13.8 2.1 6.5 13.5 2.6 4.1 8.7 18.4 3.2 6.4 6.7 4.5 3.9 3.6 5.1 23.2 1.4 10.8 8.4 3.0 0.0 0.3 148.2 0.0 175.0 190.8 0.1 27.4 86.8 5.0 7.7 0.3 0.0 0.0 0.1 143.3 0.4 0.4 34.2 0.7 2.6 0.2 1.0 0.0 0.0 0.0 129.4 0.0 0.1 195.9 0.3 9.4 3.8 4.7 1.0 0.7 0.0 0.6 2.8 0.0 3.9 0.1 0.3 0.0 2.7 11.7 4.1 0.0 0.0 0.1 0.0 9.6 0.0 0.0 0.2 38.3 0.9 0.0 0.0 69.3 4.2 13.9 0.5 0.2 0.0 0.0 3.9 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.0 2.8 3.2 2.5 4.8 4.1 5.8 3.8 3.2 3.9 3.0 3.4 0.0 0.5 1.3 0.0 4.1 0.4 0.1 2.2 2.5 1.1 1.7 1.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.6 1.9 72.3 3.0 0.0 0.0 0.2 0.0 0.3 56.3 0.0 1.7 0.0 6.4 2.5 0.0 3.1 0.0 9.0 0.0 0.0 0.0 7.8 1.3 37.9 0.9 1.8 10.3 0.0 6.8 0.0 0.0 0.6 0.0 0.0 58.6 0.1 0.0 0.0 0.1 0.0 0.2 19.7 6.6 25.5 0.6 0.1 1.2 2.6 0.8 0.7 18.5 0.0 0.1 PCOLCE "PCPE, PCPE1" ENSG00000106333 "Procollagen C-endopeptidase enhancer" Q15113 7 100602363-100608175 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Endometrial stromal cells: 491.6;Fibroblasts: 439.9;Leydig cells: 140.5;Smooth muscle cells: 442.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 879.0;BJ hTERT+: 663.0;fHDF/TERT166: 404.5;HSkMC: 973.2;SH-SY5Y: 689.9;U-2197: 1213.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 81.1" "CAB017623, HPA042927" Approved Approved "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA 1300000000 "Cluster 22: NK-cells - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Vesicles" "CAB017623: AB_2251882, HPA042927: AB_2678224" "unprognostic (4.14e-1)" "unprognostic (1.79e-1)" "unprognostic (1.34e-1)" "unprognostic (2.92e-1)" "unprognostic (1.70e-2)" "unprognostic (4.48e-2)" "unprognostic (1.33e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.16e-2)" "unprognostic (1.73e-1)" "unprognostic (6.13e-2)" "prognostic unfavorable (1.68e-5)" "unprognostic (1.04e-2)" "unprognostic (3.21e-2)" "unprognostic (1.63e-2)" "unprognostic (1.43e-2)" 101.5 45.5 2.4 51.5 3.8 0.6 72.6 3.5 10.2 162.8 4.6 30.5 7.8 81.7 11.0 26.9 80.6 112.5 110.8 2.3 2.5 21.9 59.7 72.4 41.3 3.0 2.4 47.7 20.6 10.3 31.2 59.5 2.9 45.5 16.7 0.2 24.9 33.5 16.9 45.0 21.6 59.9 3.1 13.8 22.9 13.7 3.6 10.5 49.1 32.7 17.4 86.4 86.7 2.5 0.2 0.5 2.2 3.0 321.5 879.0 2.4 355.5 663.0 161.1 142.7 14.5 0.8 1.1 1.2 404.5 0.5 0.2 0.0 1.2 15.9 2.5 2.5 0.3 6.1 19.8 82.1 0.1 3.5 973.2 0.3 86.3 0.6 0.4 0.1 1.7 8.3 2.0 0.7 2.1 0.6 3.3 72.2 0.0 4.2 1.0 1.5 0.8 0.4 0.6 1.1 689.9 0.2 2.4 1.6 8.2 2.0 0.0 3.5 391.8 107.6 1213.4 0.2 0.4 0.5 0.1 136.6 1.2 68.2 0.0 0.0 0.4 0.1 0.3 0.3 0.1 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.4 0.2 0.0 0.1 0.0 2.4 3.8 3.5 10.2 2.3 2.5 3.0 2.4 2.9 3.1 3.6 2.5 33.6 9.6 2.8 2.3 2.5 40.0 3.3 4.2 6.8 4.3 6.6 11.3 16.3 4.3 5.5 5.5 0.0 13.3 4.5 0.8 27.4 6.4 14.8 15.1 491.6 17.2 1.8 5.7 0.5 5.1 11.2 439.9 7.1 11.0 1.3 0.7 33.9 44.8 20.8 16.8 2.5 0.9 6.1 1.9 53.6 27.6 140.5 5.5 32.0 9.4 0.8 12.1 6.2 1.5 0.2 4.1 1.3 50.4 2.1 2.2 0.1 2.5 6.8 2.0 32.9 14.2 442.2 32.8 21.0 3.6 33.1 25.2 9.4 22.6 0.7 3.0 PLAGL1 "LOT1, ZAC" ENSG00000118495 "PLAG1 like zinc finger 1" Q9UM63 6 143940300-144064599 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 252.3" "Cell type enhanced" "Detected in many" "Fibroblasts: 143.6;Leydig cells: 138.5;Theca cells: 205.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 99.0;RH-30: 94.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055706 Supported "Nuclear bodies,Golgi apparatus,Vesicles" No No "Cluster 45: Eosinophils - Innate immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 33: Fibroblasts - ECM organization" "Nuclear bodies" "Golgi apparatus, Vesicles" "HPA055706: AB_2682893" "unprognostic (4.74e-3)" "unprognostic (8.35e-3)" "unprognostic (5.43e-2)" "unprognostic (1.74e-3)" "unprognostic (5.09e-2)" "unprognostic (1.95e-1)" "unprognostic (9.32e-2)" "unprognostic (6.17e-2)" "unprognostic (3.49e-2)" "unprognostic (5.02e-2)" "unprognostic (1.78e-3)" "unprognostic (2.07e-1)" "prognostic unfavorable (4.94e-6)" "prognostic unfavorable (6.61e-4)" "unprognostic (4.69e-2)" "unprognostic (5.17e-3)" "unprognostic (4.93e-3)" 37.7 74.8 4.1 18.5 5.2 21.7 29.6 1.9 7.0 31.4 5.8 28.8 9.6 29.5 9.0 32.9 20.8 26.9 26.4 3.8 2.9 17.0 3.6 26.7 12.1 3.6 4.1 36.5 27.7 9.5 81.6 252.3 3.9 26.0 21.3 1.6 30.1 12.1 12.2 61.9 20.6 19.7 3.2 15.6 26.9 8.7 6.0 6.6 13.8 22.3 12.1 39.6 34.4 4.0 0.2 5.0 99.0 0.1 39.4 78.0 0.3 32.9 21.6 16.1 33.5 0.3 6.0 2.7 16.0 30.4 4.0 0.0 0.8 12.0 32.2 3.1 4.4 45.2 58.7 0.9 13.9 40.9 8.9 60.5 4.6 15.8 13.8 23.4 33.5 16.1 4.4 0.8 18.0 6.2 16.9 19.8 17.2 0.0 3.7 20.7 94.1 0.1 33.1 1.1 8.7 10.3 51.0 0.1 0.1 29.6 0.1 50.1 19.8 0.2 35.2 77.7 36.4 9.1 9.0 0.6 25.3 16.6 2.0 4.9 12.0 25.1 1.4 9.1 1.4 3.7 1.3 1.9 14.9 5.8 0.9 1.5 21.7 2.2 2.9 6.7 2.0 3.8 4.1 5.2 1.9 7.0 3.8 2.9 3.6 4.1 3.9 3.2 6.0 4.0 19.5 51.3 51.0 28.4 15.2 21.7 14.6 5.3 34.1 2.1 16.8 14.0 8.4 5.7 12.6 5.5 0.0 4.6 19.0 16.1 7.9 11.8 1.8 8.6 91.9 23.8 16.7 19.3 60.3 11.3 15.0 143.6 11.7 13.0 18.4 38.7 8.6 0.2 20.3 8.4 76.6 33.6 18.3 26.8 27.8 5.5 138.5 26.8 8.8 49.6 37.6 0.9 2.1 10.6 5.5 13.0 22.5 97.0 5.7 52.0 4.3 15.3 4.4 0.4 13.1 61.7 31.1 0.9 1.0 24.1 43.3 9.9 10.0 205.8 28.5 19.7 PLCXD3 ENSG00000182836 "Phosphatidylinositol specific phospholipase C X domain containing 3" Q63HM9 5 41306952-41510628 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.8;heart muscle: 33.2;ovary: 22.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 138.2;Endometrial stromal cells: 58.7;Enteroendocrine cells: 42.4;Inhibitory neurons: 163.5;Microglial cells: 52.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.5;PC-3: 7.5;SH-SY5Y: 34.3;TIME: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046849 Uncertain Approved "Golgi apparatus" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA046849: AB_2679838" "unprognostic (1.71e-1)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" "unprognostic (7.04e-3)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (4.90e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-2)" "unprognostic (3.12e-1)" "unprognostic (6.38e-3)" "unprognostic (2.57e-1)" "unprognostic (2.73e-2)" "unprognostic (2.15e-3)" "unprognostic (5.91e-5)" "unprognostic (5.11e-2)" "unprognostic (6.75e-2)" 3.9 12.7 4.5 0.5 4.1 0.0 2.4 17.8 4.2 2.9 1.1 0.9 0.5 1.1 0.9 0.6 3.4 2.4 33.2 3.4 9.5 5.9 1.6 1.8 1.6 8.2 10.4 22.5 3.6 0.3 5.3 0.1 16.0 1.0 0.6 0.7 0.4 1.0 0.5 0.7 1.2 1.2 7.7 0.2 5.0 0.4 12.1 0.5 1.5 0.7 0.2 1.4 4.0 6.3 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.8 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.4 34.3 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 4.1 17.8 4.2 3.4 9.5 8.2 10.4 16.0 7.7 12.1 6.3 8.7 0.0 0.0 7.5 0.1 0.1 0.1 0.0 0.0 0.7 0.1 0.0 138.2 5.7 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.3 0.9 1.7 58.7 13.6 42.4 5.3 27.8 0.0 2.0 10.3 0.0 1.1 0.0 33.4 33.2 0.4 0.1 1.7 163.5 2.2 0.0 0.6 0.3 4.4 7.8 0.2 0.0 52.5 0.0 0.4 0.0 7.5 1.3 0.9 0.0 0.4 0.0 0.3 0.1 10.4 0.0 0.2 6.6 0.2 2.9 0.2 0.0 0.2 0.0 0.1 0.3 9.7 0.1 0.1 PLPP3 "LPP3, PAP-2b, PPAP2B" ENSG00000162407 "Phospholipid phosphatase 3" O14495 1 56494761-56645301 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 392.7;Hepatic stellate cells: 779.6;Leydig cells: 1092.6;Peritubular cells: 398.7" "Cancer enhanced" "Detected in all" "thyroid cancer: 168.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 2.4;naive B-cell: 2.3" "Lineage enriched" "Detected in single" 6 "B-cells: 2.4" "Cell line enhanced" "Detected in many" "ASC diff: 710.0;ASC TERT1: 351.8;HSkMC: 438.1;U-2197: 660.4" "Low region specificity" "Detected in all" HPA072751 Approved Supported "Golgi apparatus" NA Yes "Cluster 19: B-cells - Humoral immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" "HPA072751: AB_2686555" "unprognostic (2.50e-2)" "unprognostic (3.94e-1)" "unprognostic (1.81e-1)" "unprognostic (1.65e-1)" "unprognostic (2.71e-1)" "unprognostic (2.22e-3)" "unprognostic (5.86e-3)" "unprognostic (7.25e-2)" "unprognostic (1.59e-1)" "unprognostic (3.75e-2)" "unprognostic (3.91e-2)" "unprognostic (3.08e-1)" "prognostic favorable (4.59e-4)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (3.54e-2)" "unprognostic (2.09e-1)" 168.4 53.0 93.9 33.6 94.2 13.1 139.8 87.3 105.9 294.6 50.7 56.7 24.0 107.2 56.2 51.3 122.5 66.3 84.6 88.3 90.6 91.4 182.0 87.0 22.4 107.5 108.1 81.9 36.8 130.2 23.1 225.5 87.7 102.8 41.8 19.0 76.2 169.7 50.9 82.1 45.8 65.6 86.8 23.3 66.0 37.3 113.2 29.8 327.6 63.0 19.9 139.2 142.8 88.6 3.3 10.8 14.1 1.5 710.0 351.8 34.5 39.3 39.7 35.5 17.4 31.8 6.2 5.2 4.6 59.3 39.4 5.9 2.1 0.8 7.4 0.0 9.4 1.3 4.4 44.5 17.3 0.1 0.0 438.1 3.0 34.2 28.6 25.1 34.1 0.4 2.9 0.1 39.0 3.2 0.1 0.5 43.3 9.2 42.6 0.1 0.1 1.7 6.1 32.6 0.4 28.1 12.4 16.1 4.2 42.6 5.2 0.0 21.6 176.2 14.4 660.4 1.8 0.0 0.0 0.0 31.0 1.7 12.7 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.3 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 93.9 94.2 87.3 105.9 88.3 90.6 107.5 108.1 87.7 86.8 113.2 88.6 148.5 25.6 18.9 0.0 7.2 0.0 19.8 0.0 35.3 3.9 12.2 31.2 0.0 44.3 13.0 22.0 0.0 127.0 1.1 8.1 21.5 21.5 7.9 13.9 139.4 148.3 2.4 8.0 0.0 9.2 9.8 392.7 5.6 16.3 3.8 8.1 779.6 132.6 38.8 0.0 0.0 8.5 0.0 35.2 0.0 28.3 1092.6 14.9 0.0 0.0 0.9 136.0 0.0 0.0 0.0 7.9 5.9 398.7 7.1 20.8 15.5 21.3 4.4 4.1 138.1 179.7 107.2 4.5 3.4 16.4 0.0 214.9 5.0 22.4 7.2 20.1 PLSCR1 MMTRA1B ENSG00000188313 "Phospholipid scramblase 1" O15162 3 146515180-146544856 "Predicted intracellular proteins, Transporters" "Antiviral defense, Host-virus interaction" "DNA-binding, Host cell receptor for virus entry, Hydrolase, Nuclease, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 291.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 319.8;BJ hTERT+ SV40 Large T+ RasG12V: 418.6;HHSteC: 292.9;SK-MEL-30: 569.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068923, CAB070421" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA Yes "Cluster 25: Monocytes - Inflammatory response" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Plasma membrane" "Golgi apparatus" "CAB070421: AB_11153452, HPA068923: AB_2686059" "unprognostic (7.88e-2)" "unprognostic (1.10e-1)" "unprognostic (5.34e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.12e-1)" "unprognostic (3.35e-1)" "unprognostic (5.22e-2)" "unprognostic (7.73e-3)" "unprognostic (9.19e-3)" "unprognostic (6.93e-3)" "unprognostic (3.07e-3)" "unprognostic (1.10e-1)" "unprognostic (1.09e-3)" "unprognostic (5.26e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-1)" "unprognostic (1.63e-1)" 60.6 23.0 11.4 86.7 12.5 64.4 45.9 12.7 17.6 25.9 11.9 65.0 39.8 28.2 31.0 47.9 40.0 66.1 24.3 12.1 13.5 71.9 49.2 49.3 40.6 17.4 14.2 34.9 38.3 16.8 15.4 56.3 15.3 23.7 59.5 9.8 49.1 49.6 10.8 13.6 45.4 41.9 16.2 64.5 44.0 17.1 14.7 30.0 27.8 17.6 39.4 68.1 29.5 14.0 106.2 41.5 26.4 12.1 40.9 65.0 40.5 32.6 88.4 319.8 418.6 34.0 88.1 8.4 75.6 20.6 245.9 86.2 21.2 32.7 56.6 32.9 21.6 66.1 12.5 25.2 292.9 40.3 35.4 106.3 53.3 36.6 182.3 52.6 49.4 19.1 44.7 104.0 66.9 41.0 30.6 16.1 25.8 71.6 37.6 27.4 28.1 2.9 95.9 29.6 16.3 0.0 42.6 20.9 569.9 35.8 20.7 46.8 30.6 26.9 22.7 59.1 55.8 79.2 15.6 0.4 27.0 29.0 23.3 41.1 157.6 44.3 20.8 159.6 30.0 25.2 13.5 18.5 105.8 19.7 9.3 13.9 100.0 57.8 94.8 28.5 8.3 79.3 11.4 12.5 12.7 17.6 12.1 13.5 17.4 14.2 15.3 16.2 14.7 14.0 191.4 35.3 43.0 12.7 28.2 37.0 106.5 92.1 26.2 0.7 36.0 22.6 7.3 124.4 110.4 95.6 0.0 53.7 25.4 134.2 74.3 291.6 2.0 56.1 24.5 135.2 33.1 18.3 7.1 217.4 114.1 74.8 47.9 58.2 28.4 60.5 100.6 29.7 139.9 0.0 9.0 71.5 79.3 86.2 162.9 6.8 114.9 185.5 48.0 35.6 72.3 64.3 32.0 7.1 0.3 157.6 110.3 45.9 18.2 79.6 40.7 75.0 133.5 1.6 39.5 63.4 59.2 1.5 2.4 21.8 28.6 44.5 25.9 42.6 69.4 211.9 PNRC2 ENSG00000189266 "Proline rich nuclear receptor coactivator 2" Q9NPJ4 1 23956839-23963462 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027820, HPA045837" Uncertain Supported "Nucleoplasm,Golgi apparatus" No No "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "Golgi apparatus" "HPA027820: AB_10602147, HPA045837: AB_2679467" "prognostic favorable (6.02e-4)" "unprognostic (5.99e-2)" "unprognostic (3.15e-3)" "unprognostic (2.10e-2)" "unprognostic (3.58e-1)" "unprognostic (4.45e-3)" "prognostic unfavorable (7.97e-5)" "unprognostic (4.05e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.92e-3)" "unprognostic (1.81e-2)" "unprognostic (1.49e-1)" "unprognostic (2.18e-1)" "unprognostic (4.44e-2)" "prognostic favorable (4.05e-4)" 82.7 82.5 49.5 80.6 52.1 141.0 78.5 53.4 62.0 69.6 56.1 98.1 99.5 87.4 68.6 62.8 58.3 80.5 75.2 49.6 51.9 99.6 66.8 76.0 137.0 52.6 50.7 79.3 52.2 94.3 34.8 103.3 54.4 70.5 92.2 56.2 55.0 56.9 49.8 46.1 84.2 71.8 50.9 87.5 81.9 33.7 51.9 133.5 122.2 63.6 109.5 100.1 51.4 57.8 107.8 42.0 179.5 124.9 121.5 110.7 68.6 116.7 103.7 132.7 106.1 122.7 132.5 291.7 111.5 74.8 49.9 93.5 121.6 101.8 146.7 208.6 78.7 277.5 131.8 130.2 103.3 272.1 122.3 83.9 125.8 109.2 101.0 86.8 130.3 148.4 239.6 159.5 79.0 87.5 169.4 103.3 243.8 101.7 76.5 189.7 116.7 125.0 134.8 113.8 107.4 93.5 101.0 85.7 123.7 130.9 93.6 168.6 105.3 85.6 82.2 84.6 75.4 133.7 164.8 197.6 58.0 259.0 89.8 230.8 112.7 126.8 103.5 115.0 108.8 129.1 112.5 112.2 109.1 131.1 124.9 106.8 74.2 108.6 112.2 77.4 129.4 178.3 49.5 52.1 53.4 62.0 49.6 51.9 52.6 50.7 54.4 50.9 51.9 57.8 119.0 185.9 109.2 11.4 122.5 13.3 231.7 2.0 99.0 33.6 110.5 109.6 84.8 58.6 62.2 62.5 18.8 129.8 104.7 160.5 238.7 90.5 6.9 86.0 96.1 97.3 100.4 157.0 7.9 127.8 101.4 128.7 66.3 130.9 76.5 84.1 86.7 30.0 68.6 20.2 6.4 109.3 0.0 82.3 10.9 14.2 78.9 109.0 1.8 13.1 81.8 66.9 127.7 6.0 11.8 119.2 157.7 81.3 48.8 187.6 90.3 112.0 56.1 28.7 46.0 104.3 104.5 21.2 24.4 97.8 12.6 141.7 104.0 203.9 110.2 314.0 POMT1 LGMD2K ENSG00000130714 "Protein O-mannosyltransferase 1" Q9Y6A1 9 131502789-131523806 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 64.5;Spermatocytes: 71.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065252 Uncertain "Golgi apparatus" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA065252: AB_2685445" "unprognostic (2.00e-3)" "unprognostic (2.02e-1)" "unprognostic (1.60e-1)" "unprognostic (5.09e-3)" "unprognostic (1.67e-1)" "unprognostic (7.97e-2)" "unprognostic (5.35e-3)" "unprognostic (1.14e-1)" "unprognostic (9.76e-3)" "unprognostic (2.84e-1)" "prognostic favorable (3.90e-5)" "unprognostic (8.36e-2)" "prognostic favorable (4.68e-5)" "unprognostic (2.41e-2)" "unprognostic (1.61e-1)" "unprognostic (4.72e-2)" "unprognostic (2.12e-1)" 15.7 20.9 16.6 7.6 16.7 6.6 16.2 18.4 21.0 21.1 15.0 24.8 9.0 17.1 7.2 15.2 18.4 9.3 24.5 25.5 16.0 25.5 24.4 15.6 8.3 16.0 16.2 25.6 25.9 15.5 31.3 9.7 16.5 28.4 6.5 8.1 20.1 8.7 32.9 17.5 19.9 7.1 14.2 22.2 20.4 63.7 16.9 7.1 19.0 13.4 5.4 16.5 17.1 15.5 9.8 17.4 10.5 26.4 19.3 13.5 24.5 12.1 17.0 21.3 14.1 15.8 14.7 2.5 16.9 26.4 8.6 24.1 17.3 16.6 5.9 16.2 21.6 4.2 28.5 7.8 23.1 13.1 10.5 10.8 10.0 12.3 5.0 17.6 15.1 16.4 13.4 15.6 23.2 27.6 15.8 25.2 6.7 9.6 21.1 15.7 13.8 24.6 18.1 1.5 15.0 14.1 25.1 26.8 13.0 5.8 31.4 17.7 20.9 13.8 2.2 28.6 10.3 7.3 7.0 5.2 8.7 29.1 13.0 0.0 2.8 3.4 5.2 3.0 7.7 1.9 5.0 5.3 4.0 2.6 4.8 3.6 0.6 3.2 2.9 2.4 5.2 4.0 16.6 16.7 18.4 21.0 25.5 16.0 16.0 16.2 16.5 14.2 16.9 15.5 5.9 9.6 16.0 18.6 7.1 4.5 4.9 7.2 5.7 13.2 7.8 8.6 9.7 10.0 8.7 12.9 8.4 20.8 6.5 12.9 1.9 10.7 64.5 9.6 7.3 8.0 7.8 1.3 21.5 6.7 12.9 9.0 9.2 9.9 2.5 15.1 11.0 10.1 10.8 21.9 25.9 8.4 10.2 5.4 5.9 33.0 8.7 5.6 5.4 15.9 7.5 12.3 5.2 18.6 11.1 8.1 6.0 10.1 6.8 4.9 14.2 7.5 6.8 16.6 6.6 7.5 7.2 71.6 9.6 5.7 3.0 17.5 9.0 6.2 9.1 2.6 PPP1R15B FLJ14744 ENSG00000158615 "Protein phosphatase 1 regulatory subunit 15B" Q5SWA1 1 204403381-204411817 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Translation regulation" "Diabetes mellitus, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 125.7" "Cell type enhanced" "Detected in all" "Langerhans cells: 171.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061088 Approved "Golgi apparatus" No No "Cluster 18: Basophils - Vesicular transport" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 28: BEWO - Transcription regulation" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" "HPA061088: AB_2684426" "unprognostic (2.91e-3)" "unprognostic (8.61e-3)" "unprognostic (1.90e-1)" "unprognostic (2.75e-3)" "unprognostic (1.25e-1)" "unprognostic (1.33e-1)" "unprognostic (5.31e-2)" "unprognostic (2.66e-2)" "unprognostic (7.37e-2)" "unprognostic (7.44e-2)" "unprognostic (1.60e-1)" "unprognostic (5.36e-2)" "prognostic unfavorable (8.74e-5)" "unprognostic (9.52e-3)" "unprognostic (2.47e-1)" "unprognostic (2.99e-2)" "unprognostic (7.50e-2)" 40.7 23.1 12.9 31.0 15.3 125.7 23.0 17.8 13.9 19.6 16.4 23.4 22.4 21.4 13.1 25.9 21.5 30.8 13.0 11.7 13.2 21.0 48.1 24.2 29.1 14.4 15.2 24.5 36.8 18.7 10.5 32.6 14.6 22.5 24.1 16.0 22.1 15.9 13.2 18.1 24.3 29.9 14.6 23.8 27.0 11.7 15.2 33.3 28.2 18.2 24.7 53.2 14.7 19.7 29.3 23.0 26.9 22.8 34.1 23.2 108.7 23.6 28.3 31.9 28.7 27.6 40.3 48.2 16.0 28.9 22.2 36.3 40.2 23.9 29.5 37.3 28.7 28.5 55.7 17.8 41.5 49.1 49.0 29.3 30.4 31.4 34.5 22.9 35.1 40.4 44.4 92.8 21.8 29.1 47.1 30.6 46.2 26.8 32.9 33.2 48.9 49.8 32.0 35.4 25.7 39.3 42.6 59.8 49.3 36.0 39.4 50.2 19.8 22.2 31.3 28.6 40.3 62.5 30.0 47.3 20.0 33.1 23.4 13.1 5.5 5.7 3.2 5.1 3.4 2.0 3.2 3.0 5.0 2.1 4.9 3.5 11.8 3.2 6.2 2.0 4.4 2.9 12.9 15.3 17.8 13.9 11.7 13.2 14.4 15.2 14.6 14.6 15.2 19.7 72.2 48.1 37.9 15.3 40.8 73.7 43.0 23.1 48.3 18.5 43.7 24.6 15.6 32.9 25.9 18.4 20.9 22.9 40.3 70.4 3.9 15.9 9.0 72.0 90.8 50.9 44.7 27.3 12.3 24.0 42.7 54.7 76.5 146.7 49.4 31.0 28.9 48.6 31.8 8.4 13.0 43.3 22.4 42.0 171.9 4.6 13.1 97.9 49.8 10.3 36.8 14.4 11.3 18.1 23.2 30.3 40.5 12.8 50.9 55.0 39.5 11.0 43.0 18.5 6.6 72.7 48.6 17.2 13.2 39.8 64.2 49.3 46.8 31.2 35.6 104.5 PRR36 ENSG00000183248 "Proline rich 36" Q9H6K5 19 7868719-7874390 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.0;pituitary gland: 29.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 13.4;Breast glandular cells: 9.2;Cone photoreceptor cells: 12.5;Horizontal cells: 10.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 21.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 28.7;SCLC-21H: 8.0;SH-SY5Y: 17.9;T-47d: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062741 Uncertain Approved "Nucleoplasm,Nuclear speckles,Golgi apparatus" Yes No "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 14: REH - Unknown function" "Cluster 35: Glandular cells - Unknown function" "Golgi apparatus" "Nucleoplasm, Nuclear speckles" "HPA062741: AB_2684860" "unprognostic (3.15e-2)" "unprognostic (1.02e-1)" "unprognostic (6.23e-2)" "unprognostic (5.61e-2)" "unprognostic (1.72e-1)" "unprognostic (1.20e-2)" "unprognostic (9.62e-2)" "unprognostic (3.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.15e-3)" "unprognostic (1.75e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-3)" "unprognostic (7.89e-2)" "prognostic favorable (7.74e-4)" "unprognostic (3.56e-1)" "unprognostic (8.52e-3)" 0.1 0.9 3.5 0.1 4.0 0.0 2.5 3.0 21.0 0.8 0.0 0.3 0.2 0.6 0.3 0.3 1.2 0.1 0.2 7.5 0.0 3.3 0.2 0.9 0.0 0.0 0.0 0.7 2.8 2.0 29.6 0.0 0.0 2.5 0.0 5.0 4.1 0.3 0.0 0.7 0.2 0.0 0.0 0.1 0.8 0.8 0.0 0.0 1.1 0.0 0.0 0.3 0.3 0.0 0.1 0.9 6.6 5.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 2.9 0.0 1.9 0.0 0.6 0.1 5.1 0.0 0.0 0.0 6.4 0.0 0.3 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 3.2 0.1 0.1 0.0 3.0 0.3 0.3 2.5 0.4 0.6 28.7 0.0 0.3 3.7 5.4 8.0 17.9 0.0 0.3 0.0 0.5 9.1 0.0 0.0 0.0 3.2 0.1 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.0 3.0 21.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.5 0.0 0.8 0.0 2.2 13.4 9.2 7.7 1.3 2.8 0.0 5.5 12.5 0.2 0.2 0.2 5.9 3.0 5.4 4.5 0.7 0.2 3.6 0.0 6.9 0.9 0.4 0.3 2.6 6.7 0.0 1.1 0.0 0.5 0.1 10.1 5.8 0.7 0.0 0.0 0.0 0.7 0.6 0.4 0.0 3.7 0.0 5.4 0.0 4.5 0.8 0.9 0.1 0.0 0.6 1.3 0.1 1.5 0.0 4.5 0.0 0.3 1.1 0.3 3.7 3.1 0.0 0.3 0.3 0.5 0.3 1.0 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Oligodendrocytes: 395.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 45: Intestine - Brush border" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853" "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favorable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 25.1 22.6 44.3 26.5 80.7 39.6 28.2 62.4 56.0 28.1 48.9 49.5 50.2 25.3 26.9 35.2 22.9 31.7 18.0 47.4 51.6 35.5 31.9 32.1 22.4 73.0 63.8 22.0 22.9 35.1 11.6 43.1 71.5 24.3 46.3 23.4 22.9 23.4 18.4 38.2 49.0 27.1 55.7 22.6 31.0 32.5 60.8 26.2 36.9 23.3 30.7 35.0 19.2 119.1 37.1 55.9 50.6 20.0 68.9 49.9 46.7 52.5 60.1 52.6 66.7 69.9 88.9 23.7 34.1 50.5 43.0 94.9 43.2 40.1 57.3 54.6 26.7 27.1 35.1 34.4 63.8 27.7 50.7 50.4 71.9 44.3 54.4 48.5 43.2 26.2 31.0 46.6 50.0 72.8 21.0 35.7 22.0 64.5 40.4 26.4 42.7 30.2 73.7 76.5 28.1 38.3 57.4 53.0 47.1 45.4 66.3 60.7 45.7 53.1 43.5 44.1 25.3 30.3 47.9 23.7 44.9 32.8 33.3 126.8 94.5 96.3 23.1 106.0 22.6 23.1 22.3 19.0 83.4 31.8 20.7 20.1 129.3 42.8 125.0 43.6 37.0 70.3 44.3 80.7 62.4 56.0 47.4 51.6 73.0 63.8 71.5 55.7 60.8 119.1 22.2 28.9 30.5 35.9 25.8 28.6 24.6 24.7 12.0 17.1 25.0 17.7 12.5 15.7 30.2 23.9 39.6 27.1 30.7 79.1 5.9 27.1 22.9 26.3 26.4 22.3 16.2 12.0 38.9 26.7 29.2 23.7 32.1 47.4 18.3 29.6 15.7 24.6 30.5 13.5 40.2 39.5 24.4 50.5 40.8 12.9 16.4 52.3 16.0 39.4 51.8 13.8 14.4 48.7 395.8 38.2 58.8 15.4 23.6 38.8 76.2 13.0 29.0 28.0 26.3 20.0 19.0 40.2 14.4 20.4 33.0 49.9 21.6 18.6 41.3 51.5 PSMG1 "c21-LRP, DSCR2, LRPC21, PAC1" ENSG00000183527 "Proteasome assembly chaperone 1" O95456 21 39174769-39183488 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.3" "Group enriched" "Detected in all" 4 "Early spermatids: 673.8;Spermatocytes: 544.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057193, HPA070225" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 36: HEL - Hemostasis" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA057193: AB_2683363, HPA070225: AB_2686236" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" "unprognostic (1.27e-1)" "unprognostic (2.34e-1)" "unprognostic (2.10e-1)" "unprognostic (9.38e-2)" "unprognostic (5.06e-3)" "unprognostic (2.02e-1)" "unprognostic (1.66e-2)" "unprognostic (5.09e-2)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (2.84e-1)" "unprognostic (8.98e-2)" "unprognostic (1.32e-2)" "unprognostic (4.17e-3)" 7.5 9.8 4.0 9.1 4.0 17.3 6.8 2.7 5.5 7.3 2.5 10.5 8.9 7.8 4.8 11.8 6.4 5.4 8.3 4.6 3.8 9.7 15.9 5.7 8.9 2.2 2.4 7.2 10.8 5.1 8.0 7.7 3.2 5.5 9.9 4.9 7.3 3.2 13.8 7.1 8.2 5.1 2.1 6.3 7.1 40.3 3.7 6.3 10.8 5.6 6.2 7.8 7.4 4.0 104.0 34.7 23.5 32.9 12.3 15.1 65.0 55.3 25.9 44.8 28.2 66.6 26.9 113.7 28.9 17.1 38.1 28.5 40.3 30.3 30.2 48.9 61.6 209.6 52.4 83.6 21.9 101.0 40.4 18.9 24.6 46.2 46.5 9.8 24.9 47.0 160.4 61.9 27.2 58.2 63.0 54.7 82.2 38.9 53.5 99.6 29.8 115.8 19.1 30.4 77.6 22.7 70.4 39.1 57.4 4.0 36.6 51.4 26.7 50.1 16.8 66.7 79.9 46.4 79.3 96.8 42.0 170.4 38.6 10.6 6.8 3.9 10.5 9.0 12.3 12.0 14.7 12.4 12.2 10.6 11.5 10.3 0.6 7.5 9.1 11.3 13.7 7.9 4.0 4.0 2.7 5.5 4.6 3.8 2.2 2.4 3.2 2.1 3.7 4.0 23.7 6.4 17.6 5.2 17.8 136.0 44.1 68.6 43.9 14.2 31.3 39.0 24.8 22.8 39.9 20.2 4.2 108.9 12.6 14.7 66.5 50.8 673.8 20.8 36.5 26.3 29.9 63.3 7.5 49.7 118.6 31.8 18.8 21.6 36.1 26.2 18.9 32.7 59.5 8.4 8.0 45.7 69.2 17.7 35.5 88.4 31.7 25.0 46.2 3.7 24.4 18.0 12.3 3.5 5.9 32.4 20.0 33.1 31.7 41.5 30.6 89.4 20.8 19.7 26.3 29.5 31.3 544.1 98.7 51.7 97.7 54.5 20.1 54.7 56.9 27.9 QPCTL FLJ20084 ENSG00000011478 "Glutaminyl-peptide cyclotransferase like" Q9NXS2 19 45692403-45703989 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 5.5;granulocytes: 5.7;Inhibitory neurons: 6.5;Plasma cells: 9.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040797 Approved Supported "Golgi apparatus" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA040797: AB_10794148" "unprognostic (6.50e-2)" "unprognostic (4.14e-2)" "unprognostic (2.09e-1)" "unprognostic (7.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.26e-1)" "unprognostic (8.41e-3)" "unprognostic (2.30e-2)" "unprognostic (9.46e-2)" "unprognostic (1.69e-1)" "unprognostic (3.14e-2)" "unprognostic (6.05e-2)" "prognostic unfavorable (2.15e-8)" "unprognostic (1.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.02e-2)" "unprognostic (5.71e-2)" 4.1 7.8 3.9 3.1 3.9 4.1 4.9 3.6 4.8 4.9 4.1 5.9 4.7 4.8 3.7 4.7 4.8 2.5 3.4 4.2 4.0 5.3 9.2 6.2 4.7 4.5 3.8 6.6 7.5 4.4 7.0 3.7 4.5 6.5 3.9 2.1 6.7 3.4 1.5 5.2 5.5 2.5 3.2 8.5 6.1 4.4 4.2 2.4 6.7 0.8 3.5 4.6 4.4 3.9 16.7 10.8 8.5 36.9 8.6 4.1 6.4 10.3 15.7 15.0 24.7 11.2 12.3 19.7 11.1 11.5 15.4 9.5 10.0 11.9 8.9 5.0 12.7 6.7 10.9 24.6 14.6 7.5 12.0 7.6 14.9 12.6 17.3 10.7 13.6 10.8 9.7 32.1 9.5 13.0 7.0 7.7 5.5 14.2 5.4 7.8 6.4 16.5 16.2 8.0 7.6 4.7 10.6 8.8 18.2 3.7 6.4 10.6 8.4 7.4 12.4 7.3 10.4 28.6 20.2 18.2 26.0 17.2 5.8 1.4 0.3 0.2 1.4 0.5 0.9 0.9 0.6 0.3 0.8 0.6 0.5 0.7 1.3 1.4 0.3 1.0 0.3 0.2 3.9 3.9 3.6 4.8 4.2 4.0 4.5 3.8 4.5 3.2 4.2 3.9 0.5 0.0 1.5 2.3 3.3 1.3 1.2 1.1 0.6 1.1 0.7 0.6 0.8 1.5 1.2 0.0 0.0 0.8 2.1 1.2 0.0 0.6 5.4 0.9 1.4 0.7 0.0 1.3 5.5 0.4 1.4 0.7 1.5 1.4 5.7 0.7 0.0 1.3 0.9 1.7 6.5 0.4 0.0 0.6 1.8 1.3 0.0 1.6 1.8 0.0 0.7 0.3 1.0 3.5 1.6 0.6 0.1 0.0 9.8 1.2 0.7 0.1 2.2 2.4 0.0 0.6 1.1 1.0 0.3 1.4 1.1 0.8 2.4 1.5 1.0 0.5 RASSF2 "CENP-34, KIAA0168" ENSG00000101265 "Ras association domain family member 2" P50749 20 4780023-4823608 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 217.0;retina: 162.8" "Cell type enhanced" "Detected in many" "Kupffer cells: 87.1;Langerhans cells: 75.8;monocytes: 148.5;Oligodendrocytes: 106.7;Peritubular cells: 149.7;Rod photoreceptor cells: 160.3" "Cancer enriched" "Detected in all" 5 "glioma: 48.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 56.8;BEWO: 59.2;Daudi: 62.7;HL-60: 74.7;NB-4: 96.3;U-937: 116.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051200 Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "Golgi apparatus, Plasma membrane, Cytosol" "HPA051200: AB_2681386" "unprognostic (6.51e-2)" "unprognostic (3.67e-3)" "unprognostic (5.31e-2)" "unprognostic (1.47e-2)" "unprognostic (3.15e-1)" "unprognostic (1.46e-3)" "unprognostic (2.80e-1)" "unprognostic (7.01e-2)" "unprognostic (1.38e-2)" "unprognostic (2.41e-2)" "unprognostic (4.93e-2)" "unprognostic (3.90e-1)" "prognostic unfavorable (7.82e-4)" "unprognostic (3.51e-2)" "unprognostic (1.35e-1)" "unprognostic (3.49e-1)" "unprognostic (6.46e-2)" 16.4 9.7 76.1 47.1 135.2 91.2 6.9 155.5 113.5 27.9 40.0 8.4 5.3 25.4 22.5 10.0 22.1 15.6 4.2 68.9 94.7 4.0 5.9 25.4 58.6 217.0 148.8 7.0 3.1 1.5 5.0 9.1 186.4 7.3 9.6 162.8 3.0 9.3 1.2 4.2 14.5 38.7 135.8 32.7 7.0 20.6 120.0 19.5 4.7 5.0 73.6 20.7 4.9 197.0 0.1 14.5 34.9 56.8 0.4 0.0 59.2 3.5 10.0 0.6 0.2 3.4 0.1 62.7 5.6 3.1 1.4 0.2 5.1 0.0 0.8 22.7 2.1 41.1 0.0 0.7 0.0 74.7 40.1 0.1 0.0 1.3 0.0 1.3 23.4 7.0 0.2 24.0 0.0 0.1 11.0 96.3 7.8 0.0 1.1 17.1 3.9 23.8 0.0 29.0 0.4 2.8 0.0 1.0 1.7 7.4 0.0 47.0 0.7 1.5 7.4 0.7 4.6 0.3 5.9 37.8 0.3 116.8 0.4 85.6 61.5 101.3 7.7 50.1 14.6 24.3 12.0 10.4 46.8 16.4 7.8 6.5 139.5 8.5 59.9 30.7 11.8 42.1 76.1 135.2 155.5 113.5 68.9 94.7 217.0 148.8 186.4 135.8 120.0 197.0 5.5 0.0 8.7 7.5 49.3 4.7 0.0 0.1 0.0 39.2 4.1 1.7 1.9 1.5 1.9 0.0 27.1 3.0 43.0 0.1 1.9 1.2 6.0 3.2 19.6 18.6 0.0 6.1 1.5 0.9 5.1 10.9 1.1 1.0 54.3 4.5 11.4 1.2 27.1 6.7 1.3 0.7 0.0 87.1 75.8 25.1 33.2 64.6 8.8 26.2 148.5 19.3 7.2 33.7 106.7 0.6 0.0 149.7 14.3 1.2 0.0 0.3 0.1 160.3 0.0 9.4 3.5 0.7 1.0 0.3 2.6 1.4 20.8 0.8 0.0 2.3 RBFOX1 "A2BP1, FOX-1, HRNBP1" ENSG00000078328 "RNA binding fox-1 homolog 1" Q9NWB1 16 5239802-7713340 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "brain: 73.9;heart muscle: 25.2;skeletal muscle: 95.3;tongue: 45.3" "Group enriched" "Detected in some" 8 "Excitatory neurons: 5800.8;Inhibitory neurons: 5921.8" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Group enriched" "Detected in many" 10 "basal ganglia: 28.1;cerebral cortex: 73.9;hippocampal formation: 26.6;white matter: 22.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "RH-30: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040809, HPA066746, HPA075862" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" No No "Cluster 11: Basophils - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA040809: AB_10796228, HPA066746: , HPA075862: " "unprognostic (3.75e-3)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (5.19e-3)" "unprognostic (8.82e-5)" "unprognostic (5.02e-1)" "unprognostic (3.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.43e-2)" "unprognostic (3.24e-2)" "unprognostic (2.23e-1)" "unprognostic (5.00e-2)" "unprognostic (2.28e-1)" 0.3 1.5 3.7 0.4 28.1 0.5 0.1 2.5 73.9 0.6 0.0 0.8 0.2 0.2 3.1 1.1 1.1 0.1 25.2 26.6 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.0 1.1 0.1 0.0 1.7 0.5 5.7 2.2 4.1 95.3 0.3 0.2 0.0 2.7 0.0 0.2 1.1 2.2 0.2 0.1 45.3 0.0 0.4 0.4 22.6 0.1 0.2 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.7 0.0 0.0 0.1 1.6 0.0 0.0 0.0 25.9 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.2 0.0 0.2 0.2 0.3 0.0 0.7 0.1 0.4 0.2 0.0 0.1 0.2 0.2 0.2 0.0 0.3 0.3 0.2 0.7 0.2 0.1 0.1 0.2 0.0 3.7 28.1 2.5 73.9 26.6 0.0 0.0 0.0 0.0 2.7 2.2 22.6 0.0 0.0 0.5 97.9 0.0 0.0 0.0 0.0 0.0 10.9 0.4 0.0 98.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 6.6 0.3 1.8 0.9 0.0 0.0 5800.8 0.2 0.0 3.5 0.0 0.1 0.0 47.8 0.0 0.0 0.1 0.0 5921.8 0.5 0.0 0.0 0.3 4.9 1.2 0.5 1.8 132.1 0.6 6.6 0.0 597.6 689.4 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.7 2.8 0.0 17.0 1.2 0.6 0.5 0.0 0.0 0.0 0.1 0.7 0.7 0.0 RBP2 "CRABP-II, CRBP2, CRBPII, RBPC2" ENSG00000114113 "Retinol binding protein 2" P50120 3 139452884-139480747 "Metabolic proteins, Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 294 "intestine: 2713.5" "Cell type enriched" "Detected in some" 26 "Proximal enterocytes: 6095.4" "Group enriched" "Detected in many" 4 "colorectal cancer: 7.1;pancreatic cancer: 4.5;stomach cancer: 8.4;testis cancer: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "CACO-2: 78.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA035866 Enhanced Approved "Golgi apparatus" NA NA 140000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA035866: AB_10672232" "unprognostic (1.74e-1)" "unprognostic (2.66e-2)" "unprognostic (3.34e-2)" "unprognostic (6.72e-6)" "unprognostic (2.33e-1)" "unprognostic (4.10e-2)" "unprognostic (1.56e-2)" "unprognostic (2.24e-1)" "unprognostic (8.51e-3)" "unprognostic (3.92e-2)" "unprognostic (7.35e-2)" "unprognostic (1.24e-3)" "unprognostic (5.57e-3)" "unprognostic (1.10e-1)" "unprognostic (9.23e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" 0.4 1.1 4.6 1.1 3.2 0.7 0.5 0.3 3.2 0.2 0.0 4.0 2713.5 2.0 0.0 0.2 0.3 1.8 0.2 3.3 5.0 2.6 0.0 7.6 2.2 8.1 9.2 0.3 3.0 0.0 0.1 0.1 3.4 0.4 2.4 2.2 0.1 0.0 0.2 1.1 1886.7 1.0 3.4 0.1 3.6 1.0 9.0 0.0 0.5 0.0 0.0 0.0 0.0 5.3 0.0 0.2 0.2 0.2 0.0 0.0 7.1 0.0 0.0 0.0 0.0 78.8 0.1 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.9 0.1 0.2 0.1 0.1 0.0 11.7 0.0 0.0 4.0 10.1 0.0 0.1 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 3.2 0.3 3.2 3.3 5.0 8.1 9.2 3.4 3.4 9.0 5.3 0.0 9.6 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 12.9 8.4 0.0 0.0 14.0 0.0 0.6 0.0 0.0 0.0 0.2 1.2 0.0 1.0 6.1 0.0 3.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 185.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.5 0.9 6.1 226.3 0.0 0.0 0.0 6095.4 0.0 0.7 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 142.6 0.1 RER1 ENSG00000157916 "Retention in endoplasmic reticulum sorting receptor 1" O15258 1 2391775-2405442 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037240, HPA051400" Supported Supported "Golgi apparatus" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus" "CAB037240: AB_2179604, HPA051400: AB_2681469" "unprognostic (2.90e-2)" "unprognostic (3.35e-2)" "unprognostic (3.17e-2)" "unprognostic (2.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.07e-1)" "unprognostic (1.53e-2)" "unprognostic (1.24e-1)" "unprognostic (2.28e-1)" "unprognostic (2.72e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.23e-8)" "unprognostic (1.01e-1)" "unprognostic (5.41e-2)" "unprognostic (1.06e-1)" "unprognostic (3.27e-2)" 100.4 154.2 60.0 89.3 67.6 81.6 97.1 67.0 62.8 93.6 78.3 137.4 114.8 74.4 122.7 176.4 86.1 86.9 75.7 61.1 64.1 106.3 224.8 79.6 94.6 67.0 65.1 92.9 122.3 100.9 82.9 99.0 66.9 94.3 151.4 73.8 101.1 104.2 105.2 101.7 120.0 104.6 65.6 102.2 118.6 107.1 68.5 94.5 85.9 85.1 143.5 101.0 106.5 76.1 203.1 111.0 131.1 146.8 233.7 275.7 100.9 297.1 261.1 254.3 253.2 157.6 299.3 143.9 242.7 297.7 205.1 213.3 152.2 176.7 322.2 180.8 156.1 163.9 247.2 153.0 252.5 181.3 188.6 225.0 176.1 264.3 233.1 175.4 235.8 160.3 197.8 232.6 299.8 141.5 127.2 127.3 87.5 314.1 279.0 146.0 131.9 183.7 227.5 94.3 109.9 126.2 167.9 376.9 242.9 143.7 149.6 127.4 171.8 197.3 114.1 355.9 219.5 223.0 270.2 255.3 209.6 254.8 102.8 239.1 235.5 284.5 195.9 268.2 180.0 169.0 169.8 210.0 221.2 151.7 127.0 155.9 351.3 164.8 275.9 256.1 244.5 309.0 60.0 67.6 67.0 62.8 61.1 64.1 67.0 65.1 66.9 65.6 68.5 76.1 88.7 64.1 50.0 23.5 73.1 53.2 84.4 214.2 50.1 33.6 111.9 123.6 41.6 118.7 131.4 104.8 33.3 233.8 97.5 218.9 66.5 213.4 475.6 89.5 93.5 68.2 36.5 57.2 16.7 258.4 321.8 94.3 71.9 118.8 44.3 76.5 82.1 233.5 217.9 37.0 16.8 158.6 122.1 104.3 73.2 464.0 82.6 99.9 62.2 15.9 126.1 97.0 114.4 19.1 25.8 256.4 195.4 76.0 145.1 142.5 238.7 119.6 136.3 62.6 111.7 60.9 141.6 291.4 145.2 103.4 67.1 467.9 74.3 159.0 162.0 141.0 RINT1 "FLJ11785, RINT-1" ENSG00000135249 "RAD50 interactor 1" Q6NUQ1 7 105532169-105567677 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, ER-Golgi transport, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019875, HPA031646" Approved Approved "Golgi apparatus" Yes No "Cluster 40: NK-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "HPA019875: AB_1856283, HPA031646: AB_2673975" "unprognostic (1.58e-2)" "unprognostic (3.94e-2)" "unprognostic (9.00e-2)" "unprognostic (1.80e-1)" "unprognostic (2.50e-1)" "unprognostic (7.95e-2)" "unprognostic (4.68e-3)" "unprognostic (1.33e-2)" "unprognostic (4.96e-3)" "unprognostic (2.41e-1)" "unprognostic (8.72e-2)" "unprognostic (5.35e-2)" "unprognostic (8.75e-3)" "unprognostic (1.47e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.39e-5)" "unprognostic (1.76e-1)" 7.3 6.1 2.8 9.0 3.1 15.2 10.0 6.9 3.7 8.2 5.6 8.1 9.4 8.6 7.2 11.3 8.0 6.7 8.2 3.1 3.1 9.3 10.5 6.7 13.4 2.8 2.7 8.0 11.6 9.7 5.4 8.8 3.1 7.8 9.3 10.3 11.3 6.1 16.7 8.7 7.1 6.4 3.2 8.8 9.7 11.1 2.7 9.9 8.8 13.3 13.7 8.4 5.7 4.1 28.8 23.5 12.1 27.8 18.8 24.9 15.9 27.2 19.2 26.4 29.6 27.4 18.4 31.6 31.3 24.1 29.4 19.0 22.5 21.0 34.7 17.0 25.9 18.3 26.1 18.5 14.5 38.9 17.8 17.9 16.4 28.1 16.3 20.3 29.1 16.3 39.5 23.2 30.3 46.9 29.3 28.6 26.1 23.8 23.1 17.5 20.5 45.4 14.2 23.6 20.5 22.4 28.9 47.7 20.6 20.9 19.4 12.5 20.3 30.2 24.0 83.1 34.8 46.6 59.7 61.4 20.0 31.8 34.6 4.4 3.9 4.4 6.7 5.8 11.6 9.0 9.8 9.2 6.0 7.8 8.6 9.4 0.7 9.1 4.8 4.0 10.5 6.2 2.8 3.1 6.9 3.7 3.1 3.1 2.8 2.7 3.1 3.2 2.7 4.1 6.7 3.2 9.8 10.4 12.4 6.6 9.6 7.7 8.6 5.8 5.9 5.3 10.5 1.5 9.4 3.7 8.4 11.2 13.4 6.0 9.8 8.1 10.8 9.0 6.4 6.8 5.4 4.6 25.6 6.3 10.3 9.4 12.2 5.5 10.1 7.5 4.2 5.1 7.3 6.7 26.0 5.8 10.2 5.6 3.4 6.2 8.7 5.2 5.4 9.4 5.7 7.8 7.2 9.0 18.2 6.7 4.0 9.8 17.9 6.5 5.5 6.8 18.1 8.9 6.6 8.3 8.0 29.2 12.4 8.3 7.7 12.0 10.8 7.5 6.4 8.3 RMDN2 "FAM82A, FAM82A1, FLJ32954, RMD2" ENSG00000115841 "Regulator of microtubule dynamics 2" Q96LZ7 2 37923187-38067142 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 42.5" "Group enriched" "Detected in many" 4 "Early spermatids: 270.4;Late spermatids: 163.5;Theca cells: 77.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034705, HPA034706" Enhanced Supported "Golgi apparatus,Mitotic spindle,Cytosol" Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Mitotic spindle, Cytosol" "Golgi apparatus" "HPA034705: AB_2674292, HPA034706: AB_10696362" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.76e-1)" "unprognostic (3.06e-2)" "prognostic favorable (2.63e-4)" "unprognostic (7.85e-2)" "unprognostic (9.96e-2)" "unprognostic (7.50e-2)" "unprognostic (1.94e-1)" "unprognostic (2.88e-2)" "unprognostic (5.08e-3)" "unprognostic (1.20e-1)" "unprognostic (4.34e-3)" "unprognostic (3.34e-1)" 4.6 42.5 3.8 4.1 3.5 3.4 5.3 4.8 4.5 7.7 2.9 12.4 8.4 5.1 9.2 3.4 3.9 6.2 4.4 4.1 2.6 7.8 29.2 11.3 4.6 3.9 2.6 2.8 4.1 3.2 3.0 3.9 2.6 7.2 10.6 4.2 3.7 12.8 5.1 2.9 13.9 5.8 3.0 20.0 4.4 21.7 3.6 5.9 5.4 3.2 2.9 4.3 3.5 3.7 3.3 4.7 2.6 1.8 10.4 11.4 1.5 7.0 9.3 3.6 3.2 1.1 10.9 2.2 2.8 9.9 2.2 3.5 0.8 5.1 4.9 5.0 3.0 3.6 1.6 3.1 5.3 0.0 3.8 16.2 4.6 4.5 0.7 5.4 2.0 1.8 4.4 2.1 6.8 1.3 0.9 4.5 5.1 6.5 3.8 0.0 0.8 0.6 9.0 2.7 2.1 7.5 5.7 0.7 7.3 2.2 1.1 5.9 3.8 4.4 5.1 2.5 2.6 3.8 7.7 4.6 5.4 1.1 4.6 0.0 2.8 0.7 2.0 4.6 3.1 4.1 1.0 1.3 1.8 2.3 1.0 2.2 2.7 3.7 3.5 3.4 0.1 1.4 3.8 3.5 4.8 4.5 4.1 2.6 3.9 2.6 2.6 3.0 3.6 3.7 3.4 28.9 29.6 25.1 6.5 2.4 6.8 16.3 8.6 3.5 1.9 4.2 5.3 11.5 20.0 5.5 2.1 2.1 6.0 20.9 7.9 5.4 270.4 3.7 11.8 4.6 4.8 3.0 33.8 3.8 1.0 9.2 2.6 3.1 15.8 13.1 5.3 15.5 4.7 5.0 24.5 11.4 6.1 6.3 1.7 163.5 9.3 4.8 5.4 19.7 4.4 4.7 6.2 39.2 7.1 2.5 6.1 6.0 1.8 2.2 29.6 6.7 10.2 2.6 6.6 6.4 5.1 9.4 4.8 1.7 2.4 0.8 3.9 77.6 15.2 2.3 RTL3 "FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5" ENSG00000179300 "Retrotransposon Gag like 3" Q8N8U3 X 78656068-78659328 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 1.1;fHDF/TERT166: 1.8;GAMG: 1.4;HBF TERT88: 2.4;hTEC/SVTERT24-B: 1.7;RH-30: 2.1;U-251 MG: 1.6" "Region enriched" "Detected in single" 9 "hippocampal formation: 2.8" "HPA051991, HPA053174, HPA075136" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Golgi apparatus, Plasma membrane" "HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737" "unprognostic (3.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (6.74e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (1.23e-1)" "unprognostic (1.69e-2)" "unprognostic (2.85e-1)" "unprognostic (4.00e-6)" "unprognostic (1.53e-2)" "unprognostic (3.64e-1)" "unprognostic (2.49e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 1.0 1.1 0.0 0.0 0.0 0.0 1.8 1.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.2 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.6 0.0 1.6 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 S100A1 "S100-alpha, S100A" ENSG00000160678 "S100 calcium binding protein A1" P23297 1 153627926-153632039 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 3076.8;skeletal muscle: 3060.2;tongue: 4911.5" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 1848.3" "Group enriched" "Detected in all" 5 "melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "Hep G2: 325.8;SK-MEL-30: 1130.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002599, HPA006462" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 290000 "Cluster 10: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "Nucleoplasm, Golgi apparatus" "CAB002599: AB_2315307, HPA006462: AB_1079857" "unprognostic (6.13e-2)" "unprognostic (7.60e-2)" "unprognostic (5.96e-5)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.19e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (2.34e-3)" "unprognostic (6.83e-3)" "unprognostic (5.22e-1)" "unprognostic (5.04e-3)" "unprognostic (9.62e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.68e-1)" "unprognostic (4.56e-2)" "unprognostic (2.70e-3)" "unprognostic (9.74e-4)" 179.7 8.3 811.3 6.5 898.6 2.3 77.2 851.4 952.4 2.9 643.9 14.5 11.1 4.2 1.0 81.0 41.8 4.9 3076.8 779.4 813.6 194.9 4.5 3.9 5.1 907.6 894.8 2.0 16.8 160.9 54.6 18.1 871.2 29.0 1.2 36.5 622.1 9.3 3060.2 23.0 6.9 1.6 847.7 4.2 23.1 5.9 882.9 9.4 167.9 4911.5 4.0 4.3 2.9 967.6 6.0 3.4 3.9 33.7 0.5 0.2 2.9 7.7 0.2 0.6 0.2 6.6 3.4 3.7 137.7 0.6 2.7 10.3 0.3 0.4 0.0 4.2 3.3 8.2 5.4 325.8 0.4 3.0 2.3 0.7 0.0 0.0 0.1 7.9 0.0 1.5 27.2 3.7 0.1 10.6 1.2 4.9 1.8 4.3 2.6 22.5 3.3 8.0 6.0 12.1 6.1 1.9 3.5 10.6 1130.2 11.1 32.8 16.2 2.7 3.3 2.8 3.0 3.8 6.1 5.7 6.2 2.5 6.2 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 811.3 898.6 851.4 952.4 779.4 813.6 907.6 894.8 871.2 847.7 882.9 967.6 4.3 0.0 0.0 59.4 9.5 9.7 1.2 0.4 1.8 1.1 369.9 354.1 74.4 8.6 0.2 154.5 2.1 1.1 5.9 1.1 162.4 0.9 0.6 90.5 17.3 5.3 1.8 0.0 0.3 3.7 1.9 6.0 0.0 193.3 0.0 0.0 7.9 4.7 199.1 0.0 0.3 3.7 0.0 0.6 3.5 2.2 6.5 15.6 341.5 2.8 0.0 163.5 0.0 2.0 45.8 1.9 0.6 9.1 0.0 1.8 0.9 1848.3 0.2 2.7 0.0 67.0 4.2 3.8 2.8 1.0 2.3 3.4 8.2 2.3 1.8 0.7 S100A3 S100E ENSG00000188015 "S100 calcium binding protein A3" P33764 1 153547329-153549258 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 94.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 15.4;Ductal cells: 21.7;Endometrial stromal cells: 18.4;Exocrine glandular cells: 24.0;Pancreatic endocrine cells: 24.2;Skeletal myocytes: 24.7" "Cancer enhanced" "Detected in all" "urothelial cancer: 26.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 3.1;non-classical monocyte: 6.2;plasmacytoid DC: 7.4" "Group enriched" "Detected in many" 11 "dendritic cells: 7.4;monocytes: 6.2" "Cell line enhanced" "Detected in many" "A549: 87.0;HBEC3-KT: 45.7;HeLa: 51.4;U-2197: 47.4" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 15.8" "HPA042674, HPA056140" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" NA NA 240000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 31: Skin - Epidermis development" "Cluster 20: HeLa - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" Cytosol "Golgi apparatus, Plasma membrane" "HPA042674: AB_10796581, HPA056140: AB_2683050" "unprognostic (3.90e-2)" "unprognostic (1.60e-1)" "unprognostic (3.59e-2)" "unprognostic (1.21e-2)" "unprognostic (4.53e-2)" "unprognostic (5.37e-3)" "unprognostic (1.48e-1)" "unprognostic (2.36e-1)" "unprognostic (2.46e-1)" "unprognostic (2.08e-1)" "unprognostic (5.34e-3)" "unprognostic (3.97e-3)" "prognostic unfavorable (1.61e-6)" "unprognostic (8.13e-2)" "unprognostic (3.46e-1)" "unprognostic (6.21e-2)" "unprognostic (8.10e-2)" 7.6 1.1 0.9 3.6 1.1 1.8 4.2 0.8 1.3 6.9 0.6 2.8 0.5 3.9 0.2 17.2 3.3 1.7 2.6 0.8 1.4 13.8 0.2 16.6 1.8 1.4 1.6 1.1 0.8 0.1 0.7 2.2 1.2 3.0 1.1 0.0 4.2 1.7 1.0 94.6 1.9 2.1 1.1 0.8 1.4 0.5 2.8 0.4 1.5 1.9 5.1 6.9 9.6 1.4 7.3 87.0 0.1 0.1 8.1 5.2 0.0 6.1 31.4 7.9 12.8 2.6 2.8 0.1 19.0 16.1 10.7 22.2 0.1 45.7 3.7 0.3 0.0 0.3 51.4 15.3 2.2 0.0 0.3 4.1 24.9 17.9 19.9 4.5 1.7 0.0 0.0 0.0 39.8 0.5 0.0 0.0 0.6 0.2 11.5 0.0 5.9 4.7 26.0 18.3 1.2 0.0 5.4 6.1 2.0 24.7 0.2 0.6 8.6 2.9 4.8 47.4 6.3 1.4 1.6 0.2 38.2 0.7 19.1 0.0 0.1 0.0 0.0 3.1 0.2 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.2 7.4 0.1 0.4 0.9 1.1 0.8 1.3 0.8 1.4 1.4 1.6 1.2 1.1 2.8 1.4 2.0 3.2 0.5 0.7 0.0 10.3 2.3 15.4 4.0 0.0 0.3 0.4 0.3 1.5 5.9 0.0 0.0 0.3 0.0 0.0 1.9 21.7 0.0 2.3 18.4 7.4 0.0 1.3 0.0 24.0 4.4 8.4 0.0 1.3 0.0 0.0 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.1 0.1 4.1 0.4 1.8 0.0 3.6 0.0 0.0 0.0 0.0 24.2 0.0 0.4 0.0 1.5 0.0 0.3 1.1 0.0 0.0 24.7 9.6 0.1 0.0 5.6 6.5 1.5 0.5 1.1 0.0 2.0 SCLY SCL ENSG00000132330 "Selenocysteine lyase" Q96I15 2 238060924-238099413 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 39.1" "Group enriched" "Detected in many" 13 "Early spermatids: 90.6;Late spermatids: 156.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020190, HPA055760" Uncertain Enhanced "Golgi apparatus" NA NA 300000 "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA020190: , HPA055760: AB_2682910" "unprognostic (7.39e-3)" "unprognostic (1.43e-1)" "unprognostic (3.29e-2)" "unprognostic (8.65e-5)" "unprognostic (8.96e-2)" "unprognostic (9.85e-3)" "unprognostic (1.14e-3)" "unprognostic (4.24e-2)" "unprognostic (1.59e-2)" "unprognostic (8.38e-2)" "unprognostic (3.98e-3)" "unprognostic (1.03e-2)" "unprognostic (1.02e-3)" "unprognostic (3.73e-1)" "unprognostic (4.37e-2)" "unprognostic (2.50e-3)" "unprognostic (1.98e-1)" 5.1 4.3 7.2 5.3 9.4 5.0 4.9 9.4 9.3 6.8 6.4 7.3 8.5 8.1 5.6 5.9 6.3 3.8 8.1 6.8 8.2 12.9 39.1 4.7 5.7 9.2 8.8 6.3 22.8 6.1 5.0 2.0 9.4 5.9 3.2 4.6 4.4 4.1 6.4 3.5 8.6 3.9 7.3 7.2 5.8 16.8 8.3 5.9 7.2 3.5 4.3 7.8 5.1 10.4 11.1 19.1 11.9 31.1 9.0 6.4 23.2 11.2 5.6 11.3 14.3 11.6 8.0 18.9 3.3 5.9 35.4 16.4 44.1 21.5 10.9 21.2 41.8 21.1 24.0 37.6 16.7 17.6 18.2 7.1 11.6 21.3 22.0 5.1 21.0 26.1 38.0 5.1 11.7 16.9 17.9 33.0 36.4 16.0 15.6 22.0 23.3 18.2 11.3 3.6 13.1 28.9 12.0 19.4 20.6 8.2 6.3 26.5 8.5 16.3 11.8 24.2 23.7 14.2 13.3 9.3 11.3 37.0 14.4 1.1 3.2 4.0 2.6 2.3 2.0 2.6 3.1 4.4 3.3 1.6 2.3 2.6 0.5 2.9 3.5 0.6 3.2 2.8 7.2 9.4 9.4 9.3 6.8 8.2 9.2 8.8 9.4 7.3 8.3 10.4 2.2 0.0 0.0 0.0 4.6 1.7 2.4 1.9 5.7 5.4 1.7 1.9 2.6 1.5 1.2 0.0 8.4 1.4 3.4 1.9 3.9 5.3 90.6 1.7 3.4 2.4 2.4 9.4 0.0 3.7 2.1 1.9 5.1 2.6 0.0 3.5 1.8 3.3 4.0 6.7 0.0 3.3 8.2 0.9 3.2 156.3 3.1 2.1 1.8 0.0 2.7 2.6 2.1 0.0 0.0 3.0 5.0 0.0 4.9 1.9 3.9 2.7 1.9 6.9 0.0 1.9 3.2 6.2 5.6 3.4 1.6 0.7 4.4 2.2 4.8 1.8 SEC11A "SEC11L1, sid2895, SPC18, SPCS4A" ENSG00000140612 "SEC11 homolog A, signal peptidase complex subunit" P67812 15 84669538-84716460 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047533 Approved "Nuclear membrane,Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" "Nuclear membrane" "Golgi apparatus" "HPA047533: AB_2680078" "unprognostic (8.81e-3)" "unprognostic (1.97e-1)" "unprognostic (3.19e-2)" "prognostic favorable (1.94e-5)" "unprognostic (3.39e-2)" "prognostic unfavorable (5.99e-5)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-2)" "unprognostic (6.17e-2)" "unprognostic (6.24e-2)" "unprognostic (1.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.95e-4)" "unprognostic (7.89e-2)" 142.9 138.1 66.2 83.4 69.4 172.2 136.2 69.0 80.4 147.1 76.6 110.8 82.9 111.0 202.5 81.6 103.6 97.5 98.4 63.7 72.6 137.2 152.3 107.9 112.6 74.1 67.2 168.6 139.4 114.6 84.5 115.1 73.9 82.0 124.9 37.0 95.9 87.5 154.3 70.5 86.4 96.3 72.4 86.2 95.3 61.5 69.4 93.2 177.5 147.4 98.2 137.3 94.0 75.3 201.7 320.7 286.7 425.4 368.5 462.8 225.4 310.1 356.5 241.9 291.2 347.1 443.0 99.0 198.8 370.3 277.2 408.3 409.1 243.4 255.5 267.1 239.4 279.4 358.8 324.9 311.7 213.4 281.2 315.8 305.0 169.1 285.1 366.0 337.9 116.7 295.8 244.3 315.1 363.1 89.2 345.8 282.1 266.2 135.4 101.6 368.4 302.9 472.6 424.4 131.2 300.8 257.3 239.5 598.5 407.0 248.5 416.6 254.3 240.0 181.0 209.8 361.9 224.4 509.6 150.0 226.4 331.7 180.6 83.5 161.1 89.7 95.1 173.7 95.0 101.0 114.8 104.7 165.8 90.0 95.1 98.0 111.6 134.3 184.8 160.9 168.8 200.8 66.2 69.4 69.0 80.4 63.7 72.6 74.1 67.2 73.9 72.4 69.4 75.3 261.1 89.8 99.1 25.8 131.8 107.1 179.4 356.6 90.5 30.0 163.7 202.6 68.2 228.8 188.0 128.8 22.9 309.1 171.9 111.1 238.7 258.8 46.3 118.5 268.0 217.2 157.4 101.7 21.2 247.3 655.3 206.0 120.8 184.1 218.4 191.0 197.7 165.5 363.3 20.2 22.8 218.7 168.9 386.7 337.2 100.6 299.5 337.3 158.3 24.4 396.7 110.5 204.9 26.7 38.3 183.4 136.3 166.3 197.9 185.7 142.7 350.9 99.3 38.2 170.9 173.5 225.5 233.5 169.6 135.2 119.9 305.8 153.4 237.6 210.7 242.2 SEC11C "SEC11L3, SPC21, SPCS4C" ENSG00000166562 "SEC11 homolog C, signal peptidase complex subunit" Q9BY50 18 59139866-59158832 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ionocytes: 685.6;Muller glia cells: 544.7;Plasma cells: 1164.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 523.5;Karpas-707: 546.2;RPMI-8226: 1150.0;U-266/70: 587.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026816, HPA047533" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 22: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear membrane" "Golgi apparatus" "HPA026816: AB_10602089, HPA047533: AB_2680078" "unprognostic (1.47e-2)" "unprognostic (2.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.44e-2)" "unprognostic (3.13e-3)" "unprognostic (4.48e-3)" "unprognostic (2.95e-1)" "unprognostic (2.32e-2)" "unprognostic (1.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.80e-2)" "unprognostic (1.72e-1)" "unprognostic (6.25e-2)" "unprognostic (3.83e-2)" "unprognostic (4.63e-2)" "unprognostic (2.58e-1)" "unprognostic (1.15e-1)" 24.6 76.7 110.0 86.5 117.5 63.1 81.8 122.9 140.5 57.8 94.4 92.3 126.7 40.1 284.6 42.5 41.4 47.3 30.0 112.9 146.4 70.2 219.0 62.7 104.2 137.3 130.2 29.9 374.0 153.9 155.2 28.4 136.8 225.7 78.2 108.1 397.3 62.3 15.7 29.7 97.8 30.1 123.7 81.4 138.5 28.1 113.5 53.0 163.7 20.0 117.8 59.4 21.2 135.8 82.4 100.0 52.9 74.1 31.9 6.8 64.7 72.4 62.9 89.9 55.2 78.3 42.5 176.8 109.9 46.6 67.6 82.8 84.7 59.0 58.4 523.5 113.8 58.5 69.3 242.3 99.3 199.4 87.6 20.4 140.7 56.2 161.1 20.2 33.7 78.4 67.4 546.2 34.6 100.0 79.0 79.2 48.1 140.4 60.5 72.8 50.0 1150.0 67.5 76.1 223.2 90.5 43.1 162.5 252.8 29.9 76.0 148.5 24.7 98.5 45.4 36.5 86.9 587.3 434.4 176.0 99.4 131.8 124.5 76.4 70.7 57.9 146.1 97.6 187.6 197.8 150.4 142.5 78.8 127.9 77.7 105.4 12.2 108.3 108.8 299.6 223.7 222.1 110.0 117.5 122.9 140.5 112.9 146.4 137.3 130.2 136.8 123.7 113.5 135.8 64.8 28.9 120.7 19.2 295.9 32.6 49.3 92.4 12.5 63.6 120.0 128.3 59.3 144.4 102.5 60.7 50.1 70.8 148.7 76.3 88.0 164.4 45.4 58.7 34.2 60.3 339.3 43.8 12.2 263.1 109.1 29.2 60.6 147.1 47.5 21.5 56.4 224.7 112.9 50.5 13.3 223.1 685.6 37.1 56.9 18.8 12.5 63.9 256.1 10.3 46.4 544.7 96.8 17.1 31.2 148.9 78.4 23.0 1164.8 380.9 99.3 118.8 81.3 89.3 6.6 23.1 70.6 110.2 81.5 35.5 45.5 149.7 92.3 40.1 88.3 79.2 SGCE DYT11 ENSG00000127990 "Sarcoglycan epsilon" O43556 7 94524204-94656572 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 116.6;Oligodendrocyte precursor cells: 133.2;Oligodendrocytes: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "gdT-cell: 2.1;memory B-cell: 4.4;naive B-cell: 6.6" "Group enriched" "Detected in many" 4 "B-cells: 6.6;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074790 Approved "Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane" Yes No 170000 "Cluster 19: B-cells - Humoral immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA074790: AB_2686713" "unprognostic (3.16e-3)" "unprognostic (9.06e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-3)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (1.19e-2)" "unprognostic (2.82e-2)" "unprognostic (6.93e-2)" "unprognostic (3.37e-1)" "unprognostic (6.80e-3)" "unprognostic (9.69e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" 43.2 63.4 19.9 9.4 21.6 0.4 36.5 22.1 31.6 45.1 20.9 51.6 8.0 43.2 27.1 13.3 40.7 27.6 38.9 19.6 21.0 19.5 14.4 30.5 16.7 23.2 20.6 92.2 21.5 10.9 30.9 52.7 22.4 18.0 12.8 16.8 21.1 31.6 8.5 8.2 19.2 41.8 21.9 25.1 23.8 18.5 20.4 12.8 23.9 19.8 7.2 35.6 34.6 26.7 13.5 42.5 39.6 61.8 63.7 110.8 7.1 51.3 92.3 40.7 60.4 24.9 78.0 12.8 70.4 86.5 83.7 9.4 60.0 21.6 49.1 2.2 32.7 1.4 36.9 28.3 44.0 4.3 0.0 95.5 31.1 64.8 79.3 104.9 30.8 0.0 0.1 93.7 43.5 42.6 0.0 0.0 32.8 8.0 29.0 19.8 51.0 25.8 78.6 13.6 26.2 20.8 0.0 52.2 65.1 44.2 17.6 0.8 0.0 131.1 45.1 11.8 81.7 50.8 67.9 14.8 51.4 0.2 74.2 0.7 0.0 0.1 2.1 0.0 0.8 4.4 0.6 1.0 0.0 6.6 0.2 0.7 0.3 1.0 0.1 0.2 0.2 0.3 19.9 21.6 22.1 31.6 19.6 21.0 23.2 20.6 22.4 21.9 20.4 26.7 39.2 70.5 33.3 66.9 6.1 5.0 18.4 16.8 1.8 18.6 9.7 44.4 18.6 30.0 28.3 20.2 4.2 90.2 1.4 0.0 5.9 42.5 1.6 4.0 17.1 18.8 1.2 0.4 85.2 4.3 26.1 116.6 1.5 6.6 2.5 37.3 58.2 11.2 6.3 20.2 68.5 0.1 12.2 2.5 7.3 3.7 75.5 1.4 51.6 15.9 0.0 31.5 0.0 133.2 116.3 2.1 0.0 58.3 2.6 5.5 0.0 14.1 13.7 30.3 85.5 68.0 60.7 17.1 13.0 0.9 4.0 82.8 2.7 44.0 0.0 2.2 SIPA1L2 "KIAA1389, SPAR2" ENSG00000116991 "Signal induced proliferation associated 1 like 2" Q9P2F8 1 232397965-232630571 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 80.2;Inhibitory neurons: 95.9;Microglial cells: 183.6;Oligodendrocyte precursor cells: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 69.7;NTERA-2: 53.9;WM-115: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024181, HPA027224" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Golgi apparatus" No NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Nuclear membrane, Nuclear bodies" "Golgi apparatus" "HPA024181: AB_1856886, HPA027224: AB_2672165" "unprognostic (2.34e-2)" "unprognostic (9.67e-2)" "unprognostic (8.02e-2)" "unprognostic (1.71e-3)" "unprognostic (2.98e-1)" "unprognostic (5.68e-2)" "unprognostic (5.57e-3)" "unprognostic (7.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.80e-2)" "unprognostic (3.77e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (8.15e-4)" "unprognostic (3.36e-2)" "unprognostic (2.75e-1)" "unprognostic (5.84e-3)" "unprognostic (3.45e-3)" 12.1 3.3 8.5 6.4 7.2 5.4 9.2 9.6 11.7 10.0 0.5 19.4 3.9 4.4 2.8 20.3 4.5 8.5 31.3 9.6 16.0 7.7 6.4 16.2 3.0 44.0 21.7 11.9 3.6 4.4 8.1 18.3 44.6 8.1 18.9 14.7 8.7 4.7 7.1 9.0 9.2 7.4 14.4 9.6 5.7 7.2 18.7 2.4 8.0 9.5 3.3 12.5 14.9 9.0 0.0 7.5 69.7 0.2 0.6 0.0 29.3 1.2 2.5 3.1 2.2 2.9 0.1 5.9 13.3 26.4 2.9 1.7 13.8 2.3 2.9 0.0 12.8 0.0 7.0 0.0 5.9 1.0 7.2 3.8 9.1 0.6 6.2 0.0 15.7 25.4 0.0 0.1 1.6 3.5 7.4 0.7 53.9 0.2 10.2 0.0 0.0 3.4 8.1 11.5 3.5 11.9 23.8 0.8 9.5 15.8 1.4 0.6 5.6 8.1 0.0 17.8 2.9 6.5 0.0 0.0 10.0 6.2 46.1 0.0 0.2 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.6 0.3 0.3 0.0 0.1 8.5 7.2 9.6 11.7 9.6 16.0 44.0 21.7 44.6 14.4 18.7 9.0 53.7 6.4 1.8 22.9 0.8 8.8 9.8 8.7 15.4 23.5 10.7 8.6 62.6 12.8 10.4 3.7 52.1 4.9 4.4 29.9 0.0 7.1 11.7 19.0 21.4 22.7 7.2 0.4 80.2 0.5 7.1 15.2 5.1 47.5 1.3 16.0 1.8 3.8 10.0 5.0 95.9 29.5 14.2 16.6 7.2 9.8 0.9 19.5 14.2 183.6 6.3 12.7 1.0 104.0 21.0 1.4 39.9 1.9 0.5 13.2 9.1 0.4 7.7 35.7 0.0 21.8 23.9 6.9 24.0 45.8 7.4 14.8 2.0 11.9 23.4 23.0 SIPA1L3 "KIAA0545, SPAR3" ENSG00000105738 "Signal induced proliferation associated 1 like 3" O60292 19 37907208-38208369 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 93.7;Inhibitory neurons: 87.3;Oligodendrocyte precursor cells: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A549: 59.6" "Low region specificity" "Detected in all" "HPA042072, HPA045480, HPA074988" Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 10: Brain - Neuronal signaling" "Cluster 18: U-2197 - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA042072: AB_2677832, HPA045480: AB_2679342, HPA074988: " "unprognostic (4.24e-2)" "unprognostic (1.23e-1)" "unprognostic (1.86e-1)" "unprognostic (5.56e-2)" "unprognostic (9.99e-2)" "unprognostic (1.22e-2)" "unprognostic (1.31e-2)" "unprognostic (5.48e-2)" "unprognostic (3.11e-1)" "unprognostic (6.05e-2)" "unprognostic (3.15e-1)" "unprognostic (5.43e-2)" "unprognostic (9.26e-3)" "unprognostic (6.45e-2)" "unprognostic (4.94e-2)" "unprognostic (5.36e-2)" "unprognostic (1.96e-2)" 2.2 3.0 6.0 6.6 3.0 2.9 5.1 10.4 16.2 4.8 2.6 10.6 18.4 3.3 1.3 4.9 4.8 3.9 6.2 28.9 2.0 6.4 3.4 5.7 6.8 4.2 4.1 2.9 9.7 3.3 3.2 1.4 3.5 5.3 7.0 5.0 8.4 3.5 6.5 11.1 18.1 1.8 1.6 7.3 9.1 4.3 5.6 3.8 10.0 7.3 5.5 4.3 3.6 5.5 34.4 59.6 7.3 9.3 4.3 4.3 4.9 14.5 12.2 9.4 8.8 20.6 19.5 19.5 12.2 12.4 7.9 7.6 6.7 27.1 10.4 6.7 3.3 5.3 5.5 6.5 8.3 3.7 5.5 3.3 14.1 17.5 37.3 13.9 10.8 5.6 3.9 4.1 16.6 10.6 5.0 5.1 6.0 27.2 15.8 10.8 5.9 2.9 20.7 29.1 17.3 9.3 16.0 27.1 2.2 3.9 18.0 3.5 23.2 15.6 5.5 48.4 22.6 5.4 10.0 6.6 20.1 4.9 20.6 0.1 0.1 0.4 0.1 0.2 0.0 1.1 0.1 0.2 0.1 1.5 0.1 0.5 0.1 0.3 1.5 0.3 0.1 0.1 6.0 3.0 10.4 16.2 28.9 2.0 4.2 4.1 3.5 1.6 5.6 5.5 4.8 6.4 10.1 41.4 24.5 12.0 5.2 10.4 6.2 21.9 22.6 12.1 5.2 22.8 10.8 23.9 14.6 2.1 9.3 93.7 3.9 7.2 4.5 19.8 4.8 5.4 25.2 10.8 61.1 15.3 1.4 3.7 40.2 16.5 2.5 4.8 6.4 23.5 3.5 33.7 87.3 46.3 20.3 5.1 13.9 9.2 2.1 8.3 5.4 50.6 7.1 3.0 5.2 99.5 58.7 13.4 38.7 1.9 12.8 6.6 50.0 21.1 19.1 5.7 6.6 4.5 3.6 1.7 5.1 8.9 16.1 0.8 5.1 1.7 30.4 5.6 SLA2 "C20orf156, FLJ21992, SLAP-2" ENSG00000101082 "Src like adaptor 2" Q9H6Q3 20 36612318-36646196 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.5;lymphoid tissue: 18.3" "Cell type enhanced" "Detected in some" "dendritic cells: 97.0;Macrophages: 21.8;NK-cells: 44.3;Plasma cells: 25.8;T-cells: 59.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "gdT-cell: 28.8;MAIT T-cell: 24.1;memory CD4 T-cell: 23.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 21.8;naive CD8 T-cell: 30.5;NK-cell: 39.2;plasmacytoid DC: 48.5;T-reg: 33.4" "Group enriched" "Detected in many" 8 "dendritic cells: 48.5;NK-cells: 39.2;T-cells: 33.4" "Group enriched" "Detected in some" 7 "HEL: 91.2;JURKAT: 51.8" "Not detected" "Not detected" "HPA053746, HPA058217" Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA "Cluster 48: NK-cells - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 36: HEL - Hemostasis" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA053746: AB_2682246, HPA058217: AB_2683641" "unprognostic (4.16e-3)" "prognostic favorable (7.36e-4)" "unprognostic (4.52e-4)" "unprognostic (2.30e-6)" "unprognostic (3.37e-2)" "unprognostic (3.79e-3)" "unprognostic (2.15e-3)" "unprognostic (1.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.84e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (6.77e-8)" "unprognostic (8.48e-2)" "unprognostic (1.73e-1)" "unprognostic (1.98e-2)" "unprognostic (6.45e-3)" 1.3 0.6 0.4 5.7 0.6 12.5 0.8 1.6 0.7 0.8 0.3 1.7 2.7 1.0 0.5 0.7 0.9 2.4 0.7 0.4 0.2 0.5 1.5 4.1 10.4 0.7 0.4 0.4 0.4 0.1 0.4 0.6 0.8 0.7 1.7 0.5 1.4 0.5 0.6 0.7 3.1 0.5 0.3 8.0 2.6 0.5 0.6 18.3 0.7 0.2 9.0 2.2 0.6 1.1 0.0 0.2 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 91.2 0.6 3.4 0.0 2.5 0.3 0.1 0.1 0.0 0.0 0.0 0.1 51.8 0.1 0.2 0.0 0.2 10.9 7.6 0.1 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 2.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.1 7.6 0.1 3.0 0.4 3.8 28.8 0.7 24.1 0.4 23.8 27.1 0.4 0.3 21.8 30.5 4.8 39.2 0.1 48.5 33.4 26.5 0.4 0.6 1.6 0.7 0.4 0.2 0.7 0.4 0.8 0.3 0.6 1.1 0.6 0.0 3.9 0.0 1.6 0.4 0.1 0.0 0.0 0.3 0.5 0.3 0.3 0.0 0.7 0.0 0.0 0.1 97.0 0.6 0.0 0.2 1.1 0.4 0.4 0.4 0.0 8.2 2.2 0.0 0.2 0.5 4.1 0.6 1.3 0.0 0.7 0.1 0.2 0.0 1.7 0.0 0.0 1.6 0.4 0.0 0.3 21.8 0.0 1.9 1.2 0.4 44.3 1.5 1.4 0.3 0.1 0.0 25.8 0.1 0.0 0.1 0.0 0.9 0.0 0.3 0.4 0.0 0.2 0.2 0.1 0.1 59.2 0.0 0.2 0.3 SLC16A13 MCT13 ENSG00000174327 "Solute carrier family 16 member 13" Q7RTY0 17 7036015-7040117 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 36.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 8.2;NK-cells: 6.2;Squamous epithelial cells: 7.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 22.8;GAMG: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065245 Supported "Golgi apparatus,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 85: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" Cytosol "HPA065245: AB_2685443" "unprognostic (5.61e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (1.78e-1)" "unprognostic (2.22e-3)" "unprognostic (9.53e-2)" "unprognostic (1.62e-1)" "unprognostic (8.72e-2)" "unprognostic (1.81e-1)" "unprognostic (2.60e-1)" "prognostic favorable (1.50e-4)" "unprognostic (2.44e-2)" "unprognostic (7.31e-3)" "unprognostic (9.70e-3)" "unprognostic (3.99e-2)" "unprognostic (1.25e-1)" "unprognostic (1.14e-1)" 1.4 1.0 1.1 2.1 0.8 0.4 1.4 1.8 1.1 1.8 1.0 2.2 9.2 0.8 1.3 5.3 1.8 3.7 1.6 0.9 1.0 6.8 36.1 2.4 2.8 1.2 1.2 0.5 1.2 2.9 0.8 1.5 1.0 1.4 1.6 0.3 3.3 0.8 0.4 5.3 5.5 0.9 0.9 3.5 1.9 0.5 1.0 1.8 3.3 0.2 2.5 1.2 2.6 0.8 13.1 22.8 5.3 3.2 3.2 1.8 2.2 1.3 3.3 2.9 6.5 7.4 14.3 8.3 2.2 2.1 26.2 20.1 4.1 7.0 1.2 10.3 2.9 3.4 1.8 18.0 3.6 1.2 7.6 2.1 7.8 4.3 3.5 3.9 11.9 7.4 4.0 2.3 3.1 6.5 5.1 2.1 2.2 6.6 1.8 2.4 1.8 1.4 2.7 3.6 0.2 1.4 4.0 2.2 1.8 7.8 6.1 1.8 4.5 1.8 4.1 3.0 1.9 4.0 8.9 0.5 5.4 3.0 0.8 0.0 0.8 1.0 1.2 0.8 0.9 1.1 1.0 1.5 0.8 2.5 1.1 1.1 0.9 1.2 0.9 1.1 1.2 0.5 1.1 0.8 1.8 1.1 0.9 1.0 1.2 1.2 1.0 0.9 1.0 0.8 2.3 0.0 1.5 0.7 5.1 0.5 0.9 1.3 4.0 0.4 1.6 0.9 0.4 1.5 0.8 5.5 0.0 1.9 2.4 1.1 0.0 1.0 0.0 0.5 0.5 2.8 0.0 0.4 1.8 0.2 0.4 0.6 4.1 0.7 3.8 1.1 2.2 8.2 0.5 3.3 1.1 1.2 2.0 0.6 3.1 0.0 0.9 1.6 0.0 1.0 1.4 0.9 6.2 0.5 0.0 0.5 0.1 0.0 2.9 0.9 2.4 1.9 1.4 0.5 0.0 0.3 1.1 0.0 0.0 7.4 1.6 2.5 4.7 0.5 1.0 1.0 SLC20A1 "Glvr-1, GLVR1, PiT-1" ENSG00000144136 "Solute carrier family 20 member 1" Q8WUM9 2 112645939-112663825 "Metabolic proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Phosphate transport, Symport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 353.3;Paneth cells: 261.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 522.4;U-87 MG: 507.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019279, HPA035834" Approved Approved "Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "CAB019279: , HPA035834: AB_2674809" "unprognostic (1.81e-1)" "unprognostic (2.18e-1)" "unprognostic (5.38e-2)" "unprognostic (4.03e-3)" "unprognostic (1.39e-1)" "prognostic unfavorable (6.56e-5)" "unprognostic (1.50e-2)" "unprognostic (3.38e-2)" "unprognostic (2.32e-2)" "unprognostic (1.39e-1)" "unprognostic (7.43e-3)" "unprognostic (1.44e-1)" "prognostic unfavorable (3.44e-5)" "unprognostic (6.85e-2)" "unprognostic (1.09e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-3)" 36.1 11.7 16.2 33.2 24.3 74.6 15.6 27.8 26.3 11.8 25.0 53.6 14.4 13.7 8.4 15.0 14.5 26.4 21.8 20.7 19.8 22.1 49.0 29.2 37.1 25.5 20.7 9.2 30.7 10.4 15.9 29.7 25.2 13.3 21.9 52.3 12.8 9.3 19.7 14.5 28.4 15.0 18.6 29.5 20.2 15.7 24.5 27.2 15.9 7.5 27.5 40.8 13.3 21.2 69.0 55.5 71.1 57.8 52.9 128.8 54.4 181.6 215.3 79.1 102.2 85.0 164.9 124.0 97.5 67.7 305.0 70.5 78.8 138.0 114.8 68.5 80.4 105.5 57.1 81.3 78.2 61.2 178.9 66.0 53.8 279.1 193.9 522.4 102.2 52.9 199.5 126.3 346.7 26.8 83.9 235.9 119.3 31.8 147.6 77.8 63.5 34.9 114.5 312.8 64.4 60.8 91.7 54.9 127.9 31.4 56.0 42.9 223.6 143.5 94.7 50.8 142.4 52.1 143.7 102.2 507.2 57.9 178.3 13.4 33.5 30.1 52.8 59.8 59.4 8.3 22.2 38.4 25.4 5.0 17.5 27.6 14.7 50.2 37.2 41.8 14.6 33.9 16.2 24.3 27.8 26.3 20.7 19.8 25.5 20.7 25.2 18.6 24.5 21.2 61.7 12.8 25.9 42.4 40.3 112.8 59.1 38.7 104.7 60.0 41.9 31.6 49.6 32.9 35.3 9.2 210.6 44.7 119.1 353.3 13.7 18.1 1.5 86.0 34.3 48.2 35.7 53.2 47.3 14.0 13.5 61.5 96.4 167.8 25.3 20.6 41.0 58.1 28.2 20.2 27.2 85.8 32.6 58.5 86.2 3.3 3.7 80.5 26.6 19.7 42.8 31.8 66.9 18.6 26.1 26.9 261.6 4.9 59.8 34.0 156.3 5.2 59.6 84.6 0.0 36.9 25.9 8.5 18.7 119.5 61.8 74.3 70.4 19.0 96.5 90.3 SLC29A3 "ENT3, FLJ11160" ENSG00000198246 "Solute carrier family 29 member 3" Q9BZD2 10 71319259-71381423 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 46.1;Extravillous trophoblasts: 45.3;Hofbauer cells: 34.7;Syncytiotrophoblasts: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 31.8;Hep G2: 35.9;RT4: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046085, HPA054976, HPA057905" Approved Enhanced "Golgi apparatus,Vesicles" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus, Vesicles" "HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550" "unprognostic (1.73e-1)" "unprognostic (2.38e-3)" "unprognostic (3.23e-3)" "unprognostic (1.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (6.07e-6)" "unprognostic (1.28e-1)" "unprognostic (4.71e-1)" "unprognostic (1.81e-1)" "unprognostic (2.53e-1)" "unprognostic (3.80e-2)" "prognostic unfavorable (5.53e-5)" "unprognostic (3.37e-1)" "unprognostic (1.36e-1)" "prognostic favorable (1.16e-4)" "unprognostic (3.43e-3)" 4.7 2.6 3.1 4.1 3.9 1.1 4.8 3.7 3.7 7.3 2.7 4.4 2.1 6.8 2.5 2.2 5.8 4.4 2.4 3.0 3.6 2.5 9.4 6.7 7.1 4.7 3.7 9.7 5.2 3.5 1.7 11.2 4.2 5.1 3.5 0.3 4.9 2.9 1.4 2.6 3.7 5.1 4.2 6.5 6.1 3.7 4.4 3.7 3.8 0.6 3.8 9.8 4.4 5.0 2.1 12.3 1.8 7.8 6.8 5.3 31.8 2.3 2.2 0.7 0.4 13.8 8.8 7.4 6.4 4.7 3.2 18.3 5.7 2.9 0.1 5.6 5.6 2.2 1.0 35.9 3.3 1.8 4.5 5.2 12.9 0.3 0.6 1.5 3.2 8.5 6.5 6.8 0.9 19.1 4.2 3.8 4.2 19.2 4.5 5.7 0.6 5.9 2.3 29.5 8.5 9.6 6.4 20.3 1.7 5.2 3.2 4.0 5.2 0.2 3.8 2.3 0.1 1.8 3.1 4.0 7.6 24.0 1.3 4.2 19.3 2.2 5.4 15.3 4.6 4.9 4.5 5.1 29.1 1.9 3.5 5.0 1.5 9.4 10.3 20.2 5.5 9.5 3.1 3.9 3.7 3.7 3.0 3.6 4.7 3.7 4.2 4.2 4.4 5.0 2.0 3.2 1.1 2.0 3.1 0.3 1.5 4.0 1.8 2.3 2.7 3.8 0.8 1.5 3.8 0.0 0.0 46.1 6.3 2.6 0.0 6.1 3.6 1.8 3.2 1.8 1.8 4.2 2.4 8.9 45.3 4.7 7.1 2.4 2.5 10.2 3.3 5.4 34.7 0.0 1.3 2.5 8.2 11.8 4.4 15.2 2.8 10.9 1.8 16.9 8.5 3.0 3.1 2.5 2.7 7.9 13.1 1.5 6.0 3.2 0.1 2.0 2.6 0.4 0.0 0.2 2.5 0.6 5.0 0.7 0.0 31.7 2.9 10.0 2.5 1.7 SLC35C1 "FLJ11320, FUCT1" ENSG00000181830 "Solute carrier family 35 member C1" Q96A29 11 45804072-45813016 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 84.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 50.6;Distal enterocytes: 54.6;Pancreatic endocrine cells: 50.6;Paneth cells: 54.0;Proximal enterocytes: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064001 Enhanced Supported "Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "HPA064001: AB_2685171" "unprognostic (2.62e-2)" "unprognostic (5.16e-2)" "unprognostic (7.82e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (8.22e-2)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (2.83e-2)" "unprognostic (1.28e-1)" "unprognostic (4.09e-2)" "unprognostic (2.73e-1)" "unprognostic (7.68e-2)" "unprognostic (1.83e-3)" "unprognostic (2.18e-1)" "prognostic favorable (3.64e-4)" "unprognostic (2.30e-2)" 28.2 7.3 6.6 10.7 6.3 2.4 19.8 7.0 7.0 9.6 6.1 19.8 24.4 8.8 2.3 41.5 7.3 12.2 9.0 6.2 7.2 7.0 84.5 10.2 6.6 8.2 7.9 6.3 13.4 5.6 10.4 15.0 7.7 9.9 14.3 1.6 26.1 5.9 6.8 5.1 24.1 9.9 6.5 8.4 18.5 5.2 8.8 4.5 6.6 6.9 10.0 13.8 14.9 6.3 10.3 25.8 6.3 16.3 19.9 19.8 19.5 22.1 20.1 13.3 14.4 10.7 15.2 10.4 9.9 27.3 19.4 26.0 13.4 13.6 6.5 24.8 14.5 5.9 20.4 20.6 42.6 11.4 16.2 23.8 16.3 9.2 11.1 16.2 17.6 10.3 13.3 13.8 14.4 21.8 5.9 9.0 27.5 39.9 34.6 7.2 10.5 21.5 15.1 25.4 6.0 8.6 16.6 16.3 9.5 6.6 13.7 6.0 25.7 25.0 14.7 46.1 15.6 9.8 26.9 4.9 18.5 14.4 14.2 9.7 11.6 12.5 11.0 11.9 12.3 5.0 18.0 14.7 9.6 3.7 9.3 8.0 1.8 5.6 8.7 8.2 13.0 10.1 6.6 6.3 7.0 7.0 6.2 7.2 8.2 7.9 7.7 6.5 8.8 6.3 5.5 0.0 11.2 2.6 6.2 3.6 8.9 12.7 3.4 1.9 11.1 3.0 50.6 22.8 26.7 5.5 2.1 13.8 6.4 54.6 0.0 18.4 4.9 7.3 6.7 10.6 9.6 3.6 2.0 41.9 14.0 10.5 23.4 11.4 2.5 5.2 6.8 42.2 14.7 3.3 2.1 40.6 4.1 9.3 4.8 6.0 6.5 6.3 1.8 2.8 9.5 2.8 7.2 1.0 2.1 50.6 54.0 5.7 13.6 11.8 58.0 4.7 11.4 1.1 0.0 3.6 9.7 4.0 4.3 12.7 2.4 15.3 6.5 5.7 26.4 20.1 SLC35C2 "bA394O2.1, C20orf5, CGI-15, OVCOV1" ENSG00000080189 "Solute carrier family 35 member C2" Q9NQQ7 20 46345980-46364458 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027011 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" Nucleoplasm "HPA027011: AB_2672082" "unprognostic (7.25e-2)" "unprognostic (1.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.27e-2)" "unprognostic (1.06e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.34e-1)" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (4.05e-2)" "unprognostic (1.29e-2)" "prognostic unfavorable (8.68e-4)" "unprognostic (9.31e-2)" "unprognostic (7.15e-2)" "unprognostic (1.18e-2)" "unprognostic (3.88e-1)" 23.2 36.3 23.1 17.2 22.3 27.1 23.2 21.3 25.2 26.4 22.6 23.9 21.3 23.1 17.4 31.8 23.2 18.2 17.2 21.8 20.6 27.7 38.3 22.8 24.0 22.6 23.1 25.5 34.9 14.9 20.3 18.2 22.3 31.2 10.1 11.3 30.3 14.0 18.3 32.7 26.4 10.4 21.2 33.6 27.7 25.0 23.4 14.4 29.2 8.2 13.4 22.4 25.6 22.8 35.9 45.1 17.5 15.0 23.9 23.2 36.3 17.6 33.7 19.7 22.6 60.9 54.6 22.5 63.2 19.9 24.7 49.0 9.3 40.5 6.7 19.6 32.5 20.2 29.5 49.0 46.6 27.6 23.6 33.6 51.0 27.4 29.8 20.8 15.2 23.7 33.3 41.5 14.2 85.0 19.8 40.7 24.3 34.1 36.7 18.9 19.7 45.3 25.8 35.1 28.1 39.6 16.4 87.1 60.9 10.4 56.0 47.8 15.7 53.2 33.7 27.5 32.0 55.6 51.5 25.2 58.0 29.7 23.9 42.7 37.9 48.0 37.5 39.9 35.4 29.7 39.0 38.8 42.4 27.9 44.5 40.3 33.5 33.4 30.8 72.9 41.1 44.1 23.1 22.3 21.3 25.2 21.8 20.6 22.6 23.1 22.3 21.2 23.4 22.8 17.0 16.0 19.1 24.5 27.6 14.4 29.0 35.5 29.0 41.3 32.4 25.4 6.7 21.5 29.2 27.6 41.7 89.5 32.6 26.9 13.7 41.3 5.9 12.8 13.0 18.4 21.0 12.4 13.6 61.8 49.2 24.0 26.0 13.9 14.7 20.3 31.8 27.5 38.7 18.5 13.6 35.1 26.4 22.8 8.2 6.7 19.3 23.6 21.4 14.0 36.4 23.4 34.0 11.1 14.2 35.0 26.9 19.2 28.8 50.0 34.8 18.3 18.7 33.6 19.7 20.1 19.0 16.1 23.6 24.8 16.6 79.2 25.9 24.8 30.2 33.1 SLC35F3 FLJ37712 ENSG00000183780 "Solute carrier family 35 member F3" Q8IY50 1 233904676-234324511 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 17.7" "Group enriched" "Detected in some" 6 "Excitatory neurons: 485.2;Inhibitory neurons: 216.1;Oligodendrocyte precursor cells: 190.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 35 "plasmacytoid DC: 3.5" "Lineage enriched" "Detected in single" 35 "dendritic cells: 3.5" "Cell line enriched" "Detected in some" 7 "HDLM-2: 111.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051327, HPA061582" Uncertain Approved "Nucleoli,Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" Nucleoli "HPA051327: AB_2681443, HPA061582: AB_2684563" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.26e-1)" "unprognostic (8.62e-2)" "unprognostic (2.69e-5)" "unprognostic (3.38e-2)" "unprognostic (1.94e-1)" "unprognostic (2.60e-1)" "unprognostic (3.86e-2)" "unprognostic (9.09e-2)" "unprognostic (1.57e-3)" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (3.62e-1)" "unprognostic (3.58e-1)" 0.0 1.1 6.9 0.3 17.7 0.1 2.5 9.5 15.5 0.3 0.0 0.4 0.1 0.3 0.7 0.5 0.4 0.1 0.0 5.4 0.7 0.7 0.0 0.2 0.8 1.6 0.3 0.1 3.5 1.4 2.6 0.0 1.9 0.5 0.1 0.3 2.5 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.7 0.2 2.5 2.3 0.5 0.1 0.5 0.0 0.5 9.5 3.0 7.9 1.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 14.9 0.0 0.0 0.1 0.2 0.6 0.1 7.7 0.0 111.9 0.2 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.1 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 9.0 0.0 0.0 0.0 7.7 0.0 4.2 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.9 17.7 9.5 15.5 5.4 0.7 1.6 0.3 1.9 0.2 2.5 9.5 0.1 0.0 0.0 8.5 0.9 0.4 2.4 0.3 10.8 2.1 3.0 8.9 0.7 0.0 0.1 0.0 0.0 0.0 9.5 0.0 3.9 1.4 0.7 5.9 1.6 0.1 1.8 0.0 485.2 3.4 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 216.1 0.1 26.4 0.0 0.0 0.9 0.0 0.6 0.0 9.4 0.9 0.0 0.0 190.5 45.4 0.6 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.5 0.0 0.8 0.1 0.6 1.5 0.8 0.1 0.0 0.4 0.0 0.0 0.2 SLC5A1 "D22S675, NAGT, SGLT1" ENSG00000100170 "Solute carrier family 5 member 1" P13866 22 32043261-32113029 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "intestine: 528.1" "Cell type enriched" "Detected in many" 6 "Proximal enterocytes: 768.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 20.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "OE19: 34.2" "Region enriched" "Detected in single" 26 "cerebellum: 7.6" "Low region specificity" "Detected in many" "CAB015467, HPA051805, HPA055106" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Golgi apparatus" "Nuclear membrane, Cytosol" "CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "prognostic favorable (2.59e-4)" "unprognostic (3.85e-2)" "unprognostic (2.75e-2)" "unprognostic (1.60e-2)" "unprognostic (2.15e-1)" "unprognostic (9.22e-2)" "unprognostic (4.83e-2)" "unprognostic (6.21e-2)" "unprognostic (9.53e-2)" "prognostic favorable (6.97e-7)" "unprognostic (4.68e-3)" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.45e-2)" 0.1 0.0 0.1 4.2 0.1 0.0 9.7 0.2 0.1 12.3 0.0 10.7 528.1 0.5 3.5 5.1 1.1 26.9 75.2 0.1 0.0 6.6 1.7 2.1 0.3 0.1 0.0 0.0 1.6 0.3 1.0 0.0 0.1 3.0 9.7 0.2 19.0 2.4 0.3 13.5 302.4 0.7 0.0 2.9 7.2 2.3 0.5 0.1 0.0 0.0 4.0 0.0 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 34.2 0.0 0.0 0.0 2.1 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.2 0.1 0.0 0.0 0.3 0.2 0.6 1.7 4.2 0.0 0.0 11.6 6.5 115.2 115.8 8.2 0.0 0.0 0.0 0.2 19.8 0.0 3.0 38.4 2.4 1.4 1.0 25.4 0.0 0.4 1.4 0.0 1.4 5.6 10.3 0.0 0.0 0.0 0.3 0.0 0.0 0.3 34.1 0.0 0.0 0.0 71.3 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 32.6 1.5 0.0 17.6 768.7 6.4 2.0 0.0 0.0 0.0 0.7 10.1 4.2 2.0 5.5 0.0 0.1 0.1 41.2 6.7 SLPI "ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4" ENSG00000124107 "Secretory leukocyte peptidase inhibitor" P03973 20 45252239-45254564 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix: 27919.2;salivary gland: 14140.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 4134.5;Basal respiratory cells: 18759.4;Club cells: 20435.8;Respiratory ciliated cells: 8096.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 79 "neutrophil: 321.8" "Lineage enriched" "Detected in many" 79 "granulocytes: 321.8" "Cell line enhanced" "Detected in many" "EFO-21: 1719.5;hTCEpi: 2037.1;OE19: 767.9;SiHa: 622.1;THP-1: 531.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002303, HPA027774" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 26400000 9600000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "CAB002303: AB_564008, HPA027774: AB_10602405" "unprognostic (2.31e-2)" "unprognostic (3.07e-1)" "unprognostic (3.10e-2)" "unprognostic (2.06e-1)" "unprognostic (1.63e-1)" "unprognostic (3.16e-2)" "unprognostic (9.98e-2)" "unprognostic (2.90e-1)" "unprognostic (3.23e-1)" "unprognostic (1.83e-3)" "unprognostic (4.01e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (6.91e-5)" "unprognostic (1.53e-1)" "unprognostic (2.15e-1)" "unprognostic (8.81e-2)" "unprognostic (8.31e-2)" 259.4 13.8 4.1 70.8 4.3 353.5 306.7 5.0 22.5 27919.2 28.9 97.8 4.5 107.1 16.5 1372.7 714.2 294.7 68.4 4.5 4.8 382.6 268.0 1181.7 2.0 5.6 5.5 11.5 36.1 5.5 470.2 8.3 5.5 112.6 106.7 0.6 14140.1 2946.3 599.9 272.4 19.9 14.0 4.8 22.5 154.7 28.1 10.4 47.7 30.4 51.5 215.8 226.6 685.3 4.8 4.9 19.4 0.0 0.3 0.2 0.0 1.1 0.1 0.0 0.1 0.0 1.5 318.7 0.9 1719.5 0.2 23.9 132.8 0.0 64.1 0.0 8.6 0.3 0.3 227.1 0.2 326.4 0.5 1.0 8.8 2037.1 0.1 134.0 0.0 0.2 0.0 0.2 0.3 0.0 0.4 0.4 24.4 0.4 767.9 120.1 0.6 0.7 0.1 355.5 14.6 0.3 0.0 622.1 131.4 1.8 0.4 2.8 531.8 0.3 0.4 8.5 1.2 1.1 1.2 9.7 6.1 0.0 33.0 0.5 3.6 0.9 0.4 0.1 3.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 321.8 0.0 4.0 0.0 0.0 7.9 4.1 4.3 5.0 22.5 4.5 4.8 5.6 5.5 5.5 4.8 10.4 4.8 6.3 1807.7 4134.5 0.3 5.4 100.7 1330.7 18759.4 2.2 0.0 594.2 607.6 3.9 1609.9 20435.8 3428.2 0.0 2.3 10.1 225.8 0.0 407.5 381.6 632.0 170.7 43.3 200.2 18.7 0.0 258.9 1.2 326.0 193.7 1398.8 77.0 0.0 15.7 508.5 6.8 0.0 0.0 74.7 2616.3 8.5 73.3 69.8 25.4 27.1 39.2 0.0 5.3 0.0 0.0 1.0 0.1 901.6 370.3 0.0 1.3 1289.4 2.7 3.4 8096.4 0.0 0.0 8.6 971.2 1.8 1.8 347.3 138.9 2.1 29.5 0.0 224.5 3338.5 SNTB2 "D16S2531E, EST25263, SNT2B2, SNT3, SNTL" ENSG00000168807 "Syntrophin beta 2" Q13425 16 69187129-69309052 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 151.4;Muller glia cells: 214.1;Rod photoreceptor cells: 136.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SiHa: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001394 Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 77: Retina - Visual perception" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA001394: AB_1080170" "unprognostic (4.86e-1)" "unprognostic (3.26e-2)" "unprognostic (2.77e-2)" "unprognostic (8.07e-3)" "unprognostic (6.46e-2)" "unprognostic (9.68e-2)" "unprognostic (1.89e-2)" "unprognostic (5.50e-2)" "unprognostic (1.22e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-2)" "unprognostic (3.64e-2)" "unprognostic (5.77e-3)" "unprognostic (1.71e-2)" "unprognostic (7.43e-2)" "unprognostic (1.73e-2)" "unprognostic (1.88e-1)" 11.0 5.0 3.3 5.2 3.9 2.7 8.8 1.0 6.7 11.0 10.1 6.7 3.7 10.4 5.1 7.0 8.7 7.1 5.3 4.6 0.8 6.7 3.8 8.6 5.6 2.5 0.9 6.2 4.1 12.4 4.0 5.2 0.9 8.2 5.3 21.6 5.2 5.5 5.7 8.5 6.0 8.7 0.6 5.7 6.1 7.1 1.5 5.8 10.5 3.8 4.9 8.7 8.7 3.7 7.2 10.9 7.4 5.8 26.6 35.6 9.1 13.9 19.3 10.7 11.8 10.7 6.5 9.0 8.3 16.2 5.6 12.9 10.0 6.8 13.9 4.0 5.5 4.0 11.1 9.2 8.8 0.3 5.9 25.6 4.9 17.6 7.1 11.1 32.4 2.5 2.3 13.8 13.1 8.2 3.0 1.4 5.0 4.2 8.6 18.1 6.5 16.8 5.7 10.9 2.8 6.1 42.6 6.0 4.4 5.5 7.1 0.5 25.4 20.0 9.6 14.2 13.0 3.1 5.2 10.0 12.8 1.4 9.3 0.4 0.2 0.3 0.9 0.3 0.9 0.2 0.4 0.5 0.2 0.2 0.2 1.1 0.9 0.7 0.3 0.1 0.5 0.3 3.3 3.9 1.0 6.7 4.6 0.8 2.5 0.9 0.9 0.6 1.5 3.7 55.9 19.2 11.7 36.6 9.0 38.0 28.0 17.1 70.0 33.2 19.0 25.0 9.2 10.0 10.4 27.6 41.7 9.5 33.7 29.0 3.9 9.7 25.9 20.6 61.3 81.4 10.3 4.8 151.4 24.1 7.9 53.1 20.9 28.7 1.3 15.8 126.7 11.1 6.9 5.0 62.6 16.6 8.2 33.1 29.3 27.5 59.0 12.9 30.2 33.7 8.6 214.1 47.4 30.7 27.9 16.3 32.8 65.1 20.7 40.9 12.7 34.5 10.0 136.7 6.6 26.0 35.6 27.9 15.4 30.7 38.8 3.7 32.8 20.2 19.6 28.7 SPRY4 ENSG00000187678 "Sprouty RTK signaling antagonist 4" Q9C004 5 142310427-142326455 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 39.5;Alveolar cells type 2: 49.0;Endothelial cells: 32.8;Hepatic stellate cells: 37.1;Oligodendrocyte precursor cells: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 100.2;WM-115: 139.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008086, HPA055471, HPA072661" Enhanced Approved "Golgi apparatus,Cytosol" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" "Golgi apparatus" Cytosol "CAB008086: AB_2195454, HPA055471: AB_2682825, HPA072661: AB_2732207" "unprognostic (9.54e-3)" "prognostic unfavorable (7.12e-4)" "unprognostic (2.18e-1)" "unprognostic (1.16e-1)" "unprognostic (8.70e-2)" "unprognostic (3.23e-2)" "unprognostic (3.98e-3)" "unprognostic (1.08e-1)" "unprognostic (6.89e-2)" "unprognostic (1.44e-2)" "unprognostic (1.48e-1)" "unprognostic (9.89e-2)" "prognostic unfavorable (2.20e-4)" "unprognostic (6.29e-3)" "unprognostic (3.63e-2)" "unprognostic (4.59e-2)" "unprognostic (8.21e-2)" 30.6 18.9 8.4 4.8 8.4 0.0 14.3 6.6 9.9 4.9 13.1 9.3 6.4 6.6 1.5 3.2 7.4 8.1 19.7 8.7 9.4 22.1 12.4 26.8 2.7 9.5 8.2 2.6 4.6 7.0 20.1 13.8 8.5 9.1 5.2 4.3 4.4 4.7 5.1 3.9 7.8 6.2 6.4 8.7 8.7 1.8 8.4 2.0 19.5 6.5 1.4 8.1 4.0 6.3 3.0 5.0 48.4 100.2 29.0 20.7 12.7 35.9 12.0 5.7 6.0 5.2 5.1 0.0 25.0 9.2 6.1 2.4 0.0 10.6 7.2 0.1 0.0 0.2 0.0 22.9 9.5 0.0 0.2 16.7 0.2 15.8 8.6 9.3 5.5 0.1 11.7 0.1 21.9 4.3 0.0 14.0 21.5 16.8 31.3 1.1 6.8 1.3 17.7 32.2 0.6 14.1 0.7 4.7 42.5 14.1 0.4 2.1 8.3 12.6 0.2 2.5 32.4 0.1 1.7 0.2 19.4 0.1 139.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 8.4 6.6 9.9 8.7 9.4 9.5 8.2 8.5 6.4 8.4 6.3 39.5 6.4 49.0 6.8 0.2 1.7 3.8 1.7 17.1 9.1 7.6 10.2 3.2 1.5 1.1 3.7 0.0 1.0 0.9 7.3 0.0 2.0 0.8 10.1 4.6 32.8 13.8 0.0 11.2 0.4 2.1 12.4 6.1 17.1 3.8 0.5 37.1 3.2 0.3 0.0 17.1 7.3 0.0 2.6 1.2 1.7 0.3 0.5 7.2 22.5 0.0 1.6 0.0 96.5 0.8 5.1 2.5 0.4 0.1 4.3 5.6 1.2 0.6 0.6 19.7 17.1 24.3 0.1 1.0 3.5 0.3 3.4 1.4 1.3 7.6 1.8 ST6GALNAC1 "SIAT7A, ST6GalNAcI" ENSG00000070526 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1" Q9NSC7 17 76624761-76643786 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix: 61.1;intestine: 195.9;stomach 1: 64.9" "Cell type enriched" "Detected in many" 5 "Intestinal goblet cells: 801.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 41.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 8.9;naive CD4 T-cell: 3.4" "Lineage enriched" "Detected in single" 32 "T-cells: 8.9" "Group enriched" "Detected in some" 4 "K-562: 65.5;OE19: 107.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA014767, HPA014975" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 3500000 "Cluster 20: T-cells - T-cell receptor" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" Nucleoplasm "HPA014767: , HPA014975: AB_1857529" "unprognostic (4.59e-2)" "unprognostic (8.60e-3)" "unprognostic (5.32e-3)" "unprognostic (1.86e-3)" "unprognostic (6.31e-3)" "prognostic favorable (2.54e-5)" "unprognostic (1.39e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-1)" "unprognostic (2.58e-2)" "unprognostic (8.64e-3)" "unprognostic (2.81e-1)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (5.87e-3)" "unprognostic (5.58e-2)" 1.9 0.1 6.0 12.6 5.6 2.8 2.0 5.7 9.2 61.1 4.5 155.3 62.5 5.1 3.9 24.4 3.8 18.3 3.4 5.5 6.0 0.4 0.1 5.7 1.2 6.1 6.0 0.8 0.7 0.1 0.0 2.1 6.4 6.9 195.9 1.0 26.3 0.5 1.4 0.9 75.8 5.4 5.8 14.6 64.9 3.1 6.1 0.2 0.3 0.9 2.3 3.1 4.5 5.6 0.2 2.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 3.4 0.2 11.9 0.0 0.0 12.4 0.0 2.9 0.0 0.0 0.0 19.5 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 65.5 0.0 0.0 0.0 0.2 0.2 0.0 107.5 0.4 0.0 0.0 0.4 0.1 0.7 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.3 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.9 0.1 0.0 0.0 3.4 0.0 0.2 0.0 0.0 0.0 1.3 0.9 6.0 5.6 5.7 9.2 5.5 6.0 6.1 6.0 6.4 5.8 6.1 5.6 8.6 16.0 7.5 0.7 0.3 0.1 5.7 90.2 12.0 0.1 0.1 0.0 2.0 17.2 143.4 0.0 0.0 0.3 0.0 133.3 0.0 1.4 0.3 85.1 7.6 27.2 33.0 6.7 0.4 18.2 0.1 1.3 65.7 77.6 0.0 0.3 8.6 0.0 0.3 0.0 0.3 801.0 50.8 0.0 0.0 0.9 1.5 1.1 0.0 18.7 0.0 0.0 0.0 1.5 0.3 42.8 76.1 0.0 0.0 2.4 51.6 0.0 117.4 1.2 0.0 0.3 5.3 0.4 0.1 12.8 0.1 0.1 1.8 63.3 123.1 24.5 ST8SIA2 "HsT19690, SIAT8B, ST8SIA-II, STX" ENSG00000140557 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2" Q92186 15 92393881-92468728 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.4;heart muscle: 3.9" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 2.9;Cardiomyocytes: 4.3;Inhibitory neurons: 3.5;Muller glia cells: 2.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 25.8;LHCN-M2: 7.7;RH-30: 11.7;RPMI-8226: 8.9;SH-SY5Y: 5.0;WM-115: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA054518, HPA057819" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA054518: AB_2682514, HPA057819: " "unprognostic (4.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.26e-1)" "unprognostic (9.32e-3)" "unprognostic (1.03e-1)" "unprognostic (2.87e-2)" "unprognostic (2.32e-1)" "unprognostic (1.28e-5)" "unprognostic (3.91e-2)" "unprognostic (5.39e-3)" "unprognostic (1.59e-2)" "unprognostic (4.44e-3)" "unprognostic (4.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-1)" "unprognostic (3.00e-1)" 0.0 0.3 0.6 0.0 0.6 0.0 0.4 0.6 2.2 0.8 0.0 0.1 0.0 0.4 0.8 0.0 0.0 0.2 3.9 1.5 1.2 0.1 0.0 0.0 0.0 8.4 1.9 0.0 0.0 0.0 0.2 0.0 8.2 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.4 1.8 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.2 25.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.2 0.0 4.1 0.0 0.0 0.0 11.7 8.9 0.0 0.0 0.6 5.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 4.2 0.3 0.0 0.2 0.9 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.6 2.2 1.5 1.2 8.4 1.9 8.2 0.1 0.4 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 1.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ST8SIA3 SIAT8C ENSG00000177511 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3" O43173 18 57352557-57371731 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 21.7;pituitary gland: 8.1;retina: 7.5" "Group enriched" "Detected in some" 8 "Bipolar cells: 29.9;Excitatory neurons: 74.9;Horizontal cells: 63.9;Inhibitory neurons: 56.7;Oligodendrocyte precursor cells: 22.1" "Group enriched" "Detected in some" 11 "glioma: 0.9;pancreatic cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 26 "NTERA-2: 4.4;SCLC-21H: 8.6;SH-SY5Y: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063398, HPA066783" Enhanced Supported "Golgi apparatus" No NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA063398: AB_2685004, HPA066783: AB_2685721" "unprognostic (1.75e-1)" "unprognostic (7.85e-2)" "unprognostic (1.41e-2)" "unprognostic (5.50e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.82e-1)" 0.0 4.3 8.0 0.0 21.7 0.0 0.0 6.7 15.6 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.9 0.0 12.5 14.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 8.1 0.0 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 9.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 21.7 6.7 15.6 12.5 14.5 0.0 0.0 0.0 0.0 2.1 4.9 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 1.6 5.7 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.0 74.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 63.9 56.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 4.7 0.0 1.2 0.0 22.1 3.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 2.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STX12 "STX13, STX14" ENSG00000117758 "Syntaxin 12" Q86Y82 1 27773219-27824443 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041038, HPA055300" Approved Enhanced "Nucleoplasm,Golgi apparatus,Vesicles" No No "Cluster 51: Monocytes - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA041038: AB_10794261, HPA055300: AB_2682778" "unprognostic (3.47e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-1)" "unprognostic (8.16e-3)" "unprognostic (2.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.26e-2)" "unprognostic (3.52e-1)" "unprognostic (1.14e-2)" "unprognostic (2.78e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-1)" "unprognostic (1.91e-2)" "unprognostic (8.43e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "unprognostic (2.24e-1)" 64.2 30.1 38.1 26.6 39.0 10.8 37.0 40.8 45.6 28.8 25.4 30.7 36.3 30.9 62.9 39.2 23.9 39.8 20.9 37.3 41.7 35.2 29.1 50.0 25.6 42.0 45.3 22.1 30.3 46.5 26.6 33.3 43.6 30.7 32.5 43.2 26.9 32.1 21.4 27.0 32.8 35.9 42.2 30.5 65.5 13.4 38.4 17.3 94.7 27.1 22.2 39.1 23.4 44.6 23.2 10.9 28.8 19.0 53.9 65.0 14.8 47.9 70.3 43.1 48.5 13.5 29.5 25.2 49.6 64.6 18.5 19.0 19.2 23.9 42.9 22.2 22.8 14.4 12.0 13.7 42.2 16.1 29.0 61.3 28.7 60.6 34.5 35.3 70.3 14.3 19.1 24.6 47.7 8.5 13.7 12.3 12.1 34.3 15.3 8.7 23.1 15.5 38.1 37.5 32.3 17.6 22.4 19.3 35.2 23.3 13.1 14.0 76.2 21.9 12.5 50.0 16.6 14.5 11.2 14.3 35.1 24.1 31.2 24.6 35.7 13.7 6.1 39.4 10.6 13.6 7.3 9.7 25.2 10.8 8.1 6.8 16.5 9.2 40.6 12.4 7.9 17.4 38.1 39.0 40.8 45.6 37.3 41.7 42.0 45.3 43.6 42.2 38.4 44.6 93.0 54.5 36.3 25.1 43.6 109.4 97.2 30.7 51.2 46.2 42.0 25.7 18.9 30.0 40.8 57.0 31.3 30.0 28.3 82.8 37.2 51.9 2.0 34.7 33.1 71.1 41.3 17.7 70.9 58.4 33.5 53.2 108.6 49.4 22.8 26.7 47.8 20.4 50.6 26.9 65.7 29.5 14.2 91.4 77.7 4.2 36.1 62.3 53.4 56.2 41.3 67.9 36.0 34.7 59.1 68.4 58.6 47.4 33.9 74.9 51.3 69.7 27.4 51.2 39.5 45.7 57.5 20.0 20.1 69.9 99.2 78.0 31.6 54.0 29.9 99.9 SYDE2 FLJ13815 ENSG00000097096 "Synapse defective Rho GTPase homolog 2" Q5VT97 1 85156889-85201016 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 51.3;Cone photoreceptor cells: 54.2;Rod photoreceptor cells: 145.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 14.6;SK-BR-3: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027138, HPA058378" Uncertain Approved "Nucleoli,Nucleoli rim,Golgi apparatus" No No "Cluster 77: Retina - Visual perception" "Cluster 28: BEWO - Transcription regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoli, Nucleoli rim, Golgi apparatus" "HPA027138: AB_1857686, HPA058378: AB_2683696" "unprognostic (1.68e-1)" "unprognostic (8.90e-2)" "unprognostic (2.34e-2)" "unprognostic (3.43e-3)" "unprognostic (2.50e-1)" "unprognostic (6.98e-2)" "unprognostic (3.84e-3)" "unprognostic (6.47e-3)" "unprognostic (4.39e-2)" "unprognostic (1.85e-1)" "unprognostic (3.88e-2)" "unprognostic (4.05e-1)" "unprognostic (2.96e-3)" "unprognostic (1.57e-1)" "unprognostic (8.76e-2)" "unprognostic (7.51e-2)" "unprognostic (6.69e-2)" 1.1 0.6 0.8 0.9 0.6 0.5 2.0 0.1 1.2 0.8 4.2 4.5 1.5 1.5 0.7 1.1 0.8 2.2 3.2 1.8 0.5 2.5 3.6 3.3 0.3 0.6 0.6 1.6 1.8 4.3 0.7 2.6 0.3 1.3 1.4 7.6 1.9 1.3 0.4 0.7 1.5 2.2 0.6 0.5 1.8 1.6 0.8 0.4 2.5 1.6 0.3 1.9 0.6 0.3 2.1 0.6 0.6 0.8 2.2 0.6 14.6 2.3 1.4 1.4 2.1 4.0 0.7 0.0 0.8 1.5 2.7 3.9 7.3 1.0 2.1 0.9 2.0 1.9 1.7 1.4 2.6 1.2 0.4 1.0 1.2 1.0 0.9 0.9 0.3 1.3 2.4 0.0 1.0 2.9 1.2 0.2 3.7 1.6 0.9 0.0 3.9 0.5 1.0 5.2 0.1 0.0 1.6 8.0 2.4 3.3 1.8 1.6 0.3 1.7 3.8 0.0 2.3 0.0 0.3 0.8 0.2 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.1 1.2 1.8 0.5 0.6 0.6 0.3 0.6 0.8 0.3 3.1 51.3 12.4 9.4 1.1 8.3 8.0 1.7 8.0 6.8 10.0 6.5 24.4 4.3 6.9 1.8 54.2 10.8 0.5 2.5 7.9 1.9 3.1 11.0 2.9 2.1 19.2 3.0 12.6 4.7 4.7 7.8 3.6 5.2 1.3 4.4 3.6 8.4 1.5 0.0 5.2 4.1 2.0 0.3 4.0 1.6 2.1 0.7 19.6 1.9 1.7 9.4 1.0 5.5 0.2 3.6 1.3 2.6 0.7 6.9 8.1 5.8 14.0 145.4 0.0 6.3 5.2 16.6 9.0 8.5 4.5 2.6 3.3 6.6 4.5 4.5 SYNGR4 ENSG00000105467 "Synaptogyrin 4" O95473 19 48364367-48376377 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 54.4" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 159.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A549: 9.8;SCLC-21H: 24.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030075, HPA059286" Enhanced Approved "Golgi apparatus" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Golgi apparatus" "HPA030075: AB_10610559, HPA059286: AB_2683965" "unprognostic (1.58e-2)" "unprognostic (3.44e-2)" "unprognostic (3.18e-2)" "unprognostic (9.49e-4)" "unprognostic (2.51e-2)" "unprognostic (7.10e-2)" "unprognostic (2.52e-3)" "unprognostic (3.72e-3)" "unprognostic (2.87e-2)" "unprognostic (6.19e-2)" "unprognostic (6.69e-2)" "unprognostic (2.41e-2)" "unprognostic (2.02e-7)" "unprognostic (1.06e-2)" "unprognostic (1.74e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" 0.0 0.0 0.4 0.0 0.4 0.1 0.0 3.0 1.0 0.1 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.6 0.0 0.1 0.0 0.0 0.4 0.5 0.0 1.0 3.9 0.3 0.0 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.0 0.0 54.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 9.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.6 0.2 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.5 3.2 0.5 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.1 3.6 0.1 0.3 0.5 0.2 0.0 0.7 1.8 0.7 0.0 2.8 0.0 0.0 24.1 0.6 0.1 0.4 0.0 0.0 0.4 0.1 0.1 0.0 0.8 0.0 0.0 3.2 1.1 0.8 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 3.0 1.0 0.8 0.6 0.4 0.5 0.4 0.4 0.4 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 32.6 0.0 0.1 0.1 9.1 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.0 0.0 0.0 24.6 0.9 0.1 0.0 1.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 6.6 0.0 0.0 159.5 33.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 TBC1D14 KIAA1322 ENSG00000132405 "TBC1 domain family member 14" Q9P2M4 4 6909242-7033118 "Plasma proteins, Predicted intracellular proteins" Autophagy "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 197.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036930, HPA067398" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Yes No "Cluster 9: Neutrophils - Innate immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 3: HMC-1 - Innate immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" Nucleoplasm "HPA036930: AB_10670155, HPA067398: AB_2685833" "unprognostic (3.05e-2)" "unprognostic (7.48e-3)" "unprognostic (4.80e-3)" "unprognostic (8.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.78e-3)" "unprognostic (9.63e-2)" "unprognostic (5.25e-2)" "unprognostic (9.71e-2)" "unprognostic (7.65e-2)" "unprognostic (1.80e-1)" "unprognostic (2.90e-1)" "prognostic favorable (5.28e-10)" "unprognostic (1.56e-1)" "unprognostic (3.50e-1)" "unprognostic (5.13e-3)" "unprognostic (4.12e-2)" 26.3 42.1 42.7 31.5 41.9 15.9 27.6 38.7 43.9 19.4 50.2 26.4 22.8 20.9 22.9 34.0 23.5 17.0 30.4 42.9 44.9 44.5 27.4 24.4 29.8 49.3 45.6 28.7 19.5 41.9 27.1 23.8 44.8 24.5 26.3 18.5 31.7 20.2 51.6 49.5 26.0 22.9 45.7 34.9 58.5 30.0 48.7 40.1 19.2 41.3 26.9 19.8 22.2 44.2 34.5 36.8 40.4 45.5 32.8 27.4 24.5 27.0 29.3 24.7 21.1 38.3 69.8 54.9 15.6 32.5 62.8 24.5 68.4 61.7 30.0 15.5 22.2 91.8 23.8 40.4 22.7 42.0 197.9 21.3 85.8 23.4 38.3 31.5 23.5 51.2 88.6 19.3 30.2 22.3 64.9 42.5 54.9 41.1 40.8 80.2 53.2 59.9 36.8 23.9 61.6 44.0 22.4 24.1 84.3 31.2 33.3 39.4 23.7 27.2 20.5 24.0 40.3 36.7 91.6 55.7 25.4 53.2 26.6 2.6 13.2 5.6 8.6 8.2 13.1 8.1 9.3 9.3 10.7 8.3 6.9 6.6 40.6 8.6 3.9 11.5 11.9 10.8 42.7 41.9 38.7 43.9 42.9 44.9 49.3 45.6 44.8 45.7 48.7 44.2 8.4 6.4 17.7 22.5 15.5 9.1 7.0 15.8 15.9 10.2 21.1 16.3 4.6 10.0 14.8 14.7 14.6 12.5 16.3 17.7 19.6 11.5 68.0 12.3 10.3 7.8 6.6 7.2 25.6 10.2 7.1 9.5 14.8 11.9 7.6 18.9 8.2 24.4 26.0 25.2 25.1 15.7 10.2 33.6 8.7 41.0 7.2 27.8 19.6 27.2 24.4 13.4 16.5 51.8 27.0 11.8 14.2 8.6 15.4 12.9 12.8 19.8 10.7 6.6 0.0 12.7 7.1 17.7 18.0 19.8 11.9 16.4 16.3 12.5 19.9 10.1 TEDC1 C14orf80 ENSG00000185347 "Tubulin epsilon and delta complex 1" Q86SX3 14 105489855-105499575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 11.6;Endometrial ciliated cells: 12.0;Exocrine glandular cells: 12.7;Extravillous trophoblasts: 26.6;Hofbauer cells: 14.6;monocytes: 11.9;Pancreatic endocrine cells: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 66.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA039049, HPA039050" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 6: Brain - Smell perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039049: AB_2676320, HPA039050: AB_10670918" "unprognostic (8.06e-2)" "unprognostic (1.06e-2)" "unprognostic (9.17e-2)" "unprognostic (1.65e-1)" "unprognostic (3.06e-1)" "unprognostic (1.57e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (5.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-3)" "unprognostic (8.73e-3)" "unprognostic (2.88e-1)" "unprognostic (1.17e-1)" "unprognostic (6.18e-3)" 5.1 1.6 5.2 4.9 5.5 6.8 4.7 4.1 7.8 4.3 0.5 5.5 5.1 3.8 1.0 6.8 4.6 1.8 4.3 5.8 3.0 4.0 5.4 4.9 5.4 7.0 3.5 2.5 3.0 1.0 5.3 1.6 4.2 4.2 1.6 0.5 4.3 2.3 2.3 8.2 5.4 1.0 3.1 6.8 5.9 4.9 3.6 4.5 5.7 0.5 3.1 3.9 4.5 5.3 17.2 38.9 9.2 13.5 0.8 1.5 24.5 13.4 5.0 15.9 14.7 14.0 31.2 25.6 27.2 2.2 6.2 43.5 3.2 14.0 3.0 29.0 16.0 6.5 22.8 13.3 0.6 12.9 17.9 0.3 4.6 10.6 3.5 2.0 6.4 23.2 10.5 31.2 2.5 66.7 26.9 29.6 11.9 14.6 41.8 21.9 13.8 17.9 4.5 14.3 25.7 15.5 13.7 15.8 9.8 2.0 26.0 12.6 7.8 10.9 18.4 33.4 22.4 17.8 8.2 15.7 13.9 14.8 18.0 0.0 0.5 0.6 0.5 0.9 0.4 0.1 0.8 1.4 0.7 0.3 0.6 0.1 0.1 0.0 0.8 2.4 0.6 0.2 5.2 5.5 4.1 7.8 5.8 3.0 7.0 3.5 4.2 3.1 3.6 5.3 4.8 3.2 2.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 5.9 5.3 0.0 0.0 0.6 1.8 0.0 8.0 10.1 0.0 3.9 11.6 0.0 12.0 3.0 4.0 0.0 0.0 0.0 12.7 26.6 3.4 0.0 7.2 0.0 8.1 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 11.9 0.0 0.0 0.0 0.0 14.7 0.0 0.0 4.7 0.0 0.0 2.0 3.6 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 4.0 4.2 2.5 0.0 0.0 TENT4A "LAK-1, PAPD7, POLK, POLS, TRF4, TRF4-1" ENSG00000112941 "Terminal nucleotidyltransferase 4A" Q5XG87 5 6713432-6757044 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 19.3;Breast glandular cells: 13.4;Breast myoepithelial cells: 13.2;dendritic cells: 12.3;Endometrial stromal cells: 15.4;Glandular and luminal cells: 14.0;Granulosa cells: 14.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045487, HPA046742" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 20: HeLa - Mitochondria" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA045487: AB_2679346, HPA046742: AB_2679781" "unprognostic (1.45e-1)" "unprognostic (2.96e-1)" "unprognostic (2.08e-2)" "unprognostic (2.12e-3)" "unprognostic (7.57e-2)" "unprognostic (1.30e-2)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (2.62e-1)" "unprognostic (9.78e-2)" "unprognostic (3.10e-3)" "unprognostic (3.73e-2)" "prognostic unfavorable (7.99e-5)" "unprognostic (6.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.60e-2)" "prognostic favorable (8.55e-4)" 13.1 8.1 8.4 9.5 8.6 27.6 11.0 16.6 10.1 12.5 5.7 10.0 8.7 11.1 6.4 10.7 11.5 10.0 8.5 8.7 8.1 9.6 20.5 12.8 13.0 6.5 6.5 15.6 12.0 10.0 11.1 9.1 7.0 11.1 7.2 12.5 8.2 8.8 9.3 15.7 12.4 12.2 6.0 13.7 9.6 10.1 7.9 14.6 10.2 12.1 10.4 10.1 11.8 8.9 31.7 20.9 25.4 31.6 17.7 15.6 37.0 21.0 25.7 25.1 28.2 21.9 17.3 23.1 16.1 25.5 28.5 22.9 20.7 16.4 23.1 26.1 14.0 12.0 72.5 12.4 11.0 18.0 17.3 10.7 13.8 28.7 18.4 18.6 15.0 16.9 16.3 29.8 20.8 17.6 24.4 25.3 13.6 9.7 16.6 21.8 21.2 6.0 10.5 17.5 25.1 19.3 50.7 24.1 14.5 13.4 14.5 9.9 13.6 30.6 32.7 27.2 29.8 28.6 12.6 20.4 19.6 16.4 19.2 0.0 0.2 0.2 0.6 0.1 0.6 0.5 0.4 0.4 0.3 0.4 0.5 0.5 0.1 0.1 0.2 1.1 0.6 0.2 8.4 8.6 16.6 10.1 8.7 8.1 6.5 6.5 7.0 6.0 7.9 8.9 19.3 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 13.4 13.2 0.0 0.0 0.0 5.5 0.0 5.3 12.3 0.0 1.9 4.9 0.0 10.7 15.4 4.8 0.0 0.0 0.0 4.4 4.0 4.0 0.0 14.0 0.0 14.5 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 4.2 0.0 0.0 0.0 0.0 6.6 0.0 0.0 8.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 5.6 4.8 10.7 0.0 0.0 TFR2 "HFE3, TFRC2" ENSG00000106327 "Transferrin receptor 2" Q9UP52 7 100620416-100642779 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters" Receptor "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "liver: 346.1" "Group enriched" "Detected in some" 13 "Erythroid cells: 152.8;Hepatocytes: 455.7" "Cancer enriched" "Detected in many" 70 "liver cancer: 136.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "basophil: 2.5;eosinophil: 1.9" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.5" "Group enriched" "Detected in some" 11 "HEL: 69.7;HMC-1: 92.7;K-562: 65.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB016255, HPA017171, HPA073125" Enhanced Approved "Golgi apparatus" NA NA 410000 "Cluster 46: Basophils - DNA binding" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 1: K-562 - Erythropoiesis" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "CAB016255: AB_628395, HPA017171: , HPA073125: " "unprognostic (4.18e-2)" "unprognostic (1.97e-2)" "unprognostic (2.74e-1)" "unprognostic (1.04e-1)" "unprognostic (1.26e-2)" "unprognostic (4.13e-2)" "prognostic favorable (2.48e-4)" "unprognostic (2.29e-2)" "unprognostic (4.49e-2)" "unprognostic (9.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.90e-1)" "unprognostic (1.18e-9)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" "unprognostic (3.28e-1)" "unprognostic (8.18e-2)" 0.0 0.1 0.0 0.0 0.0 22.5 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 346.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.7 0.0 7.2 0.0 1.6 92.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 65.8 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 2.1 0.3 0.9 0.4 0.0 8.5 0.3 0.6 1.2 10.0 0.8 0.0 8.4 0.1 1.7 0.1 0.0 0.4 5.8 0.1 0.6 1.2 0.0 152.8 5.4 0.2 1.1 0.5 1.5 0.2 0.0 0.2 7.1 455.7 0.3 21.9 5.4 0.3 0.0 8.6 1.7 8.4 0.0 0.4 0.0 1.0 0.2 0.4 6.2 1.5 0.7 0.1 0.1 0.0 0.4 0.6 0.1 0.1 0.3 1.9 0.0 0.4 0.7 0.7 2.9 0.2 0.6 0.1 2.6 0.1 0.6 0.5 THAP10 ENSG00000129028 "THAP domain containing 10" Q9P2Z0 15 70881342-70892433 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 17.5;Early spermatids: 12.6;Spermatocytes: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "non-classical monocyte: 4.2" "Lineage enriched" "Detected in single" 7 "monocytes: 4.2" "Cell line enhanced" "Detected in many" "U-2197: 40.4" "HPA041416, HPA073220" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 18: U-2197 - ECM organization" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm "Golgi apparatus, Cytosol" "HPA041416: AB_10795592, HPA073220: " "unprognostic (1.00e-1)" "unprognostic (3.51e-1)" "unprognostic (5.42e-2)" "unprognostic (2.43e-2)" "unprognostic (1.34e-1)" "unprognostic (6.15e-2)" "unprognostic (6.25e-2)" "unprognostic (2.16e-2)" "unprognostic (2.99e-2)" "unprognostic (6.47e-2)" "unprognostic (1.55e-3)" "unprognostic (3.71e-2)" "prognostic favorable (3.05e-5)" "unprognostic (1.25e-2)" "unprognostic (2.12e-2)" "unprognostic (7.46e-2)" "unprognostic (9.44e-3)" 1.7 2.2 4.6 1.3 5.2 0.1 1.9 6.1 7.3 2.4 2.4 2.2 2.3 2.1 1.8 1.9 3.2 1.5 4.7 3.9 5.2 3.0 2.1 1.8 1.0 5.1 5.4 3.7 1.9 5.1 1.7 1.8 5.2 3.0 1.9 10.8 1.8 3.1 2.3 1.3 1.2 2.0 5.0 0.9 2.9 3.4 6.3 0.9 3.6 2.3 0.9 2.6 1.4 5.9 7.3 12.6 7.7 9.8 4.1 5.0 0.1 13.5 6.1 11.4 13.5 2.0 9.5 0.0 8.2 3.8 14.3 11.3 16.2 3.7 10.2 0.0 8.3 2.6 6.2 0.9 2.0 0.7 5.2 1.6 5.1 6.5 6.2 7.9 5.8 0.0 0.9 0.0 8.3 5.7 0.0 2.9 11.2 5.2 5.3 0.0 9.9 0.3 5.1 5.9 8.6 8.9 9.3 3.9 6.5 7.5 4.6 6.3 4.3 7.9 5.6 40.4 9.6 3.4 4.3 0.0 5.0 0.9 11.6 0.0 0.3 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.6 0.1 0.0 0.1 0.0 0.4 4.2 0.0 0.2 0.1 4.6 5.2 6.1 7.3 3.9 5.2 5.1 5.4 5.2 5.0 6.3 5.9 3.5 0.0 0.5 0.0 0.5 1.8 4.1 2.4 1.2 17.5 2.0 2.0 6.1 1.5 2.0 11.0 0.0 0.2 0.0 2.5 9.8 3.0 12.6 5.5 1.9 2.7 3.0 0.4 3.0 1.1 0.3 2.4 1.1 1.1 0.0 2.1 1.4 1.8 1.3 1.7 4.0 1.5 8.2 0.6 1.0 7.8 2.5 0.7 0.0 0.0 0.1 5.2 0.0 1.0 4.7 0.8 5.3 4.9 1.2 2.2 0.6 6.8 5.4 4.6 0.0 1.5 2.9 19.3 2.7 2.6 1.4 0.1 0.2 1.8 2.9 4.2 TMEM123 "KCT3, PORIMIN" ENSG00000152558 "Transmembrane protein 123" Q8N131 11 102396332-102470384 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 988.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026001, HPA062862" Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 32: Non-specific - Translation" "Golgi apparatus" "Vesicles, Cytosol" "CAB026001: , HPA062862: AB_2732691" "unprognostic (2.64e-1)" "unprognostic (8.39e-2)" "unprognostic (4.18e-3)" "unprognostic (1.40e-1)" "unprognostic (7.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.91e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.36e-4)" "unprognostic (3.08e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.67e-1)" "unprognostic (1.38e-2)" "unprognostic (8.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-2)" "unprognostic (3.65e-2)" 56.0 80.2 53.0 120.2 60.3 225.1 153.3 56.7 68.2 114.9 67.0 120.0 63.5 174.7 47.8 100.1 91.7 99.6 71.2 48.0 61.0 93.2 393.7 119.2 196.4 71.2 68.6 86.8 82.5 70.7 15.8 98.5 65.1 105.2 97.1 9.2 224.0 104.1 20.4 95.6 78.8 130.6 61.3 111.2 125.5 73.3 61.5 238.6 312.3 49.7 142.9 146.8 70.7 89.8 220.5 195.8 186.9 174.8 233.5 185.6 135.8 169.7 352.0 324.4 358.1 247.9 988.1 370.2 423.9 387.9 234.5 228.3 212.3 272.9 339.4 228.4 82.5 192.0 67.8 352.3 207.5 404.1 137.4 219.1 280.7 240.1 352.3 433.9 361.8 187.8 134.3 0.9 257.7 71.8 353.0 135.4 115.8 340.3 181.1 214.7 532.0 359.3 291.3 207.9 90.7 110.5 201.8 267.6 109.9 197.2 161.3 154.0 451.9 211.3 249.4 190.5 126.6 139.4 84.3 366.6 62.0 432.7 143.2 159.7 113.3 207.0 102.6 121.8 155.3 70.1 158.8 123.8 126.1 95.3 208.6 181.7 72.4 223.9 111.0 33.7 183.8 248.7 53.0 60.3 56.7 68.2 48.0 61.0 71.2 68.6 65.1 61.3 61.5 89.8 93.3 125.0 78.1 33.0 179.3 160.3 257.1 307.3 157.6 0.7 144.9 118.4 53.9 143.0 202.8 163.7 0.0 45.8 91.8 48.2 80.3 153.7 41.3 141.1 47.6 140.0 90.5 68.3 1.0 118.8 41.1 82.2 88.2 161.4 58.9 126.6 271.3 317.6 107.1 1.7 2.2 163.1 160.7 249.6 419.9 23.6 94.1 189.8 161.9 63.7 229.4 4.7 83.4 25.6 114.0 127.8 55.1 93.3 117.8 324.2 31.0 52.9 257.0 1.1 65.7 181.9 80.2 23.1 74.9 146.3 177.2 30.4 164.8 109.4 146.3 270.2 TMEM53 "FLJ22353, NET4" ENSG00000126106 "Transmembrane protein 53" Q6P2H8 1 44635238-44674481 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 59.5" "Cell type enriched" "Detected in many" 5 "Late spermatids: 999.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "plasmacytoid DC: 99.4" "Lineage enriched" "Detected in all" 4 "dendritic cells: 99.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021134 Approved Approved "Golgi apparatus,Focal adhesion sites" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 25: RPMI-8226 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "Focal adhesion sites" "HPA021134: AB_2205162" "unprognostic (5.28e-2)" "unprognostic (2.60e-1)" "unprognostic (5.37e-2)" "unprognostic (4.62e-2)" "unprognostic (3.93e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "unprognostic (2.88e-2)" "unprognostic (2.19e-2)" "prognostic favorable (6.96e-4)" "unprognostic (3.00e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.02e-5)" "unprognostic (1.15e-3)" "unprognostic (1.84e-2)" "unprognostic (4.07e-2)" "unprognostic (2.29e-2)" 12.8 12.0 5.7 4.4 9.2 6.7 12.1 6.8 8.3 6.8 6.3 14.2 16.4 8.9 6.8 6.0 7.0 6.2 13.9 5.7 7.2 18.3 59.5 10.5 4.0 8.5 8.5 10.6 8.3 6.3 10.1 3.9 8.5 7.2 6.9 7.1 7.2 3.3 7.6 6.6 14.6 4.2 5.8 6.3 10.1 34.9 8.8 3.3 7.9 3.7 2.1 7.5 6.1 15.4 12.9 14.7 13.0 9.6 16.6 12.5 15.6 3.8 11.1 7.2 10.5 4.7 39.9 4.1 11.8 3.6 27.4 11.5 3.6 7.8 3.8 6.5 9.2 4.7 6.0 22.7 16.5 3.7 16.6 14.8 11.9 14.4 3.1 7.9 4.0 9.1 2.0 5.1 4.3 7.7 4.5 11.2 7.6 9.9 8.5 6.8 1.8 40.0 21.6 13.4 9.0 8.7 4.1 15.7 21.3 9.3 4.8 9.9 1.7 5.3 8.8 7.5 4.7 3.7 4.7 2.3 13.6 9.6 6.3 14.1 12.9 6.3 7.3 23.1 6.3 13.9 7.4 6.3 6.6 14.8 3.5 4.5 1.4 7.8 16.2 99.4 8.1 7.6 5.7 9.2 6.8 8.3 5.7 7.2 8.5 8.5 8.5 5.8 8.8 15.4 10.9 6.4 12.0 8.1 3.5 1.7 9.5 24.2 1.8 6.9 9.0 7.6 35.5 10.0 20.4 20.2 4.2 14.5 9.5 53.1 45.0 18.6 188.3 14.0 4.6 8.5 14.4 10.1 2.9 25.7 15.5 6.9 8.2 5.7 6.3 8.6 10.0 93.0 34.3 18.5 3.6 22.6 44.7 12.6 0.7 999.9 9.0 14.0 8.8 1.9 3.8 17.1 5.2 3.0 4.8 17.5 51.3 12.4 2.6 8.9 74.3 45.9 32.8 13.8 26.3 3.7 10.6 15.6 13.2 3.9 2.3 9.3 3.7 8.3 18.0 12.7 TMPRSS11E "DESC1, TMPRSS11E2" ENSG00000087128 "Transmembrane serine protease 11E" Q9UL52 4 68447463-68497604 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "cervix: 89.5;esophagus: 220.2;salivary gland: 56.7;vagina: 156.3" "Cell type enriched" "Detected in some" 14 "Ionocytes: 476.0" "Group enriched" "Detected in many" 6 "cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.5;OE19: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043816, HPA051062" Enhanced Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "HPA043816: , HPA051062: AB_2681329" "unprognostic (2.53e-1)" "unprognostic (3.10e-1)" "unprognostic (1.84e-1)" "unprognostic (9.14e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (6.73e-4)" "unprognostic (2.22e-1)" "unprognostic (9.70e-3)" "unprognostic (2.16e-1)" "unprognostic (3.74e-2)" "unprognostic (4.03e-2)" "unprognostic (8.39e-2)" "unprognostic (1.27e-1)" "unprognostic (3.08e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 89.5 0.0 0.0 0.0 0.0 18.2 220.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 2.2 0.0 0.0 56.7 0.7 0.0 3.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 24.5 6.5 156.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 12.9 0.7 0.0 0.0 0.5 0.3 0.3 0.0 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.3 6.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 476.0 0.0 0.3 1.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.2 6.6 0.3 1.1 0.7 0.0 0.0 32.6 TSLP ENSG00000145777 "Thymic stromal lymphopoietin" Q969D9 5 111070062-111078026 "Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 11.5;urinary bladder: 12.0" "Group enriched" "Detected in many" 4 "Basal respiratory cells: 108.1;Basal squamous epithelial cells: 338.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 15.0;HHSteC: 17.1;hTCEpi: 10.3;hTEC/SVTERT24-B: 18.9;hTERT-HME1: 12.5;hTERT-RPE1: 38.6;U-87 MG: 14.1" "Not detected" "Not detected" HPA056350 Uncertain "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 38400 "Cluster 85: Liver - Metabolism" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus, Vesicles" "HPA056350: " "unprognostic (6.47e-4)" "unprognostic (3.26e-1)" "unprognostic (6.57e-2)" "unprognostic (1.93e-1)" "unprognostic (5.03e-2)" "unprognostic (7.72e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-2)" "unprognostic (5.81e-2)" "unprognostic (1.24e-1)" "unprognostic (6.15e-2)" "unprognostic (4.24e-1)" "unprognostic (1.88e-1)" "unprognostic (5.04e-2)" "unprognostic (1.95e-1)" "unprognostic (2.76e-1)" "unprognostic (1.74e-3)" 1.6 0.7 0.3 1.3 0.3 0.0 1.5 0.3 0.5 1.4 0.2 1.1 0.7 0.8 0.3 3.8 0.6 8.8 4.3 0.3 0.3 1.2 11.5 1.9 0.4 0.4 0.3 0.3 0.3 0.4 0.4 0.1 0.4 6.2 0.9 0.0 1.2 4.0 1.4 0.8 1.0 0.6 0.3 0.4 1.2 4.8 1.1 0.2 2.7 1.4 0.5 12.0 1.9 0.4 0.0 0.0 0.0 1.8 2.3 15.0 0.0 0.0 2.3 0.4 2.6 0.0 0.0 0.0 0.1 0.0 0.5 0.0 1.5 0.5 0.8 0.0 2.4 2.8 0.1 0.0 17.1 0.5 0.0 0.3 10.3 18.9 12.5 38.6 0.0 6.6 0.3 0.0 3.2 0.0 2.5 0.0 0.4 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.0 1.2 0.0 1.1 0.0 0.0 0.9 0.0 0.0 4.1 0.0 0.0 14.1 0.3 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.3 0.3 0.4 0.3 0.4 0.3 1.1 0.4 6.2 0.0 3.1 0.3 0.1 55.8 26.6 108.1 338.6 0.0 6.5 8.0 7.4 0.0 35.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 38.5 0.1 0.9 10.5 0.0 0.0 0.0 0.0 0.1 10.0 0.0 0.1 0.0 0.9 7.9 9.4 0.2 0.0 0.0 0.0 24.4 1.2 5.0 26.3 0.6 0.8 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 24.7 0.2 1.6 3.5 0.0 0.0 6.9 3.8 0.4 0.9 38.0 25.1 0.0 0.8 1.9 0.1 3.1 TSPYL5 KIAA1750 ENSG00000180543 "TSPY like 5" Q86VY4 8 97273488-97277928 "Predicted intracellular proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 44.7" "Group enriched" "Detected in many" 8 "Early spermatids: 172.9;Late spermatids: 419.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "JURKAT: 34.9;K-562: 30.5;SCLC-21H: 60.8;SH-SY5Y: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031347 Enhanced Approved "Golgi apparatus,Cytosol" No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "Golgi apparatus" "HPA031347: AB_10601454" "prognostic favorable (1.21e-4)" "unprognostic (5.13e-2)" "unprognostic (4.90e-2)" "unprognostic (1.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.06e-1)" "unprognostic (1.01e-1)" "unprognostic (1.65e-1)" "unprognostic (1.64e-1)" "unprognostic (3.46e-2)" "unprognostic (1.25e-2)" "unprognostic (1.44e-1)" "prognostic favorable (1.40e-5)" "unprognostic (3.01e-2)" "unprognostic (1.74e-1)" "unprognostic (8.31e-2)" "unprognostic (3.13e-1)" 6.0 8.6 11.1 4.3 12.6 1.2 12.1 6.7 11.4 11.4 0.8 9.7 1.8 15.2 15.5 4.5 12.4 6.6 12.4 10.0 17.6 10.0 1.7 7.2 6.2 10.3 8.6 25.2 8.7 8.1 11.8 4.3 12.5 15.3 3.2 11.3 9.7 18.3 12.9 4.1 4.1 14.3 7.6 7.3 8.4 44.7 14.4 7.4 8.3 10.5 7.3 9.7 4.6 8.7 0.0 15.9 0.0 0.0 0.4 0.4 0.1 12.4 0.0 12.2 7.9 0.0 0.5 0.0 16.8 14.8 0.0 4.4 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 19.4 0.0 17.2 0.0 0.0 0.2 34.9 30.5 0.0 0.5 23.4 0.0 0.0 0.0 0.0 0.2 23.1 0.0 0.1 10.2 0.1 60.8 47.1 0.0 4.1 0.0 8.2 0.0 1.9 0.0 0.0 26.2 0.1 0.0 14.4 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.3 0.2 0.1 0.0 0.2 0.0 0.5 0.2 0.0 11.1 12.6 6.7 11.4 10.0 17.6 10.3 8.6 12.5 7.6 14.4 8.7 7.5 6.4 4.1 0.0 5.5 2.3 4.5 0.7 6.8 12.5 9.9 8.8 16.3 2.8 2.1 9.2 20.9 0.2 2.6 0.0 5.9 5.8 172.9 6.4 13.7 9.8 2.4 3.4 0.0 3.5 0.1 12.1 10.2 2.6 0.0 19.2 6.4 0.8 6.3 8.4 0.0 0.3 2.0 5.0 5.9 419.0 24.5 4.6 7.2 0.0 2.2 13.1 0.0 0.0 0.0 3.7 0.0 21.1 0.8 7.8 0.0 1.4 4.1 12.2 6.6 12.4 9.3 35.5 31.0 5.6 1.6 0.1 1.3 9.9 0.3 4.1 TYMP "ECGF1, MNGIE" ENSG00000025708 "Thymidine phosphorylase" P19971 22 50525752-50530032 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Glycosyltransferase, Growth factor, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 643.9;Hofbauer cells: 477.4;Macrophages: 561.7;monocytes: 2174.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 135.8;eosinophil: 74.9;intermediate monocyte: 98.4;myeloid DC: 39.5;neutrophil: 114.1;non-classical monocyte: 77.1" "Group enriched" "Detected in all" 10 "dendritic cells: 39.5;granulocytes: 114.1;monocytes: 135.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 40.0;HHSteC: 95.2;Karpas-707: 68.6;U-266/70: 68.6" "Not detected" "Not detected" "HPA000530, HPA001072, CAB002518" Enhanced Approved "Nuclear bodies,Golgi apparatus,Cytosol" NA NA 11000000 "Cluster 52: Eosinophils - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 3: Monocytes - Immune response regulation" "Nuclear bodies, Golgi apparatus" Cytosol "CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274" "unprognostic (7.02e-3)" "unprognostic (1.00e-1)" "unprognostic (3.61e-1)" "prognostic favorable (4.34e-5)" "unprognostic (7.60e-2)" "unprognostic (1.16e-2)" "unprognostic (2.40e-1)" "unprognostic (7.17e-2)" "unprognostic (4.64e-2)" "unprognostic (1.33e-1)" "unprognostic (3.31e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (3.50e-8)" "unprognostic (1.32e-1)" "unprognostic (4.02e-2)" "unprognostic (1.52e-2)" "unprognostic (4.60e-2)" 46.8 19.5 6.1 77.7 6.0 22.0 37.9 7.1 7.9 32.2 12.7 20.4 26.1 7.8 0.5 58.5 30.0 7.2 26.7 6.4 8.6 38.2 82.0 63.4 31.5 22.1 18.3 4.0 13.8 4.5 8.8 15.4 15.9 21.0 3.6 0.0 40.0 5.6 10.7 24.5 32.5 9.1 10.9 86.1 31.2 3.0 18.0 15.6 25.4 1.6 15.3 22.9 27.0 12.2 27.0 2.5 0.4 0.8 1.8 2.2 5.1 3.7 0.5 6.1 17.4 0.1 40.0 1.8 4.1 5.8 1.3 21.0 0.2 1.0 0.0 9.0 16.5 1.8 3.9 3.5 95.2 1.3 26.9 4.7 4.6 5.4 0.0 0.1 0.1 0.5 2.8 68.6 0.9 1.9 1.5 9.9 0.6 1.9 9.1 5.7 0.4 35.1 0.3 1.2 0.7 5.6 22.9 17.3 6.5 0.2 4.2 13.8 6.7 0.8 4.7 1.5 1.5 68.6 15.9 5.7 1.9 1.5 1.6 19.5 135.8 74.9 2.0 98.4 1.2 6.7 2.9 1.2 39.5 6.9 1.6 1.3 114.1 9.5 77.1 9.3 3.1 10.1 6.1 6.0 7.1 7.9 6.4 8.6 22.1 18.3 15.9 10.9 18.0 12.2 122.6 12.8 29.0 0.3 122.9 58.5 57.4 169.9 53.5 3.4 101.5 90.8 3.2 50.1 88.6 33.1 4.2 17.2 65.8 154.8 29.4 340.2 2.2 55.7 56.0 55.7 16.8 19.6 0.3 643.9 300.8 81.9 38.7 59.2 53.4 3.0 38.2 93.0 477.4 0.0 0.4 50.2 24.4 371.8 409.4 8.7 5.0 561.7 113.8 4.7 2174.6 2.9 71.1 0.5 0.2 364.0 86.4 1.9 102.1 109.8 214.5 105.1 78.0 6.6 26.3 93.3 62.4 1.5 8.0 71.7 56.7 33.5 62.5 3.7 51.1 76.0 UGT3A2 ENSG00000168671 "UDP glycosyltransferase family 3 member A2" Q3SY77 5 36035021-36071358 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.5;lymphoid tissue: 14.7;skin 1: 10.3" "Group enriched" "Detected in some" 4 "Collecting duct cells: 3.7;Early spermatids: 4.4;Late spermatids: 8.2;Proximal tubular cells: 3.8" "Cancer enriched" "Detected in some" 5 "testis cancer: 4.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 6.8;JURKAT: 6.3;MOLT-4: 12.4;REH: 29.9;SuSa: 11.8;T-47d: 7.2;THP-1: 18.0" "Low region specificity" "Detected in many" HPA059475 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 14: REH - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "Golgi apparatus, Cytosol" "HPA059475: AB_2684031" "unprognostic (1.83e-4)" "unprognostic (9.94e-2)" "unprognostic (8.87e-2)" "unprognostic (4.82e-4)" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (1.56e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.36e-3)" "unprognostic (6.65e-2)" "unprognostic (7.52e-2)" "unprognostic (7.38e-2)" "unprognostic (4.52e-3)" 0.0 0.8 0.0 0.0 0.0 6.5 1.1 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 2.6 0.6 0.0 0.0 1.0 1.1 0.0 0.0 0.1 0.9 0.2 1.2 0.4 0.0 0.1 0.1 0.0 0.1 10.3 0.0 0.0 0.1 1.2 0.1 2.9 0.6 14.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.8 0.0 0.1 0.0 0.0 0.3 0.4 0.0 1.3 0.0 0.5 6.8 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 12.4 0.0 5.3 0.0 0.0 29.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 7.2 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 1.0 1.1 1.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 3.7 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 1.1 8.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 VGF "SCG7, SgVII" ENSG00000128564 "VGF nerve growth factor inducible" O15240 7 101162509-101165569 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 1407.4" "Group enriched" "Detected in many" 4 "Enteroendocrine cells: 128.3;Horizontal cells: 225.4" "Cancer enriched" "Detected in many" 6 "melanoma: 236.3" "Region enriched" "Detected in all" 6 "hypothalamus: 1407.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 172.0;SK-MEL-30: 511.5;U-2 OS: 85.9;WM-115: 141.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055177, HPA072505" Enhanced Enhanced "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 1270000 3100000 "Cluster 73: Brain - Neuropeptide signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 62: Horizontal cells - Visual perception" "Golgi apparatus, Vesicles" "HPA055177: AB_2682728, HPA072505: AB_2686528" "unprognostic (3.04e-2)" "unprognostic (3.45e-1)" "unprognostic (3.19e-3)" "prognostic unfavorable (4.25e-4)" "prognostic unfavorable (3.31e-4)" "unprognostic (1.51e-2)" "unprognostic (2.86e-2)" "unprognostic (1.66e-3)" "unprognostic (2.25e-2)" "unprognostic (8.77e-2)" "unprognostic (3.84e-3)" "unprognostic (3.70e-3)" "unprognostic (9.82e-3)" "unprognostic (3.79e-1)" "unprognostic (7.23e-2)" "unprognostic (4.36e-3)" "unprognostic (2.21e-1)" 2.1 3.1 23.7 0.8 24.8 0.1 0.1 5.5 174.6 0.0 0.0 0.5 0.1 0.7 0.0 0.0 0.0 0.0 0.1 22.7 1407.4 3.6 0.0 0.1 0.0 235.4 69.9 0.1 16.1 0.0 117.0 0.0 158.8 0.1 0.0 2.2 0.0 0.0 0.0 0.8 0.3 0.2 16.6 0.1 1.9 0.9 48.7 0.0 0.6 0.0 0.0 0.0 0.1 27.3 2.2 1.1 1.1 9.5 0.0 0.0 10.3 0.9 0.0 0.0 0.0 2.4 0.9 0.1 3.1 0.0 1.4 1.4 0.5 0.1 0.0 1.0 0.7 0.3 0.0 0.9 0.1 0.6 4.4 0.1 0.2 0.2 0.7 0.0 0.0 0.1 3.7 2.3 0.0 23.4 0.1 2.4 17.6 1.0 2.3 0.8 0.0 0.1 0.3 0.1 14.1 172.0 0.3 0.9 511.5 1.1 0.4 0.3 0.0 0.4 85.9 0.0 2.0 0.1 0.8 4.7 13.5 0.4 141.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 24.8 5.5 174.6 22.7 1407.4 235.4 69.9 158.8 16.6 48.7 27.3 1.7 0.0 0.0 3.6 0.9 1.5 1.0 0.0 1.2 22.0 0.9 0.6 2.9 0.0 0.0 0.0 0.0 1.5 1.0 1.3 29.4 0.3 0.1 0.4 0.4 0.9 128.3 0.0 22.7 0.0 8.4 0.3 3.1 0.5 0.0 1.4 0.0 0.0 0.6 225.4 37.7 4.5 0.0 0.0 0.4 0.6 0.6 0.7 0.0 11.2 0.0 2.1 0.0 4.0 4.8 5.9 2.8 0.0 0.9 4.3 2.7 1.2 0.0 5.0 0.0 0.1 0.8 0.2 4.3 0.6 2.3 1.4 0.5 5.4 2.3 0.6 VTI1B VTI2 ENSG00000100568 "Vesicle transport through interaction with t-SNAREs 1B" Q9UEU0 14 67647085-67674820 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 493.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044121, HPA048150, HPA060118" Approved Enhanced "Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA044121: AB_2678819, HPA048150: AB_2680288, HPA060118: AB_2684206" "unprognostic (2.26e-1)" "unprognostic (4.83e-2)" "unprognostic (8.09e-2)" "unprognostic (2.24e-1)" "unprognostic (3.00e-2)" "unprognostic (2.36e-3)" "unprognostic (3.25e-3)" "unprognostic (9.12e-2)" "unprognostic (1.90e-2)" "unprognostic (3.86e-1)" "unprognostic (2.60e-1)" "unprognostic (2.11e-2)" "prognostic favorable (3.53e-12)" "unprognostic (8.35e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (8.02e-3)" 53.8 26.9 55.5 20.4 56.8 22.3 39.8 54.4 102.1 22.7 49.8 42.9 28.3 18.4 53.5 44.3 18.5 28.7 60.1 56.6 58.1 53.0 41.6 26.8 23.8 55.1 56.6 21.0 44.0 23.9 17.1 21.3 56.8 22.3 35.2 23.0 30.1 13.6 46.5 31.0 24.1 22.4 56.0 26.5 40.0 30.8 56.3 12.1 34.0 28.2 27.0 33.3 23.4 56.9 111.7 54.8 31.4 18.1 61.9 37.2 45.4 48.1 30.5 23.8 23.7 27.3 38.5 32.9 40.2 54.5 27.5 30.6 36.8 36.6 37.7 34.3 22.6 33.4 32.5 34.8 26.6 20.9 22.9 36.3 39.6 25.6 26.1 60.5 27.2 23.1 22.2 25.4 34.5 131.1 26.6 77.7 20.3 76.6 88.0 31.8 35.6 12.2 35.1 65.0 17.4 35.5 33.8 45.5 71.4 23.7 41.9 58.0 38.5 62.6 93.8 51.4 45.6 23.8 27.8 53.2 52.9 38.9 29.0 88.8 61.5 143.8 49.4 80.4 42.4 49.0 43.1 51.1 59.6 43.0 40.5 50.3 27.2 56.4 70.2 38.6 60.2 58.3 55.5 56.8 54.4 102.1 56.6 58.1 55.1 56.6 56.8 56.0 56.3 56.9 47.6 25.6 35.0 13.1 48.7 42.3 61.4 91.7 33.0 23.2 82.2 65.4 30.5 67.2 64.4 66.2 22.9 107.4 47.5 138.2 217.2 109.1 141.7 58.5 43.2 51.5 46.6 102.7 15.8 131.4 167.9 51.6 40.8 49.5 64.0 43.6 73.9 95.3 131.4 15.2 18.2 96.0 50.8 99.8 49.2 493.5 41.7 80.9 71.2 11.2 121.6 65.4 78.2 13.6 17.1 130.7 119.4 39.9 51.0 120.5 165.4 268.6 55.3 44.8 19.7 36.5 58.2 104.5 57.2 58.2 52.8 125.9 46.8 35.5 91.9 124.6 WIPI1 "ATG18, ATG18A, FLJ10055, WIPI49" ENSG00000070540 "WD repeat domain, phosphoinositide interacting 1" Q5MNZ9 17 68420948-68457513 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 127.2" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 165.7;Syncytiotrophoblasts: 125.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 114.1;eosinophil: 223.6" "Lineage enriched" "Detected in all" 9 "granulocytes: 223.6" "Cell line enhanced" "Detected in many" "ASC diff: 224.3;HHSteC: 216.7;HSkMC: 180.8;SK-MEL-30: 183.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007493, CAB037230" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB037230: AB_1841265, HPA007493: AB_1848642" "unprognostic (2.83e-2)" "unprognostic (7.85e-2)" "unprognostic (1.05e-3)" "unprognostic (1.31e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-2)" "unprognostic (3.97e-3)" "unprognostic (1.78e-2)" "prognostic favorable (3.11e-4)" "unprognostic (2.86e-1)" "unprognostic (1.79e-1)" "unprognostic (3.06e-1)" "unprognostic (6.32e-3)" "unprognostic (6.56e-2)" "unprognostic (4.99e-2)" "unprognostic (1.78e-1)" "unprognostic (1.89e-3)" 31.3 18.8 11.2 14.1 11.2 26.6 30.5 12.5 15.1 33.1 19.1 36.4 12.8 15.3 14.4 14.8 12.6 23.3 78.4 10.6 12.9 33.3 18.7 26.2 8.7 12.5 12.0 11.2 29.8 25.2 17.8 62.4 12.5 17.4 38.5 8.2 55.0 18.3 127.2 21.9 14.8 18.8 11.4 12.5 29.3 9.6 15.5 5.9 21.1 97.5 16.7 22.0 14.4 11.9 4.9 9.8 8.6 12.5 224.3 167.2 49.0 36.3 163.5 13.7 43.6 7.2 7.3 3.0 16.0 74.2 47.9 3.7 3.3 22.1 23.9 4.4 4.6 34.7 3.2 42.6 216.7 2.4 48.5 180.8 39.5 54.2 72.0 44.2 61.3 5.3 2.5 82.0 41.1 29.9 0.5 7.1 1.8 12.7 15.0 0.4 30.3 35.7 20.2 16.7 2.4 11.4 7.7 103.8 183.4 44.4 54.8 9.5 61.2 65.4 10.1 31.0 8.6 78.2 92.0 10.5 98.9 16.5 29.7 114.1 18.4 223.6 11.9 22.7 5.3 4.4 3.1 11.7 9.0 1.4 0.2 5.6 39.0 10.7 24.7 6.3 2.7 15.0 11.2 11.2 12.5 15.1 10.6 12.9 12.5 12.0 12.5 11.4 15.5 11.9 26.2 9.6 11.5 12.7 13.3 7.8 11.9 45.6 0.6 15.0 24.1 8.9 7.3 28.6 48.5 16.5 2.1 44.0 18.3 30.2 31.3 31.2 6.3 26.3 19.9 17.2 12.0 56.6 9.4 57.2 165.7 41.2 25.5 40.0 7.0 12.3 33.9 11.7 35.6 10.1 8.2 67.6 44.7 18.2 14.5 5.2 46.3 37.1 42.7 20.6 34.2 10.6 20.6 6.0 12.2 28.8 20.1 42.2 83.3 55.3 8.5 71.8 49.6 15.7 26.3 10.1 24.1 5.0 5.1 3.3 6.8 125.1 13.6 27.8 28.2 36.7 YIPF2 "FinGER2, MGC3262" ENSG00000130733 "Yip1 domain family member 2" Q9BWQ6 19 10922185-10928681 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 159.1;Syncytiotrophoblasts: 174.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019902 Approved Approved "Golgi apparatus,Mitochondria" No No "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus, Mitochondria" "HPA019902: AB_1858925" "unprognostic (1.27e-1)" "unprognostic (8.56e-2)" "unprognostic (2.90e-3)" "unprognostic (8.38e-2)" "unprognostic (3.66e-1)" "unprognostic (3.96e-1)" "unprognostic (1.93e-1)" "unprognostic (7.65e-2)" "unprognostic (4.30e-2)" "unprognostic (5.62e-3)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (3.28e-2)" "unprognostic (3.92e-2)" "unprognostic (5.99e-2)" "unprognostic (2.00e-2)" 29.5 43.5 18.1 15.9 18.7 29.6 34.1 20.5 26.6 41.7 30.7 34.7 31.8 38.1 26.8 51.0 35.2 30.3 31.6 19.4 20.3 45.1 56.1 32.8 16.8 22.4 19.6 39.6 114.3 33.4 108.2 38.9 21.0 40.3 15.8 6.5 105.7 23.6 24.8 33.8 29.9 14.2 18.2 27.7 39.2 76.8 19.4 14.3 47.5 10.3 11.2 32.6 39.6 20.4 64.9 22.3 17.5 25.4 40.0 38.9 30.1 48.9 71.6 36.6 52.9 68.1 51.6 12.8 80.2 56.2 16.7 49.8 11.9 47.6 9.5 41.7 43.2 24.2 27.3 39.1 62.1 42.5 49.3 35.7 33.6 24.7 35.4 47.7 26.2 31.1 31.6 69.2 22.9 109.4 27.4 42.7 29.4 44.3 55.2 22.8 14.1 65.3 33.0 30.2 45.4 22.2 35.2 56.4 48.8 15.3 51.7 60.1 39.1 41.6 15.3 60.2 36.7 96.7 42.5 24.2 65.1 72.9 43.9 39.2 18.8 9.3 13.3 21.3 10.4 16.3 10.4 12.3 22.3 9.5 9.3 13.3 3.1 12.1 19.4 34.1 12.6 10.4 18.1 18.7 20.5 26.6 19.4 20.3 22.4 19.6 21.0 18.2 19.4 20.4 20.5 16.0 21.2 2.6 16.0 6.8 41.6 22.4 17.1 19.4 46.9 37.8 0.5 27.1 27.3 35.0 16.7 109.5 20.6 31.9 27.4 69.3 131.1 23.0 20.1 19.2 43.3 17.2 6.4 80.7 114.1 36.0 33.6 29.3 21.6 22.5 22.5 23.0 38.7 18.5 6.7 69.4 14.2 15.3 5.2 34.6 35.1 20.5 5.4 5.6 21.1 23.8 16.5 3.5 3.3 50.3 47.7 25.6 55.4 51.6 52.5 27.0 26.1 16.4 6.6 20.0 21.9 159.1 16.6 22.6 7.0 174.3 13.9 27.9 50.6 50.0 ZADH2 MGC45594 ENSG00000180011 "Zinc binding alcohol dehydrogenase domain containing 2" Q8N4Q0 18 75195113-75209139 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021468, HPA053646" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 33: Fibroblasts - ECM organization" Vesicles "Nucleoplasm, Golgi apparatus" "HPA021468: AB_1858932, HPA053646: AB_2682216" "unprognostic (3.22e-2)" "unprognostic (1.03e-2)" "unprognostic (7.14e-2)" "unprognostic (1.13e-1)" "unprognostic (4.79e-1)" "unprognostic (5.11e-3)" "unprognostic (1.15e-1)" "unprognostic (1.49e-1)" "unprognostic (3.62e-3)" "unprognostic (1.42e-1)" "unprognostic (3.05e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.02e-6)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.94e-4)" "unprognostic (2.23e-1)" 17.7 12.9 15.6 11.8 17.8 20.7 22.2 19.2 22.0 18.8 14.0 26.3 19.0 15.5 24.8 20.0 17.9 15.8 34.3 17.0 12.9 24.2 32.5 16.3 19.3 16.8 13.9 23.9 26.6 24.7 21.5 36.6 18.3 17.1 28.7 30.6 23.8 18.2 44.9 22.0 26.0 15.2 16.5 16.1 21.3 7.0 15.5 23.3 27.8 40.7 20.6 16.6 16.9 16.8 21.7 14.1 14.8 30.4 22.6 29.0 16.3 38.5 44.6 14.8 18.5 8.7 30.0 15.2 6.0 38.3 17.4 28.7 18.5 32.6 10.4 94.6 27.1 34.1 32.7 17.0 16.0 58.0 33.2 32.2 31.9 11.9 27.2 27.5 30.9 35.2 18.6 54.0 28.6 25.5 14.6 28.6 3.8 20.9 31.9 31.0 23.7 50.2 28.9 36.2 27.2 22.4 21.4 21.7 24.5 10.4 21.8 28.4 27.7 28.9 22.0 9.2 12.4 8.8 41.2 10.5 19.1 49.5 23.8 1.7 3.4 8.9 3.2 2.9 2.3 2.1 2.6 2.9 2.3 1.5 1.4 2.2 1.7 1.7 3.8 1.7 3.2 1.8 15.6 17.8 19.2 22.0 17.0 12.9 16.8 13.9 18.3 16.5 15.5 16.8 41.5 35.3 17.9 12.4 7.5 9.7 18.7 13.9 9.6 59.0 15.3 10.8 56.3 20.0 12.5 27.6 6.2 8.4 15.9 24.8 19.6 12.3 0.5 8.5 39.0 24.1 23.4 9.9 16.6 21.1 8.1 26.4 12.8 11.1 7.0 42.6 23.6 25.0 16.4 25.2 14.1 25.1 14.2 20.2 19.1 2.1 36.7 18.3 12.4 12.2 23.9 21.3 13.4 20.6 14.9 15.5 21.9 63.2 6.2 18.5 35.2 19.0 8.1 40.9 19.7 25.5 12.3 0.4 4.9 23.7 11.1 6.7 11.0 73.0 27.2 20.9 ZDHHC13 "FLJ10852, FLJ10941, HIP14L" ENSG00000177054 "Zinc finger DHHC-type palmitoyltransferase 13" Q8IUH4 11 19117099-19176422 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 120.5;Urothelial cells: 103.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 136.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016759, HPA018791" Uncertain Supported "Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Vesicles "Golgi apparatus" "HPA016759: AB_1858993, HPA018791: AB_1858992" "unprognostic (1.43e-2)" "unprognostic (4.00e-3)" "unprognostic (1.08e-1)" "unprognostic (1.11e-3)" "unprognostic (2.95e-2)" "unprognostic (1.34e-2)" "unprognostic (1.55e-2)" "unprognostic (1.57e-1)" "unprognostic (3.57e-3)" "unprognostic (3.03e-2)" "unprognostic (1.63e-1)" "unprognostic (2.16e-1)" "unprognostic (6.95e-3)" "unprognostic (1.15e-1)" "unprognostic (7.93e-2)" "unprognostic (2.17e-1)" "unprognostic (2.76e-2)" 4.8 5.7 5.2 7.8 5.2 9.7 8.9 6.6 7.1 9.3 6.6 16.9 11.2 6.7 5.1 37.2 12.9 8.7 9.1 5.4 5.7 9.2 2.2 6.1 9.6 5.5 5.0 5.3 11.2 14.9 11.7 6.2 5.8 8.2 18.2 16.1 10.2 5.4 1.6 18.8 11.3 6.1 5.3 5.7 18.5 14.4 5.0 11.7 8.7 2.9 22.4 22.4 15.4 5.2 41.6 19.3 18.0 15.5 6.3 7.2 17.3 19.4 17.8 21.3 24.4 11.7 9.7 21.1 13.1 16.3 47.9 61.3 26.0 12.8 23.3 26.4 22.6 11.1 12.6 9.7 14.6 15.2 18.5 8.3 14.7 9.0 12.5 19.9 136.8 28.9 10.7 10.3 22.1 13.5 19.6 12.2 15.1 38.7 17.6 21.3 25.0 5.0 21.9 27.0 31.3 23.0 23.2 28.0 10.7 17.3 13.2 17.6 39.6 18.9 13.2 29.2 15.8 8.7 28.5 19.2 22.6 15.5 33.6 11.6 4.7 32.7 8.5 7.9 7.8 8.7 6.6 9.6 5.9 5.5 6.2 8.3 6.0 6.3 6.4 5.6 9.4 4.6 5.2 5.2 6.6 7.1 5.4 5.7 5.5 5.0 5.8 5.3 5.0 5.2 8.1 9.6 10.7 28.7 9.6 24.2 22.3 27.2 14.2 12.0 7.5 4.8 34.1 12.8 41.3 16.5 10.4 8.7 10.6 20.1 5.9 25.1 120.5 21.5 6.6 11.3 15.6 11.6 27.2 19.2 18.8 9.2 24.5 30.8 12.0 16.2 12.8 0.9 6.1 16.8 34.9 24.7 36.7 6.8 8.3 46.6 7.8 6.2 3.6 9.4 20.8 52.8 18.6 19.6 20.9 20.4 16.4 2.2 10.4 47.4 15.5 3.5 57.0 8.8 0.0 5.4 7.4 58.1 31.7 21.3 36.2 6.3 11.4 7.7 21.4 103.0 ZDHHC7 "DHHC7, FLJ10792, FLJ20279, SERZ-B, SERZ1, ZNF370" ENSG00000153786 "Zinc finger DHHC-type palmitoyltransferase 7" Q9NXF8 16 84974175-85011535 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019215, HPA059054, HPA059642" Uncertain Supported "Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Golgi apparatus" "HPA019215: AB_2670102, HPA059054: AB_2683892, HPA059642: AB_2684093" "unprognostic (9.77e-2)" "unprognostic (2.12e-1)" "unprognostic (6.70e-2)" "unprognostic (1.09e-1)" "unprognostic (2.31e-1)" "unprognostic (8.76e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.41e-2)" "unprognostic (5.78e-2)" "unprognostic (2.21e-2)" "unprognostic (7.79e-3)" "unprognostic (8.04e-2)" "prognostic favorable (1.12e-5)" "unprognostic (1.67e-1)" "unprognostic (1.36e-2)" "unprognostic (2.45e-1)" "unprognostic (5.42e-2)" 33.0 28.1 19.0 24.7 18.8 64.2 26.8 21.4 18.6 40.0 27.1 42.5 27.1 36.8 12.8 27.6 27.7 31.2 31.2 19.1 19.8 35.4 30.0 37.2 26.5 20.1 21.0 27.7 26.9 35.5 19.6 33.4 20.3 32.8 32.4 10.3 24.1 20.0 56.5 31.8 33.5 30.0 19.1 35.4 44.7 14.1 23.5 16.1 25.5 58.4 23.5 37.4 33.1 19.6 63.8 55.0 28.5 34.5 123.1 92.3 38.9 57.4 110.8 88.4 43.7 58.3 72.4 29.1 32.7 93.5 29.0 65.6 37.1 76.1 110.9 16.4 29.7 21.0 22.0 66.5 51.5 40.0 21.2 76.7 85.4 72.5 41.5 56.0 46.1 26.7 68.9 9.7 56.8 75.8 27.0 38.1 44.3 53.2 39.5 33.6 26.2 15.7 86.4 82.5 24.2 29.8 74.3 40.9 36.1 43.0 77.6 24.0 67.9 53.1 39.9 49.8 34.3 33.5 51.0 65.5 50.1 29.1 43.0 7.5 9.7 8.3 2.1 8.2 2.6 1.4 2.0 1.7 6.3 2.2 1.5 2.2 6.4 1.4 7.2 4.3 0.5 3.6 19.0 18.8 21.4 18.6 19.1 19.8 20.1 21.0 20.3 19.1 23.5 19.6 13.3 32.1 25.2 12.1 10.8 13.3 21.5 25.4 17.1 9.2 16.2 13.2 22.5 12.8 17.9 16.5 6.2 18.5 15.7 37.7 1.9 14.1 9.7 15.5 20.1 12.2 12.6 11.6 16.4 15.6 24.9 23.0 28.5 29.1 3.8 14.3 15.0 11.6 28.1 15.2 16.2 29.4 14.2 46.8 26.7 10.9 17.4 36.2 16.0 19.7 42.9 5.9 21.6 13.6 14.7 30.0 33.9 21.1 15.2 26.2 22.1 9.5 32.6 6.7 13.1 13.7 14.9 8.3 13.0 20.1 12.8 16.1 13.4 6.8 34.7 35.3 ZNF143 "pHZ-1, SBF, STAF" ENSG00000166478 "Zinc finger protein 143" P52747 11 9460319-9528524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Sertoli cells: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003263, HPA003264, HPA074818" Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Nuclear bodies, Golgi apparatus, Vesicles" "HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715" "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (5.51e-2)" "unprognostic (9.72e-2)" "unprognostic (5.09e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.76e-5)" "unprognostic (4.87e-3)" "unprognostic (2.57e-3)" "unprognostic (9.56e-2)" "unprognostic (1.26e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.20e-3)" "unprognostic (1.92e-2)" "unprognostic (1.06e-2)" "unprognostic (7.55e-2)" 9.0 6.1 8.6 11.4 10.1 18.6 9.6 17.3 9.9 10.0 10.8 9.7 9.5 10.5 14.4 9.8 10.1 8.4 9.3 7.9 9.3 8.6 9.6 9.1 15.7 9.9 8.8 13.7 7.7 7.9 7.1 10.4 11.2 8.7 9.9 16.1 8.9 8.0 17.3 10.2 8.2 9.5 9.8 11.1 7.7 16.9 9.0 18.9 14.6 11.5 14.1 11.2 8.4 14.9 20.0 18.8 23.4 15.2 18.9 17.4 21.5 21.8 17.3 16.4 17.9 26.7 24.3 19.6 9.7 17.7 14.0 22.5 23.1 17.3 24.5 20.0 27.7 18.5 27.7 18.7 15.6 25.9 17.8 15.3 20.4 22.2 19.4 21.4 16.3 17.9 20.5 23.3 18.3 17.1 24.1 10.6 26.3 23.0 19.9 21.4 21.2 12.3 14.7 24.0 16.1 15.8 24.0 16.0 14.3 20.6 14.9 14.6 15.6 21.4 15.3 15.1 19.6 11.5 21.6 33.4 13.8 14.8 12.5 39.1 24.6 57.3 28.0 24.9 25.0 23.0 24.6 22.9 20.9 18.2 22.8 19.6 45.1 19.4 28.2 10.1 29.7 19.6 8.6 10.1 17.3 9.9 7.9 9.3 9.9 8.8 11.2 9.8 9.0 14.9 17.9 6.4 12.1 6.2 14.7 26.6 34.1 12.1 17.6 9.3 8.7 13.2 15.5 7.2 10.3 5.5 8.4 10.0 17.1 10.1 3.9 12.5 20.3 18.7 14.9 13.0 6.6 25.4 8.1 11.5 16.2 14.5 9.7 16.3 14.0 7.7 6.8 7.6 9.9 5.0 7.4 6.9 14.2 8.3 22.0 10.0 11.8 15.8 10.6 12.2 16.3 15.5 17.5 7.5 9.8 14.1 7.7 6.8 15.4 20.1 6.3 7.7 15.0 14.3 59.2 18.3 16.7 50.5 21.3 12.8 23.4 18.3 18.1 7.3 7.9 26.9 ZNF25 "FLJ31890, KOX19, Zfp9" ENSG00000175395 "Zinc finger protein 25" P17030 10 37949573-37976647 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 46.7;Inhibitory neurons: 44.6;Late spermatids: 41.9;Oligodendrocyte precursor cells: 38.2;Oligodendrocytes: 36.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030190 Uncertain Approved "Nucleoplasm,Golgi apparatus" No No "Cluster 14: Monocytes - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA030190: AB_10602687" "unprognostic (9.42e-2)" "unprognostic (6.18e-2)" "unprognostic (5.64e-2)" "unprognostic (2.93e-1)" "unprognostic (4.67e-2)" "unprognostic (1.44e-2)" "unprognostic (2.64e-2)" "unprognostic (3.85e-3)" "unprognostic (1.15e-1)" "unprognostic (5.32e-2)" "unprognostic (1.40e-3)" "unprognostic (1.45e-1)" "unprognostic (2.01e-3)" "unprognostic (1.21e-2)" "unprognostic (1.29e-1)" "unprognostic (9.30e-3)" "unprognostic (2.61e-1)" 10.2 10.1 12.3 3.5 12.5 2.6 8.2 12.5 19.1 9.7 4.1 12.3 2.2 9.9 6.1 5.4 9.2 6.1 10.0 12.5 15.9 5.7 3.0 6.4 4.8 11.9 10.9 11.1 5.4 7.6 14.3 4.7 12.4 7.3 4.4 10.6 4.6 8.9 22.3 4.8 5.3 8.9 9.8 6.5 5.8 4.7 14.6 4.6 6.0 21.5 4.3 8.8 7.1 12.6 1.6 3.0 3.3 6.7 12.1 9.2 0.6 3.6 4.9 2.8 4.2 0.5 2.3 3.1 1.0 6.4 1.0 0.4 0.9 1.5 4.5 7.3 1.6 5.0 0.0 1.0 7.7 3.3 3.1 6.5 6.6 3.1 3.6 11.1 4.9 4.0 0.4 2.3 6.9 1.0 1.1 2.6 0.6 0.6 2.2 1.2 3.7 0.6 3.3 0.6 1.2 7.6 1.2 0.2 4.7 1.2 2.9 5.3 7.1 4.3 0.8 7.1 2.2 2.8 1.4 1.3 8.2 6.3 2.9 1.3 1.5 3.4 1.6 2.5 1.7 1.0 1.4 1.3 1.9 1.3 1.8 1.5 0.2 1.0 5.2 0.3 1.2 1.2 12.3 12.5 12.5 19.1 12.5 15.9 11.9 10.9 12.4 9.8 14.6 12.6 10.0 3.2 3.2 17.9 4.8 3.4 2.5 2.5 3.4 17.3 3.8 3.6 23.6 4.3 2.9 7.3 6.2 1.2 3.5 1.0 1.9 2.0 27.9 2.4 7.0 7.6 0.0 2.1 46.7 2.5 0.5 10.6 4.1 2.7 8.2 8.2 10.4 2.9 5.7 16.8 44.6 1.2 4.1 13.2 6.8 41.9 12.2 9.5 3.6 14.0 8.1 13.7 5.2 38.2 36.7 1.8 0.3 16.1 1.5 2.6 1.3 3.1 8.1 7.1 0.0 11.4 10.4 4.4 6.4 2.4 4.0 0.3 5.2 4.8 0.8 1.3